CN101054593A - Corynebacterium glutamicum gene encoding hpr of phosphoenolpyruvate:sugar phosphotransferase system - Google Patents
Corynebacterium glutamicum gene encoding hpr of phosphoenolpyruvate:sugar phosphotransferase system Download PDFInfo
- Publication number
- CN101054593A CN101054593A CNA2007100920742A CN200710092074A CN101054593A CN 101054593 A CN101054593 A CN 101054593A CN A2007100920742 A CNA2007100920742 A CN A2007100920742A CN 200710092074 A CN200710092074 A CN 200710092074A CN 101054593 A CN101054593 A CN 101054593A
- Authority
- CN
- China
- Prior art keywords
- nucleic acid
- pts
- sequence
- protein
- corynebacterium glutamicum
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000186226 Corynebacterium glutamicum Species 0.000 title claims abstract description 297
- 108090000623 proteins and genes Proteins 0.000 title abstract description 533
- 108091000080 Phosphotransferase Proteins 0.000 title description 25
- 102000020233 phosphotransferase Human genes 0.000 title description 25
- 235000000346 sugar Nutrition 0.000 title description 17
- 229930029653 phosphoenolpyruvate Natural products 0.000 title description 14
- DTBNBXWJWCWCIK-UHFFFAOYSA-N phosphoenolpyruvic acid Chemical compound OC(=O)C(=C)OP(O)(O)=O DTBNBXWJWCWCIK-UHFFFAOYSA-N 0.000 title 1
- 150000007523 nucleic acids Chemical class 0.000 claims abstract description 257
- 102000039446 nucleic acids Human genes 0.000 claims abstract description 229
- 108020004707 nucleic acids Proteins 0.000 claims abstract description 229
- 238000000034 method Methods 0.000 claims abstract description 91
- 238000004519 manufacturing process Methods 0.000 claims abstract description 55
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 51
- 102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 44
- 239000013604 expression vector Substances 0.000 claims abstract description 36
- 125000003729 nucleotide group Chemical group 0.000 claims description 139
- 239000002773 nucleotide Substances 0.000 claims description 138
- 241000186146 Brevibacterium Species 0.000 claims description 85
- 241000894006 Bacteria Species 0.000 claims description 80
- 150000001413 amino acids Chemical group 0.000 claims description 79
- 235000001014 amino acid Nutrition 0.000 claims description 74
- 229940024606 amino acid Drugs 0.000 claims description 69
- 230000014509 gene expression Effects 0.000 claims description 66
- 102000004190 Enzymes Human genes 0.000 claims description 59
- 108090000790 Enzymes Proteins 0.000 claims description 59
- 239000012847 fine chemical Substances 0.000 claims description 58
- 230000000694 effects Effects 0.000 claims description 56
- 244000005700 microbiome Species 0.000 claims description 55
- 229920001184 polypeptide Polymers 0.000 claims description 42
- 150000001720 carbohydrates Chemical class 0.000 claims description 41
- 239000012634 fragment Substances 0.000 claims description 31
- 239000000126 substance Substances 0.000 claims description 31
- 239000001963 growth medium Substances 0.000 claims description 28
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 claims description 22
- 230000000295 complement effect Effects 0.000 claims description 21
- 241000186145 Corynebacterium ammoniagenes Species 0.000 claims description 19
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims description 19
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 claims description 19
- 230000001580 bacterial effect Effects 0.000 claims description 19
- -1 co-factor Chemical class 0.000 claims description 19
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims description 18
- 241000319304 [Brevibacterium] flavum Species 0.000 claims description 18
- 229940088594 vitamin Drugs 0.000 claims description 18
- 229930003231 vitamin Natural products 0.000 claims description 18
- 235000013343 vitamin Nutrition 0.000 claims description 18
- 239000011782 vitamin Substances 0.000 claims description 18
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims description 17
- 241000186216 Corynebacterium Species 0.000 claims description 15
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims description 15
- 235000013922 glutamic acid Nutrition 0.000 claims description 15
- 239000004220 glutamic acid Substances 0.000 claims description 15
- 241000186227 Corynebacterium diphtheriae Species 0.000 claims description 14
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 14
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 14
- 239000004472 Lysine Substances 0.000 claims description 13
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 claims description 13
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 claims description 12
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims description 12
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims description 11
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims description 11
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 claims description 11
- 229960000310 isoleucine Drugs 0.000 claims description 11
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 claims description 10
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims description 10
- 235000018977 lysine Nutrition 0.000 claims description 10
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims description 9
- 235000003704 aspartic acid Nutrition 0.000 claims description 9
- 239000002585 base Substances 0.000 claims description 9
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 claims description 9
- 239000002777 nucleoside Substances 0.000 claims description 9
- 125000003835 nucleoside group Chemical group 0.000 claims description 9
- 239000004475 Arginine Substances 0.000 claims description 8
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 8
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims description 8
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 8
- 235000009697 arginine Nutrition 0.000 claims description 8
- 238000001514 detection method Methods 0.000 claims description 8
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 claims description 8
- 235000004554 glutamine Nutrition 0.000 claims description 8
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims description 8
- 239000004471 Glycine Substances 0.000 claims description 7
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 claims description 7
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 claims description 7
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 claims description 7
- 239000004473 Threonine Substances 0.000 claims description 7
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims description 7
- 235000018417 cysteine Nutrition 0.000 claims description 7
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims description 7
- 150000002632 lipids Chemical class 0.000 claims description 7
- 229930182817 methionine Natural products 0.000 claims description 7
- 235000006109 methionine Nutrition 0.000 claims description 7
- 150000007524 organic acids Chemical class 0.000 claims description 7
- 235000008521 threonine Nutrition 0.000 claims description 7
- KPGXRSRHYNQIFN-UHFFFAOYSA-N 2-oxoglutaric acid Chemical compound OC(=O)CCC(=O)C(O)=O KPGXRSRHYNQIFN-UHFFFAOYSA-N 0.000 claims description 6
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims description 6
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims description 6
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims description 6
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims description 6
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims description 6
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims description 6
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims description 6
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims description 6
- 239000004474 valine Substances 0.000 claims description 6
- 239000000052 vinegar Substances 0.000 claims description 6
- 235000021419 vinegar Nutrition 0.000 claims description 6
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims description 5
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims description 5
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 claims description 5
- 235000004279 alanine Nutrition 0.000 claims description 5
- 150000001491 aromatic compounds Chemical class 0.000 claims description 4
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 claims description 4
- 238000004064 recycling Methods 0.000 claims description 4
- 229930001119 polyketide Natural products 0.000 claims description 3
- 150000003881 polyketide derivatives Chemical class 0.000 claims description 3
- 235000021122 unsaturated fatty acids Nutrition 0.000 claims description 3
- 150000004670 unsaturated fatty acids Chemical class 0.000 claims description 3
- 241000234435 Lilium Species 0.000 claims description 2
- 230000004071 biological effect Effects 0.000 claims description 2
- 239000012188 paraffin wax Substances 0.000 claims description 2
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 abstract description 347
- 150000001875 compounds Chemical class 0.000 abstract description 50
- 230000000692 anti-sense effect Effects 0.000 abstract description 38
- 238000003259 recombinant expression Methods 0.000 abstract description 15
- 102000037865 fusion proteins Human genes 0.000 abstract description 12
- 108020001507 fusion proteins Proteins 0.000 abstract description 12
- 238000010353 genetic engineering Methods 0.000 abstract description 4
- 230000000890 antigenic effect Effects 0.000 abstract description 2
- 235000018102 proteins Nutrition 0.000 description 340
- 210000004027 cell Anatomy 0.000 description 159
- 125000003275 alpha amino acid group Chemical group 0.000 description 85
- 108020004414 DNA Proteins 0.000 description 84
- 229940088598 enzyme Drugs 0.000 description 58
- 230000015572 biosynthetic process Effects 0.000 description 54
- 230000006870 function Effects 0.000 description 52
- 235000014633 carbohydrates Nutrition 0.000 description 39
- 101150001834 PTS gene Proteins 0.000 description 36
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 35
- 238000005516 engineering process Methods 0.000 description 35
- 239000008103 glucose Substances 0.000 description 35
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 32
- 238000004458 analytical method Methods 0.000 description 32
- 229910052799 carbon Inorganic materials 0.000 description 32
- 238000003786 synthesis reaction Methods 0.000 description 32
- 238000010367 cloning Methods 0.000 description 31
- 238000013459 approach Methods 0.000 description 30
- 239000000047 product Substances 0.000 description 30
- 108091028043 Nucleic acid sequence Proteins 0.000 description 28
- 230000001404 mediated effect Effects 0.000 description 28
- 230000005754 cellular signaling Effects 0.000 description 25
- 238000009396 hybridization Methods 0.000 description 25
- 239000013612 plasmid Substances 0.000 description 25
- 238000010361 transduction Methods 0.000 description 25
- 230000026683 transduction Effects 0.000 description 25
- 230000035772 mutation Effects 0.000 description 24
- 239000004615 ingredient Substances 0.000 description 23
- 108020004999 messenger RNA Proteins 0.000 description 23
- 239000002243 precursor Substances 0.000 description 23
- 238000012512 characterization method Methods 0.000 description 22
- 238000000926 separation method Methods 0.000 description 22
- 239000000523 sample Substances 0.000 description 21
- 241000588724 Escherichia coli Species 0.000 description 20
- 239000000543 intermediate Substances 0.000 description 20
- 108091026890 Coding region Proteins 0.000 description 19
- 108010064711 Homoserine dehydrogenase Proteins 0.000 description 19
- 108010055837 phosphocarrier protein HPr Proteins 0.000 description 19
- 108091034117 Oligonucleotide Proteins 0.000 description 18
- 239000013615 primer Substances 0.000 description 18
- 239000013598 vector Substances 0.000 description 18
- 125000000539 amino acid group Chemical group 0.000 description 17
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 16
- 238000006243 chemical reaction Methods 0.000 description 16
- 238000007479 molecular analysis Methods 0.000 description 16
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 15
- 108010055400 Aspartate kinase Proteins 0.000 description 15
- 239000002253 acid Substances 0.000 description 15
- 239000000203 mixture Substances 0.000 description 15
- 230000026731 phosphorylation Effects 0.000 description 15
- 238000006366 phosphorylation reaction Methods 0.000 description 15
- 238000013518 transcription Methods 0.000 description 15
- 230000035897 transcription Effects 0.000 description 15
- 229930006000 Sucrose Natural products 0.000 description 14
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 14
- 229960002989 glutamic acid Drugs 0.000 description 14
- 230000004060 metabolic process Effects 0.000 description 14
- 239000005720 sucrose Substances 0.000 description 14
- 230000008859 change Effects 0.000 description 13
- DTBNBXWJWCWCIK-UHFFFAOYSA-K phosphonatoenolpyruvate Chemical compound [O-]C(=O)C(=C)OP([O-])([O-])=O DTBNBXWJWCWCIK-UHFFFAOYSA-K 0.000 description 13
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 12
- 229930091371 Fructose Natural products 0.000 description 12
- 239000005715 Fructose Substances 0.000 description 12
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 12
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 12
- 230000006696 biosynthetic metabolic pathway Effects 0.000 description 12
- 230000002068 genetic effect Effects 0.000 description 12
- 238000002744 homologous recombination Methods 0.000 description 12
- 230000006801 homologous recombination Effects 0.000 description 12
- 238000011160 research Methods 0.000 description 12
- 238000010561 standard procedure Methods 0.000 description 12
- 241000233866 Fungi Species 0.000 description 11
- 241000282414 Homo sapiens Species 0.000 description 11
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 11
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 11
- 238000000855 fermentation Methods 0.000 description 11
- 230000004151 fermentation Effects 0.000 description 11
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 11
- 230000001965 increasing effect Effects 0.000 description 11
- 230000003834 intracellular effect Effects 0.000 description 11
- 238000005259 measurement Methods 0.000 description 11
- 230000037353 metabolic pathway Effects 0.000 description 11
- 230000004048 modification Effects 0.000 description 11
- 238000012986 modification Methods 0.000 description 11
- 238000010369 molecular cloning Methods 0.000 description 11
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 10
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 10
- 108700034291 EC 2.7.1.69 Proteins 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
- 239000000872 buffer Substances 0.000 description 10
- 230000004927 fusion Effects 0.000 description 10
- 235000019161 pantothenic acid Nutrition 0.000 description 10
- 239000011713 pantothenic acid Substances 0.000 description 10
- 230000014616 translation Effects 0.000 description 10
- 241000196324 Embryophyta Species 0.000 description 9
- 229910019142 PO4 Inorganic materials 0.000 description 9
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 9
- 238000012300 Sequence Analysis Methods 0.000 description 9
- 230000015556 catabolic process Effects 0.000 description 9
- 238000006731 degradation reaction Methods 0.000 description 9
- 230000012010 growth Effects 0.000 description 9
- 238000003780 insertion Methods 0.000 description 9
- 230000037431 insertion Effects 0.000 description 9
- 238000000746 purification Methods 0.000 description 9
- 238000012163 sequencing technique Methods 0.000 description 9
- 108010078791 Carrier Proteins Proteins 0.000 description 8
- 101710088194 Dehydrogenase Proteins 0.000 description 8
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 8
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 8
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 8
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- 101100245038 Synechocystis sp. (strain PCC 6803 / Kazusa) proA1 gene Proteins 0.000 description 8
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 8
- 239000000969 carrier Substances 0.000 description 8
- 239000000306 component Substances 0.000 description 8
- 230000002255 enzymatic effect Effects 0.000 description 8
- 230000010354 integration Effects 0.000 description 8
- 239000002609 medium Substances 0.000 description 8
- 229940014662 pantothenate Drugs 0.000 description 8
- 229960005190 phenylalanine Drugs 0.000 description 8
- 101150118057 proA gene Proteins 0.000 description 8
- 238000012216 screening Methods 0.000 description 8
- 239000000758 substrate Substances 0.000 description 8
- 238000013519 translation Methods 0.000 description 8
- 230000032258 transport Effects 0.000 description 8
- 108091005461 Nucleic proteins Proteins 0.000 description 7
- 102000004316 Oxidoreductases Human genes 0.000 description 7
- 108090000854 Oxidoreductases Proteins 0.000 description 7
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 7
- 230000003321 amplification Effects 0.000 description 7
- 230000001413 cellular effect Effects 0.000 description 7
- 238000013461 design Methods 0.000 description 7
- 230000033001 locomotion Effects 0.000 description 7
- 230000002503 metabolic effect Effects 0.000 description 7
- 238000003199 nucleic acid amplification method Methods 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 7
- 230000008569 process Effects 0.000 description 7
- 230000004952 protein activity Effects 0.000 description 7
- 230000001105 regulatory effect Effects 0.000 description 7
- 239000011347 resin Substances 0.000 description 7
- 229920005989 resin Polymers 0.000 description 7
- 210000001519 tissue Anatomy 0.000 description 7
- 238000011144 upstream manufacturing Methods 0.000 description 7
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 6
- 108090000489 Carboxy-Lyases Proteins 0.000 description 6
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 6
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 6
- WQXNXVUDBPYKBA-UHFFFAOYSA-N Ectoine Natural products CC1=NCCC(C(O)=O)N1 WQXNXVUDBPYKBA-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 6
- 108020004511 Recombinant DNA Proteins 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 238000005842 biochemical reaction Methods 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 230000001419 dependent effect Effects 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- WQXNXVUDBPYKBA-YFKPBYRVSA-N ectoine Chemical compound CC1=[NH+][C@H](C([O-])=O)CCN1 WQXNXVUDBPYKBA-YFKPBYRVSA-N 0.000 description 6
- 235000019441 ethanol Nutrition 0.000 description 6
- 235000019152 folic acid Nutrition 0.000 description 6
- 239000011724 folic acid Substances 0.000 description 6
- 238000002955 isolation Methods 0.000 description 6
- 239000003550 marker Substances 0.000 description 6
- 235000001968 nicotinic acid Nutrition 0.000 description 6
- 239000011664 nicotinic acid Substances 0.000 description 6
- 229910052757 nitrogen Inorganic materials 0.000 description 6
- 235000021317 phosphate Nutrition 0.000 description 6
- 239000010452 phosphate Substances 0.000 description 6
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 6
- 230000006798 recombination Effects 0.000 description 6
- 238000005215 recombination Methods 0.000 description 6
- 229960002898 threonine Drugs 0.000 description 6
- 238000012546 transfer Methods 0.000 description 6
- 229960004295 valine Drugs 0.000 description 6
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 5
- 108020004465 16S ribosomal RNA Proteins 0.000 description 5
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 5
- ZKHQWZAMYRWXGA-KQYNXXCUSA-N Adenosine triphosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-N 0.000 description 5
- 102000014914 Carrier Proteins Human genes 0.000 description 5
- 108090000994 Catalytic RNA Proteins 0.000 description 5
- 102000053642 Catalytic RNA Human genes 0.000 description 5
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 5
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 5
- 238000000018 DNA microarray Methods 0.000 description 5
- 241000238631 Hexapoda Species 0.000 description 5
- 108020003285 Isocitrate lyase Proteins 0.000 description 5
- 102000003960 Ligases Human genes 0.000 description 5
- 108090000364 Ligases Proteins 0.000 description 5
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 5
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 5
- 108700026244 Open Reading Frames Proteins 0.000 description 5
- 108091000041 Phosphoenolpyruvate Carboxylase Proteins 0.000 description 5
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 5
- 108010022394 Threonine synthase Proteins 0.000 description 5
- 102000006843 Threonine synthase Human genes 0.000 description 5
- 108090000340 Transaminases Proteins 0.000 description 5
- 102000003929 Transaminases Human genes 0.000 description 5
- 239000007984 Tris EDTA buffer Substances 0.000 description 5
- XJLXINKUBYWONI-DQQFMEOOSA-N [[(2r,3r,4r,5r)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2s,3r,4s,5s)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate Chemical compound NC(=O)C1=CC=C[N+]([C@@H]2[C@H]([C@@H](O)[C@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-DQQFMEOOSA-N 0.000 description 5
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 5
- 229910021529 ammonia Inorganic materials 0.000 description 5
- 229960003237 betaine Drugs 0.000 description 5
- 229960002685 biotin Drugs 0.000 description 5
- 235000020958 biotin Nutrition 0.000 description 5
- 239000011616 biotin Substances 0.000 description 5
- 229940041514 candida albicans extract Drugs 0.000 description 5
- 210000000170 cell membrane Anatomy 0.000 description 5
- 239000002537 cosmetic Substances 0.000 description 5
- 235000005911 diet Nutrition 0.000 description 5
- 206010013023 diphtheria Diseases 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 229960000304 folic acid Drugs 0.000 description 5
- 239000000499 gel Substances 0.000 description 5
- 239000011521 glass Substances 0.000 description 5
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 5
- 108010071598 homoserine kinase Proteins 0.000 description 5
- 230000001976 improved effect Effects 0.000 description 5
- 238000000338 in vitro Methods 0.000 description 5
- 230000005764 inhibitory process Effects 0.000 description 5
- 101150033534 lysA gene Proteins 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 230000007246 mechanism Effects 0.000 description 5
- 238000002703 mutagenesis Methods 0.000 description 5
- 231100000350 mutagenesis Toxicity 0.000 description 5
- 229960003512 nicotinic acid Drugs 0.000 description 5
- 235000015097 nutrients Nutrition 0.000 description 5
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 5
- 101150079601 recA gene Proteins 0.000 description 5
- 229960002477 riboflavin Drugs 0.000 description 5
- 235000019192 riboflavin Nutrition 0.000 description 5
- 239000002151 riboflavin Substances 0.000 description 5
- 108091092562 ribozyme Proteins 0.000 description 5
- 239000013605 shuttle vector Substances 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 238000006467 substitution reaction Methods 0.000 description 5
- 230000002194 synthesizing effect Effects 0.000 description 5
- 101150044170 trpE gene Proteins 0.000 description 5
- 239000012138 yeast extract Substances 0.000 description 5
- GMKMEZVLHJARHF-UHFFFAOYSA-N (2R,6R)-form-2.6-Diaminoheptanedioic acid Natural products OC(=O)C(N)CCCC(N)C(O)=O GMKMEZVLHJARHF-UHFFFAOYSA-N 0.000 description 4
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 4
- 108010014885 Arginine-tRNA ligase Proteins 0.000 description 4
- 102100034229 Citramalyl-CoA lyase, mitochondrial Human genes 0.000 description 4
- 108020004705 Codon Proteins 0.000 description 4
- 102000053602 DNA Human genes 0.000 description 4
- 108010070675 Glutathione transferase Proteins 0.000 description 4
- 102100029100 Hematopoietic prostaglandin D synthase Human genes 0.000 description 4
- 102100034343 Integrase Human genes 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- LKDRXBCSQODPBY-AMVSKUEXSA-N L-(-)-Sorbose Chemical compound OCC1(O)OC[C@H](O)[C@@H](O)[C@@H]1O LKDRXBCSQODPBY-AMVSKUEXSA-N 0.000 description 4
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 4
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
- 108020004687 Malate Synthase Proteins 0.000 description 4
- 241000124008 Mammalia Species 0.000 description 4
- 229930195725 Mannitol Natural products 0.000 description 4
- 108010015724 Prephenate Dehydratase Proteins 0.000 description 4
- 102100036134 Probable arginine-tRNA ligase, mitochondrial Human genes 0.000 description 4
- 108010076504 Protein Sorting Signals Proteins 0.000 description 4
- 101100408135 Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1) phnA gene Proteins 0.000 description 4
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 4
- 241001591005 Siga Species 0.000 description 4
- 108010006873 Threonine Dehydratase Proteins 0.000 description 4
- 102100033451 Thyroid hormone receptor beta Human genes 0.000 description 4
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 4
- UCMIRNVEIXFBKS-UHFFFAOYSA-N beta-alanine Chemical compound NCCC(O)=O UCMIRNVEIXFBKS-UHFFFAOYSA-N 0.000 description 4
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 4
- 230000008238 biochemical pathway Effects 0.000 description 4
- 230000033228 biological regulation Effects 0.000 description 4
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 4
- 239000005515 coenzyme Substances 0.000 description 4
- 238000010835 comparative analysis Methods 0.000 description 4
- 239000002299 complementary DNA Substances 0.000 description 4
- 239000003184 complementary RNA Substances 0.000 description 4
- 101150011371 dapA gene Proteins 0.000 description 4
- 101150000582 dapE gene Proteins 0.000 description 4
- 230000000378 dietary effect Effects 0.000 description 4
- 238000004043 dyeing Methods 0.000 description 4
- 238000001962 electrophoresis Methods 0.000 description 4
- 239000003623 enhancer Substances 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- VWWQXMAJTJZDQX-UYBVJOGSSA-N flavin adenine dinucleotide Chemical compound C1=NC2=C(N)N=CN=C2N1[C@@H]([C@H](O)[C@@H]1O)O[C@@H]1CO[P@](O)(=O)O[P@@](O)(=O)OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C2=NC(=O)NC(=O)C2=NC2=C1C=C(C)C(C)=C2 VWWQXMAJTJZDQX-UYBVJOGSSA-N 0.000 description 4
- 235000019162 flavin adenine dinucleotide Nutrition 0.000 description 4
- 239000011714 flavin adenine dinucleotide Substances 0.000 description 4
- 229940093632 flavin-adenine dinucleotide Drugs 0.000 description 4
- QEWYKACRFQMRMB-UHFFFAOYSA-N fluoroacetic acid Chemical compound OC(=O)CF QEWYKACRFQMRMB-UHFFFAOYSA-N 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 101150111615 ftsZ gene Proteins 0.000 description 4
- 238000001502 gel electrophoresis Methods 0.000 description 4
- 238000012239 gene modification Methods 0.000 description 4
- 230000005017 genetic modification Effects 0.000 description 4
- 235000013617 genetically modified food Nutrition 0.000 description 4
- 230000004190 glucose uptake Effects 0.000 description 4
- 230000034659 glycolysis Effects 0.000 description 4
- 230000002779 inactivation Effects 0.000 description 4
- 230000003993 interaction Effects 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 239000008101 lactose Substances 0.000 description 4
- 210000004962 mammalian cell Anatomy 0.000 description 4
- 239000000594 mannitol Substances 0.000 description 4
- 235000010355 mannitol Nutrition 0.000 description 4
- 238000002493 microarray Methods 0.000 description 4
- 101150034514 murC gene Proteins 0.000 description 4
- 235000016709 nutrition Nutrition 0.000 description 4
- 230000036961 partial effect Effects 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- 230000037361 pathway Effects 0.000 description 4
- 108010045020 phosphoenolpyruvate-protein phosphotransferase Proteins 0.000 description 4
- 238000013081 phylogenetic analysis Methods 0.000 description 4
- 238000003752 polymerase chain reaction Methods 0.000 description 4
- 108700022487 rRNA Genes Proteins 0.000 description 4
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 4
- 108091008146 restriction endonucleases Proteins 0.000 description 4
- 238000010008 shearing Methods 0.000 description 4
- 230000019491 signal transduction Effects 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 241000894007 species Species 0.000 description 4
- 238000012916 structural analysis Methods 0.000 description 4
- 238000001890 transfection Methods 0.000 description 4
- 230000009466 transformation Effects 0.000 description 4
- 229940035893 uracil Drugs 0.000 description 4
- 230000003612 virological effect Effects 0.000 description 4
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 3
- OTOIIPJYVQJATP-BYPYZUCNSA-N (R)-pantoic acid Chemical compound OCC(C)(C)[C@@H](O)C(O)=O OTOIIPJYVQJATP-BYPYZUCNSA-N 0.000 description 3
- PJODNTCLCCRNCO-UHFFFAOYSA-N 2,2-diaminononanoic acid Chemical compound CCCCCCCC(N)(N)C(O)=O PJODNTCLCCRNCO-UHFFFAOYSA-N 0.000 description 3
- 102100031126 6-phosphogluconolactonase Human genes 0.000 description 3
- 108010029731 6-phosphogluconolactonase Proteins 0.000 description 3
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 3
- 108010037870 Anthranilate Synthase Proteins 0.000 description 3
- 108020005544 Antisense RNA Proteins 0.000 description 3
- 108700016171 Aspartate ammonia-lyases Proteins 0.000 description 3
- 101100350224 Bacillus subtilis (strain 168) pdhB gene Proteins 0.000 description 3
- 101100096227 Bacteroides fragilis (strain 638R) argF' gene Proteins 0.000 description 3
- 241000186031 Corynebacteriaceae Species 0.000 description 3
- 101100236536 Corynebacterium glutamicum (strain ATCC 13032 / DSM 20300 / BCRC 11384 / JCM 1318 / LMG 3730 / NCIMB 10025) glcB gene Proteins 0.000 description 3
- ZAQJHHRNXZUBTE-NQXXGFSBSA-N D-ribulose Chemical compound OC[C@@H](O)[C@@H](O)C(=O)CO ZAQJHHRNXZUBTE-NQXXGFSBSA-N 0.000 description 3
- ZAQJHHRNXZUBTE-UHFFFAOYSA-N D-threo-2-Pentulose Natural products OCC(O)C(O)C(=O)CO ZAQJHHRNXZUBTE-UHFFFAOYSA-N 0.000 description 3
- 101100129336 Dictyostelium discoideum malA gene Proteins 0.000 description 3
- 101100465553 Dictyostelium discoideum psmB6 gene Proteins 0.000 description 3
- 241000192125 Firmicutes Species 0.000 description 3
- 108010018962 Glucosephosphate Dehydrogenase Proteins 0.000 description 3
- 101150005343 INHA gene Proteins 0.000 description 3
- 108010000200 Ketol-acid reductoisomerase Proteins 0.000 description 3
- 235000019766 L-Lysine Nutrition 0.000 description 3
- 229930182844 L-isoleucine Natural products 0.000 description 3
- 101100354186 Mycoplasma capricolum subsp. capricolum (strain California kid / ATCC 27343 / NCTC 10154) ptcA gene Proteins 0.000 description 3
- BAWFJGJZGIEFAR-NNYOXOHSSA-N NAD zwitterion Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-N 0.000 description 3
- 102000007981 Ornithine carbamoyltransferase Human genes 0.000 description 3
- 101710198224 Ornithine carbamoyltransferase, mitochondrial Proteins 0.000 description 3
- 108700023175 Phosphate acetyltransferases Proteins 0.000 description 3
- 101100406344 Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1) aceF gene Proteins 0.000 description 3
- 101100169519 Pyrococcus abyssi (strain GE5 / Orsay) dapAL gene Proteins 0.000 description 3
- 108010053763 Pyruvate Carboxylase Proteins 0.000 description 3
- 102100039895 Pyruvate carboxylase, mitochondrial Human genes 0.000 description 3
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 3
- 101100190460 Shigella flexneri pic gene Proteins 0.000 description 3
- 108010020764 Transposases Proteins 0.000 description 3
- 102000008579 Transposases Human genes 0.000 description 3
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 3
- 229930003779 Vitamin B12 Natural products 0.000 description 3
- 101150036393 aceB gene Proteins 0.000 description 3
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 3
- 229960004050 aminobenzoic acid Drugs 0.000 description 3
- 239000005557 antagonist Substances 0.000 description 3
- 239000000074 antisense oligonucleotide Substances 0.000 description 3
- 238000012230 antisense oligonucleotides Methods 0.000 description 3
- 101150070427 argC gene Proteins 0.000 description 3
- 101150089042 argC2 gene Proteins 0.000 description 3
- 101150056313 argF gene Proteins 0.000 description 3
- 101150040872 aroE gene Proteins 0.000 description 3
- 229940000635 beta-alanine Drugs 0.000 description 3
- 230000000975 bioactive effect Effects 0.000 description 3
- 239000006227 byproduct Substances 0.000 description 3
- 230000006652 catabolic pathway Effects 0.000 description 3
- 230000003197 catalytic effect Effects 0.000 description 3
- 210000002421 cell wall Anatomy 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 241000186254 coryneform bacterium Species 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 101150073654 dapB gene Proteins 0.000 description 3
- 150000002016 disaccharides Chemical class 0.000 description 3
- 101150027005 divIB gene Proteins 0.000 description 3
- 238000004146 energy storage Methods 0.000 description 3
- 238000006911 enzymatic reaction Methods 0.000 description 3
- 235000020776 essential amino acid Nutrition 0.000 description 3
- 239000003797 essential amino acid Substances 0.000 description 3
- 238000013467 fragmentation Methods 0.000 description 3
- 238000006062 fragmentation reaction Methods 0.000 description 3
- 101150002100 ftsK gene Proteins 0.000 description 3
- 101150026421 ftsQ gene Proteins 0.000 description 3
- 238000010230 functional analysis Methods 0.000 description 3
- 108010064177 glutamine synthetase I Proteins 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- 101150063051 hom gene Proteins 0.000 description 3
- 101150086151 hrdB gene Proteins 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 238000002093 isoelectric focusing polyacrylamide gel electrophoresis Methods 0.000 description 3
- XUWPJKDMEZSVTP-LTYMHZPRSA-N kalafungina Chemical compound O=C1C2=C(O)C=CC=C2C(=O)C2=C1[C@@H](C)O[C@H]1[C@@H]2OC(=O)C1 XUWPJKDMEZSVTP-LTYMHZPRSA-N 0.000 description 3
- 238000002372 labelling Methods 0.000 description 3
- 101150087199 leuA gene Proteins 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 101150035025 lysC gene Proteins 0.000 description 3
- 101150094164 lysY gene Proteins 0.000 description 3
- 239000011159 matrix material Substances 0.000 description 3
- 239000012092 media component Substances 0.000 description 3
- GMKMEZVLHJARHF-SYDPRGILSA-N meso-2,6-diaminopimelic acid Chemical compound [O-]C(=O)[C@@H]([NH3+])CCC[C@@H]([NH3+])C([O-])=O GMKMEZVLHJARHF-SYDPRGILSA-N 0.000 description 3
- 150000002772 monosaccharides Chemical class 0.000 description 3
- 229950006238 nadide Drugs 0.000 description 3
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 3
- 238000003499 nucleic acid array Methods 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 230000002018 overexpression Effects 0.000 description 3
- 108010071189 phosphoenolpyruvate-glucose phosphotransferase Proteins 0.000 description 3
- 230000001376 precipitating effect Effects 0.000 description 3
- 210000001236 prokaryotic cell Anatomy 0.000 description 3
- 101150096049 pyc gene Proteins 0.000 description 3
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 3
- 230000002285 radioactive effect Effects 0.000 description 3
- 230000010076 replication Effects 0.000 description 3
- 230000000717 retained effect Effects 0.000 description 3
- 101150102864 rpoD gene Proteins 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 238000012772 sequence design Methods 0.000 description 3
- 101150117326 sigA gene Proteins 0.000 description 3
- 101150057107 sigB gene Proteins 0.000 description 3
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 3
- 238000010183 spectrum analysis Methods 0.000 description 3
- 239000012134 supernatant fraction Substances 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 229960003495 thiamine Drugs 0.000 description 3
- 235000019157 thiamine Nutrition 0.000 description 3
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 3
- 101150072448 thrB gene Proteins 0.000 description 3
- 101150000850 thrC gene Proteins 0.000 description 3
- 230000002103 transcriptional effect Effects 0.000 description 3
- 229940048102 triphosphoric acid Drugs 0.000 description 3
- 101150108727 trpl gene Proteins 0.000 description 3
- 241001515965 unidentified phage Species 0.000 description 3
- 235000019163 vitamin B12 Nutrition 0.000 description 3
- 239000011715 vitamin B12 Substances 0.000 description 3
- RFLVMTUMFYRZCB-UHFFFAOYSA-N 1-methylguanine Chemical compound O=C1N(C)C(N)=NC2=C1N=CN2 RFLVMTUMFYRZCB-UHFFFAOYSA-N 0.000 description 2
- FZWGECJQACGGTI-UHFFFAOYSA-N 2-amino-7-methyl-1,7-dihydro-6H-purin-6-one Chemical compound NC1=NC(O)=C2N(C)C=NC2=N1 FZWGECJQACGGTI-UHFFFAOYSA-N 0.000 description 2
- 108010030844 2-methylcitrate synthase Proteins 0.000 description 2
- YQUVCSBJEUQKSH-UHFFFAOYSA-N 3,4-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C(O)=C1 YQUVCSBJEUQKSH-UHFFFAOYSA-N 0.000 description 2
- 108010038550 3-dehydroquinate dehydratase Proteins 0.000 description 2
- OIVLITBTBDPEFK-UHFFFAOYSA-N 5,6-dihydrouracil Chemical compound O=C1CCNC(=O)N1 OIVLITBTBDPEFK-UHFFFAOYSA-N 0.000 description 2
- HUNCSWANZMJLPM-UHFFFAOYSA-N 5-methyltryptophan Chemical compound CC1=CC=C2NC=C(CC(N)C(O)=O)C2=C1 HUNCSWANZMJLPM-UHFFFAOYSA-N 0.000 description 2
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 2
- 108010042833 7,8-diaminopelargonic acid aminotransferase Proteins 0.000 description 2
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical compound O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 2
- 108010092060 Acetate kinase Proteins 0.000 description 2
- 108010000700 Acetolactate synthase Proteins 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- 108050005273 Amino acid transporters Proteins 0.000 description 2
- 102000034263 Amino acid transporters Human genes 0.000 description 2
- 101710191958 Amino-acid acetyltransferase Proteins 0.000 description 2
- 101710149879 Arginine repressor Proteins 0.000 description 2
- 102000009042 Argininosuccinate Lyase Human genes 0.000 description 2
- 102000053640 Argininosuccinate synthases Human genes 0.000 description 2
- 108700024106 Argininosuccinate synthases Proteins 0.000 description 2
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 2
- 244000063299 Bacillus subtilis Species 0.000 description 2
- 235000014469 Bacillus subtilis Nutrition 0.000 description 2
- 101100242035 Bacillus subtilis (strain 168) pdhA gene Proteins 0.000 description 2
- 101710117026 Biotin synthase Proteins 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Natural products CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- 241000244203 Caenorhabditis elegans Species 0.000 description 2
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 2
- 239000004215 Carbon black (E152) Substances 0.000 description 2
- 108091006146 Channels Proteins 0.000 description 2
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 2
- 241000606153 Chlamydia trachomatis Species 0.000 description 2
- 108010071536 Citrate (Si)-synthase Proteins 0.000 description 2
- 102000006732 Citrate synthase Human genes 0.000 description 2
- 101100163308 Clostridium perfringens (strain 13 / Type A) argR1 gene Proteins 0.000 description 2
- 108091033380 Coding strand Proteins 0.000 description 2
- 241000918600 Corynebacterium ulcerans Species 0.000 description 2
- 241000195493 Cryptophyta Species 0.000 description 2
- 241000252867 Cupriavidus metallidurans Species 0.000 description 2
- 108050006400 Cyclin Proteins 0.000 description 2
- 102000016736 Cyclin Human genes 0.000 description 2
- 241000701022 Cytomegalovirus Species 0.000 description 2
- LXJXRIRHZLFYRP-VKHMYHEASA-N D-glyceraldehyde 3-phosphate Chemical compound O=C[C@H](O)COP(O)(O)=O LXJXRIRHZLFYRP-VKHMYHEASA-N 0.000 description 2
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 2
- 101710160937 DNA replication protein Proteins 0.000 description 2
- 238000001712 DNA sequencing Methods 0.000 description 2
- 230000006820 DNA synthesis Effects 0.000 description 2
- 102000052510 DNA-Binding Proteins Human genes 0.000 description 2
- 101710096438 DNA-binding protein Proteins 0.000 description 2
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 2
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 2
- 101100098219 Dictyostelium discoideum argS1 gene Proteins 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 102000009123 Fibrin Human genes 0.000 description 2
- 108010073385 Fibrin Proteins 0.000 description 2
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 2
- GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 description 2
- 102000001390 Fructose-Bisphosphate Aldolase Human genes 0.000 description 2
- 108010068561 Fructose-Bisphosphate Aldolase Proteins 0.000 description 2
- 101150099894 GDHA gene Proteins 0.000 description 2
- 102000005133 Glutamate 5-kinase Human genes 0.000 description 2
- 102000002667 Glycine hydroxymethyltransferase Human genes 0.000 description 2
- 108010043428 Glycine hydroxymethyltransferase Proteins 0.000 description 2
- 108090000288 Glycoproteins Proteins 0.000 description 2
- 102000003886 Glycoproteins Human genes 0.000 description 2
- 101100295959 Halobacterium salinarum (strain ATCC 700922 / JCM 11081 / NRC-1) arcB gene Proteins 0.000 description 2
- 241001502974 Human gammaherpesvirus 8 Species 0.000 description 2
- 229930010555 Inosine Natural products 0.000 description 2
- 101100123255 Komagataeibacter xylinus aceC gene Proteins 0.000 description 2
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 2
- 102000003939 Membrane transport proteins Human genes 0.000 description 2
- 108090000301 Membrane transport proteins Proteins 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 241000204051 Mycoplasma genitalium Species 0.000 description 2
- 229910002651 NO3 Inorganic materials 0.000 description 2
- 239000000020 Nitrocellulose Substances 0.000 description 2
- 108091092724 Noncoding DNA Proteins 0.000 description 2
- 102000008153 Peptide Elongation Factor Tu Human genes 0.000 description 2
- 108010049977 Peptide Elongation Factor Tu Proteins 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 101710150114 Protein rep Proteins 0.000 description 2
- 101100134871 Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1) aceE gene Proteins 0.000 description 2
- 101100217185 Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1) aruC gene Proteins 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 108020005115 Pyruvate Kinase Proteins 0.000 description 2
- 102000013009 Pyruvate Kinase Human genes 0.000 description 2
- 108090001066 Racemases and epimerases Proteins 0.000 description 2
- 102000004879 Racemases and epimerases Human genes 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 241000700157 Rattus norvegicus Species 0.000 description 2
- 241000700162 Rattus sp. Species 0.000 description 2
- 101710152114 Replication protein Proteins 0.000 description 2
- 241000316848 Rhodococcus <scale insect> Species 0.000 description 2
- 108091028664 Ribonucleotide Proteins 0.000 description 2
- 101710099182 S-layer protein Proteins 0.000 description 2
- 241000607142 Salmonella Species 0.000 description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 241001446311 Streptomyces coelicolor A3(2) Species 0.000 description 2
- 101100022072 Sulfolobus acidocaldarius (strain ATCC 33909 / DSM 639 / JCM 8929 / NBRC 15157 / NCIMB 11770) lysJ gene Proteins 0.000 description 2
- 101710183296 Surface layer protein Proteins 0.000 description 2
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 2
- 102000004357 Transferases Human genes 0.000 description 2
- 108090000992 Transferases Proteins 0.000 description 2
- DRTQHJPVMGBUCF-XVFCMESISA-N Uridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-XVFCMESISA-N 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 101150094017 aceA gene Proteins 0.000 description 2
- 235000011054 acetic acid Nutrition 0.000 description 2
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 2
- DZBUGLKDJFMEHC-UHFFFAOYSA-N acridine Chemical compound C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 description 2
- GFFGJBXGBJISGV-UHFFFAOYSA-N adenyl group Chemical group N1=CN=C2N=CNC2=C1N GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 239000000556 agonist Substances 0.000 description 2
- 229940126575 aminoglycoside Drugs 0.000 description 2
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 2
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 2
- SCJNCDSAIRBRIA-DOFZRALJSA-N arachidonyl-2'-chloroethylamide Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(=O)NCCCl SCJNCDSAIRBRIA-DOFZRALJSA-N 0.000 description 2
- 101150008194 argB gene Proteins 0.000 description 2
- 101150050866 argD gene Proteins 0.000 description 2
- 101150118463 argG gene Proteins 0.000 description 2
- 101150029940 argJ gene Proteins 0.000 description 2
- 101150089004 argR gene Proteins 0.000 description 2
- 101150024756 argS gene Proteins 0.000 description 2
- 101150037081 aroA gene Proteins 0.000 description 2
- 101150090235 aroB gene Proteins 0.000 description 2
- 101150102858 aroD gene Proteins 0.000 description 2
- 101150010999 aroP gene Proteins 0.000 description 2
- 101150108612 aroQ gene Proteins 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 101150107204 asd gene Proteins 0.000 description 2
- 229960001230 asparagine Drugs 0.000 description 2
- 235000009582 asparagine Nutrition 0.000 description 2
- 101150070136 axeA gene Proteins 0.000 description 2
- RNBGYGVWRKECFJ-ARQDHWQXSA-N beta-D-fructofuranose 1,6-bisphosphate Chemical compound O[C@H]1[C@H](O)[C@@](O)(COP(O)(O)=O)O[C@@H]1COP(O)(O)=O RNBGYGVWRKECFJ-ARQDHWQXSA-N 0.000 description 2
- 230000027455 binding Effects 0.000 description 2
- 238000012742 biochemical analysis Methods 0.000 description 2
- 230000001851 biosynthetic effect Effects 0.000 description 2
- 101150098189 brnQ gene Proteins 0.000 description 2
- 239000001110 calcium chloride Substances 0.000 description 2
- 229910001628 calcium chloride Inorganic materials 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- 102000028406 carbon-sulfur lyase Human genes 0.000 description 2
- 108010076637 carbon-sulfur lyase Proteins 0.000 description 2
- YCIMNLLNPGFGHC-UHFFFAOYSA-N catechol Chemical compound OC1=CC=CC=C1O YCIMNLLNPGFGHC-UHFFFAOYSA-N 0.000 description 2
- 230000032823 cell division Effects 0.000 description 2
- 230000019522 cellular metabolic process Effects 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000002738 chelating agent Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000004927 clay Substances 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 238000004040 coloring Methods 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 108091036078 conserved sequence Proteins 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- 101150064416 csp1 gene Proteins 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 229940104302 cytosine Drugs 0.000 description 2
- 101150064923 dapD gene Proteins 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 238000006209 dephosphorylation reaction Methods 0.000 description 2
- 108010050073 dethiobiotin synthetase Proteins 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 108010056578 diaminopimelate dehydrogenase Proteins 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 210000002889 endothelial cell Anatomy 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 229950003499 fibrin Drugs 0.000 description 2
- 229940013640 flavin mononucleotide Drugs 0.000 description 2
- 239000011768 flavin mononucleotide Substances 0.000 description 2
- FVTCRASFADXXNN-SCRDCRAPSA-N flavin mononucleotide Chemical compound OP(=O)(O)OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O FVTCRASFADXXNN-SCRDCRAPSA-N 0.000 description 2
- FVTCRASFADXXNN-UHFFFAOYSA-N flavin mononucleotide Natural products OP(=O)(O)OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O FVTCRASFADXXNN-UHFFFAOYSA-N 0.000 description 2
- 229940025237 fructose 1,6-diphosphate Drugs 0.000 description 2
- 230000005714 functional activity Effects 0.000 description 2
- 101150002054 galE gene Proteins 0.000 description 2
- 101150019455 gdh gene Proteins 0.000 description 2
- 238000012215 gene cloning Methods 0.000 description 2
- 102000034356 gene-regulatory proteins Human genes 0.000 description 2
- 108091006104 gene-regulatory proteins Proteins 0.000 description 2
- 229940049906 glutamate Drugs 0.000 description 2
- 229930195712 glutamate Natural products 0.000 description 2
- 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 2
- 239000003102 growth factor Substances 0.000 description 2
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- 125000000487 histidyl group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C([H])=N1 0.000 description 2
- 108010034653 homoserine O-acetyltransferase Proteins 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 150000002430 hydrocarbons Chemical class 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N hydrochloric acid Substances Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- FDGQSTZJBFJUBT-UHFFFAOYSA-N hypoxanthine Chemical compound O=C1NC=NC2=C1NC=N2 FDGQSTZJBFJUBT-UHFFFAOYSA-N 0.000 description 2
- 101150118781 icd gene Proteins 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 229960003786 inosine Drugs 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 238000011005 laboratory method Methods 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 101150025049 leuB gene Proteins 0.000 description 2
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 101150039489 lysZ gene Proteins 0.000 description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 230000007483 microbial process Effects 0.000 description 2
- 235000013379 molasses Nutrition 0.000 description 2
- LPUQAYUQRXPFSQ-DFWYDOINSA-M monosodium L-glutamate Chemical compound [Na+].[O-]C(=O)[C@@H](N)CCC(O)=O LPUQAYUQRXPFSQ-DFWYDOINSA-M 0.000 description 2
- 235000013923 monosodium glutamate Nutrition 0.000 description 2
- 230000036457 multidrug resistance Effects 0.000 description 2
- 229920001220 nitrocellulos Polymers 0.000 description 2
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 2
- 101150021317 odhA gene Proteins 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 150000002894 organic compounds Chemical class 0.000 description 2
- 230000008520 organization Effects 0.000 description 2
- 230000003204 osmotic effect Effects 0.000 description 2
- 238000012261 overproduction Methods 0.000 description 2
- 101150076071 panD gene Proteins 0.000 description 2
- 229940055726 pantothenic acid Drugs 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- 239000002987 primer (paints) Substances 0.000 description 2
- 238000001742 protein purification Methods 0.000 description 2
- 238000001243 protein synthesis Methods 0.000 description 2
- 210000001938 protoplast Anatomy 0.000 description 2
- 230000004144 purine metabolism Effects 0.000 description 2
- 239000002213 purine nucleotide Substances 0.000 description 2
- 150000003212 purines Chemical class 0.000 description 2
- 101150057603 putP gene Proteins 0.000 description 2
- NHZMQXZHNVQTQA-UHFFFAOYSA-N pyridoxamine Chemical compound CC1=NC=C(CO)C(CN)=C1O NHZMQXZHNVQTQA-UHFFFAOYSA-N 0.000 description 2
- 235000008160 pyridoxine Nutrition 0.000 description 2
- 239000011677 pyridoxine Substances 0.000 description 2
- 229940107700 pyruvic acid Drugs 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 238000010188 recombinant method Methods 0.000 description 2
- 238000006722 reduction reaction Methods 0.000 description 2
- 235000019231 riboflavin-5'-phosphate Nutrition 0.000 description 2
- 239000002336 ribonucleotide Substances 0.000 description 2
- 125000003607 serino group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C(O[H])([H])[H] 0.000 description 2
- 150000003384 small molecules Chemical class 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 239000011721 thiamine Substances 0.000 description 2
- 238000004809 thin layer chromatography Methods 0.000 description 2
- RYYWUUFWQRZTIU-UHFFFAOYSA-K thiophosphate Chemical compound [O-]P([O-])([O-])=S RYYWUUFWQRZTIU-UHFFFAOYSA-K 0.000 description 2
- 101150014006 thrA gene Proteins 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 108700012359 toxins Proteins 0.000 description 2
- 108091005703 transmembrane proteins Proteins 0.000 description 2
- 102000035160 transmembrane proteins Human genes 0.000 description 2
- 230000004102 tricarboxylic acid cycle Effects 0.000 description 2
- 101150019416 trpA gene Proteins 0.000 description 2
- 101150100816 trpD gene Proteins 0.000 description 2
- 101150079930 trpGD gene Proteins 0.000 description 2
- 210000004881 tumor cell Anatomy 0.000 description 2
- 239000013603 viral vector Substances 0.000 description 2
- 235000019158 vitamin B6 Nutrition 0.000 description 2
- 239000011726 vitamin B6 Substances 0.000 description 2
- 229940011671 vitamin b6 Drugs 0.000 description 2
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 description 1
- TYEIDAYBPNPVII-NFJMKROFSA-N (2r)-2-amino-3-sulfanylbutanoic acid Chemical compound CC(S)[C@H](N)C(O)=O TYEIDAYBPNPVII-NFJMKROFSA-N 0.000 description 1
- NFFPKRVXIPSSQR-BXXZVTAOSA-N (2r,3r,4r)-2,3,4,5-tetrahydroxypentanamide Chemical compound NC(=O)[C@H](O)[C@H](O)[C@H](O)CO NFFPKRVXIPSSQR-BXXZVTAOSA-N 0.000 description 1
- LXJXRIRHZLFYRP-VKHMYHEASA-L (R)-2-Hydroxy-3-(phosphonooxy)-propanal Natural products O=C[C@H](O)COP([O-])([O-])=O LXJXRIRHZLFYRP-VKHMYHEASA-L 0.000 description 1
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 1
- NAOLWIGVYRIGTP-UHFFFAOYSA-N 1,3,5-trihydroxyanthracene-9,10-dione Chemical compound C1=CC(O)=C2C(=O)C3=CC(O)=CC(O)=C3C(=O)C2=C1 NAOLWIGVYRIGTP-UHFFFAOYSA-N 0.000 description 1
- BPQAUXWAEPYEJM-PQSJUMPYSA-N 1-hydroxy-8-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyanthracene-9,10-dione Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC1=CC=CC2=C1C(=O)C1=C(O)C=CC=C1C2=O BPQAUXWAEPYEJM-PQSJUMPYSA-N 0.000 description 1
- WJNGQIYEQLPJMN-IOSLPCCCSA-N 1-methylinosine Chemical compound C1=NC=2C(=O)N(C)C=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O WJNGQIYEQLPJMN-IOSLPCCCSA-N 0.000 description 1
- UWOCFOFVIBZJGH-UHFFFAOYSA-N 2,3-dihydrodipicolinic acid Chemical compound OC(=O)C1CC=CC(C(O)=O)=N1 UWOCFOFVIBZJGH-UHFFFAOYSA-N 0.000 description 1
- HLYBTPMYFWWNJN-UHFFFAOYSA-N 2-(2,4-dioxo-1h-pyrimidin-5-yl)-2-hydroxyacetic acid Chemical compound OC(=O)C(O)C1=CNC(=O)NC1=O HLYBTPMYFWWNJN-UHFFFAOYSA-N 0.000 description 1
- JAHNSTQSQJOJLO-UHFFFAOYSA-N 2-(3-fluorophenyl)-1h-imidazole Chemical compound FC1=CC=CC(C=2NC=CN=2)=C1 JAHNSTQSQJOJLO-UHFFFAOYSA-N 0.000 description 1
- HCYQTNUNMRYQLZ-UHFFFAOYSA-N 2-[(6-methyl-2,4-dioxo-1H-pyrimidin-5-yl)amino]acetic acid Chemical compound C(=O)(O)CNC=1C(NC(NC=1C)=O)=O HCYQTNUNMRYQLZ-UHFFFAOYSA-N 0.000 description 1
- PXTNVJRXRPGATQ-UHFFFAOYSA-N 2-[(6-methyl-4-oxo-2-sulfanylidene-1H-pyrimidin-5-yl)amino]acetic acid Chemical compound C(=O)(O)CNC=1C(NC(NC=1C)=S)=O PXTNVJRXRPGATQ-UHFFFAOYSA-N 0.000 description 1
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- UDOGNMDURIJYQC-UHFFFAOYSA-N 2-amino-6-methyl-1h-pteridin-4-one Chemical compound N1C(N)=NC(=O)C2=NC(C)=CN=C21 UDOGNMDURIJYQC-UHFFFAOYSA-N 0.000 description 1
- ASJSAQIRZKANQN-CRCLSJGQSA-N 2-deoxy-D-ribose Chemical compound OC[C@@H](O)[C@@H](O)CC=O ASJSAQIRZKANQN-CRCLSJGQSA-N 0.000 description 1
- XMSMHKMPBNTBOD-UHFFFAOYSA-N 2-dimethylamino-6-hydroxypurine Chemical compound N1C(N(C)C)=NC(=O)C2=C1N=CN2 XMSMHKMPBNTBOD-UHFFFAOYSA-N 0.000 description 1
- 108010082310 2-hydroxyacid dehydrogenase Proteins 0.000 description 1
- SMADWRYCYBUIKH-UHFFFAOYSA-N 2-methyl-7h-purin-6-amine Chemical compound CC1=NC(N)=C2NC=NC2=N1 SMADWRYCYBUIKH-UHFFFAOYSA-N 0.000 description 1
- 101710157142 2-methylene-furan-3-one reductase Proteins 0.000 description 1
- AQSRRZGQRFFFGS-UHFFFAOYSA-N 2-methylpyridin-3-ol Chemical compound CC1=NC=CC=C1O AQSRRZGQRFFFGS-UHFFFAOYSA-N 0.000 description 1
- 108010080376 3-Deoxy-7-Phosphoheptulonate Synthase Proteins 0.000 description 1
- 125000004080 3-carboxypropanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C(O[H])=O 0.000 description 1
- WVMWZWGZRAXUBK-SYTVJDICSA-N 3-dehydroquinic acid Chemical compound O[C@@H]1C[C@](O)(C(O)=O)CC(=O)[C@H]1O WVMWZWGZRAXUBK-SYTVJDICSA-N 0.000 description 1
- WVMWZWGZRAXUBK-UHFFFAOYSA-N 3-dehydroquinic acid Natural products OC1CC(O)(C(O)=O)CC(=O)C1O WVMWZWGZRAXUBK-UHFFFAOYSA-N 0.000 description 1
- KPULXFNPTWGJQH-UHFFFAOYSA-N 3-hydroxy-4-oxo-4-propan-2-yloxybutanoic acid Chemical compound CC(C)OC(=O)C(O)CC(O)=O KPULXFNPTWGJQH-UHFFFAOYSA-N 0.000 description 1
- 108010039636 3-isopropylmalate dehydrogenase Proteins 0.000 description 1
- OSJPPGNTCRNQQC-UWTATZPHSA-N 3-phospho-D-glyceric acid Chemical compound OC(=O)[C@H](O)COP(O)(O)=O OSJPPGNTCRNQQC-UWTATZPHSA-N 0.000 description 1
- 108010020183 3-phosphoshikimate 1-carboxyvinyltransferase Proteins 0.000 description 1
- GJAKJCICANKRFD-UHFFFAOYSA-N 4-acetyl-4-amino-1,3-dihydropyrimidin-2-one Chemical compound CC(=O)C1(N)NC(=O)NC=C1 GJAKJCICANKRFD-UHFFFAOYSA-N 0.000 description 1
- MSTNYGQPCMXVAQ-KIYNQFGBSA-N 5,6,7,8-tetrahydrofolic acid Chemical compound N1C=2C(=O)NC(N)=NC=2NCC1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 MSTNYGQPCMXVAQ-KIYNQFGBSA-N 0.000 description 1
- MQJSSLBGAQJNER-UHFFFAOYSA-N 5-(methylaminomethyl)-1h-pyrimidine-2,4-dione Chemical compound CNCC1=CNC(=O)NC1=O MQJSSLBGAQJNER-UHFFFAOYSA-N 0.000 description 1
- LQLQRFGHAALLLE-UHFFFAOYSA-N 5-bromouracil Chemical compound BrC1=CNC(=O)NC1=O LQLQRFGHAALLLE-UHFFFAOYSA-N 0.000 description 1
- ZFTBZKVVGZNMJR-UHFFFAOYSA-N 5-chlorouracil Chemical compound ClC1=CNC(=O)NC1=O ZFTBZKVVGZNMJR-UHFFFAOYSA-N 0.000 description 1
- KSNXJLQDQOIRIP-UHFFFAOYSA-N 5-iodouracil Chemical compound IC1=CNC(=O)NC1=O KSNXJLQDQOIRIP-UHFFFAOYSA-N 0.000 description 1
- KELXHQACBIUYSE-UHFFFAOYSA-N 5-methoxy-1h-pyrimidine-2,4-dione Chemical compound COC1=CNC(=O)NC1=O KELXHQACBIUYSE-UHFFFAOYSA-N 0.000 description 1
- LRSASMSXMSNRBT-UHFFFAOYSA-N 5-methylcytosine Chemical compound CC1=CNC(=O)N=C1N LRSASMSXMSNRBT-UHFFFAOYSA-N 0.000 description 1
- 108020005075 5S Ribosomal RNA Proteins 0.000 description 1
- MSSXOMSJDRHRMC-UHFFFAOYSA-N 9H-purine-2,6-diamine Chemical compound NC1=NC(N)=C2NC=NC2=N1 MSSXOMSJDRHRMC-UHFFFAOYSA-N 0.000 description 1
- 239000007991 ACES buffer Substances 0.000 description 1
- 102000021527 ATP binding proteins Human genes 0.000 description 1
- 108091011108 ATP binding proteins Proteins 0.000 description 1
- 108010058756 ATP phosphoribosyltransferase Proteins 0.000 description 1
- 101710103719 Acetolactate synthase large subunit Proteins 0.000 description 1
- 101710182467 Acetolactate synthase large subunit IlvB1 Proteins 0.000 description 1
- 101710171176 Acetolactate synthase large subunit IlvG Proteins 0.000 description 1
- 101710176702 Acetolactate synthase small subunit Proteins 0.000 description 1
- 101710147947 Acetolactate synthase small subunit 1, chloroplastic Proteins 0.000 description 1
- 101800001241 Acetylglutamate kinase Proteins 0.000 description 1
- 108010049445 Acetylornithine transaminase Proteins 0.000 description 1
- 108010009924 Aconitate hydratase Proteins 0.000 description 1
- ORILYTVJVMAKLC-UHFFFAOYSA-N Adamantane Natural products C1C(C2)CC3CC1CC2C3 ORILYTVJVMAKLC-UHFFFAOYSA-N 0.000 description 1
- 229930024421 Adenine Natural products 0.000 description 1
- 108010024223 Adenine phosphoribosyltransferase Proteins 0.000 description 1
- 102100029457 Adenine phosphoribosyltransferase Human genes 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 241000589158 Agrobacterium Species 0.000 description 1
- 102100027211 Albumin Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 108090000072 Aldehyde-Lyases Proteins 0.000 description 1
- 102000003677 Aldehyde-Lyases Human genes 0.000 description 1
- 101100163490 Alkalihalobacillus halodurans (strain ATCC BAA-125 / DSM 18197 / FERM 7344 / JCM 9153 / C-125) aroA1 gene Proteins 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 102100023635 Alpha-fetoprotein Human genes 0.000 description 1
- 108020004306 Alpha-ketoglutarate dehydrogenase Proteins 0.000 description 1
- 102000006589 Alpha-ketoglutarate dehydrogenase Human genes 0.000 description 1
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 102100034613 Annexin A2 Human genes 0.000 description 1
- 108090000668 Annexin A2 Proteins 0.000 description 1
- 108020001077 Anthranilate Phosphoribosyltransferase Proteins 0.000 description 1
- 241000219195 Arabidopsis thaliana Species 0.000 description 1
- 208000002109 Argyria Diseases 0.000 description 1
- 241001167018 Aroa Species 0.000 description 1
- 241000227150 Arthrobacter aureus Species 0.000 description 1
- 108020004652 Aspartate-Semialdehyde Dehydrogenase Proteins 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 101000950981 Bacillus subtilis (strain 168) Catabolic NAD-specific glutamate dehydrogenase RocG Proteins 0.000 description 1
- 101100216993 Bacillus subtilis (strain 168) aroD gene Proteins 0.000 description 1
- 101100443932 Bacillus subtilis (strain 168) dppE gene Proteins 0.000 description 1
- 101100082080 Bacillus subtilis (strain 168) pabA gene Proteins 0.000 description 1
- 101100078797 Bacillus subtilis (strain 168) racE gene Proteins 0.000 description 1
- 239000002028 Biomass Substances 0.000 description 1
- 101710201279 Biotin carboxyl carrier protein Proteins 0.000 description 1
- 108010018763 Biotin carboxylase Proteins 0.000 description 1
- 108700040198 Biotin synthases Proteins 0.000 description 1
- 102000018813 CASP8 and FADD Like Apoptosis Regulating Protein Human genes 0.000 description 1
- 108010027741 CASP8 and FADD Like Apoptosis Regulating Protein Proteins 0.000 description 1
- 101100441252 Caenorhabditis elegans csp-2 gene Proteins 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 240000001432 Calendula officinalis Species 0.000 description 1
- 235000005881 Calendula officinalis Nutrition 0.000 description 1
- 101100339117 Campylobacter jejuni subsp. jejuni serotype O:2 (strain ATCC 700819 / NCTC 11168) hisF1 gene Proteins 0.000 description 1
- 108010001857 Cell Surface Receptors Proteins 0.000 description 1
- 102000000844 Cell Surface Receptors Human genes 0.000 description 1
- 108010035563 Chloramphenicol O-acetyltransferase Proteins 0.000 description 1
- 108010003662 Chorismate synthase Proteins 0.000 description 1
- 102000008169 Co-Repressor Proteins Human genes 0.000 description 1
- 108010060434 Co-Repressor Proteins Proteins 0.000 description 1
- 108020004394 Complementary RNA Proteins 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 244000289527 Cordyline terminalis Species 0.000 description 1
- 235000009091 Cordyline terminalis Nutrition 0.000 description 1
- 108700031806 Corynebacterium diphtheriae DtxR Proteins 0.000 description 1
- 101000956566 Corynebacterium glutamicum (strain ATCC 13032 / DSM 20300 / BCRC 11384 / JCM 1318 / LMG 3730 / NCIMB 10025) L-lysine transport protein Proteins 0.000 description 1
- 101100381581 Corynebacterium glutamicum (strain ATCC 13032 / DSM 20300 / BCRC 11384 / JCM 1318 / LMG 3730 / NCIMB 10025) betP gene Proteins 0.000 description 1
- 101100332744 Corynebacterium glutamicum (strain ATCC 13032 / DSM 20300 / BCRC 11384 / JCM 1318 / LMG 3730 / NCIMB 10025) ectP gene Proteins 0.000 description 1
- 101100022064 Corynebacterium glutamicum (strain ATCC 13032 / DSM 20300 / BCRC 11384 / JCM 1318 / LMG 3730 / NCIMB 10025) lysI gene Proteins 0.000 description 1
- 101100246032 Corynebacterium glutamicum (strain ATCC 13032 / DSM 20300 / BCRC 11384 / JCM 1318 / LMG 3730 / NCIMB 10025) ptsM gene Proteins 0.000 description 1
- 101100481367 Corynebacterium glutamicum (strain ATCC 13032 / DSM 20300 / BCRC 11384 / JCM 1318 / LMG 3730 / NCIMB 10025) thtR gene Proteins 0.000 description 1
- 241001485655 Corynebacterium glutamicum ATCC 13032 Species 0.000 description 1
- 108700000035 Corynebacterium glutamicum BetP Proteins 0.000 description 1
- 101900213311 Corynebacterium glutamicum Threonine synthase Proteins 0.000 description 1
- 241000031482 Corynephage phi16 Species 0.000 description 1
- 101100138542 Cupriavidus necator (strain ATCC 17699 / DSM 428 / KCTC 22496 / NCIMB 10442 / H16 / Stanier 337) phbH gene Proteins 0.000 description 1
- 101100299477 Cupriavidus necator (strain ATCC 17699 / DSM 428 / KCTC 22496 / NCIMB 10442 / H16 / Stanier 337) phbI gene Proteins 0.000 description 1
- 101710095468 Cyclase Proteins 0.000 description 1
- 102100039868 Cytoplasmic aconitate hydratase Human genes 0.000 description 1
- NGHMDNPXVRFFGS-IUYQGCFVSA-N D-erythrose 4-phosphate Chemical compound O=C[C@H](O)[C@H](O)COP(O)(O)=O NGHMDNPXVRFFGS-IUYQGCFVSA-N 0.000 description 1
- WHUUTDBJXJRKMK-GSVOUGTGSA-N D-glutamic acid Chemical compound OC(=O)[C@H](N)CCC(O)=O WHUUTDBJXJRKMK-GSVOUGTGSA-N 0.000 description 1
- 239000011703 D-panthenol Substances 0.000 description 1
- 235000004866 D-panthenol Nutrition 0.000 description 1
- KTVPXOYAKDPRHY-SOOFDHNKSA-N D-ribofuranose 5-phosphate Chemical compound OC1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O KTVPXOYAKDPRHY-SOOFDHNKSA-N 0.000 description 1
- 239000003155 DNA primer Substances 0.000 description 1
- 230000033616 DNA repair Effects 0.000 description 1
- 230000008265 DNA repair mechanism Effects 0.000 description 1
- 241000702421 Dependoparvovirus Species 0.000 description 1
- 206010012442 Dermatitis contact Diseases 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 101710092096 Diaminopimelate decarboxylase Proteins 0.000 description 1
- 108030003594 Diaminopimelate decarboxylases Proteins 0.000 description 1
- 101100012958 Dictyostelium discoideum fkbp3 gene Proteins 0.000 description 1
- 101100229207 Dictyostelium discoideum glnA3 gene Proteins 0.000 description 1
- 108010014468 Dihydrodipicolinate Reductase Proteins 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 1
- 108010028127 Dihydrolipoamide Dehydrogenase Proteins 0.000 description 1
- 102000028526 Dihydrolipoamide Dehydrogenase Human genes 0.000 description 1
- 102000016607 Diphtheria Toxin Human genes 0.000 description 1
- 108010053187 Diphtheria Toxin Proteins 0.000 description 1
- 101710155351 Diphtheria toxin repressor Proteins 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 108700035159 EC 4.2.1.15 Proteins 0.000 description 1
- 108700035100 EC 4.2.1.52 Proteins 0.000 description 1
- 108091006149 Electron carriers Proteins 0.000 description 1
- 101100491986 Emericella nidulans (strain FGSC A4 / ATCC 38163 / CBS 112.46 / NRRL 194 / M139) aromA gene Proteins 0.000 description 1
- 108010067770 Endopeptidase K Proteins 0.000 description 1
- 108010013369 Enteropeptidase Proteins 0.000 description 1
- 102100029727 Enteropeptidase Human genes 0.000 description 1
- 102000010911 Enzyme Precursors Human genes 0.000 description 1
- 108010062466 Enzyme Precursors Proteins 0.000 description 1
- YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 1
- 241000588722 Escherichia Species 0.000 description 1
- 101100218845 Escherichia coli (strain K12) bioH gene Proteins 0.000 description 1
- 101100138654 Escherichia coli (strain K12) manZ gene Proteins 0.000 description 1
- 108091029865 Exogenous DNA Proteins 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 108010021555 GTP Pyrophosphokinase Proteins 0.000 description 1
- 102100034013 Gamma-glutamyl phosphate reductase Human genes 0.000 description 1
- 101710198928 Gamma-glutamyl phosphate reductase Proteins 0.000 description 1
- 108700039691 Genetic Promoter Regions Proteins 0.000 description 1
- 206010071602 Genetic polymorphism Diseases 0.000 description 1
- 102000016901 Glutamate dehydrogenase Human genes 0.000 description 1
- 108010016106 Glutamate-5-semialdehyde dehydrogenase Proteins 0.000 description 1
- 102100034294 Glutathione synthetase Human genes 0.000 description 1
- 102100031181 Glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 1
- 102100023903 Glycerol kinase Human genes 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 1
- 102000004144 Green Fluorescent Proteins Human genes 0.000 description 1
- 241000288105 Grus Species 0.000 description 1
- 239000007995 HEPES buffer Substances 0.000 description 1
- 101150057070 HPR gene Proteins 0.000 description 1
- 241001235200 Haemophilus influenzae Rd KW20 Species 0.000 description 1
- 101100028493 Haloferax volcanii (strain ATCC 29605 / DSM 3757 / JCM 8879 / NBRC 14742 / NCIMB 2012 / VKM B-1768 / DS2) pan2 gene Proteins 0.000 description 1
- 108090001102 Hammerhead ribozyme Proteins 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 101000911390 Homo sapiens Coagulation factor VIII Proteins 0.000 description 1
- 101000955042 Homo sapiens Deoxycytidylate deaminase Proteins 0.000 description 1
- 101001069973 Homo sapiens Glutathione synthetase Proteins 0.000 description 1
- 241000701109 Human adenovirus 2 Species 0.000 description 1
- 101000805434 Human herpesvirus 8 type P (isolate GK18) viral cyclin homolog Proteins 0.000 description 1
- 102000006933 Hydroxymethyl and Formyl Transferases Human genes 0.000 description 1
- 108010072462 Hydroxymethyl and Formyl Transferases Proteins 0.000 description 1
- UGQMRVRMYYASKQ-UHFFFAOYSA-N Hypoxanthine nucleoside Natural products OC1C(O)C(CO)OC1N1C(NC=NC2=O)=C2N=C1 UGQMRVRMYYASKQ-UHFFFAOYSA-N 0.000 description 1
- 101100519490 Idiomarina loihiensis (strain ATCC BAA-735 / DSM 15497 / L2-TR) pepQ1 gene Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 235000000177 Indigofera tinctoria Nutrition 0.000 description 1
- UGQMRVRMYYASKQ-KQYNXXCUSA-N Inosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(O)=C2N=C1 UGQMRVRMYYASKQ-KQYNXXCUSA-N 0.000 description 1
- 108010061833 Integrases Proteins 0.000 description 1
- 108010075869 Isocitrate Dehydrogenase Proteins 0.000 description 1
- 102000012011 Isocitrate Dehydrogenase Human genes 0.000 description 1
- 101710088105 Isocitrate dehydrogenase [NAD] subunit 1, mitochondrial Proteins 0.000 description 1
- 101710086399 Isocitrate dehydrogenase [NAD] subunit 2, mitochondrial Proteins 0.000 description 1
- 102100021332 Isocitrate dehydrogenase [NAD] subunit alpha, mitochondrial Human genes 0.000 description 1
- 108090000769 Isomerases Proteins 0.000 description 1
- 102000004195 Isomerases Human genes 0.000 description 1
- 239000007836 KH2PO4 Substances 0.000 description 1
- PWKSKIMOESPYIA-BYPYZUCNSA-N L-N-acetyl-Cysteine Chemical compound CC(=O)N[C@@H](CS)C(O)=O PWKSKIMOESPYIA-BYPYZUCNSA-N 0.000 description 1
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 1
- FFFHZYDWPBMWHY-VKHMYHEASA-N L-homocysteine Chemical compound OC(=O)[C@@H](N)CCS FFFHZYDWPBMWHY-VKHMYHEASA-N 0.000 description 1
- FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 1
- GHSJKUNUIHUPDF-BYPYZUCNSA-N L-thialysine Chemical compound NCCSC[C@H](N)C(O)=O GHSJKUNUIHUPDF-BYPYZUCNSA-N 0.000 description 1
- 101100433987 Latilactobacillus sakei subsp. sakei (strain 23K) ackA1 gene Proteins 0.000 description 1
- 108091026898 Leader sequence (mRNA) Proteins 0.000 description 1
- 239000007993 MOPS buffer Substances 0.000 description 1
- 241000829100 Macaca mulatta polyomavirus 1 Species 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 229910021380 Manganese Chloride Inorganic materials 0.000 description 1
- GLFNIEUTAYBVOC-UHFFFAOYSA-L Manganese chloride Chemical compound Cl[Mn]Cl GLFNIEUTAYBVOC-UHFFFAOYSA-L 0.000 description 1
- 101710141619 Meso-diaminopimelate D-dehydrogenase Proteins 0.000 description 1
- 101100242684 Mesorhizobium japonicum (strain LMG 29417 / CECT 9101 / MAFF 303099) panD1 gene Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 101100129629 Methanocaldococcus jannaschii (strain ATCC 43067 / DSM 2661 / JAL-1 / JCM 10045 / NBRC 100440) mrtA gene Proteins 0.000 description 1
- 101100292591 Methanothermobacter marburgensis (strain ATCC BAA-927 / DSM 2133 / JCM 14651 / NBRC 100331 / OCM 82 / Marburg) mtrA1 gene Proteins 0.000 description 1
- 101100261636 Methanothermobacter marburgensis (strain ATCC BAA-927 / DSM 2133 / JCM 14651 / NBRC 100331 / OCM 82 / Marburg) trpB2 gene Proteins 0.000 description 1
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 1
- 241000589327 Methylobacillus flagellatus Species 0.000 description 1
- 108060004795 Methyltransferase Proteins 0.000 description 1
- 102000016397 Methyltransferase Human genes 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 241000701029 Murid betaherpesvirus 1 Species 0.000 description 1
- 241000699660 Mus musculus Species 0.000 description 1
- 241000186359 Mycobacterium Species 0.000 description 1
- SGSSKEDGVONRGC-UHFFFAOYSA-N N(2)-methylguanine Chemical compound O=C1NC(NC)=NC2=C1N=CN2 SGSSKEDGVONRGC-UHFFFAOYSA-N 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- OTCCIMWXFLJLIA-UHFFFAOYSA-N N-acetyl-DL-aspartic acid Natural products CC(=O)NC(C(O)=O)CC(O)=O OTCCIMWXFLJLIA-UHFFFAOYSA-N 0.000 description 1
- OTCCIMWXFLJLIA-BYPYZUCNSA-N N-acetyl-L-aspartic acid Chemical compound CC(=O)N[C@H](C(O)=O)CC(O)=O OTCCIMWXFLJLIA-BYPYZUCNSA-N 0.000 description 1
- 102000006746 NADH Dehydrogenase Human genes 0.000 description 1
- 108010086428 NADH Dehydrogenase Proteins 0.000 description 1
- 229910004619 Na2MoO4 Inorganic materials 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 102000008763 Neurofilament Proteins Human genes 0.000 description 1
- 108010088373 Neurofilament Proteins Proteins 0.000 description 1
- 229910021586 Nickel(II) chloride Inorganic materials 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- 239000006057 Non-nutritive feed additive Substances 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 1
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 101150093941 PORA gene Proteins 0.000 description 1
- ZNXZGRMVNNHPCA-UHFFFAOYSA-N Pantetheine Natural products OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS ZNXZGRMVNNHPCA-UHFFFAOYSA-N 0.000 description 1
- 241000364057 Peoria Species 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 108010069013 Phenylalanine Hydroxylase Proteins 0.000 description 1
- 102100038223 Phenylalanine-4-hydroxylase Human genes 0.000 description 1
- 102000009097 Phosphorylases Human genes 0.000 description 1
- 108010073135 Phosphorylases Proteins 0.000 description 1
- 108010013381 Porins Proteins 0.000 description 1
- 102000017033 Porins Human genes 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 101710196435 Probable acetolactate synthase large subunit Proteins 0.000 description 1
- 101710181764 Probable acetolactate synthase small subunit Proteins 0.000 description 1
- 101710163410 Probable glycerol kinase Proteins 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- 108010078762 Protein Precursors Proteins 0.000 description 1
- 102000014961 Protein Precursors Human genes 0.000 description 1
- 102000009516 Protein Serine-Threonine Kinases Human genes 0.000 description 1
- 108010009341 Protein Serine-Threonine Kinases Proteins 0.000 description 1
- 108010001267 Protein Subunits Proteins 0.000 description 1
- 102000002067 Protein Subunits Human genes 0.000 description 1
- 101100297447 Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1) phnB gene Proteins 0.000 description 1
- 101710104000 Putative acetolactate synthase small subunit Proteins 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 108010090051 Pyruvate Dehydrogenase Complex Proteins 0.000 description 1
- 102000012751 Pyruvate Dehydrogenase Complex Human genes 0.000 description 1
- 101710189291 Quinone oxidoreductase Proteins 0.000 description 1
- 102100034576 Quinone oxidoreductase Human genes 0.000 description 1
- 101150070524 Rel gene Proteins 0.000 description 1
- 108020005091 Replication Origin Proteins 0.000 description 1
- 108700008625 Reporter Genes Proteins 0.000 description 1
- 101100381582 Rhizobium meliloti betS gene Proteins 0.000 description 1
- 102000006382 Ribonucleases Human genes 0.000 description 1
- 108010083644 Ribonucleases Proteins 0.000 description 1
- 108020001027 Ribosomal DNA Proteins 0.000 description 1
- MEFKEPWMEQBLKI-AIRLBKTGSA-N S-adenosyl-L-methioninate Chemical compound O[C@@H]1[C@H](O)[C@@H](C[S+](CC[C@H](N)C([O-])=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 MEFKEPWMEQBLKI-AIRLBKTGSA-N 0.000 description 1
- GBFLZEXEOZUWRN-VKHMYHEASA-M S-carboxylatomethyl-L-cysteine(1-) Chemical compound [O-]C(=O)[C@@H]([NH3+])CSCC([O-])=O GBFLZEXEOZUWRN-VKHMYHEASA-M 0.000 description 1
- 108010082913 S-layer proteins Proteins 0.000 description 1
- 101100434411 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) ADH1 gene Proteins 0.000 description 1
- 108010060059 Sarcosine Oxidase Proteins 0.000 description 1
- 102000008118 Sarcosine oxidase Human genes 0.000 description 1
- 108091081021 Sense strand Proteins 0.000 description 1
- 241000607715 Serratia marcescens Species 0.000 description 1
- 108700018269 Serratia marcescens SlaA Proteins 0.000 description 1
- 108050008280 Shikimate dehydrogenase Proteins 0.000 description 1
- 108010051611 Signal Recognition Particle Proteins 0.000 description 1
- 102000013598 Signal recognition particle Human genes 0.000 description 1
- 101800002927 Small subunit Proteins 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 240000006394 Sorghum bicolor Species 0.000 description 1
- 235000011684 Sorghum saccharatum Nutrition 0.000 description 1
- 238000002105 Southern blotting Methods 0.000 description 1
- 108010073771 Soybean Proteins Proteins 0.000 description 1
- 241000592344 Spermatophyta Species 0.000 description 1
- 108091081024 Start codon Proteins 0.000 description 1
- 101000870438 Streptococcus gordonii UDP-N-acetylglucosamine-peptide N-acetylglucosaminyltransferase stabilizing protein GtfB Proteins 0.000 description 1
- 241000187747 Streptomyces Species 0.000 description 1
- 241000187432 Streptomyces coelicolor Species 0.000 description 1
- 101100125907 Streptomyces coelicolor (strain ATCC BAA-471 / A3(2) / M145) ilvC1 gene Proteins 0.000 description 1
- 101100370749 Streptomyces coelicolor (strain ATCC BAA-471 / A3(2) / M145) trpC1 gene Proteins 0.000 description 1
- 101100038645 Streptomyces griseus rppA gene Proteins 0.000 description 1
- 241001655322 Streptomycetales Species 0.000 description 1
- 108010056371 Succinyl-diaminopimelate desuccinylase Proteins 0.000 description 1
- 101710117283 Sucrose permease Proteins 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 108091008874 T cell receptors Proteins 0.000 description 1
- 102000016266 T-Cell Antigen Receptors Human genes 0.000 description 1
- 241000718007 Taenionema palladium Species 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 241000223892 Tetrahymena Species 0.000 description 1
- 101100157012 Thermoanaerobacterium saccharolyticum (strain DSM 8691 / JW/SL-YS485) xynB gene Proteins 0.000 description 1
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical compound C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 description 1
- RYYWUUFWQRZTIU-UHFFFAOYSA-N Thiophosphoric acid Chemical class OP(O)(S)=O RYYWUUFWQRZTIU-UHFFFAOYSA-N 0.000 description 1
- 108091036066 Three prime untranslated region Proteins 0.000 description 1
- 108090000190 Thrombin Proteins 0.000 description 1
- 108010043652 Transketolase Proteins 0.000 description 1
- 102100033055 Transketolase Human genes 0.000 description 1
- 101100187081 Trichormus variabilis (strain ATCC 29413 / PCC 7937) nifS1 gene Proteins 0.000 description 1
- 102000005924 Triose-Phosphate Isomerase Human genes 0.000 description 1
- 108700015934 Triose-phosphate isomerases Proteins 0.000 description 1
- 108010075344 Tryptophan synthase Proteins 0.000 description 1
- 101800000716 Tumor necrosis factor, membrane form Proteins 0.000 description 1
- 102400000700 Tumor necrosis factor, membrane form Human genes 0.000 description 1
- 102100021436 UDP-glucose 4-epimerase Human genes 0.000 description 1
- 108010075202 UDP-glucose 4-epimerase Proteins 0.000 description 1
- 108010082433 UDP-glucose-hexose-1-phosphate uridylyltransferase Proteins 0.000 description 1
- ZVNYJIZDIRKMBF-UHFFFAOYSA-N Vesnarinone Chemical compound C1=C(OC)C(OC)=CC=C1C(=O)N1CCN(C=2C=C3CCC(=O)NC3=CC=2)CC1 ZVNYJIZDIRKMBF-UHFFFAOYSA-N 0.000 description 1
- 101000645119 Vibrio campbellii (strain ATCC BAA-1116 / BB120) Nucleotide-binding protein VIBHAR_03667 Proteins 0.000 description 1
- 241000440386 Vibrio phage phi16 Species 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 239000005862 Whey Substances 0.000 description 1
- 108010046377 Whey Proteins Proteins 0.000 description 1
- 102000007544 Whey Proteins Human genes 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 102100029089 Xylulose kinase Human genes 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- INAPMGSXUVUWAF-GCVPSNMTSA-N [(2r,3s,5r,6r)-2,3,4,5,6-pentahydroxycyclohexyl] dihydrogen phosphate Chemical compound OC1[C@H](O)[C@@H](O)C(OP(O)(O)=O)[C@H](O)[C@@H]1O INAPMGSXUVUWAF-GCVPSNMTSA-N 0.000 description 1
- BUFLLCUFNHESEH-UHFFFAOYSA-N [5-(2-amino-6-oxo-3h-purin-9-yl)-4-hydroxy-2-[[hydroxy(phosphonooxy)phosphoryl]oxymethyl]oxolan-3-yl] phosphono hydrogen phosphate Chemical compound C1=2NC(N)=NC(=O)C=2N=CN1C1OC(COP(O)(=O)OP(O)(O)=O)C(OP(O)(=O)OP(O)(O)=O)C1O BUFLLCUFNHESEH-UHFFFAOYSA-N 0.000 description 1
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 101150006213 ackA gene Proteins 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 108010064926 acyl-CoA carboxylase Proteins 0.000 description 1
- 101150102866 adc1 gene Proteins 0.000 description 1
- 229960001570 ademetionine Drugs 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- 108060000200 adenylate cyclase Proteins 0.000 description 1
- 102000030621 adenylate cyclase Human genes 0.000 description 1
- 210000004100 adrenal gland Anatomy 0.000 description 1
- 238000001261 affinity purification Methods 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 230000003281 allosteric effect Effects 0.000 description 1
- 108010026331 alpha-Fetoproteins Proteins 0.000 description 1
- OBETXYAYXDNJHR-UHFFFAOYSA-N alpha-ethylcaproic acid Natural products CCCCC(CC)C(O)=O OBETXYAYXDNJHR-UHFFFAOYSA-N 0.000 description 1
- HWXBTNAVRSUOJR-UHFFFAOYSA-N alpha-hydroxyglutaric acid Natural products OC(=O)C(O)CCC(O)=O HWXBTNAVRSUOJR-UHFFFAOYSA-N 0.000 description 1
- 229940009533 alpha-ketoglutaric acid Drugs 0.000 description 1
- WUOACPNHFRMFPN-UHFFFAOYSA-N alpha-terpineol Chemical compound CC1=CCC(C(C)(C)O)CC1 WUOACPNHFRMFPN-UHFFFAOYSA-N 0.000 description 1
- 230000037354 amino acid metabolism Effects 0.000 description 1
- 238000004176 ammonification Methods 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 230000001028 anti-proliverative effect Effects 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229940041181 antineoplastic drug Drugs 0.000 description 1
- 229940114079 arachidonic acid Drugs 0.000 description 1
- 235000021342 arachidonic acid Nutrition 0.000 description 1
- 101150042732 aroC gene Proteins 0.000 description 1
- 101150083869 aroK gene Proteins 0.000 description 1
- 150000004982 aromatic amines Chemical class 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000002238 attenuated effect Effects 0.000 description 1
- 230000037358 bacterial metabolism Effects 0.000 description 1
- LFYJSSARVMHQJB-QIXNEVBVSA-N bakuchiol Chemical compound CC(C)=CCC[C@@](C)(C=C)\C=C\C1=CC=C(O)C=C1 LFYJSSARVMHQJB-QIXNEVBVSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- DRTQHJPVMGBUCF-PSQAKQOGSA-N beta-L-uridine Natural products O[C@H]1[C@@H](O)[C@H](CO)O[C@@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-PSQAKQOGSA-N 0.000 description 1
- 238000007068 beta-elimination reaction Methods 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 108091008324 binding proteins Proteins 0.000 description 1
- 101150029327 bioB gene Proteins 0.000 description 1
- 238000004166 bioassay Methods 0.000 description 1
- 230000003851 biochemical process Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 238000013378 biophysical characterization Methods 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 150000005693 branched-chain amino acids Chemical class 0.000 description 1
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 235000021074 carbohydrate intake Nutrition 0.000 description 1
- 238000010523 cascade reaction Methods 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 230000004700 cellular uptake Effects 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 238000002144 chemical decomposition reaction Methods 0.000 description 1
- 238000012824 chemical production Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 230000003399 chemotactic effect Effects 0.000 description 1
- 229940038705 chlamydia trachomatis Drugs 0.000 description 1
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
- 229960005091 chloramphenicol Drugs 0.000 description 1
- BKHZIBWEHPHYAI-UHFFFAOYSA-N chloroform;3-methylbutan-1-ol Chemical compound ClC(Cl)Cl.CC(C)CCO BKHZIBWEHPHYAI-UHFFFAOYSA-N 0.000 description 1
- ZYWFEOZQIUMEGL-UHFFFAOYSA-N chloroform;3-methylbutan-1-ol;phenol Chemical compound ClC(Cl)Cl.CC(C)CCO.OC1=CC=CC=C1 ZYWFEOZQIUMEGL-UHFFFAOYSA-N 0.000 description 1
- 238000011210 chromatographic step Methods 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 230000002759 chromosomal effect Effects 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 239000013599 cloning vector Substances 0.000 description 1
- 101150036359 clpB gene Proteins 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 238000002742 combinatorial mutagenesis Methods 0.000 description 1
- 230000009137 competitive binding Effects 0.000 description 1
- 239000008139 complexing agent Substances 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000021615 conjugation Effects 0.000 description 1
- NKLPQNGYXWVELD-UHFFFAOYSA-M coomassie brilliant blue Chemical compound [Na+].C1=CC(OCC)=CC=C1NC1=CC=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C=CC(=CC=2)N(CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=C1 NKLPQNGYXWVELD-UHFFFAOYSA-M 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 244000038559 crop plants Species 0.000 description 1
- 101150001544 crr gene Proteins 0.000 description 1
- 101150049887 cspB gene Proteins 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Natural products NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 1
- 230000001086 cytosolic effect Effects 0.000 description 1
- 238000006114 decarboxylation reaction Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- SQIFACVGCPWBQZ-UHFFFAOYSA-N delta-terpineol Natural products CC(C)(O)C1CCC(=C)CC1 SQIFACVGCPWBQZ-UHFFFAOYSA-N 0.000 description 1
- 230000030609 dephosphorylation Effects 0.000 description 1
- 230000002074 deregulated effect Effects 0.000 description 1
- 229960003949 dexpanthenol Drugs 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 108010082690 diaminopimelic acid decarboxylase Proteins 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- AIUDWMLXCFRVDR-UHFFFAOYSA-N dimethyl 2-(3-ethyl-3-methylpentyl)propanedioate Chemical class CCC(C)(CC)CCC(C(=O)OC)C(=O)OC AIUDWMLXCFRVDR-UHFFFAOYSA-N 0.000 description 1
- 101150036185 dnaQ gene Proteins 0.000 description 1
- 238000011143 downstream manufacturing Methods 0.000 description 1
- 238000009509 drug development Methods 0.000 description 1
- 238000007877 drug screening Methods 0.000 description 1
- 101150026384 dtxR gene Proteins 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 239000005712 elicitor Substances 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 150000002085 enols Chemical class 0.000 description 1
- 230000009088 enzymatic function Effects 0.000 description 1
- 238000001952 enzyme assay Methods 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 108010056732 factor EF-P Proteins 0.000 description 1
- 101150111583 fda gene Proteins 0.000 description 1
- 230000008713 feedback mechanism Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 229960002949 fluorouracil Drugs 0.000 description 1
- 101150075316 folE gene Proteins 0.000 description 1
- 229940014144 folate Drugs 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 235000019264 food flavour enhancer Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 230000022244 formylation Effects 0.000 description 1
- 238000006170 formylation reaction Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000013611 frozen food Nutrition 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 230000000855 fungicidal effect Effects 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 108091008053 gene clusters Proteins 0.000 description 1
- 238000003208 gene overexpression Methods 0.000 description 1
- 238000012252 genetic analysis Methods 0.000 description 1
- 101150081163 glnA gene Proteins 0.000 description 1
- 101150019449 glnB gene Proteins 0.000 description 1
- 101150013801 glnD gene Proteins 0.000 description 1
- 101150106096 gltA gene Proteins 0.000 description 1
- 101150041871 gltB gene Proteins 0.000 description 1
- 101150039906 gltD gene Proteins 0.000 description 1
- 101150021650 gluA gene Proteins 0.000 description 1
- 101150017583 gluC gene Proteins 0.000 description 1
- 101150074147 gluD gene Proteins 0.000 description 1
- 108010050322 glutamate acetyltransferase Proteins 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 102000006602 glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 1
- 230000002414 glycolytic effect Effects 0.000 description 1
- 125000003147 glycosyl group Chemical group 0.000 description 1
- 235000013882 gravy Nutrition 0.000 description 1
- 239000005090 green fluorescent protein Substances 0.000 description 1
- 239000007952 growth promoter Substances 0.000 description 1
- ZJYYHGLJYGJLLN-UHFFFAOYSA-N guanidinium thiocyanate Chemical compound SC#N.NC(N)=N ZJYYHGLJYGJLLN-UHFFFAOYSA-N 0.000 description 1
- 150000003278 haem Chemical class 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- XLYOFNOQVPJJNP-ZSJDYOACSA-N heavy water Substances [2H]O[2H] XLYOFNOQVPJJNP-ZSJDYOACSA-N 0.000 description 1
- CATSNJVOTSVZJV-UHFFFAOYSA-N heptan-2-one Chemical compound CCCCCC(C)=O CATSNJVOTSVZJV-UHFFFAOYSA-N 0.000 description 1
- RVRCFVVLDHTFFA-UHFFFAOYSA-N heptasodium;tungsten;nonatriacontahydrate Chemical compound O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[W].[W].[W].[W].[W].[W].[W].[W].[W].[W].[W] RVRCFVVLDHTFFA-UHFFFAOYSA-N 0.000 description 1
- 230000002363 herbicidal effect Effects 0.000 description 1
- 239000004009 herbicide Substances 0.000 description 1
- FBPFZTCFMRRESA-UHFFFAOYSA-N hexane-1,2,3,4,5,6-hexol Chemical compound OCC(O)C(O)C(O)C(O)CO FBPFZTCFMRRESA-UHFFFAOYSA-N 0.000 description 1
- 101150050908 hisA gene Proteins 0.000 description 1
- 101150054929 hisE gene Proteins 0.000 description 1
- 101150096813 hisF gene Proteins 0.000 description 1
- 101150032598 hisG gene Proteins 0.000 description 1
- 102000057593 human F8 Human genes 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 101150064958 ideR gene Proteins 0.000 description 1
- 101150090497 ilvC gene Proteins 0.000 description 1
- 101150077793 ilvH gene Proteins 0.000 description 1
- 101150060643 ilvN gene Proteins 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 101150009044 impA gene Proteins 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 229940097275 indigo Drugs 0.000 description 1
- COHYTHOBJLSHDF-UHFFFAOYSA-N indigo powder Natural products N1C2=CC=CC=C2C(=O)C1=C1C(=O)C2=CC=CC=C2N1 COHYTHOBJLSHDF-UHFFFAOYSA-N 0.000 description 1
- 239000000411 inducer Substances 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 239000012499 inoculation medium Substances 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- 101150021879 iscS gene Proteins 0.000 description 1
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 229940116298 l- malic acid Drugs 0.000 description 1
- 101150109249 lacI gene Proteins 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- WQVJUBFKFCDYDQ-BBWFWOEESA-N leubethanol Natural products C1=C(C)C=C2[C@H]([C@H](CCC=C(C)C)C)CC[C@@H](C)C2=C1O WQVJUBFKFCDYDQ-BBWFWOEESA-N 0.000 description 1
- AGBQKNBQESQNJD-UHFFFAOYSA-M lipoate Chemical compound [O-]C(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-M 0.000 description 1
- 238000001638 lipofection Methods 0.000 description 1
- 235000019136 lipoic acid Nutrition 0.000 description 1
- 235000015250 liver sausages Nutrition 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 101150076679 lysG gene Proteins 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 230000002101 lytic effect Effects 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 108010076172 malate dehydrogenase (acceptor) Proteins 0.000 description 1
- 210000005075 mammary gland Anatomy 0.000 description 1
- 239000011565 manganese chloride Substances 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 238000000816 matrix-assisted laser desorption--ionisation Methods 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 239000012533 medium component Substances 0.000 description 1
- 230000009061 membrane transport Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 229960000485 methotrexate Drugs 0.000 description 1
- LVHBHZANLOWSRM-UHFFFAOYSA-N methylenebutanedioic acid Natural products OC(=O)CC(=C)C(O)=O LVHBHZANLOWSRM-UHFFFAOYSA-N 0.000 description 1
- XBCXJKGHPABGSD-UHFFFAOYSA-N methyluracil Natural products CN1C=CC(=O)NC1=O XBCXJKGHPABGSD-UHFFFAOYSA-N 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 238000009629 microbiological culture Methods 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000003068 molecular probe Substances 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 239000004223 monosodium glutamate Substances 0.000 description 1
- 230000004899 motility Effects 0.000 description 1
- 101150069500 mtrA gene Proteins 0.000 description 1
- 101150047269 murI gene Proteins 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- FZQMZXGTZAPBAK-UHFFFAOYSA-N n-(3-methylbutyl)-7h-purin-6-amine Chemical compound CC(C)CCNC1=NC=NC2=C1NC=N2 FZQMZXGTZAPBAK-UHFFFAOYSA-N 0.000 description 1
- 210000004898 n-terminal fragment Anatomy 0.000 description 1
- 210000004897 n-terminal region Anatomy 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 238000001320 near-infrared absorption spectroscopy Methods 0.000 description 1
- 230000001338 necrotic effect Effects 0.000 description 1
- 210000005044 neurofilament Anatomy 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- QMMRZOWCJAIUJA-UHFFFAOYSA-L nickel dichloride Chemical compound Cl[Ni]Cl QMMRZOWCJAIUJA-UHFFFAOYSA-L 0.000 description 1
- 229960002715 nicotine Drugs 0.000 description 1
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 1
- 101150082753 nifS gene Proteins 0.000 description 1
- 229910017464 nitrogen compound Inorganic materials 0.000 description 1
- 150000002830 nitrogen compounds Chemical class 0.000 description 1
- 102000042567 non-coding RNA Human genes 0.000 description 1
- 230000037360 nucleotide metabolism Effects 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 229960003104 ornithine Drugs 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- KHPXUQMNIQBQEV-UHFFFAOYSA-N oxaloacetic acid Chemical compound OC(=O)CC(=O)C(O)=O KHPXUQMNIQBQEV-UHFFFAOYSA-N 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 101150081585 panB gene Proteins 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- ZNXZGRMVNNHPCA-VIFPVBQESA-N pantetheine Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCS ZNXZGRMVNNHPCA-VIFPVBQESA-N 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000004108 pentose phosphate pathway Effects 0.000 description 1
- 150000002972 pentoses Chemical class 0.000 description 1
- 101150017363 pepQ gene Proteins 0.000 description 1
- 102000023856 peptide binding proteins Human genes 0.000 description 1
- 108091008399 peptide binding proteins Proteins 0.000 description 1
- 238000010647 peptide synthesis reaction Methods 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 229940066779 peptones Drugs 0.000 description 1
- 108091005706 peripheral membrane proteins Proteins 0.000 description 1
- 210000000578 peripheral nerve Anatomy 0.000 description 1
- 238000005502 peroxidation Methods 0.000 description 1
- 238000002823 phage display Methods 0.000 description 1
- 101150023849 pheA gene Proteins 0.000 description 1
- RGCLLPNLLBQHPF-HJWRWDBZSA-N phosphamidon Chemical compound CCN(CC)C(=O)C(\Cl)=C(/C)OP(=O)(OC)OC RGCLLPNLLBQHPF-HJWRWDBZSA-N 0.000 description 1
- 108010085336 phosphoribosyl-AMP cyclohydrolase Proteins 0.000 description 1
- 230000002186 photoactivation Effects 0.000 description 1
- 238000000206 photolithography Methods 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 230000008488 polyadenylation Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 150000004032 porphyrins Chemical class 0.000 description 1
- 230000004481 post-translational protein modification Effects 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- FPWMCUPFBRFMLH-UHFFFAOYSA-N prephenic acid Natural products OC1C=CC(CC(=O)C(O)=O)(C(O)=O)C=C1 FPWMCUPFBRFMLH-UHFFFAOYSA-N 0.000 description 1
- FPWMCUPFBRFMLH-HDKIZWTHSA-N prephenic acid Chemical compound O[C@H]1C=C[C@](CC(=O)C(O)=O)(C(O)=O)C=C1 FPWMCUPFBRFMLH-HDKIZWTHSA-N 0.000 description 1
- 235000013324 preserved food Nutrition 0.000 description 1
- 101150077403 priA gene Proteins 0.000 description 1
- 238000011027 product recovery Methods 0.000 description 1
- 108010007439 proline transporter Proteins 0.000 description 1
- ULWHHBHJGPPBCO-UHFFFAOYSA-N propane-1,1-diol Chemical compound CCC(O)O ULWHHBHJGPPBCO-UHFFFAOYSA-N 0.000 description 1
- 201000005484 prostate carcinoma in situ Diseases 0.000 description 1
- 235000019833 protease Nutrition 0.000 description 1
- 229940076376 protein agonist Drugs 0.000 description 1
- 229940076372 protein antagonist Drugs 0.000 description 1
- 230000004853 protein function Effects 0.000 description 1
- 230000009145 protein modification Effects 0.000 description 1
- 230000007026 protein scission Effects 0.000 description 1
- 230000006337 proteolytic cleavage Effects 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- FCHXJFJNDJXENQ-UHFFFAOYSA-N pyridoxal hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(C=O)=C1O FCHXJFJNDJXENQ-UHFFFAOYSA-N 0.000 description 1
- 235000008151 pyridoxamine Nutrition 0.000 description 1
- 239000011699 pyridoxamine Substances 0.000 description 1
- WQGWDDDVZFFDIG-UHFFFAOYSA-N pyrogallol Chemical compound OC1=CC=CC(O)=C1O WQGWDDDVZFFDIG-UHFFFAOYSA-N 0.000 description 1
- 229940005657 pyrophosphoric acid Drugs 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 229940047431 recombinate Drugs 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 108700021653 rel Genes Proteins 0.000 description 1
- 238000004153 renaturation Methods 0.000 description 1
- 238000003571 reporter gene assay Methods 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 125000002652 ribonucleotide group Chemical group 0.000 description 1
- 239000010979 ruby Substances 0.000 description 1
- 229910001750 ruby Inorganic materials 0.000 description 1
- 108010038196 saccharide-binding proteins Proteins 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- 235000003441 saturated fatty acids Nutrition 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 238000012106 screening analysis Methods 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 101150114545 secE gene Proteins 0.000 description 1
- 101150004862 secG gene Proteins 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 108020001482 shikimate kinase Proteins 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 239000011684 sodium molybdate Substances 0.000 description 1
- TVXXNOYZHKPKGW-UHFFFAOYSA-N sodium molybdate (anhydrous) Chemical compound [Na+].[Na+].[O-][Mo]([O-])(=O)=O TVXXNOYZHKPKGW-UHFFFAOYSA-N 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 101150112901 soxA gene Proteins 0.000 description 1
- 235000019710 soybean protein Nutrition 0.000 description 1
- 230000009870 specific binding Effects 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 238000003153 stable transfection Methods 0.000 description 1
- 238000012409 standard PCR amplification Methods 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 101150111745 sucA gene Proteins 0.000 description 1
- 125000000446 sulfanediyl group Chemical group *S* 0.000 description 1
- DHCDFWKWKRSZHF-UHFFFAOYSA-N sulfurothioic S-acid Chemical compound OS(O)(=O)=S DHCDFWKWKRSZHF-UHFFFAOYSA-N 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 229940116411 terpineol Drugs 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 101150027278 thiX gene Chemical group 0.000 description 1
- 150000003544 thiamines Chemical class 0.000 description 1
- 229960002663 thioctic acid Drugs 0.000 description 1
- 229960004072 thrombin Drugs 0.000 description 1
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 1
- 101150106737 tpd gene Proteins 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 238000005891 transamination reaction Methods 0.000 description 1
- 230000013715 transcription antitermination Effects 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 230000014621 translational initiation Effects 0.000 description 1
- 230000005945 translocation Effects 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 125000002264 triphosphate group Chemical group [H]OP(=O)(O[H])OP(=O)(O[H])OP(=O)(O[H])O* 0.000 description 1
- 150000004043 trisaccharides Chemical class 0.000 description 1
- 101150035767 trp gene Proteins 0.000 description 1
- 101150081616 trpB gene Proteins 0.000 description 1
- 101150111232 trpB-1 gene Proteins 0.000 description 1
- 101150016309 trpC gene Proteins 0.000 description 1
- 101150034486 trpG gene Proteins 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 241000701161 unidentified adenovirus Species 0.000 description 1
- 241000701447 unidentified baculovirus Species 0.000 description 1
- 241001430294 unidentified retrovirus Species 0.000 description 1
- DRTQHJPVMGBUCF-UHFFFAOYSA-N uracil arabinoside Natural products OC1C(O)C(CO)OC1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-UHFFFAOYSA-N 0.000 description 1
- 230000004143 urea cycle Effects 0.000 description 1
- 229940045145 uridine Drugs 0.000 description 1
- MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- WCNMEQDMUYVWMJ-JPZHCBQBSA-N wybutoxosine Chemical compound C1=NC=2C(=O)N3C(CC([C@H](NC(=O)OC)C(=O)OC)OO)=C(C)N=C3N(C)C=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O WCNMEQDMUYVWMJ-JPZHCBQBSA-N 0.000 description 1
- 229940075420 xanthine Drugs 0.000 description 1
- 101150110790 xylB gene Proteins 0.000 description 1
- 108091022915 xylulokinase Proteins 0.000 description 1
- 210000005253 yeast cell Anatomy 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
- 239000011686 zinc sulphate Substances 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/52—Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Isolated nucleic acid molecules, designated PTS nucleic acid molecules, which encode novel PTS proteins from Corynebacterium glutamicum are described. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing PTS nucleic acid molecules, and host cells into which the expression vectors have been introduced. The invention still further provides isolated PTS proteins, mutated PTS proteins, fusion proteins, antigenic peptides and methods for the improvement of production of a desired compound from C. glutamicum based on genetic engineering of PTS genes in this organism.
Description
The application is the divisional application for the Chinese patent application 00812165.6 " Orynebacterium: the Corynebacterium glutamicum gene of sugar phosphotransferase system proteins " that the applying date is on June 27th, 2000.
Technical field
The present invention relates to the nucleic acid molecules of the new Corynebacterium glutamicum pts protein of the coding of separation.The present invention also relates to antisense nucleic acid molecule, the recombinant expression carrier containing PTS nucleic acid molecules, and imported the host cell of expression vector.The present invention is also further to isolated pts protein, PTS mutain, fused protein, Antigenic Peptide, and the method for improving the required production of chemicals carried out by the organism based on Corynebacterium glutamicum PTS gene genetic engineering.
Background technique
Specific product and by-product in cell in naturally occurring metabolic process have purposes, including food, feed, cosmetics and pharmaceutical industries in many industries.These molecules are collectively referred to as " fine chemical ", including organic acid, protein sources and amino acid, nucleotide and the nucleosides in non-protein source, lipid and fatty acid, glycol, carbohydrate, aromatic compound, vitamin and co-factor and enzyme.The bacterium of a large amount of specific required molecules can be generated and secreted by large-scale culture, and most convenient prepares these products.A kind of particularly useful organism for this purpose is exactly Corynebacterium glutamicum (Corynebacterium glutamicum), a kind of Gram-positive nonpathogenic bacteria.By bacterial strain screening, there are many mutant strains for generating large quantities of required compounds.However, the bacterial strain screening carried out to improve particular molecule production, is the process an of time-consuming and difficulty.
Summary of the invention
The present invention provides new bacterial nucleic acid molecule, these molecules serve many purposes.These purposes include that identification can produce the microorganism of fine chemical, the generation for adjusting Corynebacterium glutamicum or the fine chemical in relationship bacterium, the parting of Corynebacterium glutamicum or relationship bacterium and identification, as the reference point for drawing Corynebacterium glutamicum gene group map.These new nucleic acid molecule encoding protein, referred to herein as phosphoenolpyruvate: sugar phosphotransferase system (PTS) protein.
Corynebacterium glutamicum is a kind of Gram-positive aerobic bacterium, usually be used to that various fine chemicals be mass produced in the industry, is also used for degradation of hydrocarbon (such as in Oil spills) and oxidation terpineol.Therefore, PTS nucleic acid molecules of the invention can be used to identify the microorganism that can be used to produce fine chemical, such as pass through fermentation process.Adjust the expression of PTS nucleic acid molecules of the present invention, or the sequence of modification PTS nucleic acid molecules of the present invention, it can be used for adjusting the production (for example, the generation for improving one or more kinds of fine chemicals in bar bacterium or brevibacterium) of one or more kinds of fine chemicals in microorganism.
PTS nucleic acid molecules of the present invention can be used for identifying a kind of microorganism whether be Corynebacterium glutamicum perhaps its relationship bacterial strain or identification microorganism population mixture Glutamic Acid bar bacterium or its relationship bacterial strain presence.The present invention provides the nucleic acid sequences of many Corynebacterium glutamicum genes;Under strict conditions, the genomic DNA extracted from single microorganism or mixed microorganism culturing in groups object is detected with probe, which covers the distinctive one section of region of Corynebacterium glutamicum gene, may determine whether with the presence of the microorganism.Although Corynebacterium glutamicum itself be it is non-pathogenic, it is related with the pathogen species in human body, such as Corynebacterium diphtheriae bacterium (Corynebacterium diphtheriae) (diphtheria cause a disease original);This microorganism is detected with great Clinical practicability.
PTS nucleic acid molecules of the present invention are also used as drawing the reference point of Corynebacterium glutamicum gene group map, or draw the reference point of its relationship strain gene group map.Similar, perhaps its variant or part thereof may be used as the genetic marker of genetic engineering bar bacterium or brevibacterium to these molecules.
It, can be seeming that high-energy carbon-containing molecules as glucose are transported into Corynebacterium glutamicum, or participate in the Cellular Signaling Transduction Mediated in the microorganism for example, the pts protein of novel nucleic acids molecule encoding of the present invention.In view of the practicability for the cloning vector that can be used in corynebacterium glutamicum, such as in Sinskey et al., US patent number No.4,649, disclosed in 119, and consider Genetic Manipulative Technology (Yashihama the et al, J.Bacteriol.162:591-597 (1985) of Corynebacterium glutamicum and relationship brevibacterium strain (such as brevibacterium);Katsumata et al., J.Bacteriol.159:306-311 (1984);And Santamaria et al., J.Gen.Microbiol.130:2237-2246 (1984)), nucleic acid molecules of the invention can be used for the genetic engineering of the organism, make that one or more kinds of fine chemicals are better or the more effective producer.
PTS molecule of the invention can be modified, so that yield, production and/or the production efficiency of one or more kinds of fine chemicals are improved.For example, by modifying a kind of pts protein for participating in glucose uptake its activity can be optimized, so that the rate that glucose uptake quantity or glucose are transported into cell is improved.Glucose inside cells or other carbohydrate degradations can provide energy, the biochemical reaction that these energy can be used for pushing energy unfavorable, such as those are related to the reaction of fine chemical biosynthesis.Degradation also provides intermediate or precursor molecule necessary to certain fine chemical biosynthesis, such as amino acid, vitamin and co-factor.By modifying PTS molecule of the present invention to increase the quantity of intracellular high energy carbon molecules, not only it can increase the energy supply of metabolic pathway necessary to completing to produce one or more kinds of fine chemicals, but also endocellular metabolism substance library required for this production can be increased.
In addition, PTS molecule of the present invention can participate in one or more of Cellular Signaling Transduction Mediated approach, these signal transduction paths can influence the yield and/or throughput rate of one or more kinds of fine chemicals in Corynebacterium glutamicum.Such as, once there is sufficient amount of carbohydrate into the cell, from inputted in extracellular medium protein necessary to one or more kinds of carbohydrates (such as, HPr, Enzyme I, or one of Enzyme II complex ingredient) be often translated after modify, to prevent them from sugar is input into the cell again.The quantity of sugar when movement system is closed, for maintain may be for cell normal function it is enough, this may limit the excessive production of required chemical substance.Therefore, it modifies pts protein of the present invention and it is made to be very worthwhile there is no reaction to this negative regulator, so, intracellular one or more kinds of sugar are allowed to reach higher concentration, and extended through reaction, it, can significantly more efficient production or the one or more kinds of fine chemicals of more large-tonnage acquisition from the organism containing this pts protein mutant.
The present invention provides the nucleic acid molecules of new coding protein, this protein is referred to herein as phosphoenolpyruvate: sugar phosphotransferase system (PTS) protein, they participate in high energy carbon molecules (such as, glucose, fructose, sucrose) input Corynebacterium glutamicum, and/or participate in one or more of Corynebacterium glutamicum Cellular Signaling Transduction Mediated approach.The example of these protein, the protein including those coded by said gene listed in table 1.
Therefore, one aspect of the present invention is related to, separate containing a kind of one section of nucleic acid molecules for encoding pts protein or the nucleic acid sequence of its biologically-active moiety (such as, cDNA, DNA, perhaps RNA) and separation be suitable as detect or expand PTS code nucleic acid (such as DNA or RNA) primer or hybridization probe nucleic acid fragment.In particularly preferred embodiments, isolated nucleic acid molecules include one section of Serial No. odd number being listed in sequence table nucleic acid sequence (such as, SEQ ID NO:1, SEQ ID NO:3, SEQ ID NO:5, SEQ ID NO:7) an either this nucleotide sequence coding region or its complementary series.In other particularly preferred embodiments, the nucleic acid molecules of the present invention of separation include with the nucleotide sequence of the Serial No. odd number in sequence table (such as, SEQ ID NO:1, SEQ ID NO:3, SEQ ID NO:5, SEQ ID NO:7) or its part have at least about 50% homology, preferably there is at least about 60% homology, more preferably there is at least about 70%, 80%, or 90% homology, even more preferably have at least about 95%, 96%, 97%, 98%, 99% or higher homology.In other preferred embodiments, separated nucleic acid molecule encoding is listed in the even order amino acid sequence (for example, SEQ ID NO:2, SEQ ID NO:4, SEQ ID NO:6, SEQ ID NO:8) in sequence table.Currently preferred pts protein is it is also preferred that have at least one PTS activity described herein.
In another embodiment, a kind of protein of separated nucleic acid molecule encoding or its part, protein therein or its part include one section of amino acid sequence, the sequence and amino acid sequence of the invention (such as, the sequence of even order number in sequence table) there is sufficient homology, for example, having sufficient homology with amino acid sequence of the invention and making the protein or its part that there is PTS activity.It is preferred that, the protein of nucleic acid molecule encoding or its part, with the ability participated in high energy carbon molecules (for example, glucose, fructose, sucrose) input Corynebacterium glutamicum, and/or participate in the ability of one or more of Corynebacterium glutamicum Cellular Signaling Transduction Mediated approach.In one embodiment, a kind of protein of nucleic acid molecule encoding and amino acid sequence (for example, the complete amino acid sequence selected from the even order sequence in sequence table) of the invention have at least about 50% homology, preferably there is at least about 60% homology, more preferably have at least about 70%, 80%, 90% homology most preferably has at least about 95%, 96%, 97%, 98%, 99% or higher homology.In another preferred embodiment, protein is the Corynebacterium glutamicum protein of overall length, the protein and full length amino acid sequence of the invention (by be shown in corresponding sequence table odd serial numbers nucleic acid sequence (such as, SEQ ID NO:1, SEQ ID NO:3, SEQ IDNO:5, SEQ ID NO:7) open reading frame coding) sufficiently homologous.
In another preferred embodiment, isolated nucleic acid molecules come from Corynebacterium glutamicum, and encode a kind of a kind of protein (such as PTS fusion protein), the protein includes one section of bioactivity region, the region and a kind of amino acid sequence of the invention (such as, a sequence in sequence table even order sequence) there are at least about 50% or higher homology, and the protein can participate in a high energy carbon molecules (such as, glucose, fructose, sucrose) input Corynebacterium glutamicum, and/or participate in one or more of Corynebacterium glutamicum Cellular Signaling Transduction Mediated approach, or possess one or more kinds of activity being listed in Table 1, and the protein also includes the heterologous nucleic acid sequence of one section of encoding heterologous polypeptide or adjustment region.
In another embodiment, the length of at least 15 nucleotide of isolated nucleic acid molecules, and under strict conditions with contain nucleotide sequence of the present invention (for example, the odd serial numbers sequence in sequence table) making nucleic acid molecular hybridization.It is preferred that isolated nucleic acid molecules are consistent with naturally occurring nucleic acid molecules.More preferably, the naturally occurring Corynebacterium glutamicum pts protein of isolated nucleic acid molecule encoding or its biologically-active moiety.
Another aspect of the present invention is related to carrier, such as the recombinant expression carrier containing nucleic acid molecules of the present invention, and be introduced into the host cell of this carrier.In one embodiment, by being cultivated in suitable culture medium, this host cell be used to produce pts protein.Then the pts protein can be separated from culture medium or host cell.
In addition, another aspect of the present invention is related to a kind of microorganism by being genetically changed, PTS gene has been incorporated into wherein or has changed.In one embodiment, by introducing as the encoding wild type of transgenosis or the nucleic acid molecules of the present invention of saltant type PTS sequence, the genome of the microorganism is changed.In another embodiment, the endogenous PTS gene in the microbial genome is changed, for example, carrying out homologous recombination by using the PTS gene having changed and carrying out functional destruction.In another embodiment, endogenous or introducing PTS gene is changed by one or more point mutation, missing or inversion in the microorganism, but still can encoding function pts protein.In another embodiment, one or more adjustment region (for example, promoter, repressor or inducer) for changing microorganism PTS gene, to adjust the expression of PTS gene.In preferred embodiments, microorganism belongs to rod strain or quarter butt strain, particularly preferably Corynebacterium glutamicum.In preferred embodiments, also using compound needed for micro-organisms, such as amino acid, particularly preferably lysine.
On the other hand, the present invention provides corynebacterium diphtheriae presence or active methods in a kind of identification subject.This method include to one or more kinds of nucleic acid or amino acid sequence of the invention in subject (such as, be listed in the sequence of SEQ ID NO 1 to 34 in sequence table) detection, so as to detect the presence or activity of subject's Glutamic Acid bar bacterium.
In addition, another aspect of the present invention is related to separated pts protein or its part, such as its biologically-active moiety out.In a preferred embodiment, isolated pts protein or its part can participate in a high energy carbon molecules (such as, glucose, fructose, sucrose) input Corynebacterium glutamicum, and one or more of Corynebacterium glutamicum Cellular Signaling Transduction Mediated approach can also be participated in.In another preferred embodiment, separated pts protein or its part and a kind of amino acid sequence of the invention (such as, sequence table even order number a: sequence in sequence) there is sufficiently high homology, so that the protein or its part may participate in a high energy carbon molecules (such as, glucose, fructose, sucrose) ability of Corynebacterium glutamicum is inputted, and/or also assist in the ability of one or more of Corynebacterium glutamicum Cellular Signaling Transduction Mediated approach.
Present invention provides the Separation Products of pts protein.In preferred embodiments, pts protein includes amino acid sequence of the invention (for example, sequence table even order number: a sequence in sequence).In another preferred embodiment, the present invention is related with isolated full length protein, and the protein and all aminoacid sequence (sequence table even order number a: sequence in sequence) of the invention (being encoded by the open reading frame for the Serial No. odd number being shown in corresponding sequence table) have quite high homology.In addition, in another embodiment, protein and all aminoacid sequence of the invention (such as, even order sequence in sequence table) there is at least about 50% homology, preferably there is at least about 60% homology, more preferably there is at least about 70%, 80%, or 90% homology, most preferably have at least about 95%, 96%, 97%, 98% or 99% or higher homology.In another embodiment, amino acid sequence that isolated pts protein includes and an amino acid sequence of the invention (such as, an even order sequence in sequence table) there are at least about 50% or higher homology, and can participate in a high energy carbon molecules (such as, glucose, fructose, sucrose) input Corynebacterium glutamicum, with/and one or more of Corynebacterium glutamicum Cellular Signaling Transduction Mediated approach are participated in, or with the one or more activity listed in table 1.
In addition, isolated pts protein can contain the amino acid sequence by nucleic acid sequence encoding, one nucleic acid array hybridizing of the nucleic acid sequence and the even order number being listed in sequence table, such as hybridize under strict conditions, or have with the nucleic acid sequence at least about 50% homology, preferably there is at least about 60% homology, more preferably have at least about 70%, 80% or 90% homology even more preferably has at least about 95%, 96%, 97%, 98% or 99% or higher homology.The preferred form of pts protein equally has one or more kinds of bioactivity described herein, and preferred.
PTS polypeptide or its biologically-active moiety can effectively be connected on non-PTS polypeptide and form fused protein.In preferred embodiments, which has the activity different from independent pts protein itself.In other preferred embodiment, which causes required Corynebacterium glutamicum fine chemical yield, production and/or the increase of production efficiency.In particularly preferred embodiments, which is integrated into host cell, the production of required compound in adjustable cell.
On the other hand, the present invention provides the methods for screening the adjustable active molecule of pts protein.The molecule is by the way that perhaps substrate interaction is active to adjust pts protein perhaps in conjunction with the gametophyte of pts protein or through the transcription or translation of adjusting PTS nucleic acid molecules of the present invention with protein molecule itself.
Another aspect of the present invention is related to the method for producing fine chemical.This method is related to the cell that culture contains a kind of carrier, the expression of vectors direct PTS nucleic acid molecules of the present invention, to generate fine chemical.In a preferred embodiment, this method also includes in this step, to transfect cell using the carrier that PTS nucleic acid molecules can be instructed to express the step of acquisition containing the carrier cell.In another preferred embodiment, this method also includes the step of recycling fine chemical from culture medium.In an especially preferred embodiment, cell is rod strain perhaps quarter butt strain or selected from those of being listed in Table 3 bacterial strain.
Another aspect of the present invention relates to adjust the method that molecule generates in microorganism.This method includes using the medicament exposing cell for adjusting pts protein activity or PTS expression of nucleic acid, so that the related activity of cell is changed relative to activity when lacking this medicament.In a preferred embodiment, in order to absorb one or more kinds of carbohydrates, cell is adjusted, so that this Institute of Micro-biology needs the yield of fine chemical or generation efficiency to be improved.The active medicament of pts protein is adjusted, can be the medicament of stimulation pts protein activity or PTS expression of nucleic acid.The example for stimulating the medicament of pts protein activity or PTS expression of nucleic acid has imported the nucleic acid of the pts protein of cell including small molecule, active pts protein and coding.The example for inhibiting the medicament of pts protein activity or expression includes small molecule and antisense PTS nucleic acid molecules.
Another aspect of the present invention, the method for being related to adjusting required compound production in cell, including perhaps the saltant type PTS gene into cells gene is perhaps retained on individual plasmid or is integrated into host cell gene group wild type.If be integrated into host cell gene group, this integration can be arbitrary, or occurred by homologous recombination, so that the copy introduced replaces natural gene, the generation of required compound in cell is caused to be adjusted.In a preferred embodiment, which is increased.In another preferred embodiment, described fine chemical is amino acid.In an especially preferred embodiment, described amino acid is L-lysine.
Specific embodiment
The present invention provides PTS nucleic acid and protein molecules, they participate in Corynebacterium glutamicum intake high energy carbon molecules (for example, glucose, fructose, sucrose), and can also participate in one or more of Cellular Signaling Transduction Mediated approach in the microorganism.Molecule of the invention can be used for adjusting the production of fine chemical in microorganism.This adjusting, it may be possible to due to the increase of high energy species level generated needed for intracellular, for example, ATP, GTP and other for push seem the unfavorable biochemical reaction of energy as fine chemical biosynthesis molecule.The adjusting of fine chemical production is also likely to be due to this fact, i.e., the catabolite of many carbohydrates is used as the intermediate or precursor of other biological route of synthesis, the biosynthesis pathway including certain fine chemicals.Additionally, it is known that pts protein participates in certain Cellular Signaling Transduction Mediated approach, they, which may have the metabolic pathway of one or more of fine chemicals, adjusts activity;By utilizing these pts proteins, the biosynthesis pathway of fine chemical can be activated or inhibit its chemical degradation route.Various aspects of the invention are further described as follows.
I. fine chemical
" fine chemical " this word is well known in the art, the molecule used in various industries including organism generation, such as but is not limited solely to, pharmacy, agricultural and cosmetic industry.This compound includes organic acid, such as tartaric acid, itaconic acid and diaminopimelic acid, protein source and nonprotein source amino acid, purine bases and pyrimidine bases, nucleosides, and nucleotide (is such as description in Kuninaka, A. (1996) Nucleotides and related compounds, p.561-612, in Biotechnology vol.6, Rehm et al., in eds.VCH:Weinheim and its contained bibliography), lipid, saturation and unsaturated fatty acid (such as arachidonic acid), glycol (such as, propane diol and butanediol), aromatic compound (such as, aromatic amine, vanillic aldehyde and indigo), vitamin and Co-factor (referring to Ullmann ' s Encyclopedia of IndustrialChemistry, vol.A27, " Vitamins ", p.443-613 (1996) VCH:Weinheim and referencestherein;And Ong, A.S., Niki, E.& Packer, L. (1995) " Nutrition, Lipids, Health; andDisease " Proceedings of the UNESCO/Confederation of Scientific and TechnologicalAssociations in Malaysia, and the Society for Free Radical Research-Asia, held Sept.1-3,1994 at Penang, Malaysia, AO CS Press, (1995)), enzyme, polyketide (ployketides) (Cane et al., (1998) Science 282:63-68), and all chemical substances described in Gutcho (1983) Chemicals by Fermentation, Noyes Data Corporation, ISBN:0818805086 and its bibliography.The metabolism of these certain fine chemicals and purposes are further described as follows.
A. the metabolism and purposes of amino acid
Amino acid includes the basic structural unit of all proteins, also necessary to all organism normal cell biological functions." amino acid " this word is well known in the art.The amino acid of protein source has 20 kinds, it is the structural unit of protein, it is connected between each other by peptide bond, rather than proteinogenic amino acids (known to have several hundred kinds) are not appeared in protein under normal conditions (referring to Ulmann ' s Encyclopedia of Industrial Chemistry, vol.A2, p.57-97VCH:Weinheim (1985)).Although l-amino acid is usually the unique type in naturally occurring protein, amino acid can be D- L- optical configuration.The biosynthesis of each in 20 kinds of proteinogenic amino acids perhaps degradation pathway all have the characteristics that in prokaryotic cell or eukaryocyte it is respective (for example, see Stryer, L.Biochemistry, 3rdEdition, pages 578-590 (1988)).Why " required " amino acid (histidine, isoleucine, leucine, lysine, methionine, phenylalanine, threonine, tryptophan and valine) is named in this way, it is because the complicated nutritional condition being generally necessary of these amino acid bios synthesis, they can be converted into remaining 11 kinds of " nonessential " amino acid (alanine, arginine, asparagine, aspartic acid, cysteine, glutamic acid, glutamine, glycine, proline, serine, tyrosine) by simple biosynthesis pathway.Although higher organism has the ability for synthesizing some this amino acid really, in order to which the synthesis of normal protein must supplement essential amino acid from diet.
They are in addition to the function in protein synthesizes, these amino acid are interesting chemical substance for its own, and many of which has various applications in food, feed, chemistry, cosmetics, agricultural and pharmaceutical industries.Lysine is a kind of important amino acid not only for the mankind in terms of nutrition, and for seeming that poultry and the such nonruminant of pig are also important.Glutamic acid is most common flavor additives useful (monosodium glutamate, MSG), and is widely used in entire food industries, as aspartic acid, glycine, cysteine.Glycine, l-methionine and tryptophan are completely used for pharmaceutical industries.Glutamine, valine, leucine, isoleucine, histidine, arginine, proline, serine and alanine are all applied in pharmaceutical industries and cosmetic industry.Threonine, tryptophan and D/L- methionine are common feed addictive (Leuchtenberger, W. (1996) Amino aids-technical production and use, p.466-502 in Rehm et al. (eds.) Biocemistry vol.6, chapter 14a, VCH:Weinheim).In addition, these amino acid are also very useful as the precursor that synthesizing amino acid and protein synthesize, such as N-acetylcystein, S- carboxymethyl-L-cysteine, (S) -5-hydroxyryptophan and other in Ulmann ' s Encyclopedia of Industrial Chemistry, vol.A2, p.57-97 VCH:Weinheim, molecule described in 1985.
In the organism that can generate natural amino acid, such as bacterium, the biosynthesis of these natural amino acids has solved very sufficiently (biosynthesis and its adjusting of bacterial amino acid, referring to Umbarger, H.E. (1978) Ann.Rev.Biochem.47:533-606).Aspartic acid is synthesized by α-ketoglutaric acid reduced form ammonification, and the latter is the intermediate of citrate cycle.Glutamine, proline and arginine are sequentially generated by glutamic acid.The biosynthesis of serine is the process of three steps, starts from 3-phoshoglyceric acid (intermediate of glycolysis), after peroxidation, transamination, each step of hydrolysis, terminates at the amino acid.Cysteine and glycine are all generated by serine;The former is condensed by homocysteine and serine, and the latter is that side chain beta carbon is transferred to what tetrahydrofolic acid obtained, which be catalyzed by serine hydroxymethylase.Phenylalanine and tyrosine are synthesized in the biosynthesis pathway of 9 steps by erythrose-4-phosphate and phosphoenolpyruvate, they are the precursors of glycolytic pathway and pentose phosphate pathway, this two approach are only different after synthesizing prephenic acid.Tryptophan can also be generated by both initial moleculars, but its synthesis is the approach of 11 steps.Tyrosine can also be synthesized by phenylalanine, and reaction is catalyzed by phenylalanine hydroxylase.Alanine, valine and leucine are all the biosynthetic products of glycolysis end product pyruvic acid.Aspartic acid is synthesized by oxaloacetic acid, and the latter is the intermediate of citrate cycle.Asparagine, methionine, threonine and lysine are all transformed by aspartic acid.Isoleucine is formed by threonine.By the approach of a 9 complicated steps, histidine can be generated from a kind of activity sugar, ribose 5-phosphate -1- pyrophosphoric acid.
It cannot be stored beyond amino acid needed for cell protein synthesis, but provide intermediate after being degraded for cell main metabolic pathway and (comment on referring to Stryer, L.Biochemistry 3rd ed.Ch.21"Amino Acid Degradation and the Urea Cycle"p.495-516(1988)).Although it is useful Metabolic Intermediate that cell, which can convert extra amino acid, many energy, precursor molecule will be consumed and synthesize required enzyme by generating amino acid.Therefore it is not astonishing for the biosynthesis of amino acid being adjusted with feedback inhibition, the presence of special acid can slow down or stop completely the generation (comment for amino acid biosynthetic pathway feedback mechanism of its own, referring to Stryer, L.Biochemistry 3rd ed.Ch.24"Biosynthesis of Amino Acid and Heme"p.575-600(1988)).Therefore, the yield of any specific amino acids is all limited by intracellular existing amino acid quantity.
B. the metabolism and purposes of vitamin, co-factor and dietetic product
Vitamin, co-factor and dietetic product include another group of molecule, although other biological, such as bacterium, these molecules can be synthesized, higher mammal loses their ability of synthesis and can only absorb.These molecules perhaps itself are the intermediates that bioactive substance or the precursor of the bioactive substance bioactive substance can be electron carrier or various metabolic pathways.In addition to its nutritive value, these compounds also have great industrial value as pigment, antioxidant and catalyst or other processing aids.(the commentary for these compound structures, activity and industrial application, see, for example, Ullmann ' s Encyclopedia of Industrial Chemistry, " Vitamins " vol.A27, p.443-613 VCH:Weinheim 1996.) " vitamin " this word be it is well known in the art, contain needed for organism normal function but again cannot itself synthesis nutrient.Vitamin may include co-factor and dietetic product compound.Non-protein compound needed for term " co-factor " contains the normal enzymatic activity of progress.These compounds can be inorganic or organic;Co-factor molecule of the invention is preferably organic." dietetic product " this word contains the dietary supplement beneficial to plant and animal, especially human body.The example of these molecules is vitamin, antioxidant and certain lipids (such as more saturated fatty acids).
In the organism that can generate these molecules, for example, in bacterium these molecules biosynthesis, most of (Ullman ' s Encyclopedia of Industrial Chemistry that has been accredited, " Vitamins " vol.A27, p.443-613, VCH:Weinheim, 1996;Michal, G. (1999) BiochemicalPathways:An Atlas of Biochemistry and Molecular Biology, John Wiley&Sons;Ong, A.S., Niki, E.& Packer, L. (1995) " Nutrition, Lipids, Health; and Disease " Proceedings of the UNESCO/Confederation of Scientific and TechnologicalAssociations in Malaysia, and the Society for Free Radical Research-Asia, held Sept.1-3,1994 at Penang, Malaysia, AOCS Press:Champaign, IL X, 374 S)
Thiamine (vitamin B1) is by pyrimidine and thiazole through being connected chemically generation.Riboflavin (vitamin B2) is synthesized by 5 '-triphosphoric acid guanosines and 5 '-ribose phosphates.Riboflavin is orderly used to synthesis flavin mononucleotide (FMN) and flavin adenine dinucleotide (FAD) (FAD).The one group of compound (for example, pyridoxol, pyridoxamine, pyridoxime 5'-phosphate, and pyridoxal hydrochloride of commercialization) for being collectively referred to as " vitamin B6 " is all the derivative of common structural unit 5- hydroxyl -6- picoline.Pantothenate (pantothenic acid, (R)-(+)-N- (2,4- dihydroxy -3,3- dimethyl -1- oxo butyl)-Beta-alanine) can be obtained by chemical synthesis or fermentation.The final step of pantothenate biosynthesis includes the condensation of the Beta-alanine and pantoic acid of ATP driving.It is responsible for being converted to pantoic acid and Beta-alanine enzyme, and it is all known for being condensed into the enzyme of pantothenate.The metabolic activity form of pantothenate is coacetylase, and biosynthetic process is 5 enzymatic steps.Pantothenate, pyridoxime 5'-phosphate, cysteine and ATP are the precursors of coacetylase.These enzymes are not only catalyzed the formation of pantothenate, are also catalyzed (R)-pantoic acid, (R)-pantolacton, the generation of (R)-panthenol (dexpanthenol) pantetheine (and its derivative).
Study very detailed by the biosynthesis of precursor molecule heptanedioyl coacetylase to biotin in microorganism, and related several genes have been accredited.Many corresponding protein are also found to take part in the synthesis of iron cluster (Fe-cluster), and are nifS family protein members.Lipoic acid is used as coenzyme from octanoic acid in energetic supersession, can become a part of pyruvate dehydrogenase complex and ketoglurate dehydrogenase compound.Folate is the derivative of one group of folic acid, successively comes from Pidolidone, p-aminobenzoic acid and 6- methylpterin.The biosynthesis for originating in the folic acid and its derivative of Metabolic Intermediate 5 '-triphosphoric acid guanine (GTP), Pidolidone and p-aminobenzoic acid, there is detailed research in certain micro-organisms.
Corrinoid (such as cobalamin, and especially vitamin B12) and porphyrin belong to the chemical substance characterized by tetrapyrrole ring system.The biosynthesis of vitamin B12 is such complexity, so that its feature is thoroughly understood not yet, but many enzymes being related to and substrate are currently known.Niacin (nicotinate) and nicotine are pyridine bottom derivative, also referred to as " niacin usp ".Niacin usp is important coenzyme NAD (nicotinamide adenine dinucleotide) and NADP (nicotinamide-adenine dinucleotide phosphate) and its precursor for restoring form.
Although some such compounds can also be produced with Large-scale microbial culture, such as riboflavin and vitamin B6, pantothenic acid and biotin, these compounds are mass produced and largely also rely on acellular chemical system.Only vitamin B12 can only use fermenting and producing due to the complexity of its synthesis.In-vitro method needs considerable substance and time investment, often spends very big.
C. the metabolism and purposes of purine, pyrimidine, nucleosides and nucleotide
Purine and pyrimidine metabolic gene and its corresponding protein are tumor disease therapeutic and the important object for the treatment of of viral infections.Term " purine " and " pyrimidine " contain the nitrogenous base as nucleic acid, coenzyme and nucleotide composition.Term " nucleotide " includes nucleic acid molecules basic structural unit, and by nitrogenous base, pentose, (for RNA, which is ribose to nucleic acid molecules;For DNA, which is deoxyribose) and phosphoric acid composition.Term " nucleosides " contains the molecule as nucleotide precursor, but is the absence of phosphate portion possessed by nucleotide.It by inhibiting the biosynthesis of these molecules, or is suppressed to synthetic nucleic acid molecule and the movement that carries out, the synthesis of RNA and DNA may be inhibited;Inhibit the activity by way of orienting tumour cell, the energy of tumour cell division and duplication may be inhibited.In addition, some nucleotide is not used in form nucleic acid, and it is used as energy storage (such as AMP) or coenzyme (such as FAD and NAD).
Some publications describe the metabolism by influencing purine and/or pyrimidine, these chemical substances as these Medical indications use (such as, Christopherson, R.I.and Lyons, S.D. (1990) " Potent inhibitors of de novo pyrimidine and purine biosynthesis aschemotherapeutic agents. " Med.Res.Reviews 10:505-548).It is related to the research of purine and pyrimidine metabolic enzyme, it concentrates on above the new drug development that can be used, such as, as immunosuppressor or anti-proliferative agent (Smith, J.L., (1995) " Enzyme in nucleotidesynthesis. " Curr.Opin.Struct.Biol.5:752-757;(1995) Biochem Soc.Transact.23:877-902).However, purine and pyrimidine bases, nucleosides and nucleotide also have the function of other: as many fine chemical biosynthesis intermediate (such as, thiamine, S-adenosylmethionine, folic acid, or riboflavin), as cellular energy carrier (such as ATP or GTP), and as chemical substance itself, be typically used as flavour enhancer (such as IMP or GMP) or several medical applications (referring to, such as, Kuninaka, A. (1996) Nucleotidesand Related Compounds in Biotechnology vol.6, Rehm et al., eds.VCH:Weinheim, , p.561-612).Equally, it is related to the enzyme of purine, pyrimidine, nucleosides or nucleotide metabolism, increasingly becomes the effect target for the chemical substance for being used as protection crops developed, these chemical substances include fungicide, herbicide and insecticide.
In bacterium the metabolism of these compounds have feature (comment referring to, such as Zalkin, H.andDixon, J.E. (1992) " de novo purine nucleotide biosynthesis ", in:Progress in NucleicAcid Research and Molecular Biology, vol.42, Academic Press:, p.259-287;AndMichal, G. (1999) " Nucleotides and Nucleosides ", 8 in:BiochemicalPathways:An Atlas of Biochemistry and Molecular Biology, Wiley:New York of Chapter).Purine metabolism is always emphasis research topic, and it is necessary to cell normal function.The purine metabolism being damaged in higher mammal can result in serious disease, such as gout.Purine nucleotides is synthesized by 5 '-ribose phosphates, pass through series of steps, by intermediate 5 '-phosphoric acid inosine (IMP), it is final to generate 5 '-monophosphate guanines (GMP) and 5 '-monophosphate adenines (AMP), and the triphosphate forms as nucleotide are formed by them.These compounds also serve as energy storage, are degraded to a variety of different biochemical processes in cell and provide energy.The biosynthesis of pyrimidine is by forming 5 '-phosphoric acid uridines (UMP) by 5 '-ribose phosphates.Next UMP is transformed into 5 '-triphosphoric acid cytimidines (CTP).The deoxy forms of all these nucleotide are generated by a step reduction reaction, by nucleotide diphosphonic acid ribose form to nucleotide diphosphonic acid deoxyribose form.One is phosphorylated, these molecules can participate in the synthesis of DNA.
D. the metabolism and purposes of trehalose
Trehalose includes two glucose molecules, is connected by α, α -1,1.Usually it is used as sweetener in food industries, in dried foods or frozen food additive and beverage.Moreover, it is also employed in pharmacy, cosmetics and biotechnology industry (see, e.g. Nishimoto et al., (1998) U.S.Patent No.5,759,610;Singer, M.A.and Lindquist, S. (1998) Trends Biotech.16:460-467;Paiva, C.L.A.and Panek, A.D. (1996) Biotech.Ann.Rev.2:293-314;And Shiosaka, M. (1997) J.Japan 172:97-102).Enzyme in many microorganisms can produce trehalose, and it is naturally discharged into surrounding media, and the technically well known method that can be used therefrom is collected.
II. phosphoenolpyruvate: sugar phosphotransferase system
Cell fast-growth in the medium and division are largely dependent upon cellular uptake and the degree using high energy species, such as glucose or other carbohydrates.There are different transport proteins, they transport different carbohydrates in cell.There are carbohydrate transport protein matter, such as transhipment glucose, fructose, mannose, galactolipin, ribose, sorbose, ribulose, lactose, maltose, sucrose or gossypose, also there is the transport protein matter of starch and cellulose degradation product.Other movement systems are responsible for inputting alcohol (such as methanol or ethyl alcohol), alkane, fatty acid, and the organic acid as acetic acid or lactic acid.In bacterium, by various mechanism, carbohydrate can be transported into cell through cell membrane.Other than with the cotransporting of proton, most-often used carbohydrate capture process first is that phosphoenolpyruvate: sugar phosphotransferase system (PTS).The system is not only catalyzed the transhipment (with phosphorylation) of carbohydrate and hexitol, but also adjusts the cell metabolism for being adapted to carbohydrate validity.The PTS system exists only in bacterium, and is not present in archeobacteria and eukaryocyte.
In terms of function, PTS system includes two kinds of cytoplasm proteins, and (every kind is all referred to as and specifically descends target " enzyme II ", such as " enzyme II with carbohydrate for the special integration of the carbohydrate of enzyme I and HPr and indefinite number and peripheral membrane protein transhipment complexGlu" indicate to combine the enzyme II complex of glucose).It is known to monosaccharide, disaccharides or the special enzyme II of trisaccharide, seem to glucose, fructose, mannose, galactolipin, ribose, sorbose, ribulose, lactose, maltose, sucrose or gossypose.Phosphate group is transferred to phosphocarrier protein HPr from phosphoenolpyruvate (PEP) by enzyme I.Then phosphate group is transferred to different enzyme II again and transports complex by HPr.Although the amino acid sequence of enzyme I and HPr be in all bacteriums it is very similar, PTS transfer body can be divided into the incoherent several families of structure.In addition, the number and homology of these genes are also different in different bacteriums.Genome of E.coli encodes 38 different pts proteins, wherein 33 are the subunits for belonging to 22 different transfer bodies.Mycoplasma genitalium (M.genitalium) genome contains enzyme I and HPr gene each one, and only there are two PTS to shift body gene.T.palladium and chlamydia trachomatis (C.trachomatis) contain enzyme I and HPr similar protein gene, but shift body gene without PTS.
All PTS transfer bodies include 3 functional units, IIA, IIB and IIC, their protein subunits either in complex are (for example, IIAGlcIICBGlc) either single polypeptide chain structural region (for example, IICBAGlcNAc).IIA and IIB is successively transmitted to phosphate group from HPr the carbohydrate being transported.IIC contains carbohydrate-binding sites, and crosses over inner membrance 6 or 8 times.The transient phosphorylation in carbohydrate transfer and the region IIB is coupling.In its histidine residues phosphorylation occurs for enzyme I, HPr and IIA, and IIB subunit is that phosphorylation occurs in histidine residues or cysteine residues, this depends on related specific transporter.The phosphorylation of carbohydrate, has the advantage that after input, it can prevents carbohydrate from spreading cell membrane and return in culture medium, because electrically charged phosphate group cannot pass through the hydrophobic core of cell membrane.
Some pts proteins also play a significant role in signal transduction in the cell other than active carbohydrate transport function.These subunits adjust their purpose object by allosteric or phosphorylation.Their adjusting activity changes with phosphorylation degree (for example, ratio of unphosphorylated form and phosphorylation form), and the latter changes as sugar dependence dephosphorylation and phosphoenolpyruvate rely on the ratio of phosphorylation again.The example of this pts protein adjusted into the cell includes passing through IIA in Escherichia coliGlcDephosphorylation inhibits glycerokinase, and passes through its phosphorylation form activated adenyl cyclase.Moreover, in these microorganisms some transporters the region HPr and IIB, gene expression is adjusted by the reversible phosphorylation of transcription antitermination.In gram-positive bacterium, the activity of HPr is by HPr special serine kinase and phosphoric acid enzyme adjustment.For example, the HPr of -46 phosphorylation of serine, function is the co-repressor as the sub- CcpA of Transcription inhibition.Finally, it was found that unphosphorylated enzyme I inhibits the sensor kinase c heA in bacterium chemotactic device, the kinases provides directly connection (Sonenshein between bacterial saccharides binding transport system and the system of control bacteria motility, A.L., etal., eds.Bacillus subtilis and other gram-positive bacteria.ASM:Washington, D.C.;Neidhardt, F.C., et al., eds. (1996) Escherichia coli and Salmonella.ASM Press:Washington, D.C;Lengeler et al., (1999) .Biology of Prokaryotes.Section II, pp.68-87, Thieme Verlag:Stuttgart)
III. element of the invention and method
The present invention is at least partly built upon on the basis of discovery recruit, PTS nucleic acid and protein molecule are called it as herein, they participate in Corynebacterium glutamicums to high energy carbon molecules (such as, glucose, fructose, sucrose) intake, and one or more of Cellular Signaling Transduction Mediated approach in these microorganisms can also be participated in.In one embodiment, PTS molecule exercises the function of high energy carbon molecules being transferred to cell, the biochemical reaction energy supply that energy provided by these molecular degradations can be unfavorable for energy in cell, moreover, their catabolite may be used as the intermediate or precursor of a lot of other metabolic pathways.In another embodiment, PTS molecule can participate in one or more of Cellular Signaling Transduction Mediated approach, wherein the presence of PTS molecular modification form (for example, phosphorylation PTS molecule), signal transduction cascade reaction can be participated in, which adjusts one or more cell processes.In a preferred embodiment, the activity of PTS molecule of the present invention, has an impact for the fine chemical needed for the micro-organisms.In an especially preferred embodiment, the activity of PTS molecule of the present invention is regulated so that yield, production and the production efficiency of one or more kinds of fine chemicals in Corynebacterium glutamicum are also adjusted.
Term " pts protein " or " PTS polypeptide " contain those participate in from extracellular medium to cell interior absorb one or more kinds of energy-rich compounds (such as, monosaccharide, disaccharides or oligosaccharides seem fructose, mannose, sucrose, glucose, gossypose, galactolipin, ribose, lactose, maltose and sorbose) protein.These pts proteins can also participate in one or more of Cellular Signaling Transduction Mediated approach, such as but be not limited solely to, those control different carbohydrates and absorb approach into cell.The example of pts protein includes the protein that those are encoded by the PTS gene for being listed in Serial No. odd number in sequence table.About the comprehensive reference document of PTS system, referring to: Stryer, L. (1998) Biochemistry, Chapter 37: " Membrane Transport ", W.H.Freeman:New York, p.959-961;Darnell, J.et al. (1990) Molecular Cell BiologyScientific American Books:New York, p.552-553, and Michal, G., ed. (1999) Biochemical Pathway;An Atlas of Biochemistry and Molecular Biology, Chapter 15 " Special Bacterial Metabolism ".Term " PTS gene " or " PTS nucleic acid sequence " contain the nucleic acid sequence of coding pts protein, and the latter includes 5 ' and 3 ' sequence areas of coding region and corresponding untranslated.The example of PTS gene includes the gene that those are listed in Table 1.Term " production " or " productivity " be it is well known in the art, contain within given time and given fermentation volume, the concentration of tunning (for example, required fine chemical) (for example, product kg per liter per hour).Term " production efficiency " contains, the time needed for reaching specific production level (for example, it is desired to how long just cell can be made to reach specific fine chemical).Term " income " " product/carbon income " be it is well known in the art, contain the efficiency for carbon source being converted to product (such as fine chemical).For example, often writing every kilogram of carbon source of product kg.By improving the income or production of compound, the quantity of recycling molecule can be increased, or increase the quantity of the useful recycling molecule of the compound in the culture for giving quantity within given time.Term " biosynthesis " or " biosynthesis pathway " be it is well known in the art, contain in cell, from intermediate compound by may be multistep and be highly regulated process, synthesize compound, especially organic compound.Term " degradation " or one " degradation pathway " are well known in the art, it contains in cell, by may be multistep and be highly regulated process, compound, preferably organic compound, it is decomposed into catabolite (in general, being smaller or the smaller molecule of complexity).Term " metabolism " be it is well known in the art, contain the whole of the biochemical reaction occurred in organism.Thus, the metabolism (for example, seeming amino acid metabolism as glycine) of special compound includes all biological synthesis relevant to the compound, modification and degradation pathway in cell.Term " transhipment " and " input " be it is well known in the art, contain one or more kinds of compounds across cell membrane easyization movement, and these compounds pass through cannot pass through cell membrane otherwise.
In another embodiment, PTS molecule of the invention can be adjusted in microorganism, such as in Corynebacterium glutamicum, the generation of required compound such as fine chemical.One or more kinds of PTS molecules of the invention can be operated using recombinant genetic technology, to adjust its activity.For example, the PTS system that a kind of protein for participating in the glucose input that PTS is mediated can be adjusted, and make its activity optimization, and input glucose, can transport greater number of glucose into cell.Because glucose molecule serves not only as energy to push the unfavorable biochemical reaction of energy, such as fine chemical biosynthesis, and it can be used as the precursor and intermediate of many biological fine chemical biosynthesis pathways (for example, synthesizing serine from 3-phoshoglyceric acid).In each example, the total output or production efficiency that can perhaps increase these required fine chemicals by compound supply needed for increasing production generation are perhaps provided by energy needed for increasing production generation.
In addition, many known pts proteins play a crucial role in signal transduction path in the cell, these approach adjust the cell metabolism for maintaining carbon source supply and carbohydrate intake.For example, as it is known that the increase of intracellular fructose 1,6-diphosphate (compound generated in glycolysis) level, can lead to the phosphorylation of HPr serine residue, to prevent the protein in any PTS carbohydrate transport process as phosphate group donor.Prevent its serine residue from being phosphorylated by mutagenesis HPr, it can be with the activation HPr of composition, to increase the carbohydrate in transporte to cells, may then ensure that intracellular for more energy storages and intermediate/precursor molecule needed for fine chemical biosynthesis needed for one or more.
The nucleic acid sequence of the present invention of separation, included in the genome of Corynebacterium glutamicum strain, which can be obtained by American type culture collection, deposit number ATCC 13032.Isolated Corynebacterium glutamicum PTS DNA nucleic acid sequence, and the Corynebacterium glutamicum pts protein amino acid sequence of prediction, are listed respectively with odd serial numbers and even order number in sequence table.
It has carried out computer analysis, and these nucleic acid sequences has been classified and/or be accredited as the sequence of encoding metabolic pathway proteins matter.
The present invention is also related with such protein, and the amino acid sequence of the protein and amino acid sequence of the invention have sufficient homology the sequence of even order number (for example, in sequence table).As used herein, have has the protein of the amino acid sequence of abundant homology to have at least about 50% homology with the amino acid sequence picked out, such as the overall amino acid sequence picked out with the amino acid sequence picked out.Protein with the amino acid sequence for having very big homology with the amino acid sequence picked out, there can also be at least about 50-60% with the amino acid sequence picked out, preferably there is at least about 60% homology, more preferably there is at least about 70%, 80%, 90% homology, most preferably have at least about 95%, 96%, 97%, 98%, 99% or higher homology.
Pts protein of the invention or its biologically-active moiety or its segment, can participate in transhipment seems that high energy carbon-containing molecules as glucose enter Corynebacterium glutamicum, perhaps the Cellular Signaling Transduction Mediated in the microorganism is participated in or with the one or more activity listed in table 1.
Various aspects of the invention are described in more detail in following each section:
A. the nucleic acid molecules separated
One aspect of the present invention is related to the coding PTS polypeptide of separation or the nucleic acid molecules of its biologically-active moiety, and be used as enough hybridization probe perhaps these segments of the nucleic acid molecule fragment of primer for identifying or the nucleic acid of amplification coding PTS (such as PTS DNA).As used herein, term " nucleic acid molecules " is meant comprising DNA molecular (for example, cDNA perhaps genomic DNA) and RNA molecule (such as mRNA) and by DNA the RNA analog of nucleotide analog generation.The term also includes the non-translated sequence positioned at the end of gene coding region 3 ' and 5 ': at least 20 nucleotide of 3 ' the end downstream sequence of at least 100 nucleotide and gene coding region of 5 ' end upstream sequence of coding region.Nucleic acid molecules can be it is single-stranded or double-strand, it is preferred that being double-stranded DNA." separation " nucleic acid molecules refer to those nucleic acid molecules being separated from each other with other nucleic acid molecules being present in nucleic acid natural origin.It is preferred that " separation " nucleic acid is without containing the natural sequence (for example, the sequence for being located at the end of nucleic acid 5 ' and 3 ') positioned at organism genomic DNA amplifying nucleic acid two sides, nucleic acid is exactly to obtain from the organism.Such as, in various embodiments, isolated PTS nucleic acid molecules can be containing less than about 5kb, 4kb, 3kb, 2kb, the nucleotide sequence of 1kb, 0.5kb or 0.1kb, the sequence are naturally located at the two sides of cell genomic dna nucleic acid molecules, nucleic acid is exactly to obtain from these cells (for example, Corynebacterium glutamicum cell).In addition, " separation " nucleic acid molecules, such as DNA molecular, when producing with recombinant technique precursor or other chemical substances can be free of when perhaps culture medium is when chemical synthesis essentially free of other cellular materials.
Nucleic acid molecules of the present invention, such as the nucleotide sequence of odd serial numbers or its part in sequence table, can be isolated by standard molecular biological technique and sequence information provided herein.Such as, Corynebacterium glutamicum PTS DNA can be from Corynebacterium glutamicum library, the whole for using in sequence table in odd serial numbers sequence a sequence or its part are as hybridization probe, and standard hybridisation methods are (for example, seem description in Sambrook, J., Fritsh, E.F., and Maniatis, T.Molecular Cloning:A Laboratory Manual.2nd, in ed.Cold Spring HarborLaboratory, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 1989) and isolated.In addition, comprising a nucleic acid sequence of the present invention (such as, the nucleotide sequence of odd serial numbers in sequence table) all or part nucleic acid molecules, polymerase chain reaction can be passed through, use the oligonucleotide primer based on the sequence design, isolated (such as, comprising a nucleic acid sequence of the present invention (such as, the nucleotide sequence of odd serial numbers in sequence table) all or part nucleic acid molecules, polymerase chain reaction can be passed through, it is isolated using the oligonucleotide primer based on the identical sequence design).Such as, mRNA can it is isolated from normal endothelial cell (such as, use the guanidine thiocyanate extracting method in Chirgwin et al. (1979) Biochemistry 18:5294-5299), DNA can by reverse transcriptase (such as, Gibco/BRL, the Moloney MLV reverse transcriptase that Bethesda, MD are provided;Or SeikagakuAmerica, Inc., the AMV reverse transcriptase that St.Peterburg, FL are provided) preparation.It, can be based on the nucleotide sequence design listed in sequence table for the oligonucleotide primer of polymerase chain reaction synthesis.Nucleic acid of the invention, can be used cDNA or genomic DNA as template alternatively, and suitable oligonucleotide primer is expanded according to standard PCR amplification technology.The nucleic acid amplified in this way can be cloned into suitable carrier, and distinguish its feature with DNA sequence analysis.In addition, oligonucleotide corresponding with PTS nucleotide sequence, can be prepared, such as use automatic dna synthesizer with Standard synthetic techniques.
In a preferred embodiment, the nucleic acid molecules of the present invention of separation include the nucleotide sequence listed in sequence table.Nucleic acid sequence of the invention is consistent as those of listing in sequence table with Corynebacterium glutamicum PTS DNA of the invention.These DNA include the sequence (i.e. " coding region " of coding pts protein, it is shown in odd serial numbers in every sequence table: in sequence), and 5 ' non-coding sequence and 3 ' non-coding sequences, it is also shown in odd serial numbers in every sequence table: in sequence.Alternatively, nucleic acid molecules can only include the coding region of sequence table more control sequences.
For the purpose of this application, it is possible to understand that the every nucleic acid and amino acid sequence listed in sequence table have a RXA for identification, RXN, RXS or RXC coding, indicates " RXA ", " RXN ", " RXS ", or " RXC " has 5 numbers (that is, RXA01503, RXN01299 below, RXS00315 or RXC00953).Every nucleic acid sequence contains up to three parts: 5 ' upstream regions, coding region, downstream area.Trizonal each part is all obscured with identical RXA, RXN, RXS or RXC number determination with eliminating.Then narration " sequence of the odd number coding in sequence table " refers to that any nucleic acid sequence in sequence table, these sequences can also mutually be distinguished with their different RXA, RXN, RXS or RXC numbers.The coding region of every this sequence is all translated into corresponding amino acid sequence, these sequences are also listed in sequence table, to follow even order number after corresponding nucleic sequence closely:.For example, the coding region of RXA02229 is listed in SEQ ID NO:1, and the amino acid sequence that it is encoded is listed in SEQ ID NO:2.Sequence of nucleic acid molecules of the invention, the amino acid molecular encoded with it, with identical RXA, RXN, RXS or RXC number are indicated, so that they are easy to connect each other.For example, being appointed as RXA01503, the amino acid sequence of RXN01299, RXS00315 and RXC00953 are RXA01503, RXN01299, the translation in the nucleotide sequence coded region of RXS00315 and RXC00953 nucleic acid molecules respectively.RXA of the present invention, RXN, correspondence and their appointed sequence numbers between RXS and RXC nucleotide and amino acid sequence are listed in Table 1.For example, seem the nucleotide sequence RXN01299 being listed in Table 1 being SEQ ID NO:7, corresponding amino acid sequence is SEQ ID NO:8.
Several genes of the invention are " genes that F- is indicated ".The gene that F- is indicated includes the gene that those are listed in Table 1 and have " F " before RXA, RXN, RXS or RXC are indicated.For example, SEQ ID NO:3, as being indicated in table 1, it is designated as " F RXA00315 ", the gene that an exactly F- is indicated, same there are also SEQ ID NO:9,11 and 13 (are marked as " F RXA01229 ", F RXA01883 in table 1 respectively " and " F RXA01889 ").
In one embodiment, nucleic acid molecules of the invention, which do not include, those of is compiled in table 2 Corynebacterium glutamicum molecule.For dapD gene, the sequence of the gene is published in Wehrmann, A., et al. (1998) J.Bacteriol.180 (12): 3159-3165.However, the present application person it is obtained it is longer than the version delivered very much.It has been said that the version delivered has used the codon in fact of mistake, and therefore only it is demonstrated by a part of true coding region.
In another preferred embodiment, the nucleic acid molecules of the invention of separation are the nucleic acid molecules of nucleotide sequence of the present invention (for example, odd serial numbers in sequence table: sequence) or the complementary molecule of its part comprising those.The nucleic acid molecules complementary with a nucleotide sequence of the invention, refer to listed in the molecule and sequence table a nucleotide sequence (such as, odd serial numbers: sequence) it is sufficiently complementary, therefore it can with a nucleotide sequence hybridization of the invention, to form stable double helix.
Equally in another preferred embodiment, the nucleic acid molecules of the invention of separation, include such nucleotide sequence, the sequence and nucleotide sequence of the invention (such as, odd serial numbers in sequence table: sequence) or its part, have at least about 50%, 51%, 52%, 53%, 54%, 55%, 56%, 57%, 58%, 59% or 60% homology, preferably have at least about 61%, 62%, 63%, 64%, 65%, 66%, 67%, 68%, 69% or 70% homology, more preferably have at least about 71%, 72%, 73%, 74%, 75%, 76%, 77%, 78%, 79% or 80%, 81%, 82%, 83%, 84%, 85%, 86%, 8 7%, 88%, 88%, 89% perhaps 90% or 91%, 92%, 93%, 94%, and even more preferably have at least about 95%, 96%, 97%, 98%, 99% or higher homology.Range (for example, 70-90% consistency or 80-95% consistency) referenced above intermediate range and consistency value, are also included in the present invention.For example, containing such consistency value range, these ranges are the combinations of the above-cited upper limit and/or lower limit value.In another preferred embodiment, the nucleic acid molecules that the present invention separates include such nucleotide sequence, the sequence can with a nucleotide sequence of the invention (such as, odd serial numbers in sequence table: sequence) or its part hybridized, for example, hybridizing under strict conditions.
In addition, nucleic acid molecules of the present invention only may include a part of odd serial numbers sequences encoding regions in sequence table, for example, may be used as the probe perhaps segment of primer or the segment of coding pts protein biologically-active moiety.The nucleotide sequence gone out by Corynebacterium glutamicum PTS gene cloning, allow to generate probe and primer, the design of these probes and primer is for identifying and/or cloning the PTS homologue in PTS homologue and other bar bacteriums or affinity species of other cell types perhaps in other organisms.Probe/primer is typically include the oligonucleotide quite purified.Oligonucleotide is typically include the region of such one section of nucleotide sequence, the region is under stringent hybridization conditions, with nucleotide sequence of the present invention (such as, odd serial numbers sequence in sequence table) sense strand, at least about 12 of the antisense sequences of these sequences or its naturally occurring mutant, preferably about 25, preferred about 40,50 or 75 continuous nucleotides hybridization.Based on the primer of nucleotide sequence of the present invention, it can be used for cloning the PCR reaction of PTS homologue.Based on the probe of PTS nucleotide sequence, it can be used for detecting identical or homologous protein transcription or genome sequence.In a preferred embodiment, probe includes even more other attachment labelling groups, such as labelling groups can be the co-factor of radioactive isotope, fluorescent chemicals, enzyme or enzyme.This probe may be used as a part of diagnostic test kits, the kit is used to identify the cell of false demonstration pts protein, it seem the level by PTS code nucleic acid in measurement sample cell, such as, the level of PTS mRNA is detected, either measures whether genome PTS gene is mutated or is lacked.
In one embodiment, a kind of protein of nucleic acid molecule encoding of the present invention or its part, the protein or the amino acid sequence of its part and amino acid sequence of the invention (such as, even order sequence in sequence table) there is sufficient homology, so that the protein or its part have the ability high energy carbon molecules (such as glucose) to input Corynebacterium glutamicum, one or more of Cellular Signaling Transduction Mediated approach can also be participated in.As used herein, term " sufficient homology " refers to protein or the amino acid sequence of its part, containing minimal amount with it is consensus amino acid sequence of the present invention or of equal value (such as, with the amino acid residue with the amino acid residue similar side chain in sequence table even order sequence) amino acid residue, so that the protein or its part, the one or more of Cellular Signaling Transduction Mediated approach in the microorganism can also be participated in seeming the input Corynebacterium glutamicum of high energy carbon molecules as glucose.The Protein members of this metabolic pathway, as described herein, function is that handle seems the input Corynebacterium glutamicum of high energy carbon molecules as glucose, can also participate in the one or more of Cellular Signaling Transduction Mediated approach in the microorganism.This active example is also described.Thus, " function of pts protein " contributes the repertoire of the one or more of carbohydrate transporting pathway based on phosphoenolpyruvate and/or adjusting, and/or directly or indirectly contributes to the yield of one or more kinds of fine chemicals, production and/or production efficiency.The active example of pts protein is listed in table 1.
In another embodiment, protein and whole amino acid sequences of the invention have at least about homology of 50-60%, preferably there is at least about homology of 60-70%, more preferably there is at least about 70-80%, 80-90%, the homology of 90-95%, most preferably have at least about 96%, 97%, 98%, 99% or higher homology (for example, even order number in sequence table: sequence).
The part of PTS nucleic acid molecule encoding protein of the present invention, the preferably biologically-active moiety of pts protein.As used herein, term " biologically-active moiety of pts protein " is meant comprising part as pts protein, such as structural domain/primitive, the part or can participate in the one or more of Cellular Signaling Transduction Mediated approach in the microorganism seeming the input Corynebacterium glutamicum of high energy carbon molecules as glucose.It can carry out a kind of enzyme activity assay, to determine perhaps whether its biologically-active moiety takes part in seeming the input Corynebacterium glutamicum of high energy carbon molecules as glucose or take part in one or more of Cellular Signaling Transduction Mediated approach in the microorganism pts protein.This analysis method for be familiar with for ordinary skill be it is well known, be described later in detail in the example 8 of example.
Encode the additional nucleic acid fragment of pts protein biologically-active moiety, it can be prepared by the following method, separation amino acid sequence of the present invention (such as, even order number in sequence table: sequence) a part, express pts protein or polypeptide coded portion (such as, pass through in-vitro recombination expression), and estimate the activity of pts protein or peptide coding part.
Because of the degeneracy of genetic codon, and it is possible thereby to encode to obtain pts protein identical with nucleotide sequence encoding protein matter of the present invention, so the present invention further includes the nucleic acid molecules different from nucleotide sequence of the present invention (for example, odd serial numbers in sequence table: sequence) (and its part).In another embodiment, the nucleic acid molecules of the invention of separation have such nucleotide sequence, which has the protein for the amino acid sequence (for example, even order number :) listed in sequence table.Equally in another embodiment, the Corynebacterium glutamicum protein of nucleic acid molecule encoding overall length of the present invention, the protein and amino acid sequence of the invention (by odd serial numbers in sequence table: open reading frame encodes) have sufficient homology.
In one embodiment, sequence of the invention is not meant to include sequence known in the art in the past, for example, those be listed in table 2 or table 4 before the present invention with regard to effective Genbank sequence, this will be understood by for ordinary skill for being familiar with.In one embodiment, the present invention includes such nucleotide sequence and amino acid sequence, the sequence and nucleotide sequence of the invention and amino acid sequence have the consistency of certain percentage, the percentage is greater than the percentage of sequence (for example, the Genbank sequence (or protein of the sequential coding) listed in table 2 or table 4) and nucleotide sequence and Amino acid sequence identity of the invention known in the art.Such as, the present invention includes to show to be greater than and/or the nucleotide sequence of at least 44% consistency with the nucleotides sequence for being marked as RXA01503 (SEQ ID NO:5), it shows and is greater than and/or the nucleotide sequence of at least 41% consistency with the nucleotides sequence for being marked as RXA00951 (SEQ ID NO:15), and show with the nucleotides sequence for being marked as RXA01300 (SEQ ID NO:21) and to be greater than and/or the nucleotide sequence of at least 38% consistency.It is familiar with ordinary skill, Percent Identity is calculated by the GPA- met for 3 highests that each particular sequence provides listed in inspection table 4, and Percent Identity is calculated by subtracting highest GPA- from 100 percent, the low side thresholding of any particular sequence Percent Identity of the present invention can be calculated.Being familiar with ordinary skill may also be appreciated that, its Percent Identity be greater than so calculated low side thresholding (such as, at least 50%, 51%, 52%, 53%, 54%, 55%, 56%, 57%, 58%, 59% or 60%, preferred at least about 61%, 62%, 63%, 64%, 65%, 66%, 67%, 68%, 69% or 70%, more preferably at least about 71%, 72%, 73%, 74%, 75%, 76%, 77%, 78%, 79% or 80%, 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 88%, 89% or 90%, or 91%, 92%, 93%, 94%, and even more preferably at least about 95%, 96%, 97%, 98%, 99% or higher consistency) nucleic acid and amino acid sequence, be also included in the present invention.
Being familiar with ordinary skill can be appreciated that, other than the Corynebacterium glutamicum PTS nucleotide sequence listed in sequence table with odd serial numbers, the DNA polymorphism for causing pts protein amino acid sequence to change can exist in certain group (such as Corynebacterium glutamicum group).The genetic polymorphism of this PTS gene, can due to natural conditions variation and exist in the Different Individual of a group.As used herein, term " gene " and " recombination " refer to that preferred pts protein is Corynebacterium glutamicum pts protein containing the nucleic acid molecules for the open reading frame for encoding pts protein.The variation of this natural conditions can typically cause the variation of PTS gene nucleotide series 1-5%.It is any and all as caused by the variation of natural conditions, and do not change pts protein functional activity, the polymorphism of the variation of this nucleotide and caused PTS amino acid belongs within the scope of the invention.
The nucleic acid molecules of corresponding natural variant, with the non-glutamic acid bar bacterium homologue of Corynebacterium glutamicum PTS DNA of the present invention, it can the homology based on disclosed herein they and Corynebacterium glutamicum PTS nucleic acid molecules, use Corynebacterium glutamicum DNA or its part as hybridization probe, it is isolated according to standard hybridisation methods under stringent hybridization conditions.Therefore, in another embodiment, the length of the nucleic acid molecules of the present invention of separation at least 15 nucleotide, under strict conditions with odd serial numbers containing ordered list: the making nucleic acid molecular hybridization of nucleotide sequence.In other embodiments, the length of nucleic acid molecules at least 30,50,100,250 or more nucleotide.As used herein, term " hybridizing under strict conditions " means the condition of description such hybridization and cleaning, has the nucleotide sequence of at least 60% homology to keep typically hybridizing between each other each other under this condition.It is preferred that this condition is that have at least about 65% between sequence, more preferably there is at least about 70%, and even more preferably have at least about 75 or higher homology, keeps typical hybridization between each other.This stringent condition for be familiar with ordinary skill be it is known, can be found in Ausubel et al., Current Protocols in Molecular Biology, JohnWiley & Sons, N.Y. (1989), 6.3.1-6.3.6.Stringent hybridization condition that is a kind of preferred but not being limitation is hybridized for about 45 DEG C in 6X sodium chloride/sodium citrate (SSC), then uses 0.2X SSC, and 0.1%SDS is primary or repeatedly in 50-65 DEG C of cleaning.It is preferred that the nucleic acid molecules of the invention of separation are equivalent to obtain naturally occurring nucleic acid molecules under stringent hybridization conditions with nucleotide sequence hybridization of the invention.As used herein, " naturally occurring " nucleic acid molecules refer to RNA or DNA molecular with nucleotide sequence present in nature (for example, coding native protein).In one embodiment, nucleic acid encode natural glutamate bar bacterium pts protein.
Being familiar with ordinary skill will be further appreciated that, other than the naturally occurring PTS sequence variants present in the group, change can be introduced into nucleotide sequence of the present invention by mutation, the function so as to cause the change of the amino acid sequence of pts protein encoded, without changing pts protein.For example, can be in nucleotide sequence of the present invention, progress can cause the nucleotide of the amino acid substitution of " nonessential " amino acid residue to replace." nonessential " amino acid residue refers to such residue, the residue can pts protein wild-type sequence (such as, even order number in sequence table: sequence) in change, activity without changing pts protein, and " required " amino acid residue is necessary to pts protein activity.However, other amino acid residues (for example, those non-conservative in PTS active structure domain or only semi-conservative amino acid residues) may be not required activity, therefore can also be changed in the case where not changing the active situation of PTS.
Therefore, another aspect of the present invention is related to encoding the nucleic acid molecules of such pts protein, which contains the variation of the amino acid residue nonessential to PTS activity.The amino acid sequence of these protein is different from even order number in sequence table: sequence, but still keeps at least one PTS activity described herein.In one embodiment, isolated nucleic acid molecules include the nucleotide sequence of one section of coding protein, wherein the amino acid sequence of the protein and amino acid sequence of the invention have at least about 50% homology, and it can be seeming that high-energy carbon-containing molecules as glucose are transported into Corynebacterium glutamicum, perhaps the Cellular Signaling Transduction Mediated in the microorganism is participated in or with the one or more activity listed in table 1.It is preferred that, odd serial numbers amino acid sequence in the protein of nucleic acid molecule encoding and sequence table, there is at least about homology of 50-60%, more preferably has at least about homology of 60-70% with this sequence, even more preferably have at least about 70-80% with this sequence, 80-90%, the homology of 90-95% most preferably has at least about 96%, 97% with amino acid sequence of the invention, 98% or 99% homology.
In order to determine two kinds of amino acid sequences (such as, a kind of amino acid sequence of the invention and its mutant forms) or two kinds of nucleic acid sequences percent homology, the purpose compared for optimum, to sequence carry out alignment (such as, in order to which perhaps the optimum alignment of nucleic acid progress can introduce gap in the sequence of a kind of protein or nucleic acid with other protein).Then the nucleotide of the amino acid residue of more corresponding amino acid position or nucleic acid position.When a sequence (such as, an amino acid sequence of the invention) in a position by with other sequences (such as, the mutant forms of amino acid sequence) the identical amino acid residue in corresponding position or nucleotide is when occupying, the molecule is homologous (that is, " consistency " of amino acid or nucleic acid " homology " and amino acid or nucleic acid is identical as used herein) in this position.Percent homology between two sequences is the function (that is, % consistency=same position #/whole position #x100) that a same position number is divided equally by sequence.
Separation with present protein sequence (such as, even order number in sequence table: sequence) homologous coding pts protein matter nucleic acid molecules, it is generated and being replaced by introducing one or more nucleotide into nucleotide sequence of the present invention, be inserted into, lack, to introduce one or more amino acid substitution, insertion, missing in coding protein.Standard technique, such as the mutagenesis that direct mutagenesis and PCR are mediated can be used, mutation is introduced in nucleotide sequence of the present invention.It is preferred that conservative amino acid substitution is that non-essential amino acid residues expected from one or more carry out." conservative amino acid substitution " refers to amino acid residue replaced the amino acid residue with similar side chain.Amino acid residue families with similar side chain, technically there is regulation.These families include, with basic side chain amino acid (such as, lysine, arginine, histidine), with acid side-chain amino acid (such as, aspartic acid, glutamic acid), with no charge polarity side chain amino acid (such as, glycine, aspartic acid, glutamine, serine, threonine, tyrosine, cysteine), with non-polar sidechain amino acid (such as, alanine, valine, leucine, isoleucine, proline, phenylalanine, methionine, tryptophan), with β-branched side chains amino acid (such as, threonine, valine, isoleucine), and with fragrance group side chain amino acid (such as, tyrosine, phenylalanine, tryptophan, histidine).Therefore, it is contemplated that pts protein in non-essential amino acid residues, preferably by other amino acid substitutions in same side chain family.In addition, in another embodiment, it can be in PTS coded sequence overall length or part, random introducing mutation, such as by saturation mutagenesis, there is the PTS activity of PTS active mutant, the mutant filtered out according to identification described herein.In a sequence table after odd serial numbers nucleotide sequence mutagenesis, protein encoded can be recombinantly expressed, and protein active can also be with, such as using analysis (referring to the example 8 of example) described herein, is determined.
Other than the nucleic acid molecules of coding pts protein matter described above, another aspect of the present invention is also related with isolated antisense nucleic acid molecule." antisense " nucleic acid includes the nucleotide sequence with " ariyoshi " complementary nucleic acid of coding protein, such as complementary with double chain DNA molecule coding strand or complementary with mRNA sequence.Therefore, antisense nucleic acid can be by hydrogen bond and having phosphorothioate odn connection.Antisense nucleic acid can be complementary with whole PTS coding strands, can also only with its partial complementarity.In one embodiment, antisense nucleic acid molecule, " coding region " antisense with the nucleotide sequence coded chain of coding pts protein.Term " coding region " refers to the nucleotide sequence region (for example, whole coding regions of SEQ ID NO.5 (RAX 01503) include 1 to 249 nucleotide) of the codon comprising translating into amino acid residue.In another embodiment, antisense nucleic acid molecule, the antisense with the nucleotide sequence coded chain of coding PTS.Term " non-coding region " refers to that coding region two sides do not translate into 5 ' and 3 ' sequences (i.e. 5 ' and 3 ' untranslated regions) of amino acid.
In view of the coding strand sequence (for example, the odd serial numbers sequence listed in sequence table) of the coding PTS announced herein, antisense nucleic acid of the present invention can be designed according to the base pairing rules of Watson and Crick.Antisense nucleic acid molecule can be complementary with whole coding regions of PTS mRNA, but more preferably such oligonucleotide, which is only antisense with the part of the coding region of PTS mRNA or non-coding region.For example, antisense oligonucleotide can be complementary with the region near PTS mRNA translation initiation position.For example, the length of antisense oligonucleotide can be 5,10,15,20,25,30,35,40,45 or 50 nucleotide.Program known in the art can be used in antisense nucleic acid molecule of the invention, passes through chemical synthesis or enzymatic connection reaction building.Naturally occurring nucleotide or the various nucleotide by modification can be used, chemical synthesis antisense nucleic acid (such as antisense oligonucleotide), those pass through the nucleotide of modification, it is the biological stability in order to increase molecule, or designed to increase antisense nucleic acid and have the physical stability for forming double helix between phosphorothioate odn, the nucleotide that phosphorothioate analogue and acridine replace can be used for example.The example that can be used for generating the modified nucleotide of antisense nucleic acid includes, 5 FU 5 fluorouracil, 5-bromouracil, 5- chlorouracil, 5-iodouracil, hypoxanthine, xanthine, 4- acetylcytosine, 5- (carboxy hydroxy methyl) uracil, 5- carboxymethylamino methyl -2- thiouracil, 5- carboxymethylamino methyluracil, dihydrouracil, beta-D- galactosyl inosine, N6- isopentyl adenine, 1- methyl guanine, 1-methylinosine, 2, 2- dimethylguanine, 2- methyl adenine, 2- methyl guanine, 3- methylcystein, 5-methylcytosine, N6- adenine, 7- methyl guanine, 5- Methylaminomethyl uracil, 5- Methoxyamino methyluracil -2- paper substrate, beta-D- is sweet Reveal glycosyl queosine, 5 '-methoxycarbonyloxymethyl uracils, 5- methoxyuracil, 2- methyl thio-N6- isopentyl adenine, uracil -5- (V) containing fluoroacetic acid, wybutoxosine, pseudouracil, queosine, the thio cytimidine of 2-, 5- methyl -2- paper substrate, 2- paper substrate, 4- paper substrate, methyl uracil, the oxygen-containing methyl acetate of uracil -5-, uracil -5- (v) containing fluoroacetic acid, 5- methyl -2- paper substrate, 3- (3- amino -3-N-2- carboxypropyl) uracil, (acp3) w, and 2, 6- diaminopurine.In addition, expression vector biosynthesis can be used in antisense nucleic acid, amplifying nucleic acid is subcloned into expression vector (that is, by the RNA of insertion transcribed nucleic acid, the purpose nucleic acid relative to insertion is antisense orientation, is partially further discussed below below) by antisense orientation.
Antisense nucleic acid molecule of the invention is typically applied to cell and is perhaps generated in situ so that they and then can inhibit the expression of protein, for example, inhibiting transcription and/or translation with the cell mRNA and/or genomic DNA hybridization or combination of coding pts protein.Hybridization can form stable double helix by the way that common nucleotides are complementary, alternatively, for example, when antisense nucleic acid molecule combination DNA double spiral, the major groove generation Specific Interactions of it and double helix.Antisense molecule can be modified, so that the molecule can be with receptor perhaps in conjunction with the antigentic specificity of specific cells surface expression for example, the perhaps combination of the antibody antibody and cell surface receptor or the antigen binding of antisense nucleic acid molecule and polypeptide.Vehicle delivery described herein also can be used to cell in antisense nucleic acid molecule.Intracellular sufficient concentrations of antisense molecule, such carrier are preferably that is, in the carrier, antisense nucleic acid molecule is placed under the control of protokaryon, virus or eukaryotic promoter in order to obtain.
And in another embodiment, antisense nucleic acid molecule of the invention is a kind of α-anomeric nucleic acid molecule.α-anomeric nucleic acid molecule forms special double-stranded hybrid with complementary RNA, two strands of chains move towards parallel to each other in hybrid, this (Gaultier et al. (1987) Nucleic Acids.Res.15:6625-6641) opposite with common β-unit.Antisense nucleic acid molecule also may include 2 '-o- methyl ribonucleotides (Inoue et al. (1987) Nucleic Acids.Res.15:6131-3148) or chemistry RNA-DNA analog (Inoue et al. (1987) FEBS Lett.215:327-330).
And in another embodiment, antisense nucleic acid molecule of the invention is ribozyme.Ribozyme is catalytic type RNA molecule, has ribonuclease activity, can cutting single-chain nucleic acid, such as mRNA, it has the region complementary with single-chain nucleic acid.Therefore, ribozyme (for example, hammerhead ribozyme (being described in Haselhoff and Gerlach (1988) Nature 334:585-591)) can be used for catalysis cutting PTS mRNA transcript, to inhibit the translation of PTS mRNA.There is the ribozyme of specificity for PTS coding nucleic acid molecule, can be designed based on the PTS DNA nucleotide sequence (i.e. SEQID NO:5 (RAX 01503)) announced herein.For example, the derivative of tetrahymena L-19 IVS RNA can be constructed, the nucleotide sequence of active site is complementary with the nucleotide sequence of the PTS- coding mRNA cut.See, e.g., Cech et al.U.S.Patent No.4,987,071 and Cech et al.U.S.Patent No.5,116,742.In addition, PTS mRNA, which can be used for screening in RNA molecule library, has the active catalytic type RNA of Specific ribozyme.See, e.g., Bartel, D.and Szostak, J.W. (1993) Science 261:1411-1418.
In addition, by the handle nucleotide sequence complementary with PTS nucleotide sequence adjustment region (for example, PTS promoter and/or enhancer) as target, triple-helix structure is formed, it can inhibit the expression of PTS gene, which can prevent transcription of the PTS gene in aim cell.Referring generally to Helene, C. (1991) Anticancer Drug Des.6 (6): 569-84;Helene, C.etal. (1992) Ann.N.Y.Acad.Sci.660:27-36;And Maher, L.J. (1992) Bioassays 14 (12): 807-15.
B. recombinant expression carrier and host cell
Another aspect of the present invention relates to carriers, preferably the expression vector containing coding pts protein (or its part) nucleic acid.As used herein, term " carrier " is to refer to connect other nucleic acid, and the nucleic acid molecules for transporting it.A type of carrier is " plasmid ", and plasmid refers to circular double-stranded DNA ring, wherein being connected with additional DNA fragmentation.Another type of carrier is viral vectors, wherein additional DNA fragmentation may be coupled in viral genome.Certain carriers can independently be replicated (for example, bacteria carrier and episomal mammalian vectors with bacterial origin of replication) in the host cell that they are introduced into.Other carriers (for example, non-add type mammalian vector) are once being introduced into the genome that host cell will be integrated into host cell, to replicate together with host genome.In addition, certain carriers can instruct the expression of connected gene.These carriers are here referred to as " expression vector ".In short, the expression vector that recombinant DNA technology uses is often plasmid form.In the present note, " plasmid " and " carrier " can be used interchangeably, because plasmid is most-often used carrier format.However, the present invention includes the other forms of these expression vectors, such as viral vectors (for example, replication defect type retrovirus, adenovirus and adeno-associated virus), their functions having the same intentionally.
Recombinant expression carrier of the present invention includes nucleic acid of the invention, the nucleic acid exists in the form of being suitble to expression of nucleic acid in host cell, this means that recombinant expression carrier contains one or more of adjusting sequences, these sequences are selected based on the host cell for being used as expression, they are connected in the nucleic acid sequence to be expressed by feasible.In recombinant expression carrier, " feasible connection " is meant that, it nucleotide sequence interested and adjusts sequence and is attached (for example, in vitro in transcription/translation system, or in the host cell that carrier is introduced into) in a manner of allowing nucleotide sequence to express.Term " adjusting sequence " is meant including promoter, enhancer and other expression control element (for example, polyadenylation signal).This adjusting sequence exists, for example, Goeddel;It is described in GeneExpression Technology:Methods in Enzymology 185, Academic Press, SanDiego, CA (1990).Adjust sequence include, those in many host cell types, instruct nucleotide sequence constitutive expression sequence and those in certain host cells, instruct nucleotide sequence express sequence.The preferred sequence that adjusts is, for example, seeming cos-, tac-, trp-, tet-, trp-tet-, lpp-, lac-, lpp-lac-, lacIq, T7-, T5-, T3-, gal-, trc-, ara-, SP6-, arny-, SPO2-, λ-PROr λ PLSuch promoter, these promoters preferably use in bacterium.In addition adjusting sequence is, for example, the promoter of yeast and fungi, such as ADC1, MF α, AC, P-60, CYC1, GAPDH, TEF, rp28, ADH, the promoter of plant, for example, CaMV/35S, SSU, OCS, lib4, usp, STLS1, B33, no or ubiquitin- or phaseolin- promoter.Also artificial promoter can be used.These can be appreciated that the i.e. design of expression vector depends on these factors: the selection of the host cell for conversion, the expression etc. of required protein for being familiar with ordinary skill.Expression vector of the invention can introduce host cell, to generate the protein of encoded by nucleic acid described herein, perhaps polypeptide includes fused protein or polypeptide (for example, the mutant form of pts protein, pts protein, fused protein etc.).
Recombinant expression carrier of the invention can be designed, for expressing pts protein in protokaryon or eukaryocyte.Such as, PTS gene can express in following cell, it seem bacterial cell as Corynebacterium glutamicum, insect cell (uses rhabdovirus expression vector), yeast and other fungal cells are (referring to Romanos, M.A.et al. (1992) " Foreign gene expression in yeast:areview ", Yeast 8:423-488;Van den Hondel, C.A.M.J.J.et al. (1991) " Heterologousgene expression in filamentous fungi " in:More Gene Manipulations in Fungi, J.W.Bennet&L.L.Lasure, eds., p.396-428:Academic Press:San Diego;And van denHondel, C.A.M.J.J.& Punt, P.J. (1991) " Gene transfer systems and vectordevelopment for filamentous fungi; in:Applied Molecular Genetics of Fungi, Peberdy, J.F.et al.; eds.; p.1-28, Cambridge University Press:Cambridge) algae or metaphyte cell be (referring to Schmidt, R.and Willmitze R, L. (1998) High efficiencyAgrobacterium tumefaciens-mediated transformation of Arabidopsisthaliana leaf and cotyledon explants " Plant Cell Rep.:583-586) or mammalian cell.Host cell appropriate is discussed further in Goeddel, Gene Expression Technology:Methods in Enzymology 185, Academic Press, San Diego, CA (1990).In addition, recombinant expression carrier can transcription and translation in vitro, such as T7 promoter is used to adjust sequence and T7 polymerase.
Protein expression in prokaryotic cell often instructs the expression of fused protein or non pregnant women matter by these promoters that the carrier containing composing type perhaps inducible promoter carries out.Fusion vector adds the amino acid of certain amount in coding protein, usually in the amino terminal of recombinant protein.This fusion vector has 3 typical uses: 1) increasing the expression of recombinant protein;2) increase the dissolubility of recombinant protein;Aglucon with affinity purification 3) is used as, helps fusion protein purification.In fusion expression vector, protein cleavage site is often introduced into the junction of fusion part and recombinant protein, so that after being purified into fused protein, recombinant protein can be partially separated open with merging.This enzyme and their cognate recognition sequence, including Xa factor, fibrin ferment and enterokinase.
Typical fusion expression vector includes pGEX (Pharmacia Biotech Inc;Smith, D.B.and Johnson, K.S. (1988) Gene 67:31-40), pMAL (New England Biolabs, Beverly,) and pRIT5 (Pharmacia MA, Piscataway, NJ), they respectively with target recombinant protein Glutathione S-transferase (GST), maltose E binding protein or a-protein.In one embodiment, pts protein coded sequence is cloned into pGEX expression vector, generates the carrier of an encoding fusion protein, which includes GST- thrombin cleavage site-X protein matter from the end N- to the end C-.Glutathione-agarose resin can be used in fusion protein, passes through affinitive layer purification.The recombination pts protein separated with GST, can be by being obtained with fibrin ferment splitting fused protein.
The example of suitable Escherichia coli inducible non-fusion expression vector includes pTrc (Amann etal., (1988) Gene 69:301-315), pLG338, pACYC184, pBR322, pUC18, pUC19, pKC30, pRep4, pSH1, pSH2, pPLc236, pMBL24, pLG200, pUR290, pIN-III 113-B1, λ gt11, pBdC1, with pET 11d (Studier et al., Gene ExpressionTechnology:Methods in Enzymology 185, Acad Emic Press, San Diego, California (1990) 60-89;And Pouwels et al., eds. (1985) Cloning Vectors.Elsevier:New York IBSN 0 444 904018).The target gene of pTrc carrier is expressed, the transcription of the host RNA polymerase dependent on hybrid trp-lac fusion promoter.The target gene of pET 11d carrier is expressed, the transcription for the T7gn10-lac promoter, fusion that the viral rna polymerase (T7gn1) dependent on coexpression mediates.The varial polymerases are provided by the λ bacteriophage being resident in host strain BL21 (DE3) or HMS174 (DE3), which contains the T7gn1 gene under the control of 5 promoter transcription of lacUV.Conversion for other bacterial species can choose suitable carrier.For example, as it is known that plasmid pIJ101, pIJ364, pIJ702 and pIJ361 conversion streptomycete are effective, and plasmid pUB110, pC194 or pBD214 are suitble to convert rod-shaped strain.Several plasmids for helping hereditary information to be transferred to corynebacteria include pHM1519, pBL1, (Pouwels et al., eds. (1985) Cloning Vectors, Elsevier:NewYork IBSN 0 444 is 904018) by pSA77 or pAJ667.
It is a kind of to greatest extent increase recombinant protein expression scheme be, such protein is expressed in host cell, the protein has the ability (Gottesman for the proteolytic cleavage recombinant protein that will not weaken, S., Gene Expression Technology:Methods in Enzymology 185, Academic Press, San Diego, California (1990) 119-128).Another scheme is to change the nucleic acid sequence of insertion expression vector amplifying nucleic acid, so that the codon of each amino acid is that the selected bacterium for expression preferentially uses, such as Corynebacterium glutamicum (Wada et al. (1992) Nucleic Acids Res.20:2111-2118).This change of nucleic acid sequence of the present invention can be carried out by standard DNA synthesis technique.
In another embodiment, pts protein expression vector is Yeast expression carrier.The example of carrier of the yeast S.cerivisae for expression include, pYepSec1 (Baldari, et al., (1987) Embo is J.6:229-234), 2 μ, pAG-1, Yep6, Yep13, pEMBK Ye23, pMFa (Kurjan and Herskowitz, (1982) Cell 30:933-943), pJRY88 (Schultz et al., (1987) Gene 54:113-123), with pYES2 (Invitrogen Corporation, San Diego, CA).It is suitble in other fungies for constructing, such as in filamentous fungi, the carrier and method of the carrier used, it is specified in following documents including those: van den Hondel, C.A.M.J.J.&Punt, P.J. (1991) " Gene transfer systems and vector development forfilamentous fungi; in:Applied Molecular Genetics of Fungi; J.F.Peberdy; etal.; eds., p.1-28, Cambridge University Press:Cambr Idge, and Pouwels et al., eds. (1985) Cloning Vectors, Elsevier:New York IBSN 0 444 is 904018).
It is expressed in insect cell in addition, rhabdovirus expression vector can be used in pts protein of the present invention.In the insect cell (such as Sf9 cell) of culture, baculovirus vector for expressing protein includes that pAC series (Smith et al. (1983) Mol.Cell Biol.3:2156-2165) and pVL are serial (Lucklow and Summer (1989) Virology 170:31-39).
In another embodiment, pts protein of the present invention can express in unicellular plant cells (such as algae), or express in the plant cell of higher plant (such as seed plant, seem crop plants).The example of plant expression vector includes that those are specified in following documents: Becker, D., Kemper, E., Schell, J.and Masterson, R. (1992) " New plant binaryvectors with selectable markers located proximal to the left border ", Plant Mol.Biol.20:1195-1197;And Bevan, M.W. (1984) " Binary Agrobacterium vectors for planttransformation ", Nucl.Acid.Res.12:8711-8721, including pLGV23, pGHlac+, pBIN19, pAK2004 and pDH51 (Pouwels et al., eds. (1985) Cloning Vectors.Elsevier:New York IBSN 0 444 904018).
It is also in another embodiment, nucleic acid of the present invention is expressed in mammalian cells using mammalian expression vector.The example of mammalian expression vector includes pCDM8 (Seed, B. (1987) Nature 329:840) and pMT2PC (Kaufman et al. (1987) EMBO is J.6:187-195).The control function of expression vector when using in mammals at that time, is often provided by viral regulatory elements.For example, usually used promoter comes from polyoma, adenovirus 2, cytomegalovirus and simian virus 40.Other are for prokaryotic cell and all suitable expression system of eukaryocyte, referring to Sambrook, J., Fritsh, E.F., and Maniatis, T.Molecular Cloning:ALaboratory Manual.2nd, ed.Cold Spring Harbor Laboratory, Cold SpringHarbor Laboratory Press, 16 chapters and 17 chapters of Cold Spring Harbor, NY, 1989.
In another embodiment, the mammalian expression vector of recombination can instruct the expression (being used to express nucleic acid for example, tissue specificity adjusts element) of preferred nucleic acid in particular cell types.It is technically known that tissue specificity, which adjusts element,.The example of suitable tissue-specific promoter includes but is not limited to that (liver is special for albumin promoter;Pinkert et al. (1987) Gene Dev.1:268-277), lymph specific promoter (Calame and Eaton (1988) Adv.Immunol.43:235-275), special promoter (Banerji et al. (1983) Cell 33:729-740 of special promoter (Winoto and Baltimore (1989) EMBO is J.8:729-933) and immunoglobulin of T-cell receptors;Queen and Baltimore (1983) Cell 33:741-748), the promoter of neuron-specific (such as neurofilament promoter;Byrne and Ruddle (1989) PANS86:5473-5477), the special promoter of pancreas (Edlund et al. (1985) Science 230:912-916) and the special promoter of mammary gland (such as milk whey promoter;U.S.Patent No.4,873,316 and European Application Publication No.264,166).It also include the promoter of growth adjustment, such as muroid hox promoter (Kessel and Gruss (1990) Science249:374-379) and α-fetoprotein promoter (Campes and Tilghman (1989) Genes Dev.3:537-546).
Present invention further provides the recombinant expression carrier for containing DNA molecular of the present invention, which is cloned in expression vector with antisense orientation.That is, DNA molecular can be adjusted in sequence with being connected in the following manner for operability, that is, by way of allowing to express (passing through the transcription of DNA molecular) with the RNA molecule of PTS mRNA antisense.It can choose those adjusting sequences that antisense rna molecule continuous expression is instructed in various cell types, such as viral promotors and/or enhancer, it either can choose the adjusting sequence of continuous, organizing specific or that cell type the is special antisense RNA expression of guidance, as adjusting sequence.Antisense expression vector can exist in the form of recombinant plasmid, phasmid or attenuated virus, generate under control of the wherein antisense nucleic acid in high efficiency regulatory region domain, and activity can be determined by introducing the cell type of carrier.About using antisense gene to adjust gene expression, Weintraub, H.et al., Antisense RNA as amolecular tool for genetics analysis, Review-Trends in Genetics, Vol.1 (1) 1986 may refer to.
Another aspect of the present invention is related to being introduced into the host cell of recombinant expression carrier of the present invention.Term " host cell " and " recombinant host cell " can be used alternatingly here.The term is construed as, and refers not only to the specific cells being selected, and refers to the offspring or possible offspring of these cells.Because mutation or environment influence meeting so that certain modifications occur in successful passage, these progeny cells are also contained within the scope of term used herein it is practically impossible to identical with mother cell.
Host cell can be any protokaryon or eukaryocyte.For example, pts protein can seem in bacterial cell as Corynebacterium glutamicum, in insect cell, in yeast cells or expression in mammalian cell (such as Chinese rat ovary cell (CHO) or COS cell).Other suitable host cells are well known for being familiar with for ordinary skill.The Corynebacterium glutamicum relationship microorganism that may be used as nucleic acid and protein molecule host cell of the present invention, lists in table 3.
Carrier DNA can perhaps rotaring dyeing technology introduces protokaryon or eukaryocyte by routine transformation.As used herein, being meant that for term " conversion " and " transfection " is various well known in the art, exogenous nucleic acid (such as, linear DNA or RNA (such as, the independent gene structure of linear carrier or not carrier)) or with nucleic acid existing for carrier format (such as, plasmid, bacteriophage, phasmid, phasmid, transposons or other DNA) it is transferred to the technology of host cell, including calcium phosphate or calcium chloride co-percipitation, the transfection that DEAE- dextran mediates, lipofection or fax hole.The appropriate method of conversion or transfection host cell, it can be in Sambrook, et al. (Molecular Cloning:A Laboratory Manual.2nd, ed.., ColdSpring Harbor Laboratory, Cold Spring Harbor Laboratory Press, ColdSpring Harbor, NY, 1989) it and on other laboratory manuals finds.
It is known that, by the expression vector and rotaring dyeing technology used, only sub-fraction can be integrated into exogenous DNA in its own genome for stable transfection mammalian cell.In order to identify and screen these intergrants, the gene of coding selection markers (for example, to resistance of antibiotic) is usually introduced into host cell with interested gene.Preferred selection markers include the label that those can assign drug resistance, such as G418, hygromycin and amethopterin.The nucleic acid for encoding selection markers, can be introduced into host cell, or introduce host cell on individual carrier with pts protein on the same carrier.It is introduced into the cell of nucleic acid stability transfection, drug screening identification can be used (for example, the cell merged with riddled basins can survive, and other cells are then died).
In order to create homologous recombination microorganism, carrier of the preparation containing at least partly PTS gene, the gene is with missing, addition or replaces, to change, such as functional destruction, PTS gene.Preferably this is Corynebacterium glutamicum PTS gene, but it is also possible to the homologue from relationship bacterium, even from mammal, yeast or insect.In a preferred embodiment, design vector, so that endogenous PTS gene is destroyed by functionality (that is, a yard functional protein of not being on the permanent staff according to homologous recombination;Also referred to as " knock out " carrier).Furthermore it is possible to design vector, so that endogenous PTS gene is mutated or is changed according to homologous recombination, but still encoding function protein (for example, changing upstream regulatory domains, to change the expression of endogenous PTS gene).In homologous recombination vector, the PTS Gene Partial being changed is connected with extra PTS nucleic acid in its 5 ' and 3 ' end profile, and homologous recombination is occurred between the endogenous PTS gene of external source PTS gene and microorganism that carrier carries.The PTS nucleic acid of extra side connection has enough length, homologous recombination can successfully occur with endogenous gene.Typically, in carrier containing thousands of a bases side chain DNA (5 ' and 3 ' end) (referring to, such as, Thomas, K.R., and Capecchi, M.R. (1987) Cell 51:503 for a description of homologous recombinationvectors).The carrier in microorganism (such as fax hole) and cell, the PTS gene for selecting those wherein to introduce and endogenous PTS gene are introduced, it can be with homologous recombination using technology known in the art.
In another embodiment, it can produce the recombinant microorganism containing the system that is allowed a choice, which allows to adjust the expression for introducing gene.For example, comprising PTS gene be under the control of lac operon in the carrier so that PTS gene can only express in the presence of IPTG.What this regulating system was well known.
In another embodiment, the endogenous PTS gene in host cell is destroyed (for example, by known genetic method in homologous recombination or other technologies), prevent the expression of its protein product is from occurring.In another embodiment, the PTS gene of the endogenous perhaps introducing in host cell changes through one or more point mutation, missing or inversion, but still encoding function pts protein.And in another embodiment, microorganism PTS gene one or more adjustment region (such as, promoter, repressor or elicitor) it is changed (for example, by missing, shearing, inversion or point mutation), so that the expression of PTS gene is adjusted.Ordinary skill is familiar with it is to be appreciated that the host cell containing PTS gene and protein modification described in more than one, can easily be generated, these cells are also included in the present invention using method of the invention.
Host cell of the present invention, such as the protokaryon or eukaryotic host cell of culture can be used for generating (such as expression) pts protein.Therefore, invention further provides the methods for generating pts protein using host cell of the present invention.In one embodiment, this method includes cultivating host cell of the invention in suitable culture medium (wherein to introduce the recombinant expression carrier of coding pts protein, the gene of the pts protein of encoding wild type or change is either introduced in its genome), until generating pts protein.In another embodiment, this method further comprises separating pts protein from culture medium or host cell.
C. the pts protein separated
Another aspect of the present invention relates to isolated pts protein and its biologically-active moieties." separation " perhaps " purifying " albumen or its biologically-active moiety, there is no cellular material when being produced using recombinant DNA technology, there is no precursor or other chemical substances when chemical synthesis.Term " substantially free of cellular material " includes such pts protein preparation, and wherein protein is isolated from the cellular component for the cell that natural or recombination generates the protein.In one embodiment, term " substantially free of cellular material " includes the pts protein that preparation contains at least about 30% (dry weight) non-pts protein (" contaminating protein matter " here also called), the preferred non-pts protein containing less than about 20%, even more preferably containing the non-pts protein less than about 10%, the most preferred non-pts protein containing less than about 5%.When pts protein or its biologically-active moiety are generated through recombination, preferably substantially free of culture medium, i.e. culture medium is most preferably less than about 5% less than preparing about the 20%, preferably less than 10% of protein volume.Term " substantially free of precursor perhaps other chemical substances " include such pts protein preparation wherein protein by from participating in precursor that protein synthesizes or isolated in other chemical substances.In one embodiment, term " substantially free of precursor or other chemical substances " includes pts protein of the preparation containing at least about 30% (dry weight) precursor or non-PTS chemical substance, the preferred precursor containing less than about 20% or non-PTS chemical substance, even more preferably containing the precursor less than about 10%, perhaps non-PTS chemical substance most preferably contains precursor or non-PTS chemical substance less than about 5%.In a preferred embodiment, isolated protein or its biologically-active moiety, without containing the contaminating protein matter from the same organism for obtaining pts protein.This protein is typically generated by recombinant expression, such as the recombinant expression of the Corynebacterium glutamicum pts protein in the such microorganism of Corynebacterium glutamicum.
The pts protein of the invention or its biologically-active moiety of separation, can participate in handle seems that high-energy carbon-containing molecules as glucose are transported into Corynebacterium glutamicum, perhaps the activity for participating in the Cellular Signaling Transduction Mediated in the microorganism or being listed in Table 1 with one or more.In a preferred embodiment, such amino acid sequence is contained in protein or its part, the sequence and amino acid sequence of the invention (such as, sequence table even order number a: sequence in sequence) there is sufficient homology, so that the protein or its biologically-active moiety, it has the ability to participate in handle to seem that high-energy carbon-containing molecules as glucose are transported into Corynebacterium glutamicum, or participate in the Cellular Signaling Transduction Mediated in the microorganism.The part of protein preferably refers to biologically-active moiety described herein.In another preferred embodiment, pts protein of the invention has in sequence table with even order number: the amino acid sequence listed.In another preferred embodiment, pts protein has by nucleotide sequence coded amino acid sequence, the nucleotide sequence hybridizes with nucleotide sequence (for example, sequence table odd serial numbers: a sequence in sequence) of the invention, such as hybridizes under strict conditions.In another preferred embodiment, pts protein has by such nucleotide sequence coded amino acid sequence, the nucleotide sequence and a nucleic acid sequence of the invention or its part, have at least about 50%, 51%, 52%, 53%, 54%, 55%, 56%, 57%, 58%, 59% or 60% homology, preferably have at least about 61%, 62%, 63%, 64%, 65%, 66%, 67%, 68%, 69% or 70% homology, more preferably have at least about 71%, 72%, 73%, 74%, 75%, 76%, 77%, 78%, 79% or 80%, 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 88%, 89 % perhaps 90% or 91%, 92%, 93%, 94%, and even more preferably have at least about 95%, 96%, 97%, 98%, 99% or higher homology.Range or consistency value (for example, consistency of the consistency of 70-90% or 80-95%) between above-cited value, also intentional includes in the present invention.For example, intentional contains such consistency value range, these ranges are the combinations of the above-cited upper limit and/or lower limit value.Currently preferred pts protein it is also preferred that there is at least one PTS activity described herein.Such as, a kind of currently preferred pts protein includes such nucleotide sequence coded amino acid sequence, the nucleotide sequence and nucleotide sequence hybridization of the invention, such as hybridize under strict conditions, and it seems that high-energy carbon-containing molecules as glucose are transported into Corynebacterium glutamicum that the sequence, which can participate in handle, perhaps the activity for participating in the Cellular Signaling Transduction Mediated in the microorganism or being listed in Table 1 with one or more.
In other embodiments, pts protein and amino acid sequence of the invention (such as, sequence table even order number a: sequence in sequence) there is sufficient homology, and the functional activity with amino acid sequence protein of the present invention, as as being described in detail the above part I, amino acid sequence is different due to naturally change or being mutated.Therefore, in another embodiment, pts protein is such protein, the amino acid sequence and all aminoacid sequence of the invention that it has, have at least about 50%, 51%, 52%, 53%, 54%, 55%, 56%, 57%, 58%, 59% or 60% homology, preferably have at least about 61%, 62%, 63%, 64%, 65%, 66%, 67%, 68%, 69% or 70% homology, more preferably have at least about 71%, 72%, 73%, 74%, 75%, 76%, 77%, 78%, 79% or 80%, 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 88%, 89% or 90%, or 91%, 92%, 93%, 94%, and even more preferably have at least about 95%, 96%, 97%, 98%, 99% or higher homology, and there is at least one PTS activity described herein.Range or consistency value (for example, consistency of the consistency of 70-90% or 80-95%) between above-cited value, also intentional includes in the present invention.For example, intentional contains such consistency value range, these ranges are the combinations of the above-cited upper limit and/or lower limit value.In another embodiment, the present invention is related with such overall length Corynebacterium glutamicum protein, and the protein and amino acid sequence of the invention have sufficient homology.
The biologically-active moiety of pts protein includes such polypeptide, the polypeptide contains the amino acid sequence from pts protein amino acid sequence, such as, sequence table even order number: amino acid sequence or amino acid sequence with pts protein homologous protein, amino acid more less than overall length pts protein or overall length pts protein homologous protein is contained in the part, and shows at least one pts protein activity.Typical biologically-active moiety (peptide, for example, amino acid length be seem 5,10,15,20,30,35,36,37,38,39,40,50,100 or more peptides) include one there is the active structural domain of at least one pts protein or primitive.In addition, other biological activities part, wherein the other parts of protein have been deleted, and can be prepared by recombinant technique, and identify its one or more kinds of activity described herein.The biologically-active moiety of preferred pts protein, the biologically active structural domain/primitive selected containing one or more or its part.
Pts protein is produced preferably through recombinant DNA technology.For example, expression vector is introduced into host cell (as described above) and expresses pts protein in host cell by the cloned nucleic acid molecule of coding protein into expression vector (as described above).Then pts protein is separated from cell using standard protein purification technique according to suitable purification schemes.In addition to recombinant expression, standard peptide synthesis methods chemical synthesis pts protein, polypeptide or peptide can be used.In addition, natural pts protein can be separated from cell (such as endothelial cell), such as using anti-PTS antibody, which can be used pts protein or its part of the invention and passes through standard technique generation.
Present invention provides PTS chimeric protein or fusion proteins.As used herein, PTS " chimeric protein " or " fusion protein " contain the PTS polypeptide being operatively connected on non-PTS polypeptide." PTS polypeptide " refers to the polypeptide containing PTS related amino acid sequence, and " non-pts protein " refers to the polypeptide containing such protein related amino acid sequence, the protein and the not basic homology of pts protein, for example, the protein different from pts protein from same or different organism.In fused protein, term " operability connection " is meant that pts protein is in-frame merge between each other with non-pts protein.Non- PTS polypeptide can be fused to the end N- or the end C- of PTS polypeptide.For example, in one embodiment, fused protein is DST-PTS fusion protein, wherein PTS sequence is fused to the end C- of GST sequence.The fused protein helps to recombinate the purifying of pts protein.In another embodiment, fused protein is the pts protein for having Heterologous signal sequences in its end N-.In certain host cells (such as mammalian host cell), the expression and/or secretion of pts protein can be increased by using Heterologous signal sequences.
It is preferred that chimeric protein or fusion protein of the invention is generated by standard recombinant dna technology.Such as, it is linked together according to the DNA fragmentation that routine techniques encodes different polypeptide sequences by in-frame, such as, it is connected using the end of blunt end or staggered end, it is digested using restriction enzyme to provide suitable end, use cohesive end filling-in as suitable end, using alkaline phosphatase treatment to avoid undesirable connection, and is connected using enzymatic.In another embodiment, it includes automatic dna synthesizer synthesis fusion that routine techniques, which can be used,.In addition, the PCR amplification that anchor primer carries out genetic fragment can be used, anchor primer can increase the complementary jag between two consecutive gene fragments, consecutive gene can then carry out annealing and expand again and generate chimeric gene sequence (referring to, such as, Current Protocols in MolecularBiology, eds.Ausubel et al.John Wiley&Sons:1992).In addition, the expression vector of many encoded fusion parts (such as gst polypeptide) is that business provides.PTS- code nucleic acid can be cloned into this expression vector, so that merging, part is in-frame to be connected on pts protein.
The homologue of pts protein can be generated by mutation, such as the discontinuity point mutation or shearing of pts protein.As used herein, term " homologue " refers to the variant form of pts protein, they may be used as the active agonist of pts protein or antagonist.The bioactivity that the agonist of pts protein substantially can have pts protein identical or partial.The antagonist of pts protein can inhibit the one or more activity of the naturally occurring form of pts protein, for example, passing through downstream with the PTS system comprising pts protein or upstream member's competitive binding.Therefore, Corynebacterium glutamicum pts protein and its homologue of the invention, the activity of adjustable one or more of carbohydrate transporting pathway, or adjust the activity for the Cellular Signaling Transduction Mediated approach that pts protein plays a role in the microorganism.
In a further embodiment, the homologue of pts protein can pass through the combinatorial libraries of screening pts protein mutant, such as shearing mutant, Lai Jianding pts protein agonist or antagonist activities.In one embodiment, the diverse libraries of PTS variant generate and associativity is mutated in nucleic acid level, and are encoded by diversity gene library.The diverse libraries of PTS variant can pass through, such as, the oligonucleotide cocktail enzymatic of synthesis is connected in gene order, so that the degeneracy set of potential PTS sequence is as single polypeptide, or the wherein set of the bigger fused protein (such as phage display) containing PTS arrangement set, it can express.There are various methods to can be used for generating potential PTS homologue library from degeneracy oligonucleotide sequences.The chemical synthesis of degeneracy gene order can be carried out with automatic dna synthesizer, then synthesized gene and be connected in suitable expression vector.The use of gene degeneracy set, the full sequence of potential PTS arrangement set needed for the offer for allowing to mix encodes.The method for synthesizing degeneracy oligonucleotide is technically known (see, e.g., Narang, S.A. (1983) Tetrahedron 39:3;Itakura et al. (1984) Annu.Rev.Biochem.53:323;Itakura et al. (1984) Science 198:1056;Ike et al. (1983) Nucleic Acid Res.11:477).
In addition, the library of coding pts protein segment, can be used for generating the diverse populations of PTS segment, which is used to screen and select the homologue of pts protein.In one embodiment, the library of coding sequence fragment can generate in this way, i.e. under conditions of about per molecule only generates a notch, with the double stranded PCR fragment of nucleic acid enzymatic treatment PTS coded sequence, denatured double stranded dna, for renaturation DNA to form double-stranded DNA, which may include the sense/antisense pair that the product for having notch from difference is formed, single stranded portion is removed by S1 nucleic acid enzymatic treatment in the double helix re-formed, and the frag-ment libraries finally obtained are connected in expression vector.In this way, the expression library of the available coding end N-, the end C- and different size pts protein intermediate segment.
The technology with institute's picking up characteristics gene product in many technologies of the gene product in the combinatorial libraries obtained by point mutation or shearing, and screening cDNA library is screened, is all technically known.These technologies are suitable for the quick screening of the gene library obtained by PTS homologue combinatorial mutagenesis.Screen the most widely used technology of large-scale gene pool, it can be used in high throughput analysis, including genomic libraries of clones into reproducible expression vector, with obtained vector library conversion carrier library, and combination gene is expressed under certain condition, required active detection helps to encode the separation of the carrier of detected product gene under this condition.Assemblage mutation (REM) is returned, a kind of new technology increasing function mutation body frequency in library can be with screening analysis together for identifying PTS homologue (Arkin and Yourvan (1992) PANS 89:7811-7815;Delgrave et al. (1993) Protein Engineering 6 (3): 327-331).
In another embodiment, using method known in the art, the analysis based on cell can be used for analyzing the library diversity PTS.
D. application and method of the invention
Nucleic acid molecules, protein, protein homology object, fused protein, primer, carrier and host cell described herein can be applied in following one or more kinds of methods: identification Corynebacterium glutamicum and relationship microorganism;Draw the Genome Atlas of Corynebacterium glutamicum relationship organism;The sequence interested of identification and positioning Corynebacterium glutamicum;Study on Evolution;Determine the required region of the function of pts protein;Pts protein Active Regulation;PTS pathway activities are adjusted;Required compound, for example, fine chemical cell production adjusting.
PTS nucleic acid molecules of the present invention have various uses.Firstly, they can be used for identifying whether a kind of organism is Corynebacterium glutamicum or its close relative organism.They can be used for identification mixed microorganism group Glutamic Acid bar bacterium or the presence of its relationship organism.The present invention provides the nucleic acid sequences of many Corynebacterium glutamicum genes;Under strict conditions, using across the probe to Corynebacterium glutamicum specific gene, the genomic DNA extracted from single or mixed microorganism culture is detected, can determine that the organism whether there is.
Although Corynebacterium glutamicum itself is non-pathogenic, it is related to pathogenic type, such as corynebacterium diphtheriae.Corynebacterium diphtheriae is the etiology of diphtheria, and diphtheria is a kind of infection quickly grow, is acute, having a fever, it is related to local symptom and system symptom.When obtaining this disease, local patholoic change occurs for the upper respiratory tract, and including epithelial cell necrotic injury;Bacteria secrete toxins, toxin spread to the distal tissues of body susceptible from lesion.These tissue include heart, muscle, peripheral nerve, adrenal gland, kidney, liver and spleen, wherein as protein synthesis be suppressed and caused by go bad sexually revise, will lead to the system symptom of the disease.Diphtheria keeps high incidence in many areas in the world, these areas include the independent state in Africa, Asia, Eastern Europe and the former Soviet Union.From nineteen ninety, in the continued popularity of latter two regional diphtheria, at least 5 are resulted in, 000 people is dead.
In one embodiment, the present invention exists with corynebacterium diphtheriae in identification subject or active method is related.This method includes identifying in subject one or more of nucleic acid of the invention or amino acid sequence (for example, the odd number being listed in sequence table respectively perhaps even order sequence) to detect the presence or activity of corynebacterium diphtheriae in subject.Corynebacterium glutamicum and corynebacterium diphtheriae are akin bacteriums, and many nucleic acid and protein molecule in Corynebacterium glutamicum are the homologue of corynebacterium diphtheriae amplifying nucleic acid and protein molecule, therefore can be used for the corynebacterium diphtheriae in detection subject.
Nucleic acid and protein molecule of the invention is also used as the label of specific genome area.This is not only useful when drawing Genome Atlas, but also can be used for the research of Corynebacterium glutamicum protein function.For example, Corynebacterium glutamicum gene group can be digested in order to identify specific Corynebacterium glutamicum DNA binding protein genome area in combination, segment and DNA binding protein are incubated for.Segment in conjunction with protein can be further with nucleic acid molecules detection of the invention, it is preferable to use easily detection marks;The combination of these nucleic acid molecules and genomic fragment can position position of the segment on Corynebacterium glutamicum gene group map, moreover, helping quickly to determine protein nucleic acid sequence in combination when carrying out multi-pass operation using different enzymes.In addition, nucleic acid molecules of the present invention can have sufficient homology with relationship type, so that these nucleic acid molecules can be used as the label of building relationship bacterial genomes map, such as brevibacterium.
PTS nucleic acid molecules of the invention can be used for evolving again and protein structure research.The carbohydrate capturing system that molecule of the present invention participates in, is used by various bacteriums;The sequence of nucleic acid molecules of similar enzyme is encoded in other organisms with those by comparing sequence of nucleic acid molecules of the present invention, can be evaluated whether the evolution correlation of organism.Similar, this comparison allows to estimate conserved sequence region and non-conserved sequences region, this can contribute to determine in protein for region necessary to enzyme function.Such determination is valuable for protein engineering research, and can indicate that those protein can endure mutation without losing function.
The operation of PTS nucleic acid molecules of the present invention can cause with the generation with the pts protein of wild type pts protein different function.The efficiency or activity that these protein can be improved can be allowed to either reduce its efficiency or activity to appear in cell than usual more numbers.
The present invention provides the methods for screening the adjustable active molecule of pts protein, these molecules or by with protein itself or substrate interaction, perhaps active to adjust pts protein in conjunction with the gametophyte of pts protein or through the transcription or translation of adjusting PTS nucleic acid molecules of the present invention.In the method, the microorganism for expressing one or more kinds of pts proteins, contacts with one or more kinds of test compounds, and assesses effect of the every kind of test compound for pts protein activity or expression.
PTS molecule of the present invention can be modified, so that yield, production and/or the production efficiency of one or more kinds of chemical substances are improved.For example, optimize its activity by the pts protein that modification participates in glucose uptake, it can increase glucose uptake amount or glucose is transported rate into cell.The degradation of glucose inside cells and other carbohydrates provides the biochemical reaction that energy pushes energy unfavorable, such as those are related to the reaction of fine chemical biosynthesis.Degradation also provides intermediate or precursor molecule necessary to the certain fine chemicals of biosynthesis, such as amino acid, vitamin and co-factor.By modifying PTS molecule of the present invention to increase the quantity of intracellular high energy carbon molecules, the energy of metabolic pathway is executed necessary to producing one or more kinds of fine chemicals so as to not only increase, but also endocellular metabolism object library required for this production can be increased.Opposite, the catabolite of some carbohydrates contains a kind of compound, the compound is served only for such metabolic pathway, the approach is vied each other because of enzyme, co-factor or intermediate with the approach for generating required fine chemical is used as, it, can be with the negative regulator approach by reducing the input of these carbohydrates.
In addition, PTS molecule of the invention can participate in one or more kinds of Cellular Signaling Transduction Mediated approach, these approach can influence the yield and/or production efficiency of one or more kinds of fine chemicals in Corynebacterium glutamicum.Such as, once there is sufficient amount of carbohydrate into the cell, from inputted in extracellular medium protein necessary to one or more kinds of carbohydrates (such as, HPr, Enzyme I, or one of Enzyme II complex ingredient) be often translated after modify, to prevent them from sugar is input into the cell again.Such a example appears in Escherichia coli, and the high level of intracellular fructose 1,6-diphosphate leads to the phosphorylation of HPr serine -46, prevents the molecule from participating in the transhipment of any carbohydrate again.However, horizontal in this intracellular carbohydrate that movement system is closed, for maintain the normal function of cell be it is enough, this may limit the excessive production of required fine chemical.Therefore, it is desirable for modifying pts protein of the invention in this way, i.e. so that they are no longer effective to this negative regulator, to allow can achieve the higher intracellular concentration of one or more kinds of carbohydrates, and, extending allows to obtain one or more kinds of fine chemicals from the organism containing this mutation pts protein more effectively to produce or higher yield.
The above-mentioned list for leading to the increased PTS mutation scheme of required compound production, is not meant to be limited only to this;The variation of these mutation schemes is known better for person skilled in the art.By these mechanism, nucleic acid of the invention and protein molecule can be used for generating Corynebacterium glutamicum or its relationship bacterial strain of expression mutation PTS nucleic acid and protein molecule, to increase yield, production and/or the production efficiency of required compound.The required compound can be any natural products of Corynebacterium glutamicum, this includes the final product of biosynthesis pathway and the intermediate of naturally occurring metabolic pathway, and is not molecule that is naturally occurring in Corynebacterium glutamicum metabolism but being generated by Corynebacterium glutamicum strain of the present invention.
The present invention is further illustrated by following instance, these examples are not construed as being limited only to this.Content in the application in cited all bibliography, patent application, patent, the patent application delivered, table and sequence list is all merged into bibliography hereby.
Table 1: gene by the invention
Phosphoenolpyruvate: sugar phosphotransferase system
Nucleotide SEQ ID NO | Amino acid SEQ ID NO | Number | Contig | NT starting | NT is terminated | Function |
1 | 2 | RXS00315 | PTS system, sucrose-specificity IIABC ingredient (EIIABC-SCR) (sucrose-permease IIABC ingredient (phosphotransferase II, ABC ingredient) (EC 2.7.1.69) | |||
3 | 4 | F RXA00315 | GR00053 | 6537 | 5452 | PTS system, BETA- glucosides-specificity IIABC ingredient (EIIABC-BGL) (BETA- glucosides-permease IIABC ingredient) (phosphotransferase II, ABC ingredient) (EC 2.7.1.69) |
5 | 6 | RXA01503 | GR00424 | 10392 | 10640 | PTS system, BETA- glucosides-specificity IIABC ingredient (EIIABC-BGL) (BETA- glucosides-permease IIABC ingredient) (phosphotransferase II, ABC ingredient) (EC 2.7.1.69) |
7 | 8 | RXN01299 | VV0068 | 11954 | 9891 | PTS system, fructose-specificity IIBC ingredient (EC 2.7.1.69) |
9 | 10 | F RXA01299 | GR00375 | 6 | 446 | PTS system, fructose-specificity IIBC ingredient (EC 2.7.1.69) |
11 | 12 | F RXA01883 | GR00538 | 2154 | 2633 | PTS system, fructose-specificity IIBC ingredient (EC 2.7.1.69) |
13 | 14 | F RXA01889 | GR00540 | 77 | 631 | PTS system, fructose-specificity IIBC ingredient (EC 2.7.1.69) |
15 | 16 | RXA00951 | GR00261 | 564 | 172 | PTS system, mannitol (secret)-specificity IIA ingredient (EIIA- (C) MTL) (mannitol (secret)-permease IIA ingredient) (phosphotransferase II, A ingredient) (EC 2.7.1.69) |
17 | 18 | RXN01244 | VV0068 | 14141 | 15844 | Phosphoenolpyruvate-protein phosphotransferase (EC 2.7.3.9) |
19 | 20 | F RXA01244 | GR00359 | 4837 | 3329 | Phosphoenolpyruvate-protein phosphotransferase (EC 2.7.3.9) |
21 | 22 | RXA01300 | GR00375 | 637 | 903 | Phosphocarrier protein HPR |
23 | 24 | RXN03002 | VV0236 | 1437 | 1844 | PTS system, mannitol (secret)-specificity IIA ingredient (EIIA- (C) MTL) (mannitol (secret)-permease IIA ingredient) (phosphotransferase II, A ingredient) (EC 2.7.1.69) |
25 | 26 | RXC00953 | VV0260 | 1834 | 1082 | Transmembrane protein in PTS system |
27 | 28 | RXC03001 | Transmembrane protein in PTS system | |||
29 | 30 | RXN01943 | VV0120 | 4326 | 6374 | PTS system, glucose-specificity IIABC ingredient (EC 2.7.1.69) |
31 | 32 | F RXA02191 | GR00642 | 3395 | 4633 | Phosphoenolpyruvate carbohydrate phosphotransferase |
33 | 34 | F RXA01943 | GR00557 | 3944 | 3540 | Crr gene;Phosphotransferase system glucose-enzyme-specific III |
The gene of table 2:GENBANK identification
GenBankTMSearching number | Gene Name | Gene function | Bibliography |
A09073 | ppg | Phosphoric acid enol pyruvic acid carboxylase | Bachmann, B.et al. " DNA fragment coding for phosphoenolpyruvat corboxylase; recombinant DNA carrying said fragment; strains carrying the recombinant DNA and method for producing L-aminino acids using said strains, " Patent:EP 0358940-A 303/21/90 |
A45579, A45581, A45583, A45585 A45587 | Threonine dehydratase | Moeckel, B.et al. " Production of L-isoleucine by means of recombinant micro-organisms with deregulated threonine dehydratase, " Patent:WO 9519442-A 507/20/95 | |
AB003132 | murC;ftsQ;ftsZ | Kobayashi, M.et al. " Cloning, sequencing, and characterization of the ftsZ gene from coryneform bacteria; " Biochem.Biophys.Res.Commun., 236 (2): 383-388 (1997) | |
AB015023 | murC;ftsQ | Wachi, M.et al. " A murC gene from Coryneform bacteria, " Appl.Microbiol. Biotechnol., 51 (2): 223-228 (1999) | |
AB018530 | dtsR | Kimura, E.et al. " Molecular cloning of a novel gene; dtsR; which rescues the detergent sensitivity of a mutant derived from Brevibacterium lactofermentum; " Biosci.Biotechnol.Biochem., 60 (10): 1565-1570 (1996) | |
AB018531 | dtsR1;dtsR2 | ||
AB020624 | murI | D-Glu racemase | |
AB023377 | tkt | Transketolase | |
AB024708 | gltB;gltD | Glutamine 2-oxoglutaric acid transaminase is big and small subunit | |
AB025424 | acn | Aconitase | |
AB027714 | rep | Replication protein | |
AB027715 | rep;aad | Replication protein;Aminoglycoside adenyl transferase | |
AF005242 | argC | N- acetyl aspartate -5- semialdehyde dehydrogenase | |
AF005635 | glnA | Glutamine synthelase | |
AF030405 | hisF | Cyclase | |
AF030520 | argG | Argininosuccinate synthetase | |
AF031518 | argF | Ornithine transcarbamylase | |
AF036932 | aroD | 3- dehydroquinate dehydratase |
GenBankTM | Gene Name | Gene function | Bibliography |
Searching number | |||
AF038548 | pyc | Pyruvate carboxylase | |
AF038651 | dciAE;apt;rel | Two peptide-binding proteins;Adenine phosphoribosyl transferase;GTP pyrophosphokinase | Wehmeier, L.et al. " The role of the Corvnebacterium glutamicum rel gene in (p) ppGpp metabolism, " Microbiology, 144:1853-1862 (1998) |
AF041436 | argR | Arginine repressor | |
AF045998 | impA | Inositol monophosphate phosphorylase | |
AF048764 | argH | Argininosuccinate lyase | |
AF049897 | argC;argJ;argB; argD;argF;argR; argG;argH | N- acetylglutamyl reductase;Ornithine acetyltransferase;N-acetylglutamat kinases;Acetylornithice transminase;Ornithine transcarbamylase;Arginine repressor;Argininosuccinate synthase;Argininosuccinate lyase | |
AF050109 | inhA | Alkene acyl-acyl carrier protein reductase | |
AF050166 | hisG | ATP phosphoribosyltransferase | |
AF051846 | hisA | Phosphoribosyl formimino group -5- amino-ribose 1-phosphate -4- imidazoles carbamyl isomerase | |
AF052652 | metA | Homoserine O- transacetylase | Park, S.et al. " Isolation and analysis of metA; a methionine biosynthetic gene encoding homoserine acetyltransferase in Corynebacterium glutamicum; " Mol. Cells., 8 (3): 286-294 (1998) |
AF053071 | aroB | Dehydroquinate synthase | |
AF060558 | hisH | Glutamine amide transferase | |
AF086704 | hisE | Phosphoribosyl-ATP- pyrophosphohydrolase | |
AF114233 | aroA | 5- enolpyruvylshikimate 3- phosphate synthase | |
AF116184 | panD | L-Aspartic acid-alpha- decarboxylation enzyme precursor | Dusch, N.et al. " Expression of the Corynebacterium glutamicum panD gene encoding L-aspartate-alpha-decarboxylase leads to pantothenate overproduction in Escherichia coli; " Appl.Environ.Microbiol., 65 (4) 1530- 1539 (1999) |
GenBankTMSearching number | Gene Name | Gene function | Bibliography |
AF124518 | aroD;aroE | 3-dehydroquinase;Shikimate dehydrogenase | |
AF124600 | aroC;aroK;aroB; | Chorismate synthase;Shikimate kinase;3- dehydroquinic acid |
pepQ | Synthase;The cytosolic peptidase of supposition | ||
AF145897 | inhA | ||
AF145898 | inhA | ||
AJ001436 | ectP | Ectoine, glycinebetaine, proline transport | Peter, H.et al. " Corynebacterium glutamicum is equipped with four secondary carriers for compatible solutes:Identification; sequencing; and characterization of the proline/ectoine uptake system; ProP; and the ectoine/proline/glycine betaine carrier, EctP, " J. Bacteriol., 180 (22): 6005-6012 (1998) |
AJ004934 | dapD | Tetrahydro 2, dipicolimic acid 2 succinyl enzyme (imperfect i) | Wehrmann, A.et al. " Different modes of diaminopimelate synthesis and their role in cell wall integrity:A study with Corynebacterium glutamicum; " J. Bacteriol., 180 (12): 3159-3165 (1998) |
AJ007732 | ppc;secG;amt;ocd; soxA | Phosphoenolpyruvate-carboxylase;;High-affinity ammonia absorbs albumen;The ornithine of supposition-ring decarboxylase;Sarcosine oxidase | |
AJ010319 | FtsY, glnB, glnD;srp; amtP | Participate in cell division;PII albumen;Uridyltransferase (uridine acyl-elimination enzyme);Signal recognition particle;Low-affinity ammonia absorbs albumen | Jakoby, M.et al. " Nitrogen regulation in Corynebacterium glutamicum;Isolation of genes involved in biochemical characterization of corresponding proteins, " FEMS Microbiol., 173 (2): 303-310 (1999) |
AJ132968 | cat | Chloramphenicol acetyltransferase | |
AJ224946 | mqo | L MALIC ACID: quinone oxidoreductase | Molenaar, D.et al. " Biochemical and genetic characterization of the membrane-associated malate dehydrogenase (acceptor) from Corynebacteriun glutamicum; " Eur.J.Biochem., 254 (2): 395-403 (1998) |
AJ238250 | ndh | Nadh dehydrogenase | |
AJ238703 | porA | Porin | Lichtinger, T.et al. " Biochemical and biophysical characterization of the cell wall porin of Corynebacterium glutamicum:The channel is formed by a low molecular mass polypeptide; " Biochemistry, 37 (43): 15024-15032 (1998) |
D17429 | Transposable element IS31831 | Vertes, A.A.et al. " Isolation and characterization of IS31831; a transposable element from Corynebacterium glutamicum, " Mol.Microbiol., 11 (4): 739-746 (1994) |
GenBankTMSearching number | Gene Name | Gene function | Bibliography |
D84102 | odhA | OdhA | Usuda, Y.et al. " Molecular cloning of the Corynebacterium glutamicum (Brevibacterium lactofermentum AJ12036) odhA gene encoding a novel type of 2-oxoglutarate dehydrogenase; " Microbiology, 142:3347-3354 (1996) |
E01358 | hdh;hk | Homoserine dehydrogenase;Homoserine kinase | Katsumata, R.et al. " Production of L-thereonine and L-isoleucine, " Patent:JP 1987232392-A 1 10/12/87 |
E01359 | Homoserine kinase gene upstream from start codon | Katsumata, R.et al. " Production of L-thereonine and L-isoleucine, " Patent:JP 1987232392-A 2 10/12/87 | |
E01375 | Tryptophan operon | ||
E01376 | trpL;trpE | Leader peptide;Anthranilate synthase | Matsui, K.et al. " Tryptophan operon; peptide and protein coded thereby; utilization of tryptophan operon gene expression and production of tryptophan, " Patent:JP 1987244382-A 1 10/24/87 |
E01377 | Tryptophan operon promoter and operator region | Matsui, K.et al. " Tryptophan operon; peptide and protein coded thereby; utilization of tryptophan operon gene expression and production of tryptophan, " Patent:JP 1987244382-A 1 10/24/87 | |
E03937 | Biotin-synthase | Hatakeyama, K.et al. " DNA fragment containing gene capable of coding biotin synthetase and its utilization, " Patent:JP 1992278088-A 1 10/02/92 | |
E04040 | Diaminopelargonic acid transaminase | Kohama, K.et al. " Gene coding diaminopelargonic acid aminotransferase and desthiobiotin synthetase and its utilization, " Patent:JP 1992330284-A 1 11/18/92 | |
E04041 | Dethiobiotin synthetase | Kohama, K.et al. " Gene coding diaminopelargonic acid aminotransferase and desthiobiotin synthetase and its utilization, " Patent:JP 1992330284-A 1 11/18/92 | |
E04307 | Flavum Aspartase | Kurusu, Y.et al. " Gene DNA coding aspartase and utilization thereof, " Patent:JP 1993030977-A 1 02/09/93 | |
E04376 | Isocitratase | Katsumata, R.et al. " Gene manifestation controlling DNA, " Patent:JP 1993056782-A 3 03/09/93 | |
E04377 | Isocitratase N- terminal fragment | Katsumata, R.et al. " Gene manifestation controlling DNA, " Patent:JP 1993056782-A 3 03/09/93 | |
E04484 | Prephenate dehydratase | Sotouchi, N.et al. " Production of L-phenylalanine by fermentation, " Patent:JP 1993076352-A 2 03/30/93 | |
E05108 | Aspartokinase | Fugono, N.et al. " Gene DNA coding Aspartokinase and its use, " Patent:JP 1993184366-A 1 07/27/93 | |
E05112 | Dihydro-dipichorinate synzyme | Hatakeyama, K.et al. " Gene DNA coding dihydrodipicolinic acid synthetase and its use, " Patent:JP 1993184371-A 1 07/27/93 |
GenBankTMSearching number | Gene Name | Gene function | Bibliography |
E05776 | Diaminopimelate dehydrogenase | Kobayashi, M.et al. " Gene DNA coding Diaminopimelic acid dehydrogenase and its use, " Patent:JP 1993284970-A 1 11/02/93 | |
E05779 | Threonine synthase | Kohama, K.et al. " Gene DNA coding threonine synthase and its use, " Patent:JP 1993284972-A 1 11/02/93 |
E06110 | Prephenate dehydratase | Kikuchi, T.et al. " Production of L-phenylalanine by fermentation method, " Patent:JP 1993344881-A 1 12/27/93 | |
E06111 | It is mutated prephenate dehydratase | Kikuchi, T.et al. " Production of L-phenylalanine by fermentation method, " Patent:JP 1993344881-A 1 12/27/93 | |
E06146 | Acetohydroxy acid synthetase | Inui, M.et al. " Gene capable of coding Acetohydroxy acid synthetase and its use, " Patent:JP 1993344893-A 1 12/27/93 | |
E06825 | Aspartokinase | Sugimoto, M.et al. " Mutant aspartokinase gene, " patent:JP 1994062866-A 1 03/08/94 | |
E06826 | It is mutated aspartokinase alpha subunit | Sugimoto, M.et al. " Mutant aspartokinase gene, " patent:JP 1994062866-A 1 03/08/94 | |
E06827 | It is mutated aspartokinase alpha subunit | Sugimoto, M.et al. " Mutant aspartokinase gene, " patent:JP 1994062866-A 1 03/08/94 | |
E07701 | secY | Honno, N.et al. " Gene DNA participating in integration of membraneous protein to membrane, " Patent:JP 1994169780-A 1 06/21/94 | |
E08177 | Aspartokinase | Sato, Y.et al. " Genetic DNA capable of coding Aspartokinase released from feedback inhibition and its utilization, " Patent:JP 1994261766-A 1 09/20/94 | |
E08178, E08179, E08180, E08181, E08182 | Feedback inhibition-release aspartokinase | Sato, Y.et al. " Genetic DNA capable of coding Aspartokinase released from feedback inhibition and its utilization, " Patent:JP 1994261766-A 1 09/20/94 | |
E08232 | Acetohydroxy acid isomeroreductase | Inui, M.et al. " Gene DNA coding acetohydroxy acid isomeroreductase, " Patent:JP 1994277067-A 1 10/04/94 | |
E08234 | secE | Asai, Y.et al. " Gene DNA coding for translocation machinery of protein, " Patent:JP 1994277073-A 1 10/04/94 | |
E08643 | FT transaminase and dethiobiotin synthetase promoter region | Hatakeyama, K.et al. " DNA fragment having promoter function in coryneform bacterium, " Patent:JP 1995031476-A 1 02/03/95 | |
E08646 | Biotin synzyme | Hatakeyama, K.et al. " DNA fragment having promoter function in coryneform bacterium, " Patent:JP 1995031476-A 1 02/03/95 |
GenBankTMSearching number | Gene Name | Gene function | Bibliography |
E08649 | Aspartase | Kohama, K.et al " DNA fragment having promoter function in coryneform bacterium, " Patent:JP 1995031478-A 1 02/03/95 | |
E08900 | Dihydro 2, dipicolimic acid 2 reductase | Madori, M.et al. " DNA fragment containing gene coding Dihydrodipicolinate acid reductase and utilization thereof, " Patent:JP 1995075578-A 103/20/95 | |
E08901 | Diaminapimelate decarboxylase | Madori, M.et al. " DNA fragment containing gene coding Diaminopimelic acid decarboxylase and utilization thereof, " Patent:JP 1995075579-A 1 03/20/95 | |
E12594 | Serine hydroxymethylase | Hatakeyama, K.et al. " Production of L-trypophan, " Patent:JP 1997028391-A 1 02/04/97 | |
E12760, E12759, E12758 | Transposase | Moriya, M.et al. " Amplification of gene using artificial transposon, " Patent:JP 1997070291-A 03/18/97 | |
E12764 | Arginyl-tRNA synthetase;Diaminapimelate decarboxylase | Moriya, M.et al. " Amplification of gene using artificial transposon, " Patent:JP 1997070291-A 03/18/97 | |
E12767 | Dihydro 2, dipicolimic acid 2 synzyme | Moriya, M.et al. " Amplification of gene using artificial transposon, " Patent:JP 1997070291-A 03/18/97 | |
E12770 | Aspartokinase | Moriya, M.et al. " Amplification of gene using artificial transposon, " Patent:JP 1997070291-A 03/18/97 | |
E12773 | Dihydro 2, dipicolimic acid 2 reductase | Moriya, M.et al. " Amplification of gene using artificial transposon, " Patent:JP 1997070291-A 03/18/97 | |
E13655 | Glucose-6-phosphate dehydrogenase (G6PD) | Hatakeyama, K, et al. " Glucose-6-phosphate dehydrogenase and DNA capable of coding the same, " Patent:JP 1997224661-A 1 09/02/97 | |
L01508 | IlvA | Threonine dehydratase | Moeckel, B.et al. " Functional and structural analysis of the threonine dehydratase of Corynebacterium glutamicum, " J.Bacteriol., 174:8065-8072 (1992) |
L07603 | EC 4.2.1.15 | 3- deoxidation-D-arabinose heptanone saccharic acid -7- phosphate synthase | Chen, C.et al. " The cloning and nucleotide sequence of Corynebacterium glutamicum 3-deoxy-D-arabinoheptulosonate-7-phosphate synthase gene; " FEMS Microbiol.Lett., 107:223-230 (1993) |
L09232 | IlvB;ilvN;ilvC | Acetohydroxy acid synthase large subunit;Acetohydroxy acid synthase small subunit;Acetohydroxy acid isomeroreductase | Keilhauer, C.et al. " Isoleucine synthesis in Corynebacterium glutamicum:molecular analysis of the ilvB-ilvN-ilvC operon; " J.Bacteriol, 175 (17): 5595- 5603 (1993) |
GenBankTMSearching number | Gene Name | Gene function | Bibliography |
L18874 | PtsM | Phosphoenolpyruvate sugar phosphotransferase | Fouet, A et al. " Bacillus subtilis sucrose-specific enzyme II of the |
Phosphotransferase system:expression in Escherichia coli and homology to enzymes II from enteric bacteria, " PNAS USA, 84 (24): 8773-8777 (1987);Lee, J.K.et al. " Nucleotide sequence of the gene encoding the Corynebacterium glutamicum mannose enzyme II and analyses of the deduced protein sequence; " FEMS Microbiol.Lett., 119 (1-2): 137-145 (1994) | |||
L27123 | aceB | Malate synthase | Lee, H-S.et al. " Molecular characterization of aceB; a gene encoding malate synthase in Corynebacterium glutamicum, " J.Microbiol.Biotechnol., 4 (4): 256-263 (1994) |
L27126 | Pyruvate kinase | Jetten, M.S.et al. " Structural and functional analysis of pyruvate kinase from Corynebacterium glutamicum; " Appl.Environ.Microbiol., 60 (7): 2501-2507 (1994) | |
L28760 | aceA | Isocitratase | |
L35906 | dtxr | Diphtheria toxin repressor | Oguiza, J.A.et al. " Molecular cloning; DNA sequence analysis; and characterization of the Corynebacterium diphtheriae dtxR from Brevibacterium lactofermentum; " J.Bacteriol., 177 (2): 465-467 (1995) |
M13774 | Prephenate dehydratase | Follettie, M.T.et al. " Molecular cloning and nucleotide sequence of the Corynebacterium glutamicum pheA gene, " J.Bacteriol., 167:695-702 (1986) | |
M16175 | 5S rRNA | Park, Y-H.et al. " 56 rRNA sequences of Phylogenetic analysis of the coryneform bacteria by, " J.Bacteriol., 169:1801-1806 (1987) | |
M16663 | trpE | Anthranilate synthase, 5 ' ends | Sano, K.et al. " Structure and function of the trp operon control regions of Brevibacterium lactofermentum; a glutamic-acid-producing bacterium, " Gene, 52:191-200 (1987) |
M16664 | trpA | Tryptophan synthetase, 3 ' ends | Sano, K.et al. " Structure and function of the trp operon control regions of Brevibacterium lactofermentum; a glutamic-acid-producing bacterium, " Gene, 52:191-200 (1987) |
M25819 | Phosphoenolpyruvate carboxylase | O ' Regan, M.et al. " Cloning and nucleotide sequence of the Phosphoenolpyruvate carboxylase-coding gene of Corynebacterium glutamicum ATCC13032; " Gene, 77 (2): 237-251 (1989) | |
M85106 | 23S rRNA gene inserts | Roller, C.et al. " Gram-positive bacteria with a high DNA G+C content are characterized by a common insertion within their 23S rRNA genes; " J.Gen. Microbiol., 138:1167-1175 (1992) |
GenBankTMSearching number | Gene Name | Gene function | Bibliography |
M85107, | 23S rRNA gene inserts | Roller, C.et al. " Gram-positive bacteria with a high DNA G+C content are |
M85108 | Characterized by a common insertion within their 23S rRNA genes, " J.Gen. Microbiol., 138:1167-1175 (1992) | ||
M89931 | aecD;brnQ;yhbw | Beta C-S lyase;Branched-chain amino acid absorbs carrier;The albumen yhbw of presumption | Rossol, I.et al. " The Corynebacterium glutamicum aecD gene encodes a C-S lyase with alpha; beta-elimination activity that degrades aminoethylcysteine; " J.Bacteriol., 174 (9): 2968-2977 (1992);Tauch, A.et al. " 13032 is directed by the brnQ gene product of Isoleucine uptake in Corynebacterium glutamicum ATCC; " Arch.Microbiol., 169 (4): 303-312 (1998) |
S59299 | trp | Leading gene (promoter) | Herry, D.M.et al. " Cloning of the trp gene cluster from a tryptophan- hyperproducing strain of Corynebacterium glutamicum:identification of a mutation in the trp leader sequence; " Appl.Environ.Microbiol., 59 (3): 791-799 (1993) |
U11545 | trpD | Anthranilate phosphoribosyl transferase | O ' Gara, J.P.and Dunican, L.K. 21850 tpD gene. " Thesis of (1994) Complete nucleotide sequence of the Corynebacterium glutamicum ATCC; Microbiology Department; University College Galway, Ireland. |
U13922 | cglIM;cglIR;clgIIR | The II type 5- cytosine methyltransferase of supposition;The II type restriction enzyme of supposition;The I type or type III restriction enzyme of supposition | Schafer, A.et al. " 13032 and analysis of its role in intergeneric conjugation with Escherichia coli of Cloning and characterization of a DNA region encoding a stress-sensitive restriction system from Corynebacterium glutamicum ATCC; " J.Bacteriol., 176 (23): 73 09-7319 (1994);Schafer, A.et al. " The Corynebacterium glutamicum cglIM gene encoding a 5-cytosine in an McrBC- deficient Escherichia coli strain; " Gene, 203 (2): 95-101 (1997) |
U14965 | recA | ||
U31224 | ppx | Ankri, S.et al. " Mutations in the Corynebacterium glutamicumproline biosynthetic pathway:A natural bypass of the proA step; " J.Bacteriol., 178 (15): 4412-4419 (1996) | |
U31225 | proC | L-PROLINE: NADP+5- oxidoreducing enzyme | Ankri, S.et al. " Mutations in the Corynebacterium glutamicumproline biosynthetic pathway:A natural bypass of the proA step; " J.Bacteriol., 178 (15): 4412-4419 (1996) |
U31230 | obg;proB;unkdh | ;Gamma Glutamyl kinase;Similar to the special 2- hydroxy acid dehydrogenase of D- isomers | Ankri, S.et al. " Mutations in the Corynebacterium glutamicumproline biosynthetic pathway:A natural bypass of the proA step; " J.Bacteriol., 178 (15): 4412-4419 (1996) |
GenBankTMSearching number | Gene Name | Gene function | Bibliography |
U31281 | bioB | Biotin synthase | Serebriiskii, I.G., " Two new members of the bio B superfamily:Cloning, |
Sequencing and expression of bio B genes of Methylobacillus flagellatum and Corynebacterium glutamicum, " Gene, 175:15-22 (1996) | |||
U35023 | thtR;accBC | Thiosulfate transsulfurase;Acyl-CoA carboxylase | Jager, W.et al. " A Corynebacterium glutamicum gene encoding a two-domain protein similar to biotin carboxylases and biotin-carboxyl-carrier proteins; " Arch.Microbiol., 166 (2);76-82(1996) |
U43535 | cmr | Multi-drug resistance albumen | Jager, W.et al. " A Corynebacterium glutamicum gene conferring multidrug resistance in the heterologous host Escherichia coli; " J.Bacteriol., 179 (7): 2449-2451 (1997) |
U43536 | clpB | Heat shock ATP- binding protein | |
U53587 | aphA-3 | 3 ' 5 "-aminoglycoside phosphotransferases | |
U89648 | The Corynebacterium glutamicum for participating in histidine biosynthesis does not identify sequence, partial sequence | ||
X04960 | trpA;trpB;trpC;trpD;trpE;trpG;trpL | Tryptophan operon | Matsui, K.et al. " Complete nucleotide and deduced amino acid sequences of the Brevibacterium lactofermentum tryptophan operon; " Nucleic Acids Res., 14 (24): 10113-10114 (1986) |
X07563 | lys A | DAP decarboxylase (meso-diaminapimelate decarboxylase, EC 4.1.1.20) | Yeh, P.et al. " Nucleic sequence of the lysA gene of Corynebacterium glutamicum and possible mechanisms for modulation of its expression; " Mol. Gen.Genet., 212 (1): 112-119 (1988) |
X14234 | EC 4.1.1.31 | Phosphoenolpyruvate carboxylase | Eikmanns, B.J.et al. " The Phosphoenolpyruvate carboxylase gene of Corynebacterium glutamicum:Molecular cloning; nucleotide sequence; and expression; " Mol.Gen.Genet., 218 (2): 330-339 (1989);Lepiniec, L.et al. " Sorghum Phosphoenolpyruvate carboxylase gene family:structure; function and molecular evolution, " Plant.Mol.Biol., 21 (3): 487-502 (1993) |
X17313 | fda | Fructose-bisphosphate aldolase | Von der Osteu, C.H.et al. " Molecular cloning; nucleotide sequence and fine- structural analysis of the Corynebacterium glutamicum fda gene:structural comparison of C.glutamicum fructose-1; 6-biphosphate aldolase to class I and class II aldolases, " Mol.Micr Obiol., |
X53993 | dapA | L-2,3- dihydro 2, dipicolimic acid 2 synzyme (EC 4.2.1.52) | Bonnassie, S.et al. " Nucleic sequence of the dapA gene from Corynebacterium glutamicum, " Nucleic Acids Res., 18 (21): 6421 (1990) |
GenBankTMSearching number | Gene Name | Gene function | Bibliography |
X54223 | AttB- related locus | Cianciotto, N.et al. " DNA sequence homology between att B-related sites of |
Corynebacterium diphtheriae, Corynebacterium ulcerans, Corynebacterium glutamicum, and the attP site of lambdacorynephage; " FEMS.Microbiol. Lett., 66:299-302 (1990) | |||
X54740 | argS;lysA | Arginyl-tRNA synthetase;Diaminapimelate decarboxylase | Marcel, T.et al. " Nucleotide sequence and organization of the upstream region of the Corynebacterium glutamicum lysA gene; " Mol.Microbiol., 4 (11): 1819- 1830 (1990) |
X55994 | trpL;trpE | The leader peptide of supposition;Anthranilate synthase ingredient 1 | Heery, D.M.et al. " Nucleotide sequence of the Corynebacterium glutamicum trpE gene, " Nucleic Acids Res., 18 (23): 7138 (1990) |
X56037 | thrC | Threonine synthase | Han, K.S.et al. " The molecular structure of the Corynebacterium glutamicum threonine synthase gene, " Mol.Microbiol., 4 (10): 1693-1702 (1990) |
X56075 | AttB- related locus | Attachment site | Cianciotto, N.et al. " DNA sequence homology between att B-related sites of Corynebacterium diphtheriae; Corynebacterium ulcerans; Corynebacterium glutamicum; and the attP site of lambdacorynephage; " FEMS.Microbiol, Lett., 66:299-302 (1990) |
X57226 | lysC-alpha;lysC-beta; asd | Aspartokinase-alpha subunit;Aspartokinase-beta subunit;Aspartic acid beta semialdehyde dehydrogenase | Kalinowski, J.et al. " Genetic and biochemical analysis of the Aspartokinase from Corynebacterium glutamicum; " Mol.Microbiol., 5 (5): 1197-1204 (1991);Kalinowski, J.et al. " Aspartokinase genes lysC alpha and lysC beta overlap and are adjacent to the aspertate beta-semialdehyde dehydrogenase gene asd in Corynebacterium glutamicum; " Mol.Gen.Genet., 224 (3): 317-324 (1990) |
X59403 | gap;pgk;tpi | Glyceraldehyde-3-phosphate;Phosphoglyceric kinase;Triose-phosphate isomerase | Eikmanns, B.J. " Identification; sequence analysis; and expression of a Corynebacterium glutamicum gene cluster encoding the three glycolytic enzymes glyceraldehyde-3-phosphate dehydrogenase; 3-phosphoglycerate kinase; and triosephosphate isomeras, " J.Bacteri Ol., 174 (19): 6076-6086 (1992) |
X59404 | gdh | Glutamte dehydrogenase | Bormann, E.R.et al. " Molecular analysis of the Corynebacterium glutamicum gdh gene encoding glutamate dehydrogenase; " Mol.Microbiol., 6 (3): 317-326 (1992) |
X60312 | lysI | L-lysine permease | Seep-Feldhaus, A.H.et al. " Molecular analysis of the Corynebacterium glutamicum lysl gene involved in lysine uptake; " Mol.Microbiol., 5 (12): 2995- 3005 (1991) |
GenBankTMSearching number | Gene Name | Gene function | Bibliography |
X66078 | cop1 | Ps1 albumen | Joliff, G.et al. " Cloning and nucleotide sequence of the csp1 gene encoding |
PS1,85 complex of one of the two major secreted proteins of Corynebacterium glutamicum:The deduced N-terminal region of PS1 is similar to the Mycobacterium antigen; " Mol.Microbiol., 6 (16): 2349-2362 (1992) | |||
X66112 | glt | Citrate synthase | Eikmanns, B.J.et al. " Cloning sequence; expression and transcriptional analysis of the Corynebacterium glutamicum gltA gene encoding citrate synthase; " Microbiol., (1994) 140:1817-1828 |
X67737 | dapB | Dihydro 2, dipicolimic acid 2 reductase | |
X69103 | csp2 | S-layer proteins PS2 | Peyret, J.L.et al. " Characterization of the cspB gene encoding PS2; an ordered surface-layer protein in Corynebacterium glutamicum; " Mol.Microbiol., 9 (1): 97-109 (1993) |
X69104 | IS3 correlation is inserted into the factor | Bonamy, C.et al. " Identification of IS1206; a Corynebacterium glutamicum IS3-related insertion sequence and phylogenetic analysis; " Mol.Microbiol., 14 (3): 571-581 (1994) | |
X70959 | leuA | Isopropylmalate synthase | Patek, M.et al. " Leucine synthesis in Corynebacterium glutamicum:enzyme activities; structure of leuA; and effect of leuA inactivation on lysine synthesis; " Appl.Environ.Microbiol., 60 (1): 133-140 (1994) |
X71489 | icd | Isocitric dehydrogenase (NADP+) | Eikmanns, B.J.et al. " Cloning sequence analysis; expression; and inactivation of the Corynebacterium glutamicum icd gene encoding isocitrate dehydrogenase and biochemical characterization of the enzyme; " J.Bacteriol., 177 (3): 774-782 (1995) |
X72855 | GDHA | Glutamte dehydrogenase (NADP+) | |
X75083, X70584 | mtrA | 5-methyl tryptophan resistance | Heery, D.M.et al. " A sequence from a tryptophan-hyperproducing strain of Corynebacterium glutamicum encoding resistance to 5-methyltryptophan; " Biochem.Biophys.Res.Commun., 201 (3): 1255-1262 (1994) |
X75085 | recA | Fitzpatrick, R.et al. " Construction and characterization of recA mutant strains of Corynebacterium glutamicum and Brevibacterium lactofermentum; " Appl. Microbiol.Biotechnol., 42 (4): 575-580 (1994) | |
X75504 | aceA;thiX | Part isocitratase; | Reinscheid, D.J.et al. " Characterization of the isocitrate lyase gene from Corynebacterium glutamicum and biochemical analysis of the enzyme; " J. Bacteriol., 176 (12): 3474-3483 (1994) |
X76875 | ATP enzyme beta- subunit | Ludwig, W.et al. " Phylogenetic relationships of bacteria based on comparative sequence analysis of elongation factor Tu and ATP-synthase beta-subunit genes; " Antonie Van Leeuwenhoek, 64:285-305 (1993) | |
GenBankTMSearching number | Gene Name | Gene function | Bibliography |
X77034 | tuf | Extension factor T u | Ludwig, W.et al. " Phylogenetic relationships of bacteria based on comparative |
Sequence analysis of elongation factor Tu and ATP-synthase beta-subunit genes, " Antonie Van Leeuwenhoek, 64:285-305 (1993) | |||
X77384 | recA | Billman-Jacobe, H. " Nucleotide sequence of a recA gene from Corynebacterium glutamicum, " DNA Seq., 4 (6): 403-404 (1994) | |
X78491 | aceB | Malate synthase | Reinscheid, D.J.et al. " Malate synthase from Corynebacterium glutamicum pta-ack operon encoding phosphotransacetylase:sequence analysis; " Microbiology, 140:3099-3108 (1994) |
X80629 | 16S rDNA | 16S rRNA | Rainey, F.A.et al. " Phylogenetic analysis of the genera Rhodococcus and Norcardia and evidence for the evolutionary origin of the genus Norcardia within the radiation of Rhodococcus species; " Microbiol., (1995) 141:523-528 |
X81191 | gluA;gluB;gluC; gluD | Glutamic acid absorption system | Kronemeyer, W.et al. " Structure of the gluABCD cluster encoding the glutamate uptake system of Corynebacterium glutamicum; " J.Bacteriol., 177 (5): 1152-1158 (1995) |
X81379 | dapE | Succinyldiaminopimelate desuccinylase | Wehrmann, A.et al. " Analysis of different DNA fragments of Corynebacterium glutamicum complementing dapE of Escherichia coli; " Microbiology, 40:3349-56 (1994) |
X82061 | 16S rDNA | 16S rRNA | Ruimy, R.et al. " Phylogeny of the genus Corynebacterium dednced from analyses of small-subunit ribosomal DNA sequences; " Int.J.Syst.Bacteriol., 45 (4): 740-746 (1995) |
X82928 | asd;lysC | Aspartate-semialdehyde dehydrogenase; | Serebrijski, I.et al. " Multicopy suppression by asd gene and osmotic stress- dependent complementation by heterologous proA in proA mutants; " J. Bacteriol., 177 (24): 7255-7260 (1995) |
X82929 | proA | Gamma- glutamyl phosphate reductase | Serebrijski, I.et al. " Multicopy suppression by asd gene and osmotic stress- dependent complementation by heterologous proA in proA mutants; " J. Bacteriol., 177 (24): 7255-7260 (1995) |
X84257 | 16S rDNA | 16S rRNA | Pascual, C.et al. " Phylogenetic analysis of the genus Corynebacterium based on 16S rRNA gene sequences; " Int.J.Syst.Bacteriol., 45 (4): 724-728 (1995) |
X85965 | aroP;dapE | Aromatic amino acid permease; | Wehrmann, A.et al. " Functional analysis of sequences abjacent to dapE of Corynebacterium glutamicumproline reveals the presence of aroP; which encodes the aromatic amino acid transporter; " J.Bacteriol., 177 (20): 5991- 5993 (1995) |
GenBankTMSearching number | Gene Name | Gene function | Bibliography |
X86157 | argB;argC;argD; argF;argJ | Acetylglutamate kinase;N- acetyl-gamma- glutamy-phosphoric acid reduction enzyme;Acetyl-ornithine transaminase;Ornithine transcarbamylase;Glutamic acid N-transacetylase | Sakanyan, V.et al. " Genes and enzymes of the acetyl cycle of arginine biosynthesis in Corynebacterium glutamicum:enzyme evolution in the early steps of the arginine pathway; " Microbiology, 142:99-108 (1996) |
X89084 | pta;ackA | Phosphate acetyltransferase;Acetokinase | Reinscheid, D.J.et al. " Cloning; sequence analysis; expression and inactivation of the Corynebacterium glutamicum pta-ack operon encoding phosphotransacetylase and acetate kinase; " Microbiology, 145:503-513 (1999) |
X89850 | attB | Attachment site | Le Marrec, C.et al. " Genetic characterization of site-specific integration functions of phi AAU2 infecting " Arthrobacter aureus C70; " J.Bacteriol., 178 (7): 1996-2004 (1996) |
X90356 | Promoter fragment F1 | Patek, M.et al. " Promoters from Corynebacterium glutamicum:cloning; molecular analysis and search for a consensus motif, " Microbiology, 142:1297-1309 (1996) | |
X90357 | Promoter fragment F2 | Patek, M.et al. " Promoters from Corynebacterium glutamicum:cloning; molecular analysis and search for a consensus motif, " Microbiology, 142:1297-1309 (1996) | |
X90358 | Promoter fragment F10 | Patek, M.et al. " Promoters from Corynebacterium glutamicum:cloning; molecular analysis and search for a consensus motif, " Microbiology, 142:1297-1309 (1996) | |
X90359 | Promoter fragment F13 | Patek, M.et al. " Promoters from Corynebacterium glutamicum:cloning; molecular analysis and search for a consensus motif, " Microbiology, 142:1297-1309 (1996) | |
X90360 | Promoter fragment F22 | Patek, M.et al. " Promoters from Corynebacterium glutamicum:cloning; molecular analysis and search for a consensus motif, " Microbiology, 142:1297-1309 (1996) | |
X90361 | Promoter fragment F34 | Patek, M.et al. " Promoters from Corynebacterium glutamicum:cloning; molecular analysis and search for a consensus motif, " Microbiology, 142:1297-1309 (1996) | |
X90362 | Promoter fragment F37 | Patek, M.et al. " Promoters from Corynebacterium glutamicum:cloning; molecular analysis and search for a consensus motif, " Microbiology, 142:1297-1309 (1996) |
GenBankTMSearching number | Gene Name | Gene function | Bibliography |
X90363 | Promoter fragment F45 | Patek, M.et al. " Promoters from Corynebacterium glutamicum:cloning; molecular analysis and search for a consensus motif, " Microbiology, 142:1297-1309 (1996) |
X90364 | Promoter fragment F64 | Patek, M.et al. " Promoters from Corynebacterium glutamicum:cloning; molecular analysis and search for a consensus motif, " Microbiology, 142:1297-1309 (1996) | |
X90365 | Promoter fragment F75 | Patek, M.et al. " Promoters from Corynebacterium glutamicum:cloning; molecular analysis and search for a consensus motif, " Microbiology, 142:1297-1309 (1996) | |
X90366 | Promoter fragment PF101 | Patek, M.et al. " Promoters from Corynebacterium glutamicum:cloning; molecular analysis and search for a consensus motif, " Microbiology, 142:1297-1309 (1996) | |
X90367 | Promoter fragment PF104 | Pate k, M.et al. " Promoters from Corynebacterium glutamicum:cloning; molecular analysis and search for a consensus motif, " Microbiology, 142:1297-1309 (1996) | |
X90368 | Promoter fragment PF109 | Patek, M.et al. " Promoters from Corynebacterium glutamicum:cloning; molecular analysis and search for a consensus motif, " Microbiology, 142:1297-1309 (1996) | |
X93513 | amt | Ammonia movement system | Siewe, R.M.et al. " Functional and genetic characterization of the (methyl) ammonium uptake carrier of Corynebacterium glutamicum; " J.Biol.Chem., 271 (10): 5398-5403 (1996) |
X93514 | betP | Glycinebetaine movement system | Peter, H.et al. " Isolation; characterization; and expression of the Corynebacterium glutamicum betP gene; encoding the transport system for the compatible solute glycine betaine; " J.Bacteriol., 178 (17): 5229-5234 (1996) |
X95649 | orf4 | Patek, M.et al. " Identification and transcriptional analysis of the dapB-ORF2- dapA-ORF4 operon of Corynebacterium glutamicum; encoding two enzymes involved in L-lysine synthesis; " Biotechnol.Lett., (1997) 19:1113-1117 | |
X96471 | lysE;lysG | Lysine exports albumen;Lysine exports regulatory protein | Vrljic, M.et al. " A new type of transporter with a new type of cellular function:L-lysine export from Corynebacterium glutamicum; " Mol. Microbiol., 22 (5): 815-826 (1996) |
GenBankTMSearching number | Gene Name | Gene function | Bibliography |
X96580 | panB;panC;xylB | 3- methyl -2- oxy butyrate hydroxymethyl transferases;Pantothenic acid-beta- alanine ligase;Xylulokinase | Sahm, H.et al. " D-pantothenate synthesis in Corynebacterium glutamicum and use of panBC and genes encoding L-valine synthesis for D-pantothenate overproduction; " Appl.Environ.Microbiol., 65 (5): 1973-1979 (1999) |
X96962 | Insetion sequence IS1207 and transposase | ||
X99289 | Elongation factors P | Ramos, A.et al. " Cloning; sequencing and expression of the gene encoding elongation factor P in the amino-acid producer Brevibacterium lactofermentum (Corynebacterium glutamicum ATCC 13869); " Gene, 198:217-222 (1997) | |
Y00140 | thrB | Homoserine kinase | Mateos, L.M.et al. " Nucleotide sequence of the homoserine kinase (thrB) gene of the Brevibacterium lactofermentum; " Nucleic Acids Res., 15 (9): 3922 (1987) |
Y00151 | ddh | Meso-diaminopimelic acid D- dehydrogenase (EC 1.4.1.16) | Ishino, S.et al. " Nucleotide sequence of the meso-diaminopimelate D- dehydrogenase gene from Corynebacterium glutamicum; " Nucleic Acids Res., 15 (9): 3917 (1987) |
Y00476 | thrA | Homoserine dehydrogenase | Mateos, L.M.et al. " Nucleotide sequence of the homoserine dehydrogenase (thrA) gene of the Brevibacterium lactofermentum; " Nucleic Acids Res., 15 (24): 10598 (1987) |
Y00546 | hom;thrB | Homoserine dehydrogenase;Homoserine kinase | Peoples, O.P.et al. " Nucleotide sequence and fine structural analysis of the Corynebacterium glutamicum hom-thrB operon; " Mol.Microbiol., 2 (1): 63-72 (1988) |
Y08964 | murC;ftsQ/divD;ftsZ | UPD-N- acetylmuramic acid-alanine ligase;Division starting albumen or Cyclin;Cyclin | Honrubia, M.P.et al. " Identification; characterization; and chromosomal organization of the ftsZ gene from Brevibacterium lactofermentum; " Mol. Gen.Genet., 259 (1): 97-104 (1998) |
Y09163 | putP | High-affinity proline transporter systems | Peter, H.et al. " Isolation of the putP gene of Corynebacterium glutamicumproline and characterization of a low-affinity uptake system for compatible solutes; " Arch.Microbiol., 168 (2): 143-151 (1997) |
Y09548 | pyc | Pyruvate carboxylase | Peters-Wendisch, P.G.et al. " Pyruvate carboxylase from Corynebacterium glutamicum:characterization; expression and inactivation of the pyc gene; " Microbiology, 144:915-927 (1998) |
Y09578 | leuB | 3-Isopropylmalate dehydrogenase | Patek, M.et al. " Analysis of the leuB gene from Corynebacterium glutamicum, " Appl.Microbiol.Biotechnol., 50 (1): 42-47 (1998) |
Y12472 | Bacteriophage Phi-16 attachment site | Moreau, S.et al. " Site-specific integration of corynephage Phi-16:The construction of an integration vector, " Microbiol., 145:539-548 (1999) |
GenBankTMSearching number | Gene Name | Gene function | Bibliography |
Y12537 | proP | Proline/ectoine absorption system albumen | Peter, H.et al. " Corynebacterium glutamicum is equipped with four secondary carriers for compatible solutes:Identification; sequencing; and characterization of the proline/ectoine uptake system; ProP, and the ectoine/proline/glycine |
Betaine carrier, EctP, " J.Bacteriol., 180 (22): 6005-6012 (1998) | |||
Y13221 | glnA | Glutamine synthelase I | Jakoby, M.et al. " Isolation of Corynebacterium glutamicum glnA gene encoding glutamine synthetase I, " FEMS Microbiol.Lett., 154 (1): 81-88 (1997) |
Y16642 | lpd | Dihydrolipoamide dehydrogenase | |
Y18059 | Bar bacterium bacteriophage 304L attachment site | Moreau, S.et al. " Analysis of the integration functions of &phi;304L:An integrase module among corynephages, " Virology, 255 (1): 150-159 (1999) | |
Z21501 | argS;lysA | Arginyl-tRNA synthetase;Diaminapimelate decarboxylase (part) | Oguiza, J.A.et al. " A gene encoding arginyl-tRNA synthetase is located in the upstream region of the lysA gene in Brevibacterium lactofermentum:Regulation of argS-lysA cluster expression by arginine; " J. Bacteriol., 175 (22): 7356-7362 (1993) |
Z21502 | dapA;dapB | Dihydro 2, dipicolimic acid 2 synthase;Dihydro 2, dipicolimic acid 2 reductase | Pisabarro, A.et al. " A cluster of three genes (dapA; orf2; and dapB) of Brevibacterium lactofermentum encodes dihydrodipicolinate reductase; and a third polypeptide of unknown function; " J.Bacteriol., 175 (9): 2743-2749 (1993) |
Z29563 | thrC | Threonine synthase | Malumbres, M.et al. " Analysis and expression of the thrC gene of the encoded threonine synthase, " Appl.Environ.Microbiol., 60 (7) 2209-2219 (1994) |
Z46753 | 16S rDNA | 16S ribosomal RNA gene | |
Z49822 | sigA | The SigA sigma factor | Oguiza, J.A.et al " Multiple sigma factor genes in Brevibacterium lactofermentum:Characterization of sigA and sigB; " J.Bacteriol., 178 (2): 550- 553 (1996) |
Z49823 | galE;dtxR | UDP- galactolipin 4- epimerase catalytic activity;Diphtheria toxin regulatory protein | Oguiza, J.A.et al " The galE gene encoding the UDP-galactose 4-epimerase of Brevibacterium lactofermentum is coupled transcriptionally to the dmdR gene; " Gene, 177:103-107 (1996) |
Z49824 | orf1;sigB | ;The SigB sigma factor | Oguiza, J.A.et al " Multiple sigma factor genes in Brevibacterium lactofermentum:Characterization of sigA and sigB; " J.Bacteriol., 178 (2): 550- 553 (1996) |
Z66534 | Transposase | Correia, A.et al. " Cloning and characterization of an IS-like element present in the genome of Brevibacterium lactofermentum ATCC 13869; " Gene, 170 (1): 91-94 (1996) |
1The gene order has disclosed in listed bibliography.But the sequence that the present invention obtains is obviously long compared with sequence is disclosed.Speculate disclosed ATG code of sequence mistake, therefore a segment in only actual coding area.
Table 3: it can be used for implementing bar bacterium and Brevibacterium flavum strain of the invention
Generic name | Kind name | ATCC | FERM | NRRL | CECT | NCIMB | CBS | NCTC | DSMZ |
Brevibacterium | Brevibacterium ammoniagene | 21054 | |||||||
Brevibacterium | Brevibacterium ammoniagene | 19350 | |||||||
Brevibacterium | Brevibacterium ammoniagene | 19351 | |||||||
Brevibacterium | Brevibacterium ammoniagene | 19352 | |||||||
Brevibacterium | Brevibacterium ammoniagene | 19353 | |||||||
Brevibacterium | Brevibacterium ammoniagene | 19354 | |||||||
Brevibacterium | Brevibacterium ammoniagene | 19355 | |||||||
Brevibacterium | Brevibacterium ammoniagene | 19356 | |||||||
Brevibacterium | Brevibacterium ammoniagene | 21055 | |||||||
Brevibacterium | Brevibacterium ammoniagene | 21077 | |||||||
Brevibacterium | Brevibacterium ammoniagene | 21553 | |||||||
Brevibacterium | Brevibacterium ammoniagene | 21580 | |||||||
Brevibacterium | Brevibacterium ammoniagene | 39101 | |||||||
Brevibacterium | butanicum | 21196 | |||||||
Brevibacterium | Branch brevibacterium | 21792 | P928 | ||||||
Brevibacterium | Brevibacterium flavum | 21474 | |||||||
Brevibacterium | Brevibacterium flavum | 21129 | |||||||
Brevibacterium | Brevibacterium flavum | 21518 | |||||||
Brevibacterium | Brevibacterium flavum | B11474 | |||||||
Brevibacterium | Brevibacterium flavum | B11472 | |||||||
Brevibacterium | Brevibacterium flavum | 21127 | |||||||
Brevibacterium | Brevibacterium flavum | 21128 | |||||||
Brevibacterium | Brevibacterium flavum | 21427 | |||||||
Brevibacterium | Brevibacterium flavum | 21475 | |||||||
Brevibacterium | Brevibacterium flavum | 21517 | |||||||
Brevibacterium | Brevibacterium flavum | 21528 | |||||||
Brevibacterium | Brevibacterium flavum | 21529 | |||||||
Brevibacterium | Brevibacterium flavum | B11477 | |||||||
Brevibacterium | Brevibacterium flavum | B11478 | |||||||
Brevibacterium | Brevibacterium flavum | 21127 | |||||||
Brevibacterium | Brevibacterium flavum | B11474 | |||||||
Brevibacterium | Xi Shi brevibacterium | 15527 | |||||||
Brevibacterium | Ketoglutaric acid brevibacterium | 21004 | |||||||
Brevibacterium | Ketoglutaric acid brevibacterium | 21089 | |||||||
Brevibacterium | ketosoreductum | 21914 | |||||||
Brevibacterium | Brevibacterium | 70 | |||||||
Brevibacterium | Brevibacterium | 74 | |||||||
Brevibacterium | Brevibacterium | 77 | |||||||
Brevibacterium | Brevibacterium | 21798 | |||||||
Brevibacterium | Brevibacterium | 21799 | |||||||
Brevibacterium | Brevibacterium | 21800 | |||||||
Brevibacterium | Brevibacterium | 21801 | |||||||
Brevibacterium | Brevibacterium | B11470 | |||||||
Brevibacterium | Brevibacterium | B11471 | |||||||
Brevibacterium | Brevibacterium | 21086 | |||||||
Brevibacterium | Brevibacterium | 21420 |
Brevibacterium | Brevibacterium | 21086 | |||||||
Brevibacterium | Brevibacterium | 31269 | |||||||
Brevibacterium | Extension brevibacterium | 9174 | |||||||
Brevibacterium | Extension brevibacterium | 19391 | |||||||
Brevibacterium | Extension brevibacterium | 8377 | |||||||
Brevibacterium | Solve paraffin brevibacterium | 11160 | |||||||
Brevibacterium | Kind | 717.73 | |||||||
Brevibacterium | Kind | 717.73 | |||||||
Brevibacterium | Kind | 14604 | |||||||
Brevibacterium | Kind | 21860 | |||||||
Brevibacterium | Kind | 21864 | |||||||
Brevibacterium | Kind | 21865 | |||||||
Brevibacterium | Kind | 21866 | |||||||
Brevibacterium | Kind | 19240 | |||||||
Bar bacterium | Corynebacterium acctoacidophlum | 21476 | |||||||
Bar bacterium | Corynebacterium acctoacidophlum | 13870 | |||||||
Bar bacterium | Vinegar paddy bar bacterium | B11473 | |||||||
Bar bacterium | Vinegar paddy bar bacterium | B11475 | |||||||
Bar bacterium | Vinegar paddy bar bacterium | 15806 | |||||||
Bar bacterium | Vinegar paddy bar bacterium | 21491 | |||||||
Bar bacterium | Vinegar paddy bar bacterium | 31270 | |||||||
Bar bacterium | Thermophilic acetyl bar bacterium | B3671 | |||||||
Bar bacterium | Corynebacterium ammoniagenes | 6872 | 2399 | ||||||
Bar bacterium | Corynebacterium ammoniagenes | 15511 | |||||||
Bar bacterium | fujiokense | 21496 | |||||||
Bar bacterium | Corynebacterium glutamicum | 14067 | |||||||
Bar bacterium | Corynebacterium glutamicum | 39137 | |||||||
Bar bacterium | Corynebacterium glutamicum | 21254 | |||||||
Bar bacterium | Corynebacterium glutamicum | 21255 | |||||||
Bar bacterium | Corynebacterium glutamicum | 31830 | |||||||
Bar bacterium | Corynebacterium glutamicum | 13032 | |||||||
Bar bacterium | Corynebacterium glutamicum | 14305 | |||||||
Bar bacterium | Corynebacterium glutamicum | 15455 | |||||||
Bar bacterium | Corynebacterium glutamicum | 13058 | |||||||
Bar bacterium | Corynebacterium glutamicum | 13059 | |||||||
Bar bacterium | Corynebacterium glutamicum | 13060 | |||||||
Bar bacterium | Corynebacterium glutamicum | 21492 | |||||||
Bar bacterium | Corynebacterium glutamicum | 21513 | |||||||
Bar bacterium | Corynebacterium glutamicum | 21526 | |||||||
Bar bacterium | Corynebacterium glutamicum | 21543 | |||||||
Bar bacterium | Corynebacterium glutamicum | 13287 | |||||||
Bar bacterium | Corynebacterium glutamicum | 21851 | |||||||
Bar bacterium | Corynebacterium glutamicum | 21253 | |||||||
Bar bacterium | Corynebacterium glutamicum | 21514 | |||||||
Bar bacterium | Corynebacterium glutamicum | 21516 | |||||||
Bar bacterium | Corynebacterium glutamicum | 21299 | |||||||
Bar bacterium | Corynebacterium glutamicum | 21300 | |||||||
Bar bacterium | Corynebacterium glutamicum | 39684 | |||||||
Bar bacterium | Corynebacterium glutamicum | 21488 | |||||||
Bar bacterium | Corynebacterium glutamicum | 21649 |
Bar bacterium | Corynebacterium glutamicum | 21650 | |||||||
Bar bacterium | Corynebacterium glutamicum | 19223 | |||||||
Bar bacterium | Corynebacterium glutamicum | 13869 | |||||||
Bar bacterium | Corynebacterium glutamicum | 21157 | |||||||
Bar bacterium | Corynebacterium glutamicum | 21158 | |||||||
Bar bacterium | Corynebacterium glutamicum | 21159 | |||||||
Bar bacterium | Corynebacterium glutamicum | 21355 | |||||||
Bar bacterium | Corynebacterium glutamicum | 31808 | |||||||
Bar bacterium | Corynebacterium glutamicum | 21674 | |||||||
Bar bacterium | Corynebacterium glutamicum | 21562 | |||||||
Bar bacterium | Corynebacterium glutamicum | 21563 | |||||||
Bar bacterium | Corynebacterium glutamicum | 21564 | |||||||
Bar bacterium | Corynebacterium glutamicum | 21565 | |||||||
Bar bacterium | Corynebacterium glutamicum | 21566 | |||||||
Bar bacterium | Corynebacterium glutamicum | 21567 | |||||||
Bar bacterium | Corynebacterium glutamicum | 21568 | |||||||
Bar bacterium | Corynebacterium glutamicum | 21569 | |||||||
Bar bacterium | Corynebacterium glutamicum | 21570 | |||||||
Bar bacterium | Corynebacterium glutamicum | 21571 | |||||||
Bar bacterium | Corynebacterium glutamicum | 21572 | |||||||
Bar bacterium | Corynebacterium glutamicum | 21573 | |||||||
Bar bacterium | Corynebacterium glutamicum | 21579 | |||||||
Bar bacterium | Corynebacterium glutamicum | 19049 | |||||||
Bar bacterium | Corynebacterium glutamicum | 19050 | |||||||
Bar bacterium | Corynebacterium glutamicum | 19051 | |||||||
Bar bacterium | Corynebacterium glutamicum | 19052 | |||||||
Bar bacterium | Corynebacterium glutamicum | 19053 | |||||||
Bar bacterium | Corynebacterium glutamicum | 19054 | |||||||
Bar bacterium | Corynebacterium glutamicum | 19055 | |||||||
Bar bacterium | Corynebacterium glutamicum | 19056 | |||||||
Bar bacterium | Corynebacterium glutamicum | 19057 | |||||||
Bar bacterium | Corynebacterium glutamicum | 19058 | |||||||
Bar bacterium | Corynebacterium glutamicum | 19059 | |||||||
Bar bacterium | Corynebacterium glutamicum | 19060 | |||||||
Bar bacterium | Corynebacterium glutamicum | 19185 | |||||||
Bar bacterium | Corynebacterium glutamicum | 13286 | |||||||
Bar bacterium | Corynebacterium glutamicum | 21515 | |||||||
Bar bacterium | Corynebacterium glutamicum | 21527 | |||||||
Bar bacterium | Corynebacterium glutamicum | 21544 | |||||||
Bar bacterium | Corynebacterium glutamicum | 21492 | |||||||
Bar bacterium | Corynebacterium glutamicum | B8183 | |||||||
Bar bacterium | Corynebacterium glutamicum | B8182 | |||||||
Bar bacterium | Corynebacterium glutamicum | B12416 | |||||||
Bar bacterium | Corynebacterium glutamicum | B12417 | |||||||
Bar bacterium | Corynebacterium glutamicum | B12418 | |||||||
Bar bacterium | Corynebacterium glutamicum | B11476 | |||||||
Bar bacterium | Corynebacterium glutamicum | 21608 | |||||||
Bar bacterium | Lily bar bacterium | P973 | |||||||
Bar bacterium | nitrilophilus | 21419 | 11594 | ||||||
Bar bacterium | Kind | P4445 |
Bar bacterium | Kind | P4446 | |||||||
Bar bacterium | Kind | 31088 | |||||||
Bar bacterium | Kind | 31089 | |||||||
Bar bacterium | Kind | 31090 | |||||||
Bar bacterium | Kind | 31090 | |||||||
Bar bacterium | Kind | 31090 | |||||||
Bar bacterium | Kind | 15954 | 20145 | ||||||
Bar bacterium | Kind | 21857 | |||||||
Bar bacterium | Kind | 21862 | |||||||
Bar bacterium | Kind | 21863 |
ATCC: American type culture collection, Rockville, MD, USA
FERM: fermentation research institute, Chiba, Japan
NRRL: agricultural research institute's collection, northern areas research laboratory, Peoria, IL, USA
CECT: Spain's Type Tissue Collection, Valencia, Spain
NCIMB: state-run industry and Marine Bacteria center, Aberdeen, UK
CBS: fungi strain collection, Baarn, NL
NCTC: state-run Type Tissue Collection, London, UK
DSMZ: Mikroorganismen collection, Braunschweig, Germany
It can be found in Sugawara, H.et al. (1993) World directory of collections of cultures of microorganisms:Bacteria, fungi and yeasts (4thEdn), World federation for culture collections world data center onmicroorganisms, Saimata, Japen.
Table 4: sequence comparison result
ID# | Genbank hit results (NT) | Length | Searching number | Genbank hit results title | Genbank hit results source | % homology (GAP) | It is put in storage day |
rxa00315 | 1527 GB_BA1:AB007125 GB_IN1:CELC47D2 GB_HTG2:AC006732 | 4078 17381 159453 | AB007125 U64861 AC006732 | Serratia marcescens slaA gene for surface layer protein, completecds, isolate 8000Caenorhabditis elegans cosmid C47D2.Caenorhabditis elegans clone Y32G9,***SEQUENCING INPROGRESS***, 9 unordered pieces. | Serratia marcescens Caenorhabditis elegans Caenorhabditis elegans | 40,386 36,207 36,436 | 26-MAR-1998 28-Jul-96 23-Feb-99 |
rxa01503 | 372 GB_PR3:AC005019 GB_GSS12:AQ390040 GB_GSS5:AQ784231 | 188362 680 542 | AC005019 AQ390040 AQ784231 | Homo sapiens BAC clone GS250A16 from 7p21-p22, completeRPCI11-157C9.TJ RPCI-11 Homo sapiens genomic clone RPCI-11-157C9, genomic survey sequence.HS_3087_B1_C10_T7C CIT Approved Human Genomic SpermLibrary D Homo sapiens genomic clone Plate=3087 Col=19Row=F, ge Nomic survey sequence. | Homo sapiens Homo sapiens Homo sapiens | 39,722 43,137 37,643 | 27-Aug-98 21-MAY-1999 3-Aug-99 |
rxa01299 | 2187 GB_EST38:AW047296 GB_RO:AB004056 GB_RO:AB004056 | 614 1581 1581 | AW047296 AB004056 AB004056 | UI-M-BH1-amh-e-03-0-UI.s1 NIH_BMAP_M_S2 Mus musculuscDNA clone UI-M-BH1-amh-e-03-0-UI 3 ', mRNA sequenceRattus norvegicus mRNA for BarH-class homeodomaintranscription factor.complete cds.Rattus norvegicus mRNA for BarH-class homeodomaintranscription factor, c Omplete cds. | Mus musculus Rattus norvegicus Rattus norvegicus | 41,475 41,031 40,717 | 18-Sep-99 2-Sep-98 2-Sep-98 |
rxa00951 | 416 GB_BA1:SCJ21 GB_VI:MCU68299 GB_VI:U93872 | 31717 230278 133661 | AL109747 U68299 U93872 | 1 complete genomic sequence.Kaposi ' s sarcoma-associated herpesvirus glycoprotein M of Streptomyces coelicclor cosmid J21. Mouse cytomegalovirus, DNAreplication protein, glycoprotein, DNA replication protein, FLICEinhibitory protein and v-cyclin genes, complete cds , and tegument | Streptomyces coelicolor A3(2) Mouse cytomegalovirus 1 Kaposi′s sarcoma- associated herpesvirus | 34,913 40,097 36,029 | 5-Aug-99 04-DEC-1996 9-Jul-97 |
rxa01244 | 1827 GB_BA1:AFAPHBHI GB_PR3:HSJ836E13 GB_EST24:AI170227 | 4501 78055 409 | M69036 AL050326 AI170227 | Alcaligenes eutrophus protein H (phbH) and protein I (phbI) genes, complete cds.Human DNA sequence from clone 836E13 on chromosome 20Contains ESTs, STS and GSSs, complete sequence.EST216152 Normalized rat lung, Banto Soares Rattus sp.cDNAclone RLUCF56 3 ' end, mRNA s Equence. | Ralstonia eutropha Homo sapiens Rattus sp. | 45,624 37,303 39,098 | 26-Apr-93 23-Nov-99 20-Jan-99 |
rxa01300 | 390 GB_PR3:HUMDODDA GB_PAT:140899 GB_PAT:140900 | 26764 26764 1317 | L39874 I40899 I40900 | 1 from patent US 5622851.Sequence of Homo sapiens deoxycytidylate deaminase gene, complete cds.Sequence, 2 from patent US 5622851. | Homo sapiens Unknown. Unknown. | 37,644 37,644 37,644 | 11-Aug-95 13-MAY-1997 13-MAY-1997 |
rxa00953 | 789 GB_BA1:SCJ21 GB_BA1:BLTRP GB_PAT:E01375 | 31717 7725 7726 | AL 109747 X04960 E01375 | Streptomyces coelicolor cosmid J21. Brevibacterium lactofermentum tryptophan operon. DNA sequence of tryptophan operon | Streptomyces coelicolor A3(2) Corynebacterium glutamicum Corynebacterium glutamicum | 39,398 39,610 46,753 | 5-Aug-99 10-Feb-99 29-Sep-97 |
4 (Continued) of table
rxa01943 | 2172 GB_BA1:CORPTSMA GB_BA1:BRLPTSG GB_BA2:AF045481 | 2656 3163 2841 | L18874 L18875 AF045481 | Corynebacterium glutamicum phosphoenolpyruvate sugar phosphotransferase (ptsM) mRNA, complete cds. Brevibacterium lactofermentum phosphoenolpyruvate sugar phosphotransferase (ptsG) gene.complete cds. Corynebacterium ammoniagenes glucose permease (ptsG) gene , complete cds | Corynebacterium glutamicum Brevibacterium lactofermentum Corynebacterium ammoniagenes | 100,000 84,963 53,558 | 24-Nov-94 01-OCT-1993 29-Jul-98 |
Embodiment
Embodiment 1: the preparation of 13032 full gene group DNA of Corynebacterium glutamicum ATCC
Corynebacterium glutamicum (ATCC 13032) culture in BHI culture medium (Difco), stay overnight by 30 DEG C of violent shaken cultivations.Cell is collected by centrifugation, abandons supernatant, cell is resuspended in 5ml buffer I (all volumes pointed out of the 5%- of culture original volume are calculated for 100ml culture volume).The composition of buffer I: 140.34g/l sucrose, 2.46g/l MgSO4×7H2O, 10ml/l KH2PO4Solution (100g/l, KOH are adjusted to PH6.7), 50g/l M12 concentrate (10g/l (NH4)2SO4, 1g/l NaCl, 2g/l MgSO4× 7H2O, 0.2g/l CaCl2, 0.5g/l yeast extract (Difco)), 10ml/l trace element mixture (200mg/l FeSO4×H2O, 10mg/l ZnSO4×7H2O, 3mg/l MnCl2×4H2O, 30mg/l H3BO3, 20mg/lCoCl2×6H2O, 1mg/l NiCl2×6H2O, 3mg/l Na2MoO4×2H2O), 500mg/l complexing agent (EDTA or citric acid), 100ml/l vitamin mixtures (0.2mg/l biotin, 0.2mg/l folic acid, 20mg/l p- amino benzoic acid, 20mg/l riboflavin, 40mg/lpanthothenate, 140mg/l niacin, 40mg/l hydrochloric acid Vitamin B6,200mg/l inositol).Lysozyme is added in suspension to final concentration 2.5mg/ml.After 37 DEG C are incubated for about 4 hours, cell wall is degraded, and obtained protoplast is with being collected by centrifugation.Precipitating is washed once with 5ml buffer I, is washed once with 5ml TE buffer (10mM Tris-HCl, 1ml EDTA, pH8).Precipitating is resuspended with 4ml TE buffer, and 0.5ml SDS solution (10%) and 0.5ml NaCl solution (5M) is added.Proteinase K is added to 200 μ g/ml of final concentration, suspension is incubated for about 18 hours at 37 DEG C.DNA phenol, phenol chloroform-isoamyl alcohol, chloroform-isoamyl alcohol are according to standardization program extraction purification.Then, the 3M sodium acetate of 1/50 volume and the ethyl alcohol of 2 times of volumes is added, is incubated for 30 minutes at -20 DEG C, with the supercentrifuge 12 for using SS34 rotary head (Sorvall), 000rpm is centrifuged 30 minutes, precipitates DNA.DNA is dissolved in the 1ml TE buffer containing 20 μ g/ml RNaseA, is dialysed at least 3 hours for 4 DEG C in 1000ml TE buffer.In this period, replace buffer 3 times.In the DNA solution of every 0.4ml dialysis, 0.4ml 2M LiCl and 0.8ml ethyl alcohol is added.After -20 DEG C are incubated for 30 minutes, DNA is collected in centrifugation (13,000rpm, Biofuge Fresco, Heraeus, Hanau, Germany).DNA precipitating is melted in TE buffer.It can be used for all purposes by DNA prepared by the program, the building including southern hybridization and genomic library.
Embodiment 2: in the building of the genomic library of Escherichia coli Glutamic Acid bar bacterium ATCC13032
Use the DNA prepared as described in Example 1, according to method that is known and sufficiently establishing (referring to, such as Sambrook, J.et al. (1989) " Molecular Cloning:ALaboratory Manual " Cold Spring Harbor Laboratory, Cold Spring HarborLaboratory Press, or Ausubel, F.M.et al. (1994) " Current Protocols inMolecular Bilogy ", John Wiley&Sons.), can construct cosmid library and Plasmid library.
Any plasmid and clay can be used.PBR322 plasmid (Sutcliffe, J.G. (1979) Proc.Natl.Acad.Sci.USA, 75:3737-3741);PACY177 (Change&Cohen (1978) J.Bacteriol 134:1141-1156), pBS series plasmids (pBSSK+, pBSSK- and other plasmids;Stratagene, LaJolla, USA), clay SuperCos1 (Stratagene, LaJolla, USA) or Lorist6 (Gibson, T.J., Rosenthal A.and Waterson, R.H. (1987) Gene53:283-286) it can be used for specific use.The gene library specially used in corynebacterium glutamicum can be constructed with plasmid pSL109 (Lee, H.-S.and A.J.Sinskey (1994) J.Microbiol.Biotechnol.4:256-263).
Embodiment 3:DNA sequencing and computer function analysis
According to standard method, use such as described genomic library in example 2, it can carry out DNA sequencing, especially with using ABI377 sequenator chain termination method (referring to, such as Fleischman, R.D.et al. (1995) " Whole-genome Random Sequencing andAssembly of Haemophilus Influenzae Rd., Science, 269:496-512).Use the sequencing primer with following nucleotide sequence: 5 '-GGAAACAGTATGACCATG-3 ' or 5 '-GTAAAACGACGGCCAGT-3 '.
Embodiment 4: vivo mutations
Can by Escherichia coli or other microorganisms (such as, the certain bacterium of bacillus or seem saccharomyces cerevisiae yeast) plasmid (or other carriers) DNA passage, the vivo mutations of Corynebacterium glutamicum are carried out, wherein these microorganisms keep the ability of its hereditary information globality to be damaged.Typical mutant strain has mutation (for example, mutHLS, mutD, mutT etc. in the gene of DNA repair system;Bibliography is referring to Rupp, W.D. (1996) DNA repair mechanisms, in:Escherichia coli and Salmonella, p.2277-2294, ASM:Washington.).These bacterial strains are well known for the man skilled in the art.The use of these bacterial strains is set forth in, such as Greener, in A.and Callahan, M. (1994) Strategies 7:32-34.
Embodiment 5: the DNA transmitted between Escherichia coli and Corynebacterium glutamicum
Bar bacterium and brevibacterium strain contain the indigenous plasmid (seeming for example, pHM1519 or pBL1) of the spontaneous duplication of energy (comment is see, e.g., Martin, J.F.et al. (1987) Biotechnology, 5:137-146).The shuttle vector of Escherichia coli and Corynebacterium glutamicum, the standard vector that Escherichia coli can be used readily constructs (Sambrook, J.et al. (1989) " Molecular Cloning:A Laboratory Manual " Cold Spring Harbor Laboratory, Cold Spring Harbor Laboratory Press or Ausubel, F.M.et al. (1994) " Current Protocols in Molecular Bilogy ", John Wiley&Sons.), i.e., glutamic acid is added wherein The replication fork starting point of bar bacterium and suitable label.This replication origin, what the indigenous plasmid preferably separated from bar bacterium and brevibacterium strain obtained.That as these strain transformation markers this specific uses is kalamycin resistance gene (such as from those of Tn5 Tn903 transposons kalamycin resistance gene) or chloramphenicol resistance gene (Winnacker, E.L. (1987) " From Genes to Clones-Introduction to Gene Technology; VCH, Weinheim).Constructing many of the document of various wild type shuttle vectors example, these shuttle vectors can replicate in Escherichia coli and Corynebacterium glutamicum, and it can be used for various purposes, including gene overexpression, (bibliography is see, e.g., Yoshihama, M.et al. (1985) J.Bacteriol.162:591-597, Martin J.F.et al. (1987) Biotechnology, 5:137-146 and Eikmanns, B.J.et a;(1991) Gene, 102:93-98).
Can be interested gene cloning into above-mentioned shuttle vector using standard method, and the hybridization can be carried and be introduced into Corynebacterium glutamicum strain.The conversion of Corynebacterium glutamicum can pass through protoplast transformation (Kastsumata, R.et al. (1984) J.Bacteriol.159306-311), fax hole (Liebl, E.et al. (1989) FEMS Microbiol.Letters, 53:399-303) realize, when using special carrier, it can also be realized by combination (such as in Sch fer, A et al. (1990) J.Bacteriol.172:1663-1666).Shuttle vector can also be transferred to Escherichia coli from Corynebacterium glutamicum by preparing Plasmid DNA (using standard method known in the art) from Corynebacterium glutamicum and being transformed into Escherichia coli.Standard method progress can be used in this step of converting, but Mcr defective escherichia coli bacterial strain, such as NM522 (Gough&Murray (1983) J.Mol.Biol.166:1-19) is used to be advantageous.
Using contain pCG1 (U.S.Patent No.4,617, or the plasmid of its segment 267), and it can choose the kalamycin resistance gene (Grindley from TN903, N.D.and Joyce, C.M. (1980) Proc.Natl.Acad.Sci.USA 77 (12): 7176-7180), so that it may overexpression gene in corynebacterium glutamicum.In addition, can also overexpression gene in corynebacterium glutamicum using plasmid pSL109 (Lee, H.-S.and A.J.Sinskey (1994) J.Microbiol.Biotechnol.4:256-263).
Other than using reproducible plasmid, the overexpression of gene can also be realized by genome conformity.The genome conformity of Corynebacterium glutamicum or other bar bacteriums or brevibacterium strain, it can be realized by well known method, such as the homologous recombination of genome area, restriction endonuclease mediate integration (REMI) (see, for example, DE Patent 19823834), or by using transposons.Can also by modification adjustment region (such as, promoter, repressor and/or enhancer), it is based on sequence modification, insertion or the missing of chance event method (such as transposon mutant or REMI), either by using site-directed method (such as homologous recombination) to adjust the activity of gene of interest.Nucleic acid sequence as transcription terminator can also be inserted into the 3 ' of one or more gene coding region of the invention;What such terminator was well known, and describe in such as Winnacker, E.L. (1987) From Genes to Clones-Introduction to Gene Technology.VCH:Weinheim.
Embodiment 6: the estimation of mutein expression
The fact that be converted the active observation of mutein in host cell, depend on, i.e. mutein are expressed in a manner of similar with wild-type protein with similar quantity.Determine mutated gene transcriptional level (quantitative index of the mRNA for gene product translation) the useful method of one kind be carry out Northern hybridization (bibliography referring to, such as, Ausubel et al. (1988) CurrentProtocols in Molecular Biology, Wiley:New York), that wherein designs has detectable label (usually radioactive or chemiluminescent) for the primer mark in conjunction with gene of interest, to, when whole RNA of organism culture are extracted, run gel electrophoresis, it is transferred in stable and is incubated for the probe, the combination of bonding probes and quantity just indicate the presence and quantity of the gene mRNA.The information is the evidence of mutated gene transcription degree.Several method can be used and prepare whole cell RNAs from Corynebacterium glutamicum, what this was well known, such as description is in Bormann, E.R.et al. (1992) Mol.Microbiol.6:317-326.
In order to estimate by the presence and relative populations of the mRNA protein translated, it can be used standard technique, such as Wesstern hybridization (see, e.g., Ausubel et al. (1988) CurrentProtocols in Molecular Biology, Wiley:New York).In the method, whole cell proteins are extracted, are separated by gel electrophoresis, is transferred to and seems on medium as nitrocellulose, and are incubated for altogether with the probe of required protein specific bond, such as antibody.The probe usually marks chemiluminescent or colorimetric the label for having detection.The presence and quantity of the label observed indicate the presence and quantity for appearing in the required mutein in cell.
Embodiment 7: the growth-medium and condition of culture of the Corynebacterium glutamicum of genetic modification
The Corynebacterium glutamicum of genetic modification can be cultivated in synthesis or spontaneous growth culture medium.A variety of different growth mediums for Corynebacterium glutamicum are known and are readily available (Lieb, et al. (1989) Appl.Microbiol.Biotechno., 32:205-210;Von der Ostenet al. (1998) Biotechnology Letters, 11:11-16;Patent DE 4,120,867;Liebl (1992) " The Genus Corynebacterium, in:Procaryotes, Volume II, Balows, A.et al., eds.Springer-Verlag).These culture mediums contain one or more kinds of carbon sources, nitrogen source, inorganic salts, vitamin and microelement.Preferred carbon source is carbohydrate, such as monosaccharide, disaccharides or polysaccharide.For example, glucose, fructose, mannose, galactolipin, ribose, sorbose, ribulose, lactose, maltose, sucrose, gossypose, starch or cellulose, are used as good carbon source.Carbohydrate, such as molasses or the by-product of other carbohydrates refining can also be provided to culture medium by complex compound.The mixture for improving different carbon source is also advantageous.Other available carbon sources have alcohol and organic acid, such as methanol, ethyl alcohol, acetic acid or lactic acid.Nitrogen source is usually organic perhaps inorganic nitrogen compound or the substance containing these compounds.Representative nitrogen source includes ammonia or ammonium salt, such as NH4Cl or (NH4)2SO4、NH4OH, nitrate, urea, amino acid perhaps complexity nitrogen source for example corn steep liquor, soy meal, soybean protein, yeast extract, meat extract or other.
It may include inorganic salt compound in the medium, calcium, magnesium, sodium, cobalt, molybdenum, potassium, manganese, zinc, copper or iron including hydrochloride, phosphate or sulfate.Chelating agent may be added in culture medium, to maintain the metal ion in solution.Particularly useful chelating agent includes dihydroxy phenol, seems catechol and protocatechuic acid or organic acid, seems citric acid.Culture medium typically also contains growth factor, such as vitamin and growth promoter, their example includes biotin, riboflavin, thiamines, folic acid, niacin, pantothenate and pyridoxol.Growth factor and salt are often from complicated medium component, such as yeast extract, molasses, corn steep liquor and other compositions.The definite composition of culture based compound is strongly dependent upon direct experiment, and for each concrete condition concrete decision.The information optimized about culture medium passes through in textbook " AppliedMicrobiol.Physiology; A Practical Approach " (eds.P.M.Rhodes, P.F.Stanbury, IRL Press (1997) pp.53-73, ISBN 0 19 is 9635773) " in.It can also seem standard 1 (Merck) perhaps BHI (grain heart infusion DIFCO) or others from commercial supplier there selection growth medium.
All nutrient media components will pass through heating (1.5bar, 120 DEG C, 20 minutes) or the sterilizing that is sterile filtered.Component can sterilize together, or if necessary separate individually sterilizing.All nutrient media components can just be added in the beginning of growth, either can choose continuity or be added portionwise.
Condition of culture determines each experiment respectively.Temperature should be within the scope of 15 DEG C to 45 DEG C.Temperature can be kept constant, or be changed in an experiment.The pH of culture medium is in 5 to 8.5 ranges, preferably about 7.0, and can be maintained by the addition of buffer in culture medium.It is kaliumphosphate buffer for the representational buffer of this purpose.Buffer, such as MOPS, HEPES, ACES and others are synthesized, also can replace use or is used simultaneously.Addition NaOH or NH can also be passed through during the growth process4OH, to maintain stable culture pH.If using seeming complexity nutrient media components as yeast extract, it is possible to reduce the necessity of buffer is added, this is because many complex compounds have the fact that very strong buffer capacity.If ammonia control pH also can be used using fermentation tank culture microorganism.
Incubation time is usually within a few houres to several days.The selection of this time is to allow to accumulate the maximum amount of product in liquid medium.The growth experiment of announcement can be to carry out in various containers, for example, microtiter plate, teat glass, glass shaking flask or different size of glass or metal fermentor.In order to screen a large amount of clone, microorganism should be cultivated in having baffle or the not microtiter plate of baffle, teat glass or shaking flask.100ml shaking flask is preferably used, the required culture medium of 10% (volume) is added.Shaking flask should be placed on shake (25 millimeters of amplitude), velocity interval 100-300rpm on shaking table.It can be by keeping wet air to reduce evaporation loss;Alternatively, carrying out mathematics amendment to evaporation loss.
If detecting the clone of genetic modification, it should also detect unmodified control clone or be cloned containing basic plasmid but without the control of any insertion.Use growth 30 DEG C of cells being incubated for, such as CM plate (10g/l glucose, 2.5g/l NaCl, 2g/l urea on a lbmc agar plate, the more peptones of 10g/l, 5g/l yeast extract, 5g/l gravy extract, 22g/l agar, 2M NaOH are adjusted to pH 6.8), inoculation medium to OD600Value is 0.5-1.5.The inoculation of culture medium can be realized by the salt suspensioning liquid of Corynebacterium glutamicum cell of the introducing from CM plate, or the liquid pre-culture by the way that the bacterium is added.
Embodiment 8: the analyzed in vitro of mutein function
The measurement of the activity and kinetic parameter of enzyme has technically established very well.It is any that the given determination of activity by the enzyme changed is tested, it is necessary to be suitble to the sp act of wild-type enzyme, this is completely within the ability of technology skilful person.It, can be for example below with reference to being found in document: Dixon about the Summarizing comment of enzyme, and about structure, dynamics, principle, method, application and the clear details for determining many enzymatic activity examples, M., and Webb, E.C., (1979) Enzymes.Longmans:London;Fersht, (1985) Enzyme Structure and Mechanism.Freeman:NewYork;Walsh, (1979) Enzymatic Reaction Mechanisms.Freeman:San Francisco;Price, N.C., Stevens, L. (1982) Fundamentals of Enzymology.Oxford Univ.Press:Oxford;Boyer, P.D., ed. (1983) The Enzymes, 3rdEd.Academic Press:New York;Bisswanger, H., (1994) Enzymkinetik, 2ndEd.VCH:Weinheim (ISBN 3527300325);Bergmeyer, H.U., Bergmeyer, J., Gra β l, M., eds. (1983-1986) Methods of EnzymaticAnalysis, 3rdEd., vol.I-XII, Verlag Chemie:Weinheim;And Ullmann ' s Encyclopediaof Industrial Chemistry (1987) vol.A9, " Enzymes " .VCH:Weinheim, p.352-363.
It can be measured by several methods known in the art in conjunction with the activity of the protein of DNA, such as DNA band shift analysis (also referred to as gel retardation assay).Effect of these protein to other developed by molecule, can be measured with reporter gene assays (such as description is in Kolmar, H.et al. (1995) EMBO J.14:3895-3904 in, and its bibliography of reference).Reporter gene test systems are known, and the application in protokaryon and eukaryocyte all has been established, using seeming BgaA, enzyme as green fluorescent protein and other several protein.
The active measurement of protein called membrane transporters matter can be according to such as description in Gennis, R.B. (1989) " Pores, Channels and Transporters ", in Biomembrane, Molecular Structureand Function, Springer:Heidelberg, p.85-137;199-234;Technology carries out those of in and 270-322.
Embodiment 9: the analysis for the effect that mutein produces required product
The effect that Corynebacterium glutamicum genetic modification produces required compound (such as amino acid), it can estimate in this way, the microorganism modified is grown by (such as those described above) under appropraite condition, and analyze the culture medium and/or cellular component for increasing required product (for example, amino acid) production.These analytical technologies are well known for skilled ordinary skill, including spectrum analysis, thin-layer chromatography, various colouring methods, enzymatic method and microbial process, it and seem high performance liquid chromatography (Ullman, Encyclopedia of Industrial Chemistry, vol.A2, p.89-90 andp.443-613, VCH:Weinheim (1985);Fallon, A.et al., (1987) " Applications ofHPLC in Biochemistry " in:Laboratory Techniques in Biochemistry and MolecularBiology, vol.17;Rehm et al. (1993) Biotechnology, vol.3, Chapter III: " Productrecovery and purification ", page 469-714, VCH:Weinheim;Belter, P.A.et al. (1988) Bioseparations:downstream processing for biotechnology, John Wiley and Sons;Kennedy, J.F.and Cabral, J.M.S. (1992) Recovery processes for biologicalmaterials, John Wiley and Sons;Shaeiwitz, J.A.and Henry, J.D. (1988) Biochemicalseparations, in:Ulmann ' s Encyclopedia of Industrial Chemistry, vol.B3, Chapter11, page 1-27, VCH:Weinheim;And Dechow, F.J. (1989) Separation and purificationtechniques in biotechnology, Noyes Publications) such analysis chromatography.
In addition to the measurement to final tunning, the other components of the metabolic pathway for required production of chemicals can also be analyzed, such as intermediate and by-product, to determine the production capacity of organism, yield, and/or the production efficiency of compound.Analysis method include nutrient level in culture medium (such as, carbohydrate, hydrocarbon, nitrogen source, phosphoric acid and other ions) measurement, the measurement of biomass composition and growth, the analysis of the production of biosynthesis pathway common metabolic product, and the measurement to gas is generated in fermentation.In Applied MicrobialPhysiology, A Practical Approach, P.M.Rhodes and P.F.Stanbury, eds., IRL Press, p.103-163 the standard method of these measurements outlines;And 165-192 (ISBN:0199635773) and its reference bibliography in.
Embodiment 10: the purifying of required product in Corynebacterium glutamicum culture
Required product is recycled from Corynebacterium glutamicum cell or in the supernatant of above-mentioned culture medium, can be carried out by various methods known in the art.If required product is not that cell is secreted, cell can be collected from culture medium by low-speed centrifugal, with standard technique lytic cell, such as mechanical force or ultrasonic wave.It is centrifuged off cell fragment, retains the supernatant fraction containing soluble protein for required compound to be further purified.If product is secreted from Corynebacterium glutamicum cell, cell is removed from culture medium with low-speed centrifugal, retains supernatant fraction for being further purified.
The supernatant fraction that any purification process obtains is chromatographed with suitable resin, and required molecule is retained by chromatographic resin, and many impurity in sample are not preserved or impurity is retained by resin, and sample is not preserved.Using same or different chromatographic resin, this chromatographic step of repetition can according to need.It is familiar with the suitable chromatographic resin of the selection that ordinary skill can be very skilled, and knows the application most effective for specific molecular to be purified of these resins.The product of purifying can use filtering or ultrafiltration concentration, and be stored at the maximum temperature of product stability.
Purification process known in the art is very more, and purification process above-mentioned is not meant to be limited only to this.The description of these purification process exists, such as in Bailey, J.E.& Ollis, D.F.BiochmicalEngineering Fundamentals, McGraw-Hill:New York (1986).
The characteristic and purity for separating compound, can be estimated with technical standard technique.This includes high performance liquid chromatography (HPLC), light-splitting method, colouring method, thin-layer chromatography, NIRS, enzymatic method or microbial process.These analysis methods have comment in the following documents: Patek et al. (1994) Appl.Environ.Microbiol.60:133-140;Malakhova et al. (1996) Biotekhnologiya 11:27-32;And Schmidt et al. (1998) Bioprocess Engineer.19:67-70.Ulmann ' sEncyclopedia of Industrial Chemistry, (1996) vol.A27, VCH:Weinheim, p.89-90, p.521-540, p.540-547, p.559-566,575-581 and is p.581-587;Michal, G. (1999) Biochemical Pathways:An Atlas of Biochemistry and Molecular Biology, JohnWiley and Sons;Fallon, A.et al. (1987) Applications of HPLC in Biochemistry in:Laboratory Techniques in Biochemistry and Molecular Biology, vol.17.
Embodiment 11: the analysis of gene order of the present invention
Sequence compares the measurement of the percent homology between two sequences, it is technology known in the art, the completion of mathematical operation rule can be used, such as the algorithm in Karlin and Altschul (1990) Proc.Natl.Acad.Sci.USA 87:2264-68, the algorithm have modification in Karlin andAltschul (1993) Proc.Natl.Acad.Sci.USA 90:5873-77.The algorithm is incorporated into Altschul, in NBLAST the and XBLAST program (2.0 editions) in et al. (1990) J.Mol.Biol.215:403-10.BLAST nucleotide searches can be carried out with NBLAST program, score=100, wordlength=12, the available nucleotide sequence with PTS nucleic acid molecule homologous of the present invention.BLAST protein searches can be carried out with XBLAST program, score=50, wordlength=3, the available amino acid sequence with pts protein matter molecule homologous of the present invention.For comparison purposes, in order to obtain the alignment in gap, description can be used in Altschul et al., (1997) Nucleic Acids Res.25 (17): the GappedBLAST in 3389-3402.When using BLAST and Gapped blast program, it is familiar with ordinary skill knows the parameter for how optimizing program (for example, XBLAST and NBLAST) for specific sequence to be analyzed.
Another mathematical operation rule example compared for sequence is Meyers and Miller algorithm ((1998) Comput.Appl.Biosci.4:11-17).The algorithm is incorporated into ALIGN program (2.0 editions), which is a part of GCG sequence nucleotide sequence comparison software packet.When using ALIGN program comparing amino acid sequence, PAM120 weight residue table, gap length punishment 12, gap punishment 4 can be used.Other sequence analytic operation rules are technically also known, including ADVANCE and ADAM, are described in Torelli and Robotti (1994) Comput.Appl.Biosci.10:3-5;And FASTA, it describes in Pearson and Lipman (1998) P.N.A.S.85:2444-8.
The realization of the GAP program in GCG software package (http://www.gcg.com is provided with) also can be used in Percent homology between two amino acid sequences, use 250 matrix of 62 matrix of Blosum or PAM, the perhaps 4 length component 2,3 or 4 of gap component 12,10,8,6.The realization of the GAP program in GCG software package can be used in Percent homology between two nucleic acid sequences, uses standard parameter, such as gap component 50 and length component 3.
Comparative analysis in gene order of the present invention and Genbank between sequence, can be used technology known in the art carry out (referring to, such as, Bexevanis and Ouellette, eds. (1998) Bioinformatics:A Practical Guide to the Analysis of Genes and Proteins.John Wiley and Sons:New York).Gene order of the present invention is compared by the method for three steps with the sequence in Genbank.In the first step, BLASTN analysis (for example, local sequence comparative analysis) is carried out with respect to the nucleotide sequence in Genbank to each sequence of the invention, retains highest 500 matchings and is further analysed.Then FASTA is made to this 500 matchings and searches (for example, local and global composite sequence comparative analysis, is wherein carrying out alignment to the sequence area of restriction).Next, matching to every gene order of the invention with three highests of FASTA, whole world alignment is carried out using the GAP program (using standard parameter) in GCG software package.Correct result in order to obtain, the sequence length selected from Genbank are adjusted to the length of search sequence using technical well known method.The result of the analysis is listed in Table 4.Although the result obtained in this way, obtained result is analyzed with the independent GAP (whole world) carried out is compareed relative to Genbank every to every gene of the invention, it is consistent, but for the GAP of large database concept (whole world) analysis, the required calculating time greatly reduces.The sequence of the present invention for not obtaining the above alignment of cutoff value shows to lack alignment's information in table 4.Being familiar with ordinary skill further can understand, GAP alignment's percent homology under the title " %homology (GPA) " listed in table 4, is to be listed with Digital European format, wherein ', ' represents decimal system point.For example, " 40,345 " represent " 40.345% " to the value in the column.
The building and operation of embodiment 12:DNA microarray
Sequence of the invention can be also used for DNA microarray and (known to the design of DNA array, methods and applications are technically, describe for example, Schena, M.te al. (1995) Science 270:467-470;Wodicka, L.et al. (1997) Nature Biotechnology 15:1359-1367;DeSaizieu, A.et al. (1998) Nature Biotechnology 16:45-48;And DeRisi, J.L.et al. (1997) Science 278:680-686) building and application.
Using solid, perhaps flexible support includes nitrocellulose, nylon, glass, silicon or other materials to DNA microarray.Nucleic acid molecules can be connected to surface in an orderly way.After suitable marker, other nucleic acid or mixtures of nucleic acids can be with fixed making nucleic acid molecular hybridizations, and marking can be used for the individual signal strength that monitoring and measurement determines region hybrid molecule.The opposite or absolute quantity for the whole or selected nucleic acid in nucleic acid samples or mixture that this method allows simultaneous quantitative applicable.Therefore, DNA microarray allows the analysis of a variety of (up to 6800 or more) similar expression of nucleic acid (see, for example, Schena, M. (1996) BioEssays 18 (5): 427-431).
Sequence of the present invention can be used for designing oligonucleotide primer, these primers can expand the determination region of one or more of Corynebacterium glutamicum genes by the nucleic acid amplification reaction as polymerase chain reaction.The selection and design of 5 ' or 3 ' oligonucleotide primers or suitable linker, the surface that the PCR product allowed is covalently attached to above-mentioned supporting dielectric (is also described in, for example, Schena, M.et al. (1995) Science 270:467-470).
Nucleic acid microarray can also be by such as in Wodicka, the synthesis building of original position oligonucleotide described in L.et al. (1997) NatureBiotechnology 15:1359-1367.By photolithography method, region exactly determined in matrix can be exposed in light.Blocking group is photo-labile, to be activated and add through subject nucleotide, but is covered up and can not see the region of light without any modification.Next protection and photoactivation circulation, allow in the synthesis for determining position difference oligonucleotide.Present invention determine that zonule can be synthesized on the micro-array by solid phase oligonucleotide.
The nucleic acid molecules of the present invention in sample or mixture of ribonucleotides are appeared in, it can be with microarray hybridization.These nucleic acid molecules can be marked according to standard method.Briefly, nucleic acid molecules (for example, mRNA molecule or DNA molecular) can be labeled for example, in reverse transcription or DNA synthesis and in conjunction with the isotope perhaps nucleotide of fluorescent marker.Labeling nucleic acid was described (such as in Schena, M.et al. (1995) supra with hybridizing for microarray;Wodicka, L.et al. (1997), supra;In and DeSaizieu A.et al. (1998), supra).The detection of hybrid molecule and to be quantitatively suitble to specific binding marker.Radioactive label can be detected, for example, described in M.at al. (1995) supra, fluorescent marker can also be detected, such as use the method for Shalon etal. (1996) Gemone Research 6:639-645 in Schena.
As described above, application of the sequence of the present invention in DNA microarray, allows the comparative analysis of different Corynebacterium glutamicum strain or other bar bacteriums.For example, the research changed in the bacterial strains based on individual transcription distribution diagrams can be promoted by nucleic acid array methodologies, and promote to it is specific and/or required seem the important gene of strain characteristics as pathogenic, production capacity and pressure tolerance identification.Equally, using nucleic acid array technology, the distribution diagram of gene expression of the present invention during fermentation reaction can also be compared.
Embodiment 13: the analysis (proteomics) of cell protein group dynamics
Gene, composition and method of the invention can be used for studying the interaction and dynamics of protein population, referred to as " proteomics ".Interested protein population includes, but it is not limited to, Corynebacterium glutamicum all protein group (such as, it compares up with the protein population of other organisms), under particular surroundings or metabolic conditions (such as, medium and high temperature of fermenting perhaps low temperature or high pH or low pH) active those protein or in those active protein of particular growth or stage of development.
Protein population, such as gel electrophoresis can be analyzed with various well known technologies.Cell protein can also can be used various electrophoretic techniques and be separated from each other for example, by cracking or extracting acquisition.Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) protein isolate matter, is based largely on their molecular wt.Isoelectric focusing polyacrylamide gel electrophoresis (IEF-PAGE) passes through equal point (this not only reflects amino acid sequence, but also has shown the posttranslational modification of protein) protein isolate matter.Another more preferred protein analysis method is that the continuous combination of IEF-PAGE and SDS-PAGE, referred to as 2-D- gel electrophoresis are (in such as Hermann et al. (1998) Electrophoresis 19:3217-3221;Fountoulakis et al. (1998) Electrophoresis 19:1193-1202;Langen et al. (1997) Electrophoresis 18:1184-1192;It is described in Antelmann et al. (1997) Electrophoresis18:1451-1463).
It can be shown by standard technique with the protein that these methods separate, such as by dyeing or marking.Suitably dyeing is technically known, including Coomassie brilliant blue, silver staining or fluorescent dye, such as Sypro Ruby (Molecular Probes).Include in Corynebacterium glutamicum culture medium radiolabeled amino acid or other protein precursors (for example,35S- methionine,35S- cysteine,14C- labeled amino acid,15N- amino acid,15NO3Or15NH4 +Or13C- labeled amino acid), it can make these cells before its Separation of Proteins with regard to labelled protein.Similar, fluorescent marker also can be used.These labelled proteins can be extracted, are isolated and separated according to aforementioned techniques.
The protein shown with these technologies can be further analysed by measuring dyestuff or label used.Such as optical means can be used in the quantity of specific protein, is quantitatively determined, and can be compared with the quantity of other protein on same gel or on other gels.Can compare for example, by optics, spectrum analysis, gel images analysis and scanning, either by using photographic film or display, the protein on gel is compared.What these technologies were well known.
In order to determine the characteristic of specific protein, direct sequence measurement or other standards technology can be used.Such as, the sequencing of N- and/or C- end amino acid (such as Edman degradation) can be used, and mass spectral analysis (especially MALDI ESI technology (see, for example, Langen et al. (1997) Electrophoresis 18:1184-1192)).Protein sequence provided herein may be used as the Corynebacterium glutamicum protein identification carried out by these technologies.
The information obtained by these technologies, it can be used for the various modes of the different sample rooms modifications (for example, different organisms, fermentation time point, culture medium condition or biotic environment in other conditions) under comparison protein presence, activity, different biotic factors.The data that these tests obtain, it can be individual, or what is combined with other technologies is used for various applications, such as compare under specific condition the behavior of (such as metabolic condition) various organisms, increase the production capacity of the bacterial strain of production fine chemical, or increases the efficiency of fine chemical production.
Equivalents
Being familiar with ordinary skill will recognize, or can determine and routine experiment is only used only, and specific embodiment of the invention described herein has many equivalents.Following claim is intended to encompass these equivalents.
Sequence table
<110>BASF AG (BASF Aktiengesellschaft)
<120>Orynebacterium: the Corynebacterium glutamicum gene of sugar phosphotransferase system albumen
<130>BGI-122CPPC
<140>PCT/IB00/00973
<141>2000-06-27
<150>US 60/142,691
<151>1999-07-01
<150>US 60/150,310
<151>1999-08-23
<150>DE 19942095.5
<151>1999-09-03
<150>DE 19942097.1
<151>1999-09-03
<160>36
<210>1
<211>1527
<212>DNA
<213>Corynebacterium glutamicum (Corynebacterium glutamicum)
<220>
<221>CDS
<222>(101)..(1504)
<223>RXS00315
<400>1
ctcatggcat ctgcgccgtt cgcgttcttg ccagtgttgg ttggtttcac cgcaaccaag 60
cgtttcggcg gcaatgagtt cctgggcgcc gcgtattggt atg gcg atg gtg ttc 115
Met Ala Met Val Phe
1 5
ccg agc ttg gtg aac ggc tac gac gtg gcc gcc acc atg gct gcg ggc 163
Pro Ser Leu Val Asn Gly Tyr Asp Val Ala Ala Thr Met Ala Ala Gly
10 15 20
gaa atg cca atg tgg tcc ctg ttt ggt tta gat gtt gcc caa gcc ggt 211
Glu Met Pro Met Trp Ser Leu Phe Gly Leu Asp Val Ala Gln Ala Gly
25 30 35
tac cag ggc acc gtg ctt cct gtg ctg gtg gtt tct tgg att ctg gca 259
Tyr Gln Gly Thr Val Leu Pro Val Leu Val Val Ser Trp Ile Leu Ala
40 45 50
acg atc gag aag ttc ctg cac aag cga ctc aag ggc act gca gac ttc 307
Thr Ile Glu Lys Phe Leu His Lys Arg Leu Lys Gly Thr Ala Asp Phe
55 60 65
ctg atc act cca gtg ctg acg ttg ctg ctc acc gga ttc ctt aca ttc 355
Leu Ile Thr Pro Val Leu Thr Leu Leu Leu Thr Gly Phe Leu Thr Phe
70 75 80 85
atc gcc att ggc cca gca atg cgc tgg gtg ggc gat gtg ctg gca cac 403
Ile Ala Ile Gly Pro Ala Met Arg Trp Val Gly Asp Val Leu Ala His
90 95 100
ggt cta cag gga ctt tat gat ttc ggt ggt cca gtc ggc ggt ctg ctc 451
Gly Leu Gln Gly Leu Tyr Asp Phe Gly Gly Pro Val Gly Gly Leu Leu
105 110 115
ttc ggt ctg gtc tac tca cca atc gtc atc act ggt ctg cac cag tcc 499
Phe Gly Leu Val Tyr Ser Pro Ile Val Ile Thr Gly Leu His Gln Ser
120 125 130
ttc ccg cca att gag ctg gag ctg ttt aac cag ggt gga tcc ttc atc 547
Phe Pro Pro Ile Glu Leu Glu Leu Phe Asn Gln Gly Gly Ser Phe Ile
135 140 145
ttc gca acg gca tct atg gct aat atc gcc cag ggt gcg gca tgt ttg 595
Phe Ala Thr Ala Ser Met Ala Asn Ile Ala Gln Gly Ala Ala Cys Leu
150 155 160 165
gca gtg ttc ttc ctg gcg aag agt gaa aag ctc aag ggc ctt gca ggt 643
Ala Val Phe Phe Leu Ala Lys Ser Glu Lys Leu Lys Gly Leu Ala Gly
170 175 180
gct tca ggt gtc tcc gct gtt ctt ggt att acg gag cct gcg atc ttc 691
Ala Ser Gly Val Ser Ala Val Leu Gly Ile Thr Glu Pro Ala Ile Phe
185 190 195
ggt gtg aac ctt cgc ctg cgc tgg ccg ttc ttc atc ggt atc ggt acc 739
Gly Val Asn Leu Arg Leu Arg Trp Pro Phe Phe Ile Gly Ile Gly Thr
200 205 210
gca gct atc ggt ggc gct ttg att gca ctc ttt aat atc aag gca gtt 787
Ala Ala Ile Gly Gly Ala Leu Ile Ala Leu Phe Asn Ile Lys Ala Val
215 220 225
gcg ttg ggc gct gca ggt ttc ttg ggt gtt gtt tct att gat gct cca 835
Ala Leu Gly Ala Ala Gly Phe Leu Gly Val Val Ser Ile Asp Ala Pro
230 235 240 245
gat atg gtc atg ttc ttg gtg tgt gca gtt gtt acc ttc ttc atc gca 883
Asp Met Val Met Phe Leu Val Cys Ala Val Val Thr Phe Phe Ile Ala
250 255 260
ttc ggc gca gcg att gct tat ggc ctt tac ttg gtt cgc cgc aac ggc 931
Phe Gly Ala Ala Ile Ala Tyr Gly Leu Tyr Leu Val Arg Arg Asn Gly
265 270 275
agc att gat cca gat gca acc gct gct cca gtg cct gca gga acg acc 979
Ser Ile Asp Pro Asp Ala Thr Ala Ala Pro Val Pro Ala Gly Thr Thr
280 285 290
aaa gcc gaa gca gaa gca ccc gca gaa ttt tca aac gat tcc acc atc 1027
Lys Ala Glu Ala Glu Ala Pro Ala Glu Phe Ser Asn Asp Ser Thr Ile
295 300 305
atc cag gca cct ttg acc ggt gaa gct att gca ctg agc agc gtc agc 1075
Ile Gln Ala Pro Leu Thr Gly Glu Ala Ile Ala Leu Ser Ser Val Ser
310 315 320 325
gat gcc atg ttt gcc agc gga aag ctt ggc tcg ggc gtt gcc atc gtc 1123
Asp Ala Met Phe Ala Ser Gly Lys Leu Gly Ser Gly Val Ala Ile Val
330 335 340
cca acc aag ggg cag tta gtt tct ccg gtg agt gga aag att gtg gtg 1171
Pro Thr Lys Gly Gln Leu Val Ser Pro Val Ser Gly Lys Ile Val Val
345 350 355
gca ttc cca tct ggc cat gct ttc gca gtt cgc acc aag gct gag gat 1219
Ala Phe Pro Ser Gly His Ala Phe Ala Val Arg Thr Lys Ala Glu Asp
360 365 370
ggt tcc aat gtg gat atc ttg atg cac att ggt ttc gac aca gta aac 1267
Gly Ser Asn Val Asp Ile Leu Met His Ile Gly Phe Asp Thr Val Asn
375 380 385
ctc aac ggc acg cac ttt aac ccg ctg aag aag cag ggc gat gaa gtc 1315
Leu Asn Gly Thr His Phe Asn Pro Leu Lys Lys Gln Gly Asp Glu Val
390 395 400 405
aaa gca ggg gag ctg ctg tgt gaa ttc gat att gat gcc att aag gct 1363
Lys Ala Gly Glu Leu Leu Cys Glu Phe Asp Ile Asp Ala Ile Lys Ala
410 415 420
gca ggt tat gag gta acc acg ccg att gtt gtt tcg aat tac aag aaa 1411
Ala Gly Tyr Glu Val Thr Thr Pro Ile Val Val Ser Asn Tyr Lys Lys
425 430 435
acc gga cct gta aac act tac ggt ttg ggc gaa att gaa gcg gga gcc 1459
Thr Gly Pro Val Asn Thr Tyr Gly Leu Gly Glu Ile Glu Ala Gly Ala
440 445 450
aac ctg ctc aac gtc gca aag aaa gaa gcg gtg cca gca aca cca 1504
Asn Leu Leu Asn Val Ala Lys Lys Glu Ala Val Pro Ala Thr Pro
455 460 465
taagttgaaa ccttgagtgt tcg 1527
<210>2
<211>468
<212>PRT
<213>Corynebacterium glutamicum (Corynebacterium glutamicum)
<400>2
Met Ala Met Val Phe Pro Ser Leu Val Asn Gly Tyr Asp Val Ala Ala
1 5 10 15
Thr Met Ala Ala Gly Glu Met Pro Met Trp Ser Leu Phe Gly Leu Asp
20 25 30
Val Ala Gln Ala Gly Tyr Gln Gly Thr Val Leu Pro Val Leu Val Val
35 40 45
Ser Trp Ile Leu Ala Thr Ile Glu Lys Phe Leu His Lys Arg Leu Lys
50 55 60
Gly Thr Ala Asp Phe Leu Ile Thr Pro Val Leu Thr Leu Leu Leu Thr
65 70 75 80
Gly Phe Leu Thr Phe Ile Ala Ile Gly Pro Ala Met Arg Trp Val Gly
85 90 95
Asp Val Leu Ala His Gly Leu Gln Gly Leu Tyr Asp Phe Gly Gly Pro
100 105 110
Val Gly Gly Leu Leu Phe Gly Leu Val Tyr Ser Pro Ile Val Ile Thr
115 120 125
Gly Leu His Gln Ser Phe Pro Pro Ile Glu Leu Glu Leu Phe Asn Gln
130 135 140
Gly Gly Ser Phe Ile Phe Ala Thr Ala Ser Met Ala Asn Ile Ala Gln
145 150 155 160
Gly Ala Ala Cys Leu Ala Val Phe Phe Leu Ala Lys Ser Glu Lys Leu
165 170 175
Lys Gly Leu Ala Gly Ala Ser Gly Val Ser Ala Val Leu Gly Ile Thr
180 185 190
Glu Pro Ala Ile Phe Gly Val Asn Leu Arg Leu Arg Trp Pro Phe Phe
195 200 205
Ile Gly Ile Gly Thr Ala Ala Ile Gly Gly Ala Leu Ile Ala Leu Phe
210 215 220
Asn Ile Lys Ala Val Ala Leu Gly Ala Ala Gly Phe Leu Gly Val Val
225 230 235 240
Ser Ile Asp Ala Pro Asp Met Val Met Phe Leu Val Cys Ala Val Val
245 250 255
Thr Phe Phe Ile Ala Phe Gly Ala Ala Ile Ala Tyr Gly Leu Tyr Leu
260 265 270
Val Arg Arg Asn Gly Ser Ile Asp Pro Asp Ala Thr Ala Ala Pro Val
275 280 285
Pro Ala Gly Thr Thr Lys Ala Glu Ala Glu Ala Pro Ala Glu Phe Ser
290 295 300
Asn Asp Ser Thr Ile Ile Gln Ala Pro Leu Thr Gly Glu Ala Ile Ala
305 310 315 320
Leu Ser Ser Val Ser Asp Ala Met Phe Ala Ser Gly Lys Leu Gly Ser
325 330 335
Gly Val Ala Ile Val Pro Thr Lys Gly Gln Leu Val Ser Pro Val Ser
340 345 350
Gly Lys Ile Val Val Ala Phe Pro Ser Gly His Ala Phe Ala Val Arg
355 360 365
Thr Lys Ala Glu Asp Gly Ser Asn Val Asp Ile Leu Met His Ile Gly
370 375 380
Phe Asp Thr Val Asn Leu Asn Gly Thr His Phe Asn Pro Leu Lys Lys
385 390 395 400
Gln Gly Asp Glu Val Lys Ala Gly Glu Leu Leu Cys Glu Phe Asp Ile
405 410 415
Asp Ala Ile Lys Ala Ala Gly Tyr Glu Val Thr Thr Pro Ile Val Val
420 425 430
Ser Asn Tyr Lys Lys Thr Gly Pro Val Asn Thr Tyr Gly Leu Gly Glu
435 440 445
Ile Glu Ala Gly Ala Asn Leu Leu Asn Val Ala Lys Lys Glu Ala Val
450 455 460
Pro Ala Thr Pro
465
<210>3
<211>1109
<212>DNA
<213>Corynebacterium glutamicum (Corynebacterium glutamicum)
<220>
<221>CDS
<222>(1)..(1086)
<223>FRXA00315
<400>3
tat gat ttc ggc ggt cca gtc ggc ggt ctg ctc ttc ggt ctg gtc tac 48
Tyr Asp Phe Gly Gly Pro Val Gly Gly Leu Leu Phe Gly Leu Val Tyr
1 5 10 15
tca cca atc gtc atc act ggt ctg cac cag tcc ttc ccg cca att gag 96
Ser Pro Ile Val Ile Thr Gly Leu His Gln Ser Phe Pro Pro Ile Glu
20 25 30
ctg gag ctg ttt aac cag ggt gga tcc ttc atc rtc gca acg gca tct 144
Leu Glu Leu Phe Asn Gln Gly Gly Ser Phe Ile Phe Ala Thr Ala Ser
35 40 45
atg gct aat atc gcc cag ggt gcg gca tgt ttg gca gtg ttc ttc ctg 192
Met Ala Asn Ile Ala Gln Gly Ala Ala Cys Leu Ala Val Phe Phe Leu
50 55 60
gcg aag agt gaa aag ctc aag ggc ctt gca ggt gct tca ggt gtc tcc 240
Ala Lys Ser Glu Lys Leu Lys Gly Leu Ala Gly Ala Ser Gly Val Ser
65 70 75 80
gct gtt ctt ggt att acg gag cct gcg atc ttc ggt gtg aac ctt cgc 288
Ala Val Leu Gly Ile Thr Glu Pro Ala Ile Phe Gly Val Asn Leu Arg
85 90 95
ctg cgc tgg ccg ttc ttc atc ggt atc ggt acc gca gct atc ggt ggc 336
Leu Arg Trp Pro Phe Phe Ile Gly Ile Gly Thr Ala Ala Ile Gly Gly
100 105 110
gct ttg att gca ctc ttt aat atc aag gca gtt gcg ttg ggc gct gca 384
Ala Leu Ile Ala Leu Phe Asn Ile Lys Ala Val Ala Leu Gly Ala Ala
115 120 125
ggt ttc ttg ggt gtt gtt tct att gat gct cca gat atg gtc atg ttc 432
Gly Phe Leu Gly Val Val Ser Ile Asp Ala Pro Asp Met Val Met Phe
130 135 140
ttg gtg tgt gca gtt gtt acc ttc ttc atc gca ttc ggc gca gcg att 480
Leu Val Cys Ala Val Val Thr Phe Phe Ile Ala Phe Gly Ala Ala Ile
145 150 155 160
gct tat ggc ctt tac ttg gtt cgc cgc aac ggc agc att gat cca gat 528
Ala Tyr Gly Leu Tyr Leu Val Arg Arg Asn Gly Ser Ile Asp Pro Asp
165 170 175
gca acc gct gct cca gtg cct gca gga acg acc aaa gcc gaa gca gaa 576
Ala Thr Ala Ala Pro Val Pro Ala Gly Thr Thr Lys Ala Glu Ala Glu
180 185 190
gca ccc gca gaa ttt tca aac gat tcc acc atc atc cag gca cct ttg 624
Ala Pro Ala Glu Phe Ser Asn Asp Ser Thr Ile Ile Gln Ala Pro Leu
195 200 205
acc ggt gaa gct att gca ctg agc agc gtc agc gat gcc atg ttt gcc 672
Thr Gly Glu Ala Ile Ala Leu Ser Ser Val Ser Asp Ala Met Phe Ala
210 215 220
agc gga aag ctt ggc tcg ggc gtt gcc atc gtc cca acc aag ggg cag 720
Ser Gly Lys Leu Gly Ser Gly Val Ala Ile Val Pro Thr Lys Gly Gln
225 230 235 240
tta gtt tct ccg gtg agt gga aag att gtg gtg gca ttc cca tct ggc 768
Leu Val Ser Pro Val Ser Gly Lys Ile Val Val Ala Phe Pro Ser Gly
245 250 255
cat gct ttc gca gtt cgc acc aag gct gag gat ggt tcc aat gtg gat 816
His Ala Phe Ala Val Arg Thr Lys Ala Glu Asp Gly Ser Asn Val Asp
260 265 270
atc ttg atg cac att ggt ttc gac aca gta aac ctc aac ggc acg cac 864
Ile Leu Met His Ile Gly Phe Asp Thr Val Asn Leu Asn Gly Thr His
275 280 285
ttt aac ccg ctg aag aag cag ggc gat gaa gtc aaa gca ggg gag ctg 912
Phe Asn Pro Leu Lys Lys Gln Gly Asp Glu Val Lys Ala Gly Glu Leu
290 295 300
ctg tgt gaa ttc gat att gat gcc att aag gct gca ggt tat gag gta 960
Leu Cys Glu Phe Asp Ile Asp Ala Ile Lys Ala Ala Gly Tyr Glu Val
305 310 315 320
acc acg ccg att gtt gtt tcg aat tac aag aaa acc gga cct gta aac 1008
Thr Thr Pro Ile Val Val Ser Asn Tyr Lys Lys Thr Gly Pro Val Asn
325 330 335
act tac ggt ttg ggc gaa att gaa gcg gga gcc aac ctg ctc aac gtc 1056
Thr Tyr Gly Leu Gly Glu Ile Glu Ala Gly Ala Asn Leu Leu Asn Val
340 345 350
gca aag aaa gaa gcg gtg cca gca aca cca taagttgaaa ccttgagtgt 1106
Ala Lys Lys Glu Ala Val Pro Ala Thr Pro
355 360
tcg 1109
<210>4
<211>362
<212>PRT
<213>Corynebacterium glutamicum (Corynebacterium glutamicum)
<400>4
Tyr Asp Phe Gly Gly Pro Val Gly Gly Leu Leu Phe Gly Leu Val Tyr
1 5 10 15
Ser Pro Ile Val Ile Thr Gly Leu His Gln Ser Phe Pro Pro Ile Glu
20 25 30
Leu Glu Leu Phe Asn Gln Gly Gly Ser Phe Ile Phe Ala Thr Ala Ser
35 40 45
Met Ala Asn Ile Ala Gln Gly Ala Ala Cys Leu Ala Val Phe Phe Leu
50 55 60
Ala Lys Ser Glu Lys Leu Lys Gly Leu Ala Gly Ala Ser Gly Val Ser
65 70 75 80
Ala Val Leu Gly Ile Thr Glu Pro Ala Ile Phe Gly Val Asn Leu Arg
85 90 95
Leu Arg Trp Pro Phe Phe Ile Gly Ile Gly Thr Ala Ala Ile Gly Gly
100 105 110
Ala Leu Ile Ala Leu Phe Asn Ile Lys Ala Val Ala Leu Gly Ala Ala
115 120 125
Gly Phe Leu Gly Val Val Ser Ile Asp Ala Pro Asp Met Val Met Phe
130 135 140
Leu Val Cys Ala Val Val Thr Phe Phe Ile Ala Phe Gly Ala Ala Ile
145 150 155 160
Ala Tyr Gly Leu Tyr Leu Val Arg Arg Asn Gly Ser Ile Asp Pro Asp
165 170 175
Ala Thr Ala Ala Pro Val Pro Ala Gly Thr Thr Lys Ala Glu Ala Glu
180 185 190
Ala Pro Ala Glu Phe Ser Asn Asp Ser Thr Ile Ile Gln Ala Pro Leu
195 200 205
Thr Gly Glu Ala Ile Ala Leu Ser Ser Val Ser Asp Ala Met Phe Ala
210 215 220
Ser Gly Lys Leu Gly Ser Gly Val Ala Ile Val Pro Thr Lys Gly Gln
225 230 235 240
Leu Val Ser Pro Val Ser Gly Lys Ile Val Val Ala Phe Pro Ser Gly
245 250 255
His Ala Phe Ala Val Arg Thr Lys Ala Glu Asp Gly Ser Asn Val Asp
260 265 270
Ile Leu Met His Ile Gly Phe Asp Thr Val Asn Leu Asn Gly Thr His
275 280 285
Phe Asn Pro Leu Lys Lys Gln Gly Asp Glu Val Lys Ala Gly Glu Leu
290 295 300
Leu Cys Glu Phe Asp Ile Asp Ala Ile Lys Ala Ala Gly Tyr Glu Val
305 310 315 320
Thr Thr Pro Ile Val Val Ser Asn Tyr Lys Lys Thr Gly Pro Val Asn
325 330 335
Thr Tyr Gly Leu Gly Glu Ile Glu Ala Gly Ala Asn Leu Leu Asn Val
340 345 350
Ala Lys Lys Glu Ala Val Pro Ala Thr Pro
355 360
<210>5
<211>372
<212>DNA
<213>Corynebacterium glutamicum (Corynebacterium glutamicum)
<220>
<221>CDS
<222>(101)..(349)
<223>RXA01503
<400>5
gtatcctcaa aggccttcta gctgttgcag ctgcagcgca ctcggtggat acgacatcca 60
cgacctatca aattctttat gctgcaggcg atgccttttc atg ttc ttg gca gtc 115
Met Phe Leu Ala Val
1 5
att ttg gcg att act gcg gct cgt aaa ttc ggt gcc aat gtc ttt aca 163
Ile Leu Ala Ile Thr Ala Ala Arg Lys Phe Gly Ala Asn Val Phe Thr
10 15 20
tca gtc gca ctc gct ggt gca ttg ctg cac aca cag ctt cag gca gta 211
Ser Val Ala Leu Ala Gly Ala Leu Leu His Thr Gln Leu Gln Ala Val
25 30 35
acc gtg ttg gtt gac ggt gaa ctc cag tcg atg act ctg gtg gct ttc 259
Thr Val Leu Val Asp Gly Glu Leu Gln Ser Met Thr Leu Val Ala Phe
40 45 50
caa aag gct ggt aat gac gtc acc ttc ctg ggc att cca gtg gtg ctg 307
Gln Lys Ala Gly Asn Asp Val Thr Phe Leu Gly Ile Pro Val Val Leu
55 60 65
cag ttg gcg ttg cat gta gcg agt ttg atg aag ttg tcg cga 349
Gln Leu Ala Leu His Val Ala Ser Leu Met Lys Leu Ser Arg
70 75 80
taagaggagg ggcgtgtcgg tct 372
<210>6
<211>83
<212>PRT
<213>Corynebacterium glutamicum (Corynebacterium glutamicum)
<400>6
Met Phe Leu Ala Val Ile Leu Ala Ile Thr Ala Ala Arg Lys Phe Gly
1 5 10 15
Ala Asn Val Phe Thr Ser Val Ala Leu Ala Gly Ala Leu Leu His Thr
20 25 30
Gln Leu Gln Ala Val Thr Val Leu Val Asp Gly Glu Leu Gln Ser Met
35 40 45
Thr Leu Val Ala Phe Gln Lys Ala Gly Asn Asp Val Thr Phe Leu Gly
50 55 60
Ile Pro Val Val Leu Gln Leu Ala Leu His Val Ala Ser Leu Met Lys
65 70 75 80
Leu Ser Arg
<210>7
<211>2187
<212>DNA
<213>Corynebacterium glutamicum (Corynebacterium glutamicum)
<220>
<221>CDS
<222>(101)..(2164)
<223>RXN01299
<400>7
cgactgcggc gtctcttcct ggcactacca ttcctcgtcc tgaccaactc gccacagctg 60
gtgcaacggt cacccaagtc aaaggattga aagaatcagc atg aat agc gta aat 115
Met Asn Ser Val Asn
1 5
aat tcc tcg ctt gtc cgg ctg gat gtc gat ttc ggc gac tcc acc acg 163
Asn Ser Ser Leu Val Arg Leu Asp Val Asp Phe Gly Asp Ser Thr Thr
10 15 20
gat gtc atc aac aac ctt gcc act gtt att ttc gac gct ggc cga gct 211
Asp Val Ile Asn Asn Leu Ala Thr Val Ile Phe Asp Ala Gly Arg Ala
25 30 35
tcc tcc gcc gac gcc ctt gcc aaa gac gcg ctg gat cgt gaa gca aag 259
Ser Ser Ala Asp Ala Leu Ala Lys Asp Ala Leu Asp Arg Glu Ala Lys
40 45 50
tcc ggc acc ggc gtt cct ggt caa gtt gct atc ccc cac tgc cgt tcc 307
Ser Gly Thr Gly Val Pro Gly Gln Val Ala Ile Pro His Cys Arg Ser
55 60 65
gaa gcc gta tct gtc cct acc ttg ggc ttt gct cgc ctg agc aag ggt 355
Glu Ala Val Ser Val Pro Thr Leu Gly Phe Ala Arg Leu Ser Lys Gly
70 75 80 85
gtg gac ttc agc gga cct gat ggc gat gcc aac ttg gtg ttc ctc att 403
Val Asp Phe Ser Gly Pro Asp Gly Asp Ala Asn Leu Val Phe Leu Ile
90 95 100
gca gca cct gct ggc ggc ggc aaa gag cac ctg aag atc ctg tcc aag 451
Ala Ala Pro Ala Gly Gly Gly Lys Glu His Leu Lys Ile Leu Ser Lys
105 110 115
ctt gct cgc tcc ttg gtg aag aag gat ttc atc aag gct ctg cag gaa 499
Leu Ala Arg Ser Leu Val Lys Lys Asp Phe Ile Lys Ala Leu Gln Glu
120 125 130
gcc acc acc gag cag gaa atc gtc gac gtt gtc gat gcc gtg ctc aac 547
Ala Thr Thr Glu Gln Glu Ile Val Asp Val Val Asp Ala Val Leu Asn
135 140 145
cca gca cca aaa acc acc gag cca gct gca gct ccg gct gcg gcg gcg 595
Pro Ala Pro Lys Thr Thr Glu Pro Ala Ala Ala Pro Ala Ala Ala Ala
150 155 160 165
gtt gct gag agt ggg gcg gcg tcg aca agc gtt act cgt atc gtg gca 643
Val Ala Glu Ser Gly Ala Ala Ser Thr Ser Val Thr Arg Ile Val Ala
170 175 180
atc acc gca tgc cca acc ggt atc gca cac acc tac atg gct gcg gat 691
Ile Thr Ala Cys Pro Thr Gly Ile Ala His Thr Tyr Met Ala Ala Asp
185 190 195
tcc ctg acg caa aac gcg gaa ggc cgc gat gat gtg gaa ctc gtt gtg 739
Ser Leu Thr Gln Asn Ala Glu Gly Arg Asp Asp Val Glu Leu Val Val
200 205 210
gag act cag ggc tct tcc gct gtc acc cca gtc gat ccg aag atc atc 787
Glu Thr Gln Gly Ser Ser Ala Val Thr Pro Val Asp Pro Lys Ile Ile
215 220 225
gaa gct gcc gac gcc gtc atc ttc gcc acc gac gtg gga gtt aaa gac 835
Glu Ala Ala Asp Ala Val Ile Phe Ala Thr Asp Val Gly Val Lys Asp
230 235 240 245
cgc gag cgt ttc gct ggc aag cca gtc att gaa tcc ggc gtc aag cgc 883
Arg Glu Arg Phe Ala Gly Lys Pro Val Ile Glu Ser Gly Val Lys Arg
250 255 260
gcg atc aat gag cca gcc aag atg atc gac gag gcc atc gca gcc tcc 931
Ala Ile Asn Glu Pro Ala Lys Met Ile Asp Glu Ala Ile Ala Ala Ser
265 270 275
aag aac cca aac gcc cgc aag gtt tcc ggt tcc ggt gtc gcg gca tct 979
Lys Asn Pro Asn Ala Arg Lys Val Ser Gly Ser Gly Val Ala Ala Ser
280 285 290
gct gaa acc acc ggc gag aag ctc ggc tgg ggc aag cgc atc cag cag 1027
Ala Glu Thr Thr Gly Glu Lys Leu Gly Trp Gly Lys Arg Ile Gln Gln
295 300 305
gca gtc atg acc ggc gtg tcc tac atg gtt cca ttc gta gct gcc ggc 1075
Ala Val Met Thr Gly Val Ser Tyr Met Val Pro Phe Val Ala Ala Gly
310 315 320 325
ggc ctc ctg ttg gct ctc ggc ttc gca ttc ggt gga tac gac atg gcg 1123
Gly Leu Leu Leu Ala Leu Gly Phe Ala Phe Gly Gly Tyr Asp Met Ala
330 335 340
aac ggc tgg caa gca atc gcc acc cag ttc tct ctg acc aac ctg cca 1171
Asn Gly Trp Gln Ala Ile Ala Thr Gln Phe Ser Leu Thr Asn Leu Pro
345 350 355
ggc aac acc gtc gat gtt gac ggc gtg gcc atg acc ttc gag cgt tca 1219
Gly Asn Thr Val Asp Val Asp Gly Val Ala Met Thr Phe Glu Arg Ser
360 365 370
ggc ttc ctg ttg tac ttc ggc gca gtc ctg ttc gcc acc ggc caa gca 1267
Gly Phe Leu Leu Tyr Phe Gly Ala Val Leu Phe Ala Thr Gly Gln Ala
375 380 385
gcc atg ggc ttc atc gtg gca gcc ctg tct ggc tac acc gca tac gca 1315
Ala Met Gly Phe Ile Val Ala Ala Leu Ser Gly Tyr Thr Ala Tyr Ala
390 395 400 405
ctt gct gga cgc cca ggc atc gcg ccg ggc ttc gtc ggt ggc gcc atc 1363
Leu Ala Gly Arg Pro Gly Ile Ala Pro Gly Phe Val Gly Gly Ala Ile
410 415 420
tcc gtc acc atc ggc gct ggc ttc att ggt ggt ctg gtt acc ggt atc 1411
Ser Val Thr Ile Gly Ala Gly Phe Ile Gly Gly Leu Val Thr Gly Ile
425 430 435
ttg gct ggt ctc att gcc ctg tgg att ggc tcc tgg aag gtg cca cgc 1459
Leu Ala Gly Leu Ile Ala Leu Trp Ile Gly Ser Trp Lys Val Pro Arg
440 445 450
gtg gtg cag tca ctg atg cct gtg gtc atc atc ccg cta ctt acc tca 1507
Val Val Gln Ser Leu Met Pro Val Val Ile Ile Pro Leu Leu Thr Ser
455 460 465
gtg gtt gtt ggt ctc gtc atg tac ctc ctg ctg ggt cgc cca ctc gca 1555
Val Val Val Gly Leu Val Met Tyr Leu Leu Leu Gly Arg Pro Leu Ala
470 475 480 485
tcc atc atg act ggt ttg cag gac tgg cta tcg tca atg tcc gga agc 1603
Ser Ile Met Thr Gly Leu Gln Asp Trp Leu Ser Ser Met Ser Gly Ser
490 495 500
tcc gcc atc ttg ctg ggt atc atc ttg ggc ctc atg atg tgt ttc gac 1651
Ser Ala Ile Leu Leu Gly Ile Ile Leu Gly Leu Met Met Cys Phe Asp
505 510 515
ctc ggc gga cca gta aac aag gca gcc tac ctc ttt ggt acc gca ggc 1699
Leu Gly Gly Pro Val Asn Lys Ala Ala Tyr Leu Phe Gly Thr Ala Gly
520 525 530
ctg tct acc ggc gac caa gct tcc atg gaa atc atg gcc gcg atc atg 1747
Leu Ser Thr Gly Asp Gln Ala Ser Met Glu Ile Met Ala Ala Ile Met
535 540 545
gca gct ggc atg gtc cca cca atc gcg ttg tcc att gct acc ctg ctg 1795
Ala Ala Gly Met Val Pro Pro Ile Ala Leu Ser Ile Ala Thr Leu Leu
550 555 560 565
cgc aag aag ctg ttc acc cca gca gag caa gaa aac ggc aag tct tcc 1843
Arg Lys Lys Leu Phe Thr Pro Ala Glu Gln Glu Asn Gly Lys Ser Ser
570 575 580
tgg ctg ctt ggc ctg gca ttc gtc tcc gaa ggt gcc atc cca ttc gcc 1891
Trp Leu Leu Gly Leu Ala Phe Val Ser Glu Gly Ala Ile Pro Phe Ala
585 590 595
gca gct gac cca ttc cgt gtg atc cca gca atg atg gct ggc ggt gca 1939
Ala Ala Asp Pro Phe Arg Val Ile Pro Ala Met Met Ala Gly Gly Ala
600 605 610
acc act ggt gca atc tcc atg gca ctg ggc gtc ggc tct cgg gct cca 1987
Thr Thr Gly Ala Ile Ser Met Ala Leu Gly Val Gly Ser Arg Ala Pro
615 620 625
cac ggc ggt atc ttc gtg gtc tgg gca atc gaa cca tgg tgg ggc tgg 2035
His Gly Gly Ile Phe Val Val Trp Ala Ile Glu Pro Trp Trp Gly Trp
630 635 640 645
ctc atc gca ctt gca gca ggc acc atc gtg tcc acc atc gtt gtc atc 2083
Leu Ile Ala Leu Ala Ala Gly Thr Ile Val Ser Thr Ile Val Val Ile
650 655 660
gca ctg aag cag ttc tgg cca aac aag gcc gtc gct gca gaa gtc gcg 2131
Ala Leu Lys Gln Phe Trp Pro Asn Lys Ala Val Ala Ala Glu Val Ala
665 670 675
aag caa gaa gca caa caa gca gct gta aac gca taatcggacc ttgacccgat 2184
Lys Gln Glu Ala Gln Gln Ala Ala Val Asn Ala
680 685
gtc 2187
<210>8
<211>688
<212>PRT
<213>Corynebacterium glutamicum (Corynebacterium glutamicum)
<400>8
Met Asn Ser Val Asn Asn Ser Ser Leu Val Arg Leu Asp Val Asp Phe
1 5 10 15
Gly Asp Ser Thr Thr Asp Val Ile Asn Asn Leu Ala Thr Val Ile Phe
20 25 30
Asp Ala Gly Arg Ala Ser Ser Ala Asp Ala Leu Ala Lys Asp Ala Leu
35 40 45
Asp Arg Glu Ala Lys Ser Gly Thr Gly Val Pro Gly Gln Val Ala Ile
50 55 60
Pro His Cys Arg Ser Glu Ala Val Ser Val Pro Thr Leu Gly Phe Ala
65 70 75 80
Arg Leu Ser Lys Gly Val Asp Phe Ser Gly Pro Asp Gly Asp Ala Asn
85 90 95
Leu Val Phe Leu Ile Ala Ala Pro Ala Gly Gly Gly Lys Glu His Leu
100 105 110
Lys Ile Leu Ser Lys Leu Ala Arg Ser Leu Val Lys Lys Asp Phe Ile
115 120 125
Lys Ala Leu Gln Glu Ala Thr Thr Glu Gln Glu Ile Val Asp Val Val
130 135 140
Asp Ala Val Leu Asn Pro Ala Pro Lys Thr Thr Glu Pro Ala Ala Ala
145 150 155 160
Pro Ala Ala Ala Ala Val Ala Glu Ser Gly Ala Ala Ser Thr Ser Val
165 170 175
Thr Arg Ile Val Ala Ile Thr Ala Cys Pro Thr Gly Ile Ala His Thr
180 185 190
Tyr Met Ala Ala Asp Ser Leu Thr Gln Asn Ala Glu Gly Arg Asp Asp
195 200 205
Val Glu Leu Val Val Glu Thr Gln Gly Ser Ser Ala Val Thr Pro Val
210 215 220
Asp Pro Lys Ile Ile Glu Ala Ala Asp Ala Val Ile Phe Ala Thr Asp
225 230 235 240
Val Gly Val Lys Asp Arg Glu Arg Phe Ala Gly Lys Pro Val Ile Glu
245 250 255
Ser Gly Val Lys Arg Ala Ile Asn Glu Pro Ala Lys Met Ile Asp Glu
260 265 270
Ala Ile Ala Ala Ser Lys Asn Pro Asn Ala Arg Lys Val Ser Gly Ser
275 280 285
Gly Val Ala Ala Ser Ala Glu Thr Thr Gly Glu Lys Leu Gly Trp Gly
290 295 300
Lys Arg Ile Gln Gln Ala Val Met Thr Gly Val Ser Tyr Met Val Pro
305 310 315 320
Phe Val Ala Ala Gly Gly Leu Leu Leu Ala Leu Gly Phe Ala Phe Gly
325 330 335
Gly Tyr Asp Met Ala Asn Gly Trp Gln Ala Ile Ala Thr Gln Phe Ser
340 345 350
Leu Thr Asn Leu Pro Gly Asn Thr Val Asp Val Asp Gly Val Ala Met
355 360 365
Thr Phe Glu Arg Ser Gly Phe Leu Leu Tyr Phe Gly Ala Val Leu Phe
370 375 380
Ala Thr Gly Gln Ala Ala Met Gly Phe Ile Val Ala Ala Leu Ser Gly
385 390 395 400
Tyr Thr Ala Tyr Ala Leu Ala Gly Arg Pro Gly Ile Ala Pro Gly Phe
405 410 415
Val Gly Gly Ala Ile Ser Val Thr Ile Gly Ala Gly Phe Ile Gly Gly
420 425 430
Leu Val Thr Gly Ile Leu Ala Gly Leu Ile Ala Leu Trp Ile Gly Ser
435 440 445
Trp Lys Val Pro Arg Val Val Gln Ser Leu Met Pro Val Val Ile Ile
450 455 460
Pro Leu Leu Thr Ser Val Val Val Gly Leu Val Met Tyr Leu Leu Leu
465 470 475 480
Gly Arg Pro Leu Ala Ser Ile Met Thr Gly Leu Gln Asp Trp Leu Ser
485 490 495
Ser Met Ser Gly Ser Ser Ala Ile Leu Leu Gly Ile Ile Leu Gly Leu
500 505 510
Met Met Cys Phe Asp Leu Gly Gly Pro Val Asn Lys Ala Ala Tyr Leu
515 520 525
Phe Gly Thr Ala Gly Leu Ser Thr Gly Asp Gln Ala Ser Met Glu Ile
530 535 540
Met Ala Ala Ile Met Ala Ala Gly Met Val Pro Pro Ile Ala Leu Ser
545 550 555 560
Ile Ala Thr Leu Leu Arg Lys Lys Leu Phe Thr Pro Ala Glu Gln Glu
565 570 575
Asn Gly Lys Ser Ser Trp Leu Leu Gly Leu Ala Phe Val Ser Glu Gly
580 585 590
Ala Ile Pro Phe Ala Ala Ala Asp Pro Phe Arg Val Ile Pro Ala Met
595 600 605
Met Ala Gly Gly Ala Thr Thr Gly Ala Ile Ser Met Ala Leu Gly Val
610 615 620
Gly Ser Arg Ala Pro His Gly Gly Ile Phe Val Val Trp Ala Ile Glu
625 630 635 640
Pro Trp Trp Gly Trp Leu Ile Ala Leu Ala Ala Gly Thr Ile Val Ser
645 650 655
Thr Ile Val Val Ile Ala Leu Lys Gln Phe Trp Pro Asn Lys Ala Val
660 665 670
Ala Ala Glu Val Ala Lys Gln Glu Ala Gln Gln Ala Ala Val Asn Ala
675 680 685
<210>9
<211>464
<212>DNA
<213>Corynebacterium glutamicum (Corynebacterium glutamicum)
<220>
<221>CDS
<222>(1)..(441)
<223>FRXA01299
<400>9
atg gaa atc atg gcc gcg atc atg gca gct ggc atg gtc cca cca atc 48
Met Glu Ile Met Ala Ala Ile Met Ala Ala Gly Met Val Pro Pro Ile
1 5 10 15
gcg ttg tcc att gct acc ctg ctg cgc aag aag ctg ttc acc cca gca 96
Ala Leu Ser Ile Ala Thr Leu Leu Arg Lys Lys Leu Phe Thr Pro Ala
20 25 30
gag caa gaa aac ggc aag tct tcc tgg ctg ctt ggc ctg gca ttc gtc 144
Glu Gln Glu Asn Gly Lys Ser Ser Trp Leu Leu Gly Leu Ala Phe Val
35 40 45
tcc gaa ggt gcc atc cca ttc gcc gca gct gac cca ttc cgt gtg atc 192
Ser Glu Gly Ala Ile Pro Phe Ala Ala Ala Asp Pro Phe Arg Val Ile
50 55 60
cca gca atg atg gct ggc ggt gca acc act ggt gca atc tcc atg gca 240
Pro Ala Met Met Ala Gly Gly Ala Thr Thr Gly Ala Ile Ser Met Ala
65 70 75 80
ctg ggc gtc ggc tct cgg gct cca cac ggc ggt atc ttc gtg gtc tgg 288
Leu Gly Val Gly Ser Arg Ala Pro His Gly Gly Ile Phe Val Val Trp
85 90 95
gca atc gaa cca tgg tgg ggc tgg ctc atc gca ctt gca gca ggc acc 336
Ala Ile Glu Pro Trp Trp Gly Trp Leu Ile Ala Leu Ala Ala Gly Thr
100 105 110
atc gtg tcc acc atc gtt gtc atc gca ctg aag cag ttc tgg cca aac 384
Ile Val Ser Thr Ile Val Val Ile Ala Leu Lys Gln Phe Trp Pro Asn
115 120 125
aag gcc gtc gct gca gaa gtc gcg aag caa gaa gca caa caa gca gct 432
Lys Ala Val Ala Ala Glu Val Ala Lys Gln Glu Ala Gln Gln Ala Ala
130 135 140
gta aac gca taatcggacc ttgacccgat gtc 464
Val Asn Ala
145
<210>10
<211>147
<212>PRT
<213>Corynebacterium glutamicum (Corynebacterium glutamicum)
<400>10
Met Glu Ile Met Ala Ala Ile Met Ala Ala Gly Met Val Pro Pro Ile
1 5 10 15
Ala Leu Ser Ile Ala Thr Leu Leu Arg Lys Lys Leu Phe Thr Pro Ala
20 25 30
Glu Gln Glu Asn Gly Lys Ser Ser Trp Leu Leu Gly Leu Ala Phe Val
35 40 45
Ser Glu Gly Ala Ile Pro Phe Ala Ala Ala Asp Pro Phe Arg Val Ile
50 55 60
Pro Ala Met Met Ala Gly Gly Ala Thr Thr Gly Ala Ile Ser Met Ala
65 70 75 80
Leu Gly Val Gly Ser Arg Ala Pro His Gly Gly Ile Phe Val Val Trp
85 90 95
Ala Ile Glu Pro Trp Trp Gly Trp Leu Ile Ala Leu Ala Ala Gly Thr
100 105 110
Ile Val Ser Thr Ile Val Val Ile Ala Leu Lys Gln Phe Trp Pro Asn
115 120 125
Lys Ala Val Ala Ala Glu Val Ala Lys Gln Glu Ala Gln Gln Ala Ala
130 135 140
Val Asn Ala
145
<210>11
<211>580
<212>DNA
<213>Corynebacterium glutamicum (Corynebacterium glutamicum)
<220>
<221>CDS
<222>(101)..(580)
<223>FRXA01883
<400>11
cgactgcggc gtctcttcct ggcactacca ttcctcgtcc tgaccaactc gccacagctg 60
gtgcaacggt cacccaagtc aaaggattga aagaatcagc atg aat agc gta aat 115
Met Asn Ser Val Asn
1 5
aat tcc tcg ctt gtc cgg ctg gat gtc gat ttc ggc gac tcc acc acg 163
Asn Ser Ser Leu Val Arg Leu Asp Val Asp Phe Gly Asp Ser Thr Thr
10 15 20
gat gtc atc aac aac ctt gcc act gtt att ttc gac gct ggc cga gct 211
Asp Val Ile Asn Asn Leu Ala Thr Val Ile Phe Asp Ala Gly Arg Ala
25 30 35
tcc tcc gcc gac gcc ctt gcc aaa gac gcg ctg gat cgt gaa gca aag 259
Ser Ser Ala Asp Ala Leu Ala Lys Asp Ala Leu Asp Arg Glu Ala Lys
40 45 50
tcc ggc acc ggc gtt cct ggt caa gtt gct atc ccc cac tgc cgt tcc 307
Ser Gly Thr Gly Val Pro Gly Gln Val Ala Ile Pro His Cys Arg Ser
55 60 65
gaa gcc gta tct gtc cct acc ttg ggc ttt gct cgc ctg agc aag ggt 355
Glu Ala Val Ser Val Pro Thr Leu Gly Phe Ala Arg Leu Ser Lys Gly
70 75 80 85
gtg gac ttc agc gga cct gat ggc gat gcc aac ttg gtg ttc ctc att 403
Val Asp Phe Ser Gly Pro Asp Gly Asp Ala Asn Leu Val Phe Leu Ile
90 95 100
gca gca cct gct ggc ggc ggc aaa gag cac ctg aag atc ctg tcc aag 451
Ala Ala Pro Ala Gly Gly Gly Lys Glu His Leu Lys Ile Leu Ser Lys
105 110 115
ctt gct cgc tcc ttg gtg aag aag gat ttc atc aag gct ctg cag gaa 499
Leu Ala Arg Ser Leu Val Lys Lys Asp Phe Ile Lys Ala Leu Gln Glu
120 125 130
gcc acc acc gag cag gaa atc gtc gac gtt gtc gat gcc gtg ctc aac 547
Ala Thr Thr Glu Gln Glu Ile Val Asp Val Val Asp Ala Val Leu Asn
135 140 145
cca gca cca aaa aac cac cga gcc agc tgc agc 580
Pro Ala Pro Lys Asn His Arg Ala Ser Cys Ser
150 155 160
<210>12
<211>160
<212>PRT
<213>Corynebacterium glutamicum (Corynebacterium glutamicum)
<400>12
Met Asn Ser Val Asn Asn Ser Ser Leu Val Arg Leu Asp Val Asp Phe
1 5 10 15
Gly Asp Ser Thr Thr Asp Val Ile Asn Asn Leu Ala Thr Val Ile Phe
20 25 30
Asp Ala Gly Arg Ala Ser Ser Ala Asp Ala Leu Ala Lys Asp Ala Leu
35 40 45
Asp Arg Glu Ala Lys Ser Gly Thr Gly Val Pro Gly Gln Val Ala Ile
50 55 60
Pro His Cys Arg Ser Glu Ala Val Ser Val Pro Thr Leu Gly Phe Ala
65 70 75 80
Arg Leu Ser Lys Gly Val Asp Phe Ser Gly Pro Asp Gly Asp Ala Asn
85 90 95
Leu Val Phe Leu Ile Ala Ala Pro Ala Gly Gly Gly Lys Glu His Leu
100 105 110
Lys Ile Leu Ser Lys Leu Ala Arg Ser Leu Val Lys Lys Asp Phe Ile
115 120 125
Lys Ala Leu Gln Glu Ala Thr Thr Glu Gln Glu Ile Val Asp Val Val
130 135 140
Asp Ala Val Leu Asn Pro Ala Pro Lys Asn His Arg Ala Ser Cys Ser
145 150 155 160
<210>13
<211>631
<212>DNA
<213>Corynebacterium glutamicum (Corynebacterium glutamicum)
<220>
<221>CDS
<222>(77)..(631)
<223>FRXA01889
<400>13
accgagccag ctgcagctcc ggctgcggcg gccggttgtt aagagtgggg cggcgtcgac 60
aagcgttact cgtatc gtg gca atc acc gca tgc cca acc ggt atc gca cac 112
Val Ala Ile Thr Ala Cys Pro Thr Gly Ile Ala His
1 5 10
acc tac atg gct gcg gat tcc ctg acg caa aac gcg gaa ggc cgc gat 160
Thr Tyr Met Ala Ala Asp Ser Leu Thr Gln Asn Ala Glu Gly Arg Asp
15 20 25
gat gtg gaa ctc gtt gtg gag act cag ggc tct tcc gct gtc acc cca 208
Asp Val Glu Leu Val Val Glu Thr Gln Gly Ser Ser Ala Val Thr Pro
30 35 40
gtc gat ccg aag atc atc gaa gct gcc gac gcc gtc atc ttc gcc acc 256
Val Asp Pro Lys Ile Ile Glu Ala Ala Asp Ala Val Ile Phe Ala Thr
45 50 55 60
gac gtg gga gtt aaa gac cgc gag cgt ttc gct ggc aag cca gtc att 304
Asp Val Gly Val Lys Asp Arg Glu Arg Phe Ala Gly Lys Pro Val Ile
65 70 75
gaa tcc ggc gtc aag cgc gcg atc aat gag cca gcc aag atg atc gac 352
Glu Ser Gly Val Lys Arg Ala Ile Asn Glu Pro Ala Lys Met Ile Asp
80 85 90
gag gcc atc gca gcc tcc aag aac cca aac gcc cgc aag gtt tcc ggt 400
Glu Ala Ile Ala Ala Ser Lys Asn Pro Asn Ala Arg Lys Val Ser Gly
95 100 105
tcc ggt gtc gcg gca tct gct gaa acc acc ggc gag aag ctc ggc tgg 448
Ser Gly Val Ala Ala Ser Ala Glu Thr Thr Gly Glu Lys Leu Gly Trp
110 115 120
ggc aag cgc atc cag cag gca gtc atg acc ggc gtg tcc tac atg gtt 496
Gly Lys Arg Ile Gln Gln Ala Val Met Thr Gly Val Ser Tyr Met Val
125 130 135 140
cca ttc gta gct gcc ggc ggc ctc ctg ttg gct ctc ggc ttc gca ttc 544
Pro Phe Val Ala Ala Gly Gly Leu Leu Leu Ala Leu Gly Phe Ala Phe
145 150 155
ggt gga tac gac atg gcg aac ggc tgg caa gca atc gcc acc cag ttc 592
Gly Gly Tyr Asp Met Ala Asn Gly Trp Gln Ala Ile Ala Thr Gln Phe
160 165 170
tct ctg acc aac ctg cca ggc aac acc gtc gat gtt gac 631
Ser Leu Thr Asn Leu Pro Gly Asn Thr Val Asp Val Asp
175 180 185
<210>14
<211>185
<212>PRT
<213>Corynebacterium glutamicum (Corynebacterium glutamicum)
<400>14
Val Ala Ile Thr Ala Cys Pro Thr Gly Ile Ala His Thr Tyr Met Ala
1 5 10 15
Ala Asp Ser Leu Thr Gln Asn Ala Glu Gly Arg Asp Asp Val Glu Leu
20 25 30
Val Val Glu Thr Gln Gly Ser Ser Ala Val Thr Pro Val Asp Pro Lys
35 40 45
Ile Ile Glu Ala Ala Asp Ala Val Ile Phe Ala Thr Asp Val Gly Val
50 55 60
Lys Asp Arg Glu Arg Phe Ala Gly Lys Pro Val Ile Glu Ser Gly Val
65 70 75 80
Lys Arg Ala Ile Asn Glu Pro Ala Lys Met Ile Asp Glu Ala Ile Ala
85 90 95
Ala Ser Lys Asn Pro Asn Ala Arg Lys Val Ser Gly Ser Gly Val Ala
100 105 110
Ala Ser Ala Glu Thr Thr Gly Glu Lys Leu Gly Trp Gly Lys Arg Ile
115 120 125
Gln Gln Ala Val Met Thr Gly Val Ser Tyr Met Val Pro Phe Val Ala
130 135 140
Ala Gly Gly Leu Leu Leu Ala Leu Gly Phe Ala Phe Gly Gly Tyr Asp
145 150 155 160
Met Ala Asn Gly Trp Gln Ala Ile Ala Thr Gln Phe Ser Leu Thr Asn
165 170 175
Leu Pro Gly Asn Thr Val Asp Val Asp
180 185
<210>15
<211>416
<212>DNA
<213>Corynebacterium glutamicum (Corynebacterium glutamicum)
<220>
<221>CDS
<222>(1)..(393)
<223>RXA00951
<400>15
atc caa gca atc tta gag aag gca gca gcg ccg gcg aag cag aag gct 48
Ile Gln Ala Ile Leu Glu Lys Ala Ala Ala Pro Ala Lys Gln Lys Ala
1 5 10 15
cct gct gtg gct cct gct gta aca ccc act gac gct cct gca gcc tca 96
Pro Ala Val Ala Pro Ala Val Thr Pro Thr Asp Ala Pro Ala Ala Ser
20 25 30
gtc caa tcc aaa acc cac gac aag atc ctc acc gtc tgt ggc aac ggc 144
Val Gln Ser Lys Thr His Asp Lys Ile Leu Thr Val Cys Gly Asn Gly
35 40 45
ttg ggt acc tcc ctc ttc ctc aaa aac acc ctt gag caa gtt ttc gac 192
Leu Gly Thr Ser Leu Phe Leu Lys Asn Thr Leu Glu Gln Val Phe Asp
50 55 60
acc tgg ggt tgg ggt cca tac atg acg gtg gag gca acc gac act atc 240
Thr Trp Gly Trp Gly Pro Tyr Met Thr Val Glu Ala Thr Asp Thr Ile
65 70 75 80
tcc gcc aag ggc aaa gcc aag gaa gct gat ctc atc atg acc tct ggt 288
Ser Ala Lys Gly Lys Ala Lys Glu Ala Asp Leu Ile Met Thr Ser Gly
85 90 95
gaa atc gcc cgc acg ttg ggt gat gtt gga atc ccg gtt cac gtg atc 336
Glu Ile Ala Arg Thr Leu Gly Asp Val Gly Ile Pro Val His Val Ile
100 105 110
aat gac ttc acg agc acc gat gaa atc gat gct gcg ctt cgt gaa cgc 384
Asn Asp Phe Thr Ser Thr Asp Glu Ile Asp Ala Ala Leu Arg Glu Arg
115 120 125
tac gac atc taactacttt aaaaggacga aaa 416
Tyr Asp Ile
130
<210>16
<211>131
<212>PRT
<213>Corynebacterium glutamicum (Corynebacterium glutamicum)
<400>16
Ile Gln Ala Ile Leu Glu Lys Ala Ala Ala Pro Ala Lys Gln Lys Ala
1 5 10 15
Pro Ala Val Ala Pro Ala Val Thr Pro Thr Asp Ala Pro Ala Ala Ser
20 25 30
Val Gln Ser Lys Thr His Asp Lys Ile Leu Thr Val Cys Gly Asn Gly
35 40 45
Leu Gly Thr Ser Leu Phe Leu Lys Asn Thr Leu Glu Gln Val Phe Asp
50 55 60
Thr Trp Gly Trp Gly Pro Tyr Met Thr Val Glu Ala Thr Asp Thr Ile
65 70 75 80
Ser Ala Lys Gly Lys Ala Lys Glu Ala Asp Leu Ile Met Thr Ser Gly
85 90 95
Glu Ile Ala Arg Thr Leu Gly Asp Val Gly Ile Pro Val His Val Ile
100 105 110
Asn Asp Phe Thr Ser Thr Asp Glu Ile Asp Ala Ala Leu Arg Glu Arg
115 120 125
Tyr Asp Ile
130
<210>17
<211>1827
<212>DNA
<213>Corynebacterium glutamicum (Corynebacterium glutamicum)
<220>
<221>CDS
<222>(101)..(1804)
<223>RXN01244
<400>17
gatatgtgtt tgtttgtcaa tatccaaatg tttgaatagt tgcacaactg ttggttttgt 60
ggtgatcttg aggaaattaa ctcaatgatt gtgaggatgg gtg gct act gtg gct 115
Val Ala Thr Val Ala
1 5
gat gtg aat caa gac act gta ctg aag ggc acc ggc gtt gtc ggt gga 163
Asp Val Asn Gln Asp Thr Val Leu Lys Gly Thr Gly Val Val Gly Gly
10 15 20
gtc cgt tat gca agc gcg gtg tgg att acc cca cgc ccc gaa cta ccc 211
Val Arg Tyr Ala Ser Ala Val Trp Ile Thr Pro Arg Pro Glu Leu Pro
25 30 35
caa gca ggc gaa gtc gtc gcc gaa gaa aac cgt gaa gca gag cag gag 259
Gln Ala Gly Glu Val Val Ala Glu Glu Asn Arg Glu Ala Glu Gln Glu
40 45 50
cgt ttc gac gcc gct gca gcc aca gtc tct tct cgt ttg ctt gag cgc 307
Arg Phe Asp Ala Ala Ala Ala Thr Val Ser Ser Arg Leu Leu Glu Arg
55 60 65
tcc gaa gct gct gaa gga cca gca gct gag gtg ctt aaa gct act gct 355
Ser Glu Ala Ala Glu Gly Pro Ala Ala Glu Val Leu Lys Ala Thr Ala
70 75 80 85
ggc atg gtc aat gac cgt ggc tgg cgt aag gct gtc atc aag ggt gtc 403
Gly Met Val Asn Asp Arg Gly Trp Arg Lys Ala Val Ile Lys Gly Val
90 95 100
aag ggt ggt cac cct gcg gaa tac gcc gtg gtt gca gca aca acc aag 451
Lys Gly Gly His Pro Ala Glu Tyr Ala Val Val Ala Ala Thr Thr Lys
105 110 115
ttc atc tcc atg ttc gaa gcc gca ggc ggc ctg atc gcg gag cgc acc 499
Phe Ile Ser Met Phe Glu Ala Ala Gly Gly Leu Ile Ala Glu Arg Thr
120 125 130
aca gac ttg cgc gac atc cgc gac cgc gtc atc gca gaa ctt cgt ggc 547
Thr Asp Leu Arg Asp Ile Arg Asp Arg Val Ile Ala Glu Leu Arg Gly
135 140 145
gat gaa gag cca ggt ctg cca gct gtt tcc gga cag gtc att ctc ttt 595
Asp Glu Glu Pro Gly Leu Pro Ala Val Ser Gly Gln Val Ile Leu Phe
150 155 160 165
gca gat gac ctc tcc cca gca gac acc gcg gca cta gac aca gat ctc 643
Ala Asp Asp Leu Ser Pro Ala Asp Thr Ala Ala Leu Asp Thr Asp Leu
170 175 180
ttt gtg gga ctt gtc act gag ctg ggt ggc cca acg agc cac acc gcg 691
Phe Val Gly Leu Val Thr Glu Leu Gly Gly Pro Thr Ser His Thr Ala
185 190 195
atc atc gca cgc cag ctc aac gtg cct tgc atc gtc gca tcc ggc gcc 739
Ile Ile Ala Arg Gln Leu Asn Val Pro Cys Ile Val Ala Ser Gly Ala
200 205 210
ggc atc aag gac atc aag tcc ggc gaa aag gtg ctt atc gac ggc agc 787
Gly Ile Lys Asp Ile Lys Ser Gly Glu Lys Val Leu Ile Asp Gly Ser
215 220 225
ctc ggc acc att gac cgc aac gcg gac gaa gct gaa gca acc aag ctc 835
Leu Gly Thr Ile Asp Arg Asn Ala Asp Glu Ala Glu Ala Thr Lys Leu
230 235 240 245
gtc tcc gag tcc ctc gag cgc gct gct cgc atc gcc gag tgg aag ggt 883
Val Ser Glu Ser Leu Glu Arg Ala Ala Arg Ile Ala Glu Trp Lys Gly
250 255 260
cct gca caa acc aag gac ggc tac cgc gtt cag ctg ttg gcc aac gtc 931
Pro Ala Gln Thr Lys Asp Gly Tyr Arg Val Gln Leu Leu Ala Asn Val
265 270 275
caa gac ggc aac tct gca cag cag gct gca cag acc gaa gca gaa ggc 979
Gln Asp Gly Asn Ser Ala Gln Gln Ala Ala Gln Thr Glu Ala Glu Gly
280 285 290
atc ggc ctg ttc cgc acc gaa ctg tgc ttc ctt tcc gcc acc gaa gag 1027
Ile Gly Leu Phe Arg Thr Glu Leu Cys Phe Leu Ser Ala Thr Glu Glu
295 300 305
cca agc gtt gat gag cag gct gcg gtc tac tca aag gtg ctt gaa gca 1075
Pro Ser Val Asp Glu Gln Ala Ala Val Tyr Ser Lys Val Leu Glu Ala
310 315 320 325
ttc cca gag tcc aag gtc gtt gtc cgc tcc ctc gac gca ggt tct gac 1123
Phe Pro Glu Ser Lys Val Val Val Arg Ser Leu Asp Ala Gly Ser Asp
330 335 340
aag cca gtt cca ttc gca tcg atg gct gat gag atg aac cca gca ctg 1171
Lys Pro Val Pro Phe Ala Ser Met Ala Asp Glu Met Asn Pro Ala Leu
345 350 355
ggt gtt cgt ggc ctg cgt atc gca cgt gga cag gtt gat ctg ctg act 1219
Gly Val Arg Gly Leu Arg Ile Ala Arg Gly Gln Val Asp Leu Leu Thr
360 365 370
cgc cag ctc gac gca att gcg aag gcc agc gaa gaa ctc ggc cgt ggc 1267
Arg Gln Leu Asp Ala Ile Ala Lys Ala Ser Glu Glu Leu Gly Arg Gly
375 380 385
gac gac gcc cca acc tgg gtt atg gct cca atg gtg gct acc gct tat 1315
Asp Asp Ala Pro Thr Trp Val Met Ala Pro Met Val Ala Thr Ala Tyr
390 395 400 405
gaa gca aag tgg ttt gct gac atg tgc cgt gag cgt ggc cta atc gcc 1363
Glu Ala Lys Trp Phe Ala Asp Met Cys Arg Glu Arg Gly Leu Ile Ala
410 415 420
ggc gcc atg atc gaa gtt cca gca gca tcc ctg atg gca gac aag atc 1411
Gly Ala Met Ile Glu Val Pro Ala Ala Ser Leu Met Ala Asp Lys Ile
425 430 435
atg cct cac ctg gac ttt gtt tcc atc ggt acc aac gac ctg acc cag 1459
Met Pro His Leu Asp Phe Val Ser Ile Gly Thr Asn Asp Leu Thr Gln
440 445 450
tac acc atg gca gcg gac cgc atg tct cct gag ctt gcc tac ctg acc 1507
Tyr Thr Met Ala Ala Asp Arg Met Ser Pro Glu Leu Ala Tyr Leu Thr
455 460 465
gat cct tgg cag cca gca gtc ctg cgc ctg atc aag cac acc tgt gac 1555
Asp Pro Trp Gln Pro Ala Val Leu Arg Leu Ile Lys His Thr Cys Asp
470 475 480 485
gaa ggt gct cgc ttt aac acc ccg gtc ggt gtt tgt ggt gaa gca gca 1603
Glu Gly Ala Arg Phe Asn Thr Pro Val Gly Val Cys Gly Glu Ala Ala
490 495 500
gca gac cca ctg ttg gca act gtc ctc acc ggt ctt ggc gtg aac tcc 1651
Ala Asp Pro Leu Leu Ala Thr Val Leu Thr Gly Leu Gly Val Asa Ser
505 510 515
ctg tcc gca gca tcc act gct ctc gca gca gtc ggt gca aag ctg tca 1699
Leu Ser Ala Ala Ser Thr Ala Leu Ala Ala Val Gly Ala Lys Leu Ser
520 525 530
gag gtc acc ctg gaa acc tgt aag aag gca gca gaa gca gca ctt gac 1747
Glu Val Thr Leu Glu Thr Cys Lys Lys Ala Ala Glu Ala Ala Leu Asp
535 540 545
gct gaa ggt gca act gaa gca cgc gat gct gta cgc gca gtg atc gac 1795
Ala Glu Gly Ala Thr Glu Ala Arg Asp Ala Val Arg Ala Val Ile Asp
550 555 560 565
gca gca gtc taaaccactg ttgagctaaa aag 1827
Ala Ala Val
<210>18
<211>568
<212>PRT
<213>Corynebacterium glutamicum (Corynebacterium glutamicum)
<400>18
Val Ala Thr Val Ala Asp Val Asn Gln Asp Thr Val Leu Lys Gly Thr
1 5 10 15
Gly Val Val Gly Gly Val Arg Tyr Ala Ser Ala Val Trp Ile Thr Pro
20 25 30
Arg Pro Glu Leu Pro Gln Ala Gly Glu Val Val Ala Glu Glu Asn Arg
35 40 45
Glu Ala Glu Gln Glu Arg Phe Asp Ala Ala Ala Ala Thr Val Ser Ser
50 55 60
Arg Leu Leu Glu Arg Ser Glu Ala Ala Glu Gly Pro Ala Ala Glu Val
65 70 75 80
Leu Lys Ala Thr Ala Gly Met Val Asn Asp Arg Gly Trp Arg Lys Ala
85 90 95
Val Ile Lys Gly Val Lys Gly Gly His Pro Ala Glu Tyr Ala Val Val
100 105 110
Ala Ala Thr Thr Lys Phe Ile Ser Met Phe Glu Ala Ala Gly Gly Leu
115 120 125
Ile Ala Glu Arg Thr Thr Asp Leu Arg Asp Ile Arg Asp Arg Val Ile
130 135 140
Ala Glu Leu Arg Gly Asp Glu Glu Pro Gly Leu Pro Ala Val Ser Gly
145 150 155 160
Gln Val Ile Leu Phe Ala Asp Asp Leu Ser Pro Ala Asp Thr Ala Ala
165 170 175
Leu Asp Thr Asp Leu Phe Val Gly Leu Val Thr Glu Leu Gly Gly Pro
180 185 190
Thr Ser His Thr Ala Ile Ile Ala Arg Gln Leu Asn Val Pro Cys Ile
195 200 205
Val Ala Ser Gly Ala Gly Ile Lys Asp Ile Lys Ser Gly Glu Lys Val
210 215 220
Leu Ile Asp Gly Ser Leu Gly Thr Ile Asp Arg Asn Ala Asp Glu Ala
225 230 235 240
Glu Ala Thr Lys Leu Val Ser Glu Ser Leu Glu Arg Ala Ala Arg Ile
245 250 255
Ala Glu Trp Lys Gly Pro Ala Gln Thr Lys Asp Gly Tyr Arg Val Gln
260 265 270
Leu Leu Ala Asn Val Gln Asp Gly Asn Ser Ala Gln Gln Ala Ala Gln
275 280 285
Thr Glu Ala Glu Gly Ile Gly Leu Phe Arg Thr Glu Leu Cys Phe Leu
290 295 300
Ser Ala Thr Glu Glu Pro Ser Val Asp Glu Gln Ala Ala Val Tyr Ser
305 310 315 320
Lys Val Leu Glu Ala Phe Pro Glu Ser Lys Val Val Val Arg Ser Leu
325 330 335
Asp Ala Gly Ser Asp Lys Pro Val Pro Phe Ala Ser Met Ala Asp Glu
340 345 350
Met Asn Pro Ala Leu Gly Val Arg Gly Leu Arg Ile Ala Arg Gly Gln
355 360 365
Val Asp Leu Leu Thr Arg Gln Leu Asp Ala Ile Ala Lys Ala Ser Glu
370 375 380
Glu Leu Gly Arg Gly Asp Asp Ala Pro Thr Trp Val Met Ala Pro Met
385 390 395 400
Val Ala Thr Ala Tyr Glu Ala Lys Trp Phe Ala Asp Met Cys Arg Glu
405 410 415
Arg Gly Leu Ile Ala Gly Ala Met Ile Glu Val Pro Ala Ala Ser Leu
420 425 430
Met Ala Asp Lys Ile Met Pro His Leu Asp Phe Val Ser Ile Gly Thr
435 440 445
Asn Asp Leu Thr Gln Tyr Thr Met Ala Ala Asp Arg Met Ser Pro Glu
450 455 460
Leu Ala Tyr Leu Thr Asp Pro Trp Gln Pro Ala Val Leu Arg Leu Ile
465 470 475 480
Lys His Thr Cys Asp Glu Gly Ala Arg Phe Asn Thr Pro Val Gly Val
485 490 495
Cys Gly Glu Ala Ala Ala Asp Pro Leu Leu Ala Thr Val Leu Thr Gly
500 505 510
Leu Gly Val Asn Ser Leu Ser Ala Ala Ser Thr Ala Leu Ala Ala Val
515 520 525
Gly Ala Lys Leu Ser Glu Val Thr Leu Glu Thr Cys Lys Lys Ala Ala
530 535 540
Glu Ala Ala Leu Asp Ala Glu Gly Ala Thr Glu Ala Arg Asp Ala Val
545 550 555 560
Arg Ala Val Ile Asp Ala Ala Val
565
<210>19
<211>1629
<212>DNA
<213>Corynebacterium glutamicum (Corynebacterium glutamicum)
<220>
<221>CDS
<222>(98)..(1606)
<223>FRXA01244
<400>19
agatgtcgat ttctcgagga agaagttaac gccgaagaaa accgtgaatc agagcaggag 60
cgcttcgacg ccgctgcagc cacagtctct tcttcgt ttg ctt gag cgc tcc gaa 115
Leu Leu Glu Arg Ser Glu
1 5
gct gct gaa gga cca gca gct gag gtg ctt aaa gct act gct ggc atg 163
Ala Ala Glu Gly Pro Ala Ala Glu Val Leu Lys Ala Thr Ala Gly Met
10 15 20
gtc aat gac cgt ggc tgg cgt aag gct gtc atc aag ggt gtc aag ggt 211
Val Asn Asp Arg Gly Trp Arg Lys Ala Val Ile Lys Gly Val Lys Gly
25 30 35
ggt cac cct gcg gaa tac gcc gtg gtt gca gca aca acc aag ttc atc 259
Gly His Pro Ala Glu Tyr Ala Val Val Ala Ala Thr Thr Lys Phe Ile
40 45 50
tcc atg ttc gaa gcc gca ggc ggc ctg atc gcg gag cgc acc aca gac 307
Ser Met Phe Glu Ala Ala Gly Gly Leu Ile Ala Glu Arg Thr Thr Asp
55 60 65 70
ttg cgc gac atc cgc gac cgc gtc atc gca gaa ctt cgt ggc gat gaa 355
Leu Arg Asp Ile Arg Asp Arg Val Ile Ala Glu Leu Arg Gly Asp Glu
75 80 85
gag cca ggt ctg cca gct gtt tcc gga cag gtc att ctc ttt gca gat 403
Glu Pro Gly Leu Pro Ala Val Ser Gly Gln Val Ile Leu Phe Ala Asp
90 95 100
gac ctc tcc cca gca gac acc gcg gca cta gac aca gat ctc ttt gtg 451
Asp Leu Ser Pro Ala Asp Thr Ala Ala Leu Asp Thr Asp Leu Phe Val
105 110 115
gga ctt gtc act gag ctg ggt ggc cca acg agc cac acc gcg atc atc 499
Gly Leu Val Thr Glu Leu Gly Gly Pro Thr Ser His Thr Ala Ile Ile
120 125 130
gca cgc cag ctc aac gtg cct tgc atc gtc gca tcc ggc gcc ggc atc 547
Ala Arg Gln Leu Asn Val Pro Cys Ile Val Ala Ser Gly Ala Gly Ile
135 140 145 150
aag gac atc aag tcc ggc gaa aag gtg ctt atc gac ggc agc ctc ggc 595
Lys Asp Ile Lys Ser Gly Glu Lys Val Leu Ile Asp Gly Ser Leu Gly
155 160 165
acc att gac cgc aac gcg gac gaa gct gaa gca acc aag ctc gtc tcc 643
Thr Ile Asp Arg Asn Ala Asp Glu Ala Glu Ala Thr Lys Leu Val Ser
170 175 180
gag tcc ctc gag cgc gct gct cgc atc gcc gag tgg aag ggt cct gca 691
Glu Ser Leu Glu Arg Ala Ala Arg Ile Ala Glu Trp Lys Gly Pro Ala
185 190 195
caa acc aag gac ggc tac cgc gtt cag ctg ttg gcc aac gtc caa gac 739
Gln Thr Lys Asp Gly Tyr Arg Val Gln Leu Leu Ala Asn Val Gln Asp
200 205 210
ggc aac tct gca cag cag gct gca cag acc gaa gca gaa ggc atc ggc 787
Gly Asn Ser Ala Gln Gln Ala Ala Gln Thr Glu Ala Glu Gly Ile Gly
215 220 225 230
ctg ttc cgc acc gaa ctg tgc ttc ctt tcc gcc acc gaa gag cca agc 835
Leu Phe Arg Thr Glu Leu Cys Phe Leu Ser Ala Thr Glu Glu Pro Ser
235 240 245
gtt gat gag cag gct gcg gtc tac tca aag gtg ctt gaa gca ttc cca 883
Val Asp Glu Gln Ala Ala Val Tyr Ser Lys Val Leu Glu Ala Phe Pro
250 255 260
gag tcc aag gtc gtt gtc cgc tcc ctc gac gca ggt tct gac aag cca 931
Glu Ser Lys Val Val Val Arg Ser Leu Asp Ala Gly Ser Asp Lys Pro
265 270 275
gtt cca ttc gca tcg atg gct gat gag atg aac cca gca ctg ggt gtt 979
Val Pro Phe Ala Ser Met Ala Asp Glu Met Asn Pro Ala Leu Gly Val
280 285 290
cgt ggc ctg cgt atc gca cgt gga cag gtt gat ctg ctg act cgc cag 1027
Arg Gly Leu Arg Ile Ala Arg Gly Gln Val Asp Leu Leu Thr Arg Gln
295 300 305 310
ctc gac gca att gcg aag gcc agc gaa gaa ctc ggc cgt ggc gac gac 1075
Leu Asp Ala Ile Ala Lys Ala Ser Glu Glu Leu Gly Arg Gly Asp Asp
315 320 325
gcc cca acc tgg gtt atg gct cca atg gtg gct acc gct tat gaa gca 1123
Ala Pro Thr Trp Val Met Ala Pro Met Val Ala Thr Ala Tyr Glu Ala
330 335 340
aag tgg ttt gct gac atg tgc cgt gag cgt ggc cta atc gcc ggc gcc 1171
Lys Trp Phe Ala Asp Met Cys Arg Glu Arg Gly Leu Ile Ala Gly Ala
345 350 355
atg atc gaa gtt cca gca gca tcc ctg atg gca gac aag atc atg cct 1219
Met Ile Glu Val Pro Ala Ala Ser Leu Met Ala Asp Lys Ile Met Pro
360 365 370
cac ctg gac ttt gtt tcc atc ggt acc aac gac ctg acc cag tac acc 1267
His Leu Asp Phe Val Ser Ile Gly Thr Asn Asp Leu Thr Gln Tyr Thr
375 380 385 390
atg gca gcg gac cgc atg tct cct gag ctt gcc tac ctg acc gat cct 1315
Met Ala Ala Asp Arg Met Ser Pro Glu Leu Ala Tyr Leu Thr Asp Pro
395 400 405
tgg cag cca gca gtc ctg cgc ctg atc aag cac acc tgt gac gaa ggt 1363
Trp Gln Pro Ala Val Leu Arg Leu Ile Lys His Thr Cys Asp Glu Gly
410 415 420
gct cgc ttt aac acc ccg gtc ggt gtt tgt ggt gaa gca gca gca gac 1411
Ala Arg Phe Asn Thr Pro Val Gly Val Cys Gly Glu Ala Ala Ala Asp
425 430 435
cca ctg ttg gca act gtc ctc acc ggt ctt ggc gtg aac tcc ctg tcc 1459
Pro Leu Leu Ala Thr Val Leu Thr Gly Leu Gly Val Asn Ser Leu Ser
440 445 450
gca gca tcc act gct ctc gca gca gtc ggt gca aag ctg tca gag gtc 1507
Ala Ala Ser Thr Ala Leu Ala Ala Val Gly Ala Lys Leu Ser Glu Val
455 460 465 470
acc ctg gaa acc tgt aag aag gca gca gaa gca gca ctt gac gct gaa 1555
Thr Leu Glu Thr Cys Lys Lys Ala Ala Glu Ala Ala Leu Asp Ala Glu
475 480 485
ggt gca act gaa gca cgc gat gct gta cgc gca gtg atc gac gca gca 1603
Gly Ala Thr Glu Ala Arg Asp Ala Val Arg Ala Val Ile Asp Ala Ala
490 495 500
gtc taaaccactg ttgagctaaa aag 1629
Val
<210>20
<211>503
<212>PRT
<213>Corynebacterium glutamicum (Corynebacterium glutamicum)
<400>20
Leu Leu Glu Arg Ser Glu Ala Ala Glu Gly Pro Ala Ala Glu Val Leu
1 5 10 15
Lys Ala Thr Ala Gly Met Val Asn Asp Arg Gly Trp Arg Lys Ala Val
20 25 30
Ile Lys Gly Val Lys Gly Gly His Pro Ala Glu Tyr Ala Val Val Ala
35 40 45
Ala Thr Thr Lys Phe Ile Ser Met Phe Glu Ala Ala Gly Gly Leu Ile
50 55 60
Ala Glu Arg Thr Thr Asp Leu Arg Asp Ile Arg Asp Arg Val Ile Ala
65 70 75 80
Glu Leu Arg Gly Asp Glu Glu Pro Gly Leu Pro Ala Val Ser Gly Gln
85 90 95
Val Ile Leu Phe Ala Asp Asp Leu Ser Pro Ala Asp Thr Ala Ala Leu
100 105 110
Asp Thr Asp Leu Phe Val Gly Leu Val Thr Glu Leu Gly Gly Pro Thr
115 120 125
Ser His Thr Ala Ile Ile Ala Arg Gln Leu Asn Val Pro Cys Ile Val
130 135 140
Ala Ser Gly Ala Gly Ile Lys Asp Ile Lys Ser Gly Glu Lys Val Leu
145 150 155 160
Ile Asp Gly Ser Leu Gly Thr Ile Asp Arg Asn Ala Asp Glu Ala Glu
165 170 175
Ala Thr Lys Leu Val Ser Glu Ser Leu Glu Arg Ala Ala Arg Ile Ala
180 185 190
Glu Trp Lys Gly Pro Ala Gln Thr Lys Asp Gly Tyr Arg Val Gln Leu
195 200 205
Leu Ala Asn Val Gln Asp Gly Asn Ser Ala Gln Gln Ala Ala Gln Thr
210 215 220
Glu Ala Glu Gly Ile Gly Leu Phe Arg Thr Glu Leu Cys Phe Leu Ser
225 230 235 240
Ala Thr Glu Glu Pro Ser Val Asp Glu Gln Ala Ala Val Tyr Ser Lys
245 250 255
Val Leu Glu Ala Phe Pro Glu Ser Lys Val Val Val Arg Ser Leu Asp
260 265 270
Ala Gly Ser Asp Lys Pro Val Pro Phe Ala Ser Met Ala Asp Glu Met
275 280 285
Asn Pro Ala Leu Gly Val Arg Gly Leu Arg Ile Ala Arg Gly Gln Val
290 295 300
Asp Leu Leu Thr Arg Gln Leu Asp Ala Ile Ala Lys Ala Ser Glu Glu
305 310 315 320
Leu Gly Arg Gly Asp Asp Ala Pro Thr Trp Val Met Ala Pro Met Val
325 330 335
Ala Thr Ala Tyr Glu Ala Lys Trp Phe Ala Asp Met Cys Arg Glu Arg
340 345 350
Gly Leu Ile Ala Gly Ala Met Ile Glu Val Pro Ala Ala Ser Leu Met
355 360 365
Ala Asp Lys Ile Met Pro His Leu Asp Phe Val Ser Ile Gly Thr Asn
370 375 380
Asp Leu Thr Gln Tyr Thr Met Ala Ala Asp Arg Met Ser Pro Glu Leu
385 390 395 400
Ala Tyr Leu Thr Asp Pro Trp Gln Pro Ala Val Leu Arg Leu Ile Lys
405 410 415
His Thr Cys Asp Glu Gly Ala Arg Phe Asn Thr Pro Val Gly Val Cys
420 425 430
Gly Glu Ala Ala Ala Asp Pro Leu Leu Ala Thr Val Leu Thr Gly Leu
435 440 445
Gly Val Asn Ser Leu Ser Ala Ala Ser Thr Ala Leu Ala Ala Val Gly
450 455 460
Ala Lys Leu Ser Glu Val Thr Leu Glu Thr Cys Lys Lys Ala Ala Glu
465 470 475 480
Ala Ala Leu Asp Ala Glu Gly Ala Thr Glu Ala Arg Asp Ala Val Arg
485 490 495
Ala Val Ile Asp Ala Ala Val
500
<210>21
<211>390
<212>DNA
<213>Corynebacterium glutamicum (Corynebacterium glutamicum)
<220>
<221>CDS
<222>(101)..(367)
<223>RXA01300
<400>21
gatcgacatt aaatcccctc ccttgggggg tttaactaac aaatcgctgc gccctaatcc 60
gttcggatta acggcgtagc aacacgaaag gacactttcc atg gct tcc aag act 115
Met Ala Ser Lys Thr
1 5
gta acc gtc ggt tcc tcc gtt ggc ctg cac gca cgt cca gca tcc atc 163
Val Thr Val Gly Ser Ser Val Gly Leu His Ala Arg Pro Ala Ser Ile
10 15 20
atc gct gaa gcg gct gct gag tac gac gac gaa atc ttg ctg acc ctg 211
Ile Ala Glu Ala Ala Ala Glu Tyr Asp Asp Glu Ile Leu Leu Thr Leu
25 30 35
gtt ggc tcc gat gat gac gaa gag acc gac gcg tcc tct tcc ctc atg 259
Val Gly Ser Asp Asp Asp Glu Glu Thr Asp Ala Ser Ser Ser Leu Met
40 45 50
atc atg gcg ctg ggc gca gag cac ggc aac gaa gtt acc gtc acc tcc 307
Ile Met Ala Leu Gly Ala Glu His Gly Asn Glu Val Thr Val Thr Ser
55 60 65
gac aac gct gaa gct gtt gag aag atc gct gcg ctt atc gca cag gac 355
Asp Asn Ala Glu Ala Val Glu Lys Ile Ala Ala Leu Ile Ala Gln Asp
70 75 80 85
ctt gac gct gag taaacaacgc tctgcttgtt aaa 390
Leu Asp Ala Glu
<210>22
<211>89
<212>PRT
<213>Corynebacterium glutamicum (Corynebacterium glutamicum)
<400>22
Met Ala Ser Lys Thr Val Thr Val Gly Ser Ser Val Gly Leu His Ala
1 5 10 15
Arg Pro Ala Ser Ile Ile Ala Glu Ala Ala Ala Glu Tyr Asp Asp Glu
20 25 30
Ile Leu Leu Thr Leu Val Gly Ser Asp Asp Asp Glu Glu Thr Asp Ala
35 40 45
Ser Ser Ser Leu Met Ile Met Ala Leu Gly Ala Glu His Gly Asn Glu
50 55 60
Val Thr Val Thr Ser Asp Asn Ala Glu Ala Val Glu Lys Ile Ala Ala
65 70 75 80
Leu Ile Ala Gln Asp Leu Asp Ala Glu
85
<210>23
<211>508
<212>DNA
<213>Corynebacterium glutamicum (Corynebacterium glutamicum)
<220>
<221>CDS
<222>(101)..(508)
<223>RXN03002
<400>23
ggaacttcga ggtgtcttcg tggggcgtac ggagatctag caagtgtggc tttatgtttg 60
accctatccg aatcaacatg cagtgaatta acatctactt atg ttt gta ctc aaa 115
Met Phe Val Leu Lys
1 5
gat ctg cta aag gca gaa cgc ata gaa ctc gac cgc acg gtc acc gat 163
Asp Leu Leu Lys Ala Glu Arg Ile Glu Leu Asp Arg Thr Val Thr Asp
10 15 20
tgg cgt gaa ggc atc cgc gcc gca ggt gta ctc cta gaa aag aca aac 211
Trp Arg Glu Gly Ile Arg Ala Ala Gly Val Leu Leu Glu Lys Thr Asn
25 30 35
agc att gat tcc gcc tac acc gat gcc atg atc gcc agc gtg gaa gaa 259
Ser Ile Asp Ser Ala Tyr Thr Asp Ala Met Ile Ala Ser Val Glu Glu
40 45 50
aaa ggc ccc tac att gtg gtc gct cca ggt ttc gct ttc gcg cac gcc 307
Lys Gly Pro Tyr Ile Val Val Ala Pro Gly Phe Ala Phe Ala His Ala
55 60 65
cgc ccc agc aga gca gtc cgc gag acc gct atg tcg tgg gtg cgc ctg 355
Arg Pro Ser Arg Ala Val Arg Glu Thr Ala Met Ser Trp Val Arg Leu
70 75 80 85
gcc tcc cct gtt tcc ttc ggt cac agt aag aat gat ccc ctc aat ctc 403
Ala Ser Pro Val Ser Phe Gly His Ser Lys Asn Asp Pro Leu Asn Leu
90 95 100
atc gtt gct ctc gct gcc aaa gat gcc acc gca cat acc caa gcg atg 451
Ile Val Ala Leu Ala Ala Lys Asp Ala Thr Ala His Thr Gln Ala Met
105 110 115
gcg gca ttg gct aaa gct tta gga aaa tac cga aag gat ctc gac gag 499
Ala Ala Leu Ala Lys Ala Leu Gly Lys Tyr Arg Lys Asp Leu Asp Glu
120 125 130
gca caa agt 508
Ala Gln Ser
135
<210>24
<211>136
<212>PRT
<213>Corynebacterium glutamicum (Corynebacterium glutamicum)
<400>24
Met Phe Val Leu Lys Asp Leu Leu Lys Ala Glu Arg Ile Glu Leu Asp
1 5 10 15
Arg Thr Val Thr Asp Trp Arg Glu Gly Ile Arg Ala Ala Gly Val Leu
20 25 30
Leu Glu Lys Thr Asn Ser Ile Asp Ser Ala Tyr Thr Asp Ala Met Ile
35 40 45
Ala Ser Val Glu Glu Lys Gly Pro Tyr Ile Val Val Ala Pro Gly Phe
50 55 60
Ala Phe Ala His Ala Arg Pro Ser Arg Ala Val Arg Glu Thr Ala Met
65 70 75 80
Ser Trp Val Arg Leu Ala Ser Pro Val Ser Phe Gly His Ser Lys Asn
85 90 95
Asp Pro Leu Asn Leu Ile Val Ala Leu Ala Ala Lys Asp Ala Thr Ala
100 105 110
His Thr Gln Ala Met Ala Ala Leu Ala Lys Ala Leu Gly Lys Tyr Arg
115 120 125
Lys Asp Leu Asp Glu Ala Gln Ser
130 135
<210>25
<211>789
<212>DNA
<213>Corynebacterium glutamicum (Corynebacterium glutamicum)
<220>
<221>CDS
<222>(14)..(766)
<223>RXC00953
<400>25
cttgcattcc cca atg gcg cca cca acg gta ggc aac tac atc atg cag tcc 52
Met Ala Pro Pro Thr Val Gly Asn Tyr Ile Met Gln Ser
1 5 10
ttc act caa ggt ctg cag ttc ggc gtt gca gtt gcc gtg att ctc ttt 100
Phe Thr Gln Gly Leu Gln Phe Gly Val Ala Val Ala Val Ile Leu Phe
15 20 25
ggt gtc cgc acc att ctt ggt gaa ctg gtc ccc gca ttc caa ggt att 148
Gly Val Arg Thr Ile Leu Gly Glu Leu Val Pro Ala Phe Gln Gly Ile
30 35 40 45
gct gcg aag gtt gtt ccc gga gct atc ccc gca ttg gat gca ccg atc 196
Ala Ala Lys Val Val Pro Gly Ala Ile Pro Ala Leu Asp Ala Pro Ile
50 55 60
gtg ttc ccc tac gcg cag aac gcc gtt ctc att ggt ttc ttg tct tcc 244
Val Phe Pro Tyr Ala Gln Asn Ala Val Leu Ile Gly Phe Leu Ser Ser
65 70 75
ttc gtc ggt ggc ttg gtt ggc ctg act gtt ctt gca tcg tgg ctg aac 292
Phe Val Gly Gly Leu Val Gly Leu Thr Val Leu Ala Ser Trp Leu Asn
80 85 90
cca gct ttt ggt gtc gcg ttg att ctg cct ggt ttg gtc ccc cac ttc 340
Pro Ala Phe Gly Val Ala Leu Ile Leu Pro Gly Leu Val Pro His Phe
95 100 105
ttc act ggt ggc gcg gcg ggc gtt tac ggt aat gcc acg ggt ggt cgt 388
Phe Thr Gly Gly Ala Ala Gly Val Tyr Gly Asn Ala Thr Gly Gly Arg
110 115 120 125
cga gga gca gta ttt ggc gcc ttt gcc aac ggt ctt ctg att acc ttc 436
Arg Gly Ala Val Phe Gly Ala Phe Ala Asn Gly Leu Leu Ile Thr Phe
130 135 140
ctc cct gct ttc ctg ctt ggt gtg ctt ggt tcc ttc ggg tca gag aac 484
Leu Pro Ala Phe Leu Leu Gly Val Leu Gly Ser Phe Gly Ser Glu Asn
145 150 155
acc act ttc ggt gat gcg gac ttt ggt tgg ttc gga atc gtt gtt ggt 532
Thr Thr Phe Gly Asp Ala Asp Phe Gly Trp Phe Gly Ile Val Val Gly
160 165 170
tct gca gcc aag gtg gaa ggt gct ggc ggg ctc atc ttg ttg ctc atc 580
Ser Ala Ala Lys Val Glu Gly Ala Gly Gly Leu Ile Leu Leu Leu Ile
175 180 185
atc gca gcg gtt ctt ctg ggt ggc gcg atg gtc ttc cag aag cgc gtc 628
Ile Ala Ala Val Leu Leu Gly Gly Ala Met Val Phe Gln Lys Arg Val
190 195 200 205
gtg aat ggg cac tgg gat cca gct ccc aac cgt gag cgc gtg gag aag 676
Val Asn Gly His Trp Asp Pro Ala Pro Asn Arg Glu Arg Val Glu Lys
210 215 220
gcg gaa gct gat gcc act cca acg gct ggg gct cgg acc tac cct aag 724
Ala Glu Ala Asp Ala Thr Pro Thr Ala Gly Ala Arg Thr Tyr Pro Lys
225 230 235
att gct cct ccg gcg ggc gct cct acc cca ccg gct cga agc 766
Ile Ala Pro Pro Ala Gly Ala Pro Thr Pro Pro Ala Arg Ser
240 245 250
taagatctcc aaaaccctga gat 789
<210>26
<211>251
<212>PRT
<213>Corynebacterium glutamicum (Corynebacterium glutamicum)
<400>26
Met Ala Pro Pro Thr Val Gly Asn Tyr Ile Met Gln Ser Phe Thr Gln
1 5 10 15
Gly Leu Gln Phe Gly Val Ala Val Ala Val Ile Leu Phe Gly Val Arg
20 25 30
Thr Ile Leu Gly Glu Leu Val Pro Ala Phe Gln Gly Ile Ala Ala Lys
35 40 45
Val Val Pro Gly Ala Ile Pro Ala Leu Asp Ala Pro Ile Val Phe Pro
50 55 60
Tyr Ala Gln Asn Ala Val Leu Ile Gly Phe Leu Ser Ser Phe Val Gly
65 70 75 80
Gly Leu Val Gly Leu Thr Val Leu Ala Ser Trp Leu Asn Pro Ala Phe
85 90 95
Gly Val Ala Leu Ile Leu Pro Gly Leu Val Pro His Phe Phe Thr Gly
100 105 110
Gly Ala Ala Gly Val Tyr Gly Asn Ala Thr Gly Gly Arg Arg Gly Ala
115 120 125
Val Phe Gly Ala Phe Ala Asn Gly Leu Leu Ile Thr Phe Leu Pro Ala
130 135 140
Phe Leu Leu Gly Val Leu Gly Ser Phe Gly Ser Glu Asn Thr Thr Phe
145 150 155 160
Gly Asp Ala Asp Phe Gly Trp Phe Gly Ile Val Val Gly Ser Ala Ala
165 170 175
Lys Val Glu Gly Ala Gly Gly Leu Ile Leu Leu Leu Ile Ile Ala Ala
180 185 190
Val Leu Leu Gly Gly Ala Met Val Phe Gln Lys Arg Val Val Asn Gly
195 200 205
His Trp Asp Pro Ala Pro Asn Arg Glu Arg Val Glu Lys Ala Glu Ala
210 215 220
Asp Ala Thr Pro Thr Ala Gly Ala Arg Thr Tyr Pro Lys Ile Ala Pro
225 230 235 240
Pro Ala Gly Ala Pro Thr Pro Pro Ala Arg Ser
245 250
<210>27
<211>553
<212>DNA
<213>Corynebacterium glutamicum (Corynebacterium glutamicum)
<220>
<221>CDS
<222>(101)..(553)
<223>RXC03001
<400>27
cccggttcac gtgatcaatg acttcacgag caccgatgaa atcgatgctg cgcttcgtga 60
acgctacgac atctaactac tttaaaagga cgaaaatatt atg gac tgg tta acc 115
Met Asp Trp Leu Thr
1 5
att cct ctt ttc ctc gtt aat gaa atc ctt gcg gtt ccg gct ttc ctc 163
Ile Pro Leu Phe Leu Val Asn Glu Ile Leu Ala Val Pro Ala Phe Leu
10 15 20
atc ggt atc atc acc gcc gtg gga ttg ggt gcc atg ggg cgt tcc gtc 211
Ile Gly Ile Ile Thr Ala Val Gly Leu Gly Ala Met Gly Arg Ser Val
25 30 35
ggt cag gtt atc ggt gga gca atc aaa gca acg ttg ggc ttt ttg ctc 259
Gly Gln Val Ile Gly Gly Ala Ile Lys Ala Thr Leu Gly Phe Leu Leu
40 45 50
att ggt gcg ggt gcc acg ttg gtc act gcc tcc ctg gag cca ctg ggt 307
Ile Gly Ala Gly Ala Thr Leu Val Thr Ala Ser Leu Glu Pro Leu Gly
55 60 65
gcg atg atc atg ggt gcc aca ggc atg cgt ggt gtt gtc cca acg aat 355
Ala Met Ile Met Gly Ala Thr Gly Met Arg Gly Val Val Pro Thr Asn
70 75 80 85
gaa gcc atc gcc gga atc gca cag gct gaa tac ggc gcg cag gtg gcg 403
Glu Ala Ile Ala Gly Ile Ala Gln Ala Glu Tyr Gly Ala Gln Val Ala
90 95 100
tgg ctg atg att ctg ggc ttc gcc atc tct ttg gtg ttg gct cgt ttc 451
Trp Leu Met Ile Leu Gly Phe Ala Ile Ser Leu Val Leu Ala Arg Phe
105 110 115
acc aac ctg cgt tat gtc ttg ctc aac gga cac cac gtg ctg ttg atg 499
Thr Asn Leu Arg Tyr Val Leu Leu Asn Gly His His Val Leu Leu Met
120 125 130
tgc acc atg ctc acc atg gtc ttg gcc acc gga aga gtt gat gcg tgg 547
Cys Thr Met Leu Thr Met Val Leu Ala Thr Gly Arg Val Asp Ala Trp
135 140 145
atc ttc 553
Ile Phe
150
<210>28
<211>151
<212>PRT
<213>Corynebacterium glutamicum (Corynebacterium glutamicum)
<400>28
Met Asp Trp Leu Thr Ile Pro Leu Phe Leu Val Asn Glu Ile Leu Ala
1 5 10 15
Val Pro Ala Phe Leu Ile Gly Ile Ile Thr Ala Val Gly Leu Gly Ala
20 25 30
Met Gly Arg Ser Val Gly Gln Val Ile Gly Gly Ala Ile Lys Ala Thr
35 40 45
Leu Gly Phe Leu Leu Ile Gly Ala Gly Ala Thr Leu Val Thr Ala Ser
50 55 60
Leu Glu Pro Leu Gly Ala Met Ile Met Gly Ala Thr Gly Met Arg Gly
65 70 75 80
Val Val Pro Thr Asn Glu Ala Ile Ala Gly Ile Ala Gln Ala Glu Tyr
85 90 95
Gly Ala Gln Val Ala Trp Leu Met Ile Leu Gly Phe Ala Ile Ser Leu
100 105 110
Val Leu Ala Arg Phe Thr Asn Leu Arg Tyr Val Leu Leu Asn Gly His
115 120 125
His Val Leu Leu Met Cys Thr Met Leu Thr Met Val Leu Ala Thr Gly
130 135 140
Arg Val Asp Ala Trp Ile Phe
145 150
<210>29
<211>2172
<212>DNA
<213>Corynebacterium glutamicum (Corynebacterium glutamicum)
<220>
<221>CDS
<222>(101)..(2149)
<223>RXN01943
<400>29
ccgattcttt ttcggcccaa ttcgtaacgg cgatcctctt aagtggacaa gaaagtctct 60
tgcccgcggg agacagaccc tacgtttaga aaggtttgac atg gcg tcc aaa ctg 115
Met Ala Ser Lys Leu
1 5
acg acg aca tcg caa cat att ctg gaa aac ctt ggt gga cca gac aat 163
Thr Thr Thr Ser Gln His Ile Leu Glu Asn Leu Gly Gly Pro Asp Asn
10 15 20
att act tcg atg act cac tgt gcg act cgc ctt cgc ttc caa gtg aag 211
Ile Thr Ser Met Thr His Cys Ala Thr Arg Leu Arg Phe Gln Val Lys
25 30 35
gat caa tcc att gtt gat caa caa gaa att gac tcc gac cca tca gtt 259
Asp Gln Ser Ile Val Asp Gln Gln Glu Ile Asp Ser Asp Pro Ser Val
40 45 50
ctt ggc gta gta ccc caa gga tcc acc ggt atg cag gtg gtg atg ggt 307
Leu Gly Val Val Pro Gln Gly Ser Thr Gly Met Gln Val Val Met Gly
55 60 65
gga tct gtt gca aac tat tac caa gaa atc ctc aaa ctt gat gga atg 355
Gly Ser Val Ala Asn Tyr Tyr Gln Glu Ile Leu Lys Leu Asp Gly Met
70 75 80 85
aag cac ttc gcc gac ggt gaa gct aca gag agt tca tcc aag aag gaa 403
Lys His Phe Ala Asp Gly Glu Ala Thr Glu Ser Ser Ser Lys Lys Glu
90 95 100
tac ggc gga gtc cgt ggc aag tac tcg tgg att gac tac gcc ttc gag 451
Tyr Gly Gly Val Arg Gly Lys Tyr Ser Trp Ile Asp Tyr Ala Phe Glu
105 110 115
ttc ttg tct gat act ttc cga cca atc ctg tgg gcc ctg ctt ggt gcc 499
Phe Leu Ser Asp Thr Phe Arg Pro Ile Leu Trp Ala Leu Leu Gly Ala
120 125 130
tca ctg att att acc ttg ttg gtt ctt gcg gat act ttc ggt ttg caa 547
Ser Leu Ile Ile Thr Leu Leu Val Leu Ala Asp Thr Phe Gly Leu Gln
135 140 145
gac ttc cgc gct cca atg gat gag cag cct gat act tat gta ttc ctg 595
Asp Phe Arg Ala Pro Met Asp Glu Gln Pro Asp Thr Tyr Val Phe Leu
150 155 160 165
cac tcc atg tgg cgc tcg gtc ttc tac ttc ctg cca att atg gtt ggt 643
His Ser Met Trp Arg Ser Val Phe Tyr Phe Leu Pro Ile Met Val Gly
170 175 180
gcc acc gca gct cga aag ctc ggc gca aac gag tgg att ggt gca gct 691
Ala Thr Ala Ala Arg Lys Leu Gly Ala Asn Glu Trp Ile Gly Ala Ala
185 190 195
att cca gcc gca ctt ctt act cca gaa ttc ttg gca ctg ggt tct gcc 739
Ile Pro Ala Ala Leu Leu Thr Pro Glu Phe Leu Ala Leu Gly Ser Ala
200 205 210
ggc gat acc gtc aca gtc ttt ggc ctg cca atg gtt ctg aat gac tac 787
Gly Asp Thr Val Thr Val Phe Gly Leu Pro Met Val Leu Asn Asp Tyr
215 220 225
tcc gga cag gta ttc cca ccg ctg att gca gca att ggt ctg tac tgg 835
Ser Gly Gln Val Phe Pro Pro Leu Ile Ala Ala Ile Gly Leu Tyr Trp
230 235 240 245
gtg gaa aag gga ctg aag aag atc atc cct gaa gca gtc caa atg gtg 883
Val Glu Lys Gly Leu Lys Lys Ile Ile Pro Glu Ala Val Gln Met Val
250 255 260
ttc gtc cca ttc ttc tcc ctg ctg att atg atc cca gcg acc gca ttc 931
Phe Val Pro Phe Phe Ser Leu Leu Ile Met Ile Pro Ala Thr Ala Phe
265 270 275
ctg ctt gga cct ttc ggc atc ggt gtt ggt aac gga att tcc aac ctg 979
Leu Leu Gly Pro Phe Gly Ile Gly Val Gly Asn Gly Ile Ser Asn Leu
280 285 290
ctt gaa gcg att aac aac ttc agc cca ttt att ctt tcc atc gtt atc 1027
Leu Glu Ala Ile Asn Asn Phe Ser Pro Phe Ile Leu Ser Ile Val Ile
295 300 305
cca ttg ctc tac cca ttc ttg gtt cca ctt gga ttg cac tgg cca cta 1075
Pro Leu Leu Tyr Pro Phe Leu Val Pro Leu Gly Leu His Trp Pro Leu
310 315 320 325
aac gcc atc atg atc cag aac atc aac acc ctg ggt tac gac ttc att 1123
Asn Ala Ile Met Ile Gln Asn Ile Asn Thr Leu Gly Tyr Asp Phe Ile
330 335 340
cag gga cca atg ggt gcc tgg aac ttc gcc tgc ttc ggc ctg gtc acc 1171
Gln Gly Pro Met Gly Ala Trp Asn Phe Ala Cys Phe Gly Leu Val Thr
345 350 355
ggc gtg ttc ttg ctc tcc att aag gaa cga aac aag gcc atg cgt cag 1219
Gly Val Phe Leu Leu Ser Ile Lys Glu Arg Asn Lys Ala Met Arg Gln
360 365 370
gtt tcc ctg ggt ggc atg ttg gct ggt ttg ctc ggc ggc att tcc gag 1267
Val Ser Leu Gly Gly Met Leu Ala Gly Leu Leu Gly Gly Ile Ser Glu
375 380 385
cct tcc ctc tac ggt gtt ctg ctc cga ttc aag aag acc tac ttc cgc 1315
Pro Ser Leu Tyr Gly Val Leu Leu Arg Phe Lys Lys Thr Tyr Phe Arg
390 395 400 405
ctc ctg ccg ggt tgt ttg gca ggc ggt atc gtg atg ggc atc ttc gac 1363
Leu Leu Pro Gly Cys Leu Ala Gly Gly Ile Val Met Gly Ile Phe Asp
410 415 420
atc aag gcg tac gct ttc gtg ttc acc tcc ttg ctt acc atc cca gca 1411
Ile Lys Ala Tyr Ala Phe Val Phe Thr Ser Leu Leu Thr Ile Pro Ala
425 430 435
atg gac cca tgg ttg ggc tac acc att ggt atc gca gtt gca ttc ttc 1459
Met Asp Pro Trp Leu Gly Tyr Thr Ile Gly Ile Ala Val Ala Phe Phe
440 445 450
gtt tcc atg ttc ctt gtt ctc gca ctg gac tac cgt tcc aac gaa gag 1507
Val Ser Met Phe Leu Val Leu Ala Leu Asp Tyr Arg Ser Asn Glu Glu
455 460 465
cgc gat gag gca cgt gca aag gtt gct gct gac aag cag gca gaa gaa 1555
Arg Asp Glu Ala Arg Ala Lys Val Ala Ala Asp Lys Gln Ala Glu Glu
470 475 480 485
gat ctg aag gca gaa gct aat gca act cct gca gct cca gta gct gct 1603
Asp Leu Lys Ala Glu Ala Asn Ala Thr Pro Ala Ala Pro Val Ala Ala
490 495 500
gca ggt gcg gga gcc ggt gca ggt gca gga gcc gct gct ggc gct gca 1651
Ala Gly Ala Gly Ala Gly Ala Gly Ala Gly Ala Ala Ala Gly Ala Ala
505 510 515
acc gcc gtg gca gct aag ccg aag ctg gcc gct ggg gaa gta gtg gac 1699
Thr Ala Val Ala Ala Lys Pro Lys Leu Ala Ala Gly Glu Val Val Asp
520 525 530
att gtt tcc cca ctc gaa ggc aag gca att cca ctt tct gaa gta cct 1747
Ile Val Ser Pro Leu Glu Gly Lys Ala Ile Pro Leu Ser Glu Val Pro
535 540 545
gac cca atc ttt gca gca ggc aag ctt gga cca ggc att gca atc caa 1795
Asp Pro Ile Phe Ala Ala Gly Lys Leu Gly Pro Gly Ile Ala Ile Gln
550 555 560 565
cca act gga aac acc gtt gtt gct cca gca gac gct act gtc atc ctt 1843
Pro Thr Gly Asn Thr Val Val Ala Pro Ala Asp Ala Thr Val Ile Leu
570 575 580
gtc cag aaa tct gga cac gca gtg gca ttg cgc tta gat agc gga gtt 1891
Val Gln Lys Ser Gly His Ala Val Ala Leu Arg Leu Asp Ser Gly Val
585 590 595
gaa atc ctt gtc cac gtt gga ttg gac acc gtg caa ttg ggc ggc gaa 1939
Glu Ile Leu Val His Val Gly Leu Asp Thr Val Gln Leu Gly Gly Glu
600 605 610
ggc ttc acc gtt cac gtt gag cgc agg cag caa gtc aag gcg ggg gat 1987
Gly Phe Thr Val His Val Glu Arg Arg Gln Gln Val Lys Ala Gly Asp
615 620 625
cca ctg atc act ttt gac gct gac ttc att cga tcc aag gat cta cct 2035
Pro Leu Ile Thr Phe Asp Ala Asp Phe Ile Arg Ser Lys Asp Leu Pro
630 635 640 645
ttg atc acc cca gtt gtg gtg tct aac gcc gcg aaa ttc ggt gaa att 2083
Leu Ile Thr Pro Val Val Val Ser Asn Ala Ala Lys Phe Gly Glu Ile
650 655 660
gaa ggt att cct gca gat cag gca aat tct tcc acg act gtg atc aag 2131
Glu Gly Ile Pro Ala Asp Gln Ala Asn Ser Ser Thr Thr Val Ile Lys
665 670 675
gtc aac ggc aag aac gag taacctggga tccatgttgc gca 2172
Val Asn Gly Lys Asn Glu
680
<210>30
<211>683
<212>PRT
<213>Corynebacterium glutamicum (Corynebacterium glutamicum)
<400>30
Met Ala Ser Lys Leu Thr Thr Thr Ser Gln His Ile Leu Glu Asn Leu
1 5 10 15
Gly Gly Pro Asp Asn Ile Thr Ser Met Thr His Cys Ala Thr Arg Leu
20 25 30
Arg Phe Gln Val Lys Asp Gln Ser Ile Val Asp Gln Gln Glu Ile Asp
35 40 45
Ser Asp Pro Ser Val Leu Gly Val Val Pro Gln Gly Ser Thr Gly Met
50 55 60
Gln Val Val Met Gly Gly Ser Val Ala Asn Tyr Tyr Gln Glu Ile Leu
65 70 75 80
Lys Leu Asp Gly Met Lys His Phe Ala Asp Gly Glu Ala Thr Glu Ser
85 90 95
Ser Ser Lys Lys Glu Tyr Gly Gly Val Arg Gly Lys Tyr Ser Trp Ile
100 105 110
Asp Tyr Ala Phe Glu Phe Leu Ser Asp Thr Phe Arg Pro Ile Leu Trp
115 120 125
Ala Leu Leu Gly Ala Ser Leu Ile Ile Thr Leu Leu Val Leu Ala Asp
130 135 140
Thr Phe Gly Leu Gln Asp Phe Arg Ala Pro Met Asp Glu Gln Pro Asp
145 150 155 160
Thr Tyr Val Phe Leu His Ser Met Trp Arg Ser Val Phe Tyr Phe Leu
165 170 175
Pro Ile Met Val Gly Ala Thr Ala Ala Arg Lys Leu Gly Ala Asn Glu
180 185 190
Trp Ile Gly Ala Ala Ile Pro Ala Ala Leu Leu Thr Pro Glu Phe Leu
195 200 205
Ala Leu Gly Ser Ala Gly Asp Thr Val Thr Val Phe Gly Leu Pro Met
210 215 220
Val Leu Asn Asp Tyr Ser Gly Gln Val Phe Pro Pro Leu Ile Ala Ala
225 230 235 240
Ile Gly Leu Tyr Trp Val Glu Lys Gly Leu Lys Lys Ile Ile Pro Glu
245 250 255
Ala Val Gln Met Val Phe Val Pro Phe Phe Ser Leu Leu Ile Met Ile
260 265 270
Pro Ala Thr Ala Phe Leu Leu Gly Pro Phe Gly Ile Gly Val Gly Asn
275 280 285
Gly Ile Ser Asn Leu Leu Glu Ala Ile Asn Asn Phe Ser Pro Phe Ile
290 295 300
Leu Ser Ile Val Ile Pro Leu Leu Tyr Pro Phe Leu Val Pro Leu Gly
305 310 315 320
Leu His Trp Pro Leu Asn Ala Ile Met Ile Gln Asn Ile Asn Thr Leu
325 330 335
Gly Tyr Asp Phe Ile Gln Gly Pro Met Gly Ala Trp Asn Phe Ala Cys
340 345 350
Phe Gly Leu Val Thr Gly Val Phe Leu Leu Ser Ile Lys Glu Arg Asn
355 360 365
Lys Ala Met Arg Gln Val Ser Leu Gly Gly Met Leu Ala Gly Leu Leu
370 375 380
Gly Gly Ile Ser Glu Pro Ser Leu Tyr Gly Val Leu Leu Arg Phe Lys
385 390 395 400
Lys Thr Tyr Phe Arg Leu Leu Pro Gly Cys Leu Ala Gly Gly Ile Val
405 410 415
Met Gly Ile Phe Asp Ile Lys Ala Tyr Ala Phe Val Phe Thr Ser Leu
420 425 430
Leu Thr Ile Pro Ala Met Asp Pro Trp Leu Gly Tyr Thr Ile Gly Ile
435 440 445
Ala Val Ala Phe Phe Val Ser Met Phe Leu Val Leu Ala Leu Asp Tyr
450 455 460
Arg Ser Asn Glu Glu Arg Asp Glu Ala Arg Ala Lys Val Ala Ala Asp
465 470 475 480
Lys Gln Ala Glu Glu Asp Leu Lys Ala Glu Ala Asn Ala Thr Pro Ala
485 490 495
Ala Pro Val Ala Ala Ala Gly Ala Gly Ala Gly Ala Gly Ala Gly Ala
500 505 510
Ala Ala Gly Ala Ala Thr Ala Val Ala Ala Lys Pro Lys Leu Ala Ala
515 520 525
Gly Glu Val Val Asp Ile Val Ser Pro Leu Glu Gly Lys Ala Ile Pro
530 535 540
Leu Ser Glu Val Pro Asp Pro Ile Phe Ala Ala Gly Lys Leu Gly Pro
545 550 555 560
Gly Ile Ala Ile Gln Pro Thr Gly Asn Thr Val Val Ala Pro Ala Asp
565 570 575
Ala Thr Val Ile Leu Val Gln Lys Ser Gly His Ala Val Ala Leu Arg
580 585 590
Leu Asp Ser Gly Val Glu Ile Leu Val His Val Gly Leu Asp Thr Val
595 600 605
Gln Leu Gly Gly Glu Gly Phe Thr Val His Val Glu Arg Arg Gln Gln
610 615 620
Val Lys Ala Gly Asp Pro Leu Ile Thr Phe Asp Ala Asp Phe Ile Arg
625 630 635 640
Ser Lys Asp Leu Pro Leu Ile Thr Pro Val Val Val Ser Asn Ala Ala
645 650 655
Lys Phe Gly Glu Ile Glu Gly Ile Pro Ala Asp Gln Ala Asn Ser Ser
660 665 670
Thr Thr Val Ile Lys Val Asn Gly Lys Asn Glu
675 680
<210>31
<211>1339
<212>DNA
<213>Corynebacterium glutamicum (Corynebacterium glutamicum)
<220>
<221>CDS
<222>(101)..(1339)
<223>FRXA02191
<400>31
ccgattcttt ttcggcccaa ttcgtaacgg cgatcctctt aagtggacaa gaaagtctct 60
tgcccgcggg agacagaccc tacgtttaga aaggtttgac atg gcg tcc aaa ctg 115
Met Ala Ser Lys Leu
1 5
acg acg aca tcg caa cat att ctg gaa aac ctt ggt gga cca gac aat 163
Thr Thr Thr Ser Gln His Ile Leu Glu Asn Leu Gly Gly Pro Asp Asn
10 15 20
att act tcg atg act cac tgt gcg act cgc ctt cgc ttc caa gtg aag 211
Ile Thr Ser Met Thr His Cys Ala Thr Arg Leu Arg Phe Gln Val Lys
25 30 35
gat caa tcc att gtt gat caa caa gaa att gac tcc gac cca tca gtt 259
Asp Gln Ser Ile Val Asp Gln Gln Glu Ile Asp Ser Asp Pro Ser Val
40 45 50
ctt ggc gta gta ccc caa gga tcc acc ggt atg cag gtg gtg atg ggt 307
Leu Gly Val Val Pro Gln Gly Ser Thr Gly Met Gln Val Val Met Gly
55 60 65
gga tct gtt gca aac tat tac caa gaa atc ctc aaa ctt gat gga atg 355
Gly Ser Val Ala Asn Tyr Tyr Gln Glu Ile Leu Lys Leu Asp Gly Met
70 75 80 85
aag cac ttc gcc gac ggt gaa gct aca gag agt tca tcc aag aag gaa 403
Lys His Phe Ala Asp Gly Glu Ala Thr Glu Ser Ser Ser Lys Lys Glu
90 95 100
tac ggc gga gtc cgt ggc aag tac tcg tgg att gac tac gcc ttc gag 451
Tyr Gly Gly Val Arg Gly Lys Tyr Ser Trp Ile Asp Tyr Ala Phe Glu
105 110 115
ttc ttg tct gat act ttc cga cca atc ctg tgg gcc ctg ctt ggt gcc 499
Phe Leu Ser Asp Thr Phe Arg Pro Ile Leu Trp Ala Leu Leu Gly Ala
120 125 130
tca ctg att att acc ttg ttg gtt ctt gcg gat act ttc ggt ttg caa 547
Ser Leu Ile Ile Thr Leu Leu Val Leu Ala Asp Thr Phe Gly Leu Gln
135 140 145
gac ttc cgc gct cca atg gat gag cag cct gat act tat gta ttc ctg 595
Asp Phe Arg Ala Pro Met Asp Glu Gln Pro Asp Thr Tyr Val Phe Leu
150 155 160 165
cac tcc atg tgg cgc tcg gtc ttc tac ttc ctg cca att atg gtt ggt 643
His Ser Met Trp Arg Ser Val Phe Tyr Phe Leu Pro Ile Met Val Gly
170 175 180
gcc acc gca gct cga aag ctc ggc gca aac gag tgg att ggt gca gct 691
Ala Thr Ala Ala Arg Lys Leu Gly Ala Asn Glu Trp Ile Gly Ala Ala
185 190 195
att cca gcc gca ctt ctt act cca gaa ttc ttg gca ctg ggt tct gcc 739
Ile Pro Ala Ala Leu Leu Thr Pro Glu Phe Leu Ala Leu Gly Ser Ala
200 205 210
ggc gat acc gtc aca gtc ttt ggc ctg cca atg gtt ctg aat gac tac 787
Gly Asp Thr Val Thr Val Phe Gly Leu Pro Met Val Leu Asn Asp Tyr
215 220 225
tcc gga cag gta ttc cca ccg ctg att gca gca att ggt ctg tac tgg 835
Ser Gly Gln Val Phe Pro Pro Leu Ile Ala Ala Ile Gly Leu Tyr Trp
230 235 240 245
gtg gaa aag gga ctg aag aag atc atc cct gaa gca gtc caa atg gtg 883
Val Glu Lys Gly Leu Lys Lys Ile Ile Pro Glu Ala Val Gln Met Val
250 255 260
ttc gtc cca ttc ttc tcc ctg ctg att atg atc cca gcg acc gca ttc 931
Phe Val Pro Phe Phe Ser Leu Leu Ile Met Ile Pro Ala Thr Ala Phe
265 270 275
ctg ctt gga cct ttc ggc atc ggt gtt ggt aac gga att tcc aac ctg 979
Leu Leu Gly Pro Phe Gly Ile Gly Val Gly Asn Gly Ile Ser Asn Leu
280 285 290
ctt gaa gcg att aac aac ttc agc cca ttt att ctt tcc atc gtt atc 1027
Leu Glu Ala Ile Asn Asn Phe Ser Pro Phe Ile Leu Ser Ile Val Ile
295 300 305
cca ttg ctc tac cca ttc ttg gtt cca ctt gga ttg cac tgg cca cta 1075
Pro Leu Leu Tyr Pro Phe Leu Val Pro Leu Gly Leu His Trp Pro Leu
310 315 320 325
aac gcc atc atg atc cag aac atc aac acc ctg ggt tac gac ttc att 1123
Asn Ala Ile Met Ile Gln Asn Ile Asn Thr Leu Gly Tyr Asp Phe Ile
330 335 340
cag gga cca atg ggt gcc tgg aac ttc gcc tgc ttc ggc ctg gtc acc 1171
Gln Gly Pro Met Gly Ala Trp Asn Phe Ala Cys Phe Gly Leu Val Thr
345 350 355
ggc gtg ttc ttg ctc tcc att aag gaa cga aac aag gcc atg cgt cag 1219
Gly Val Phe Leu Leu Ser Ile Lys Glu Arg Asn Lys Ala Met Arg Gln
360 365 370
gtt tcc ctg ggt ggc atg ttg gct ggt ttg ctc ggc ggc att tcc gag 1267
Val Ser Leu Gly Gly Met Leu Ala Gly Leu Leu Gly Gly Ile Ser Glu
375 380 385
cct tcc ctc tac ggt gtt ctg ctc cga ttc aag aag acc tac ttc cgc 1315
Pro Ser Leu Tyr Gly Val Leu Leu Arg Phe Lys Lys Thr Tyr Phe Arg
390 395 400 405
ctc ctg ccg ggt tgt ttg gca gca 1339
Leu Leu Pro Gly Cys Leu Ala Ala
410
<210>32
<211>413
<212>PRT
<213>Corynebacterium glutamicum (Corynebacterium glutamicum)
<400>32
Met Ala Ser Lys Leu Thr Thr Thr Ser Gln His Ile Leu Glu Asn Leu
1 5 10 15
Gly Gly Pro Asp Asn Ile Thr Ser Met Thr His Cys Ala Thr Arg Leu
20 25 30
Arg Phe Gln Val Lys Asp Gln Ser Ile Val Asp Gln Gln Glu Ile Asp
35 40 45
Ser Asp Pro Ser Val Leu Gly Val Val Pro Gln Gly Ser Thr Gly Met
50 55 60
Gln Val Val Met Gly Gly Ser Val Ala Asn Tyr Tyr Gln Glu Ile Leu
65 70 75 80
Lys Leu Asp Gly Met Lys His Phe Ala Asp Gly Glu Ala Thr Glu Ser
85 90 95
Ser Ser Lys Lys Glu Tyr Gly Gly Val Arg Gly Lys Tyr Ser Trp Ile
100 105 110
Asp Tyr Ala Phe Glu Phe Leu Ser Asp Thr Phe Arg Pro Ile Leu Trp
115 120 125
Ala Leu Leu Gly Ala Ser Leu Ile Ile Thr Leu Leu Val Leu Ala Asp
130 135 140
Thr Phe Gly Leu Gln Asp Phe Arg Ala Pro Met Asp Glu Gln Pro Asp
145 150 155 160
Thr Tyr Val Phe Leu His Ser Met Trp Arg Ser Val Phe Tyr Phe Leu
165 170 175
Pro Ile Met Val Gly Ala Thr Ala Ala Arg Lys Leu Gly Ala Asn Glu
180 185 190
Trp Ile Gly Ala Ala Ile Pro Ala Ala Leu Leu Thr Pro Glu Phe Leu
195 200 205
Ala Leu Gly Ser Ala Gly Asp Thr Val Thr Val Phe Gly Leu Pro Met
210 215 220
Val Leu Asn Asp Tyr Ser Gly Gln Val Phe Pro Pro Leu Ile Ala Ala
225 230 235 240
Ile Gly Leu Tyr Trp Val Glu Lys Gly Leu Lys Lys Ile Ile Pro Glu
245 250 255
Ala Val Gln Met Val Phe Val Pro Phe Phe Ser Leu Leu Ile Met Ile
260 265 270
Pro Ala Thr Ala Phe Leu Leu Gly Pro Phe Gly Ile Gly Val Gly Asn
275 280 285
Gly Ile Ser Asn Leu Leu Glu Ala Ile Asn Asn Phe Ser Pro Phe Ile
290 295 300
Leu Ser Ile Val Ile Pro Leu Leu Tyr Pro Phe Leu Val Pro Leu Gly
305 310 315 320
Leu His Trp Pro Leu Asn Ala Ile Met Ile Gln Asn Ile Asn Thr Leu
325 330 335
Gly Tyr Asp Phe Ile Gln Gly Pro Met Gly Ala Trp Asn Phe Ala Cys
340 345 350
Phe Gly Leu Val Thr Gly Val Phe Leu Leu Ser Ile Lys Glu Arg Asn
355 360 365
Lys Ala Met Arg Gln Val Ser Leu Gly Gly Met Leu Ala Gly Leu Leu
370 375 380
Gly Gly Ile Ser Glu Pro Ser Leu Tyr Gly Val Leu Leu Arg Phe Lys
385 390 395 400
Lys Thr Tyr Phe Arg Leu Leu Pro Gly Cys Leu Ala Ala
405 410
<210>33
<211>428
<212>DNA
<213>Corynebacterium glutamicum (Corynebacterium glutamicum)
<220>
<221>CDS
<222>(1)..(405)
<223>FRXA01943
<400>33
cct gac cca atc ttt gca gca ggc aag ctt gga cca ggc att gca atc 48
Pro Asp Pro Ile Phe Ala Ala Gly Lys Leu Gly Pro Gly Ile Ala Ile
1 5 10 15
caa cca act gga aac acc gtt gtt gct cca gca gac gct act gtc atc 96
Gln Pro Thr Gly Asn Thr Val Val Ala Pro Ala Asp Ala Thr Val Ile
20 25 30
ctt gtc cag aaa tct gga cac gca gtg gca ttg cgc tta gat agc gga 144
Leu Val Gln Lys Ser Gly His Ala Val Ala Leu Arg Leu Asp Ser Gly
35 40 45
gtt gaa atc ctt gtc cac gtt gga ttg gac acc gtg caa ttg ggc ggc 192
Val Glu Ile Leu Val His Val Gly Leu Asp Thr Val Gln Leu Gly Gly
50 55 60
gaa ggc ttc acc gtt cac gtt gag cgc agg cag caa gtc aag gcg ggg 240
Glu Gly Phe Thr Val His Val Glu Arg Arg Gln Gln Val Lys Ala Gly
65 70 75 80
gat cca ctg atc act ttt gac gct gac ttc att cga tcc aag gat cta 288
Asp Pro Leu Ile Thr Phe Asp Ala Asp Phe Ile Arg Ser Lys Asp Leu
85 90 95
cct ttg atc acc cca gtt gtg gtg tct aac gcc gcg aaa ttc ggt gaa 336
Pro Leu Ile Thr Pro Val Val Val Ser Asn Ala Ala Lys Phe Gly Glu
100 105 110
att gaa ggt att cct gca gat cag gca aat tct tcc acg act gtg atc 384
Ile Glu Gly Ile Pro Ala Asp Gln Ala Asn Ser Ser Thr Thr Val Ile
115 120 125
aag gtc aac ggc aag aac gag taacctggga tccatgttgc gca 428
Lys Val Asn Gly Lys Asa Glu
130 135
<210>34
<211>135
<212>PRT
<213>Corynebacterium glutamicum (Corynebacterium glutamicum)
<400>34
Pro Asp Pro Ile Phe Ala Ala Gly Lys Leu Gly Pro Gly Ile Ala Ile
1 5 10 15
Gln Pro Thr Gly Asn Thr Val Val Ala Pro Ala Asp Ala Thr Val Ile
20 25 30
Leu Val Gln Lys Ser Gly His Ala Val Ala Leu Arg Leu Asp Ser Gly
35 40 45
Val Glu Ile Leu Val His Val Gly Leu Asp Thr Val Gln Leu Gly Gly
50 55 60
Glu Gly Phe Thr Val His Val Glu Arg Arg Gln Gln Val Lys Ala Gly
65 70 75 80
Asp Pro Leu Ile Thr Phe Asp Ala Asp Phe Ile Arg Ser Lys Asp Leu
85 90 95
Pro Leu Ile Thr Pro Val Val Val Ser Asn Ala Ala Lys Phe Gly Glu
100 105 110
Ile Glu Gly Ile Pro Ala Asp Gln Ala Asn Ser Ser Thr Thr Val Ile
115 120 125
Lys Val Asn Gly Lys Asn Glu
130 135
<210>35
<211>18
<212>DNA
<213>artificial sequence
<220>
<223>artificial sequence note: primer
<400>35
ggaaacagta tgaccatg 18
<210>36
<211>17
<212>DNA
<213>artificial sequence
<220>
<223>artificial sequence note: primer
<400>36
gtaaaacgac ggccagt 17
Claims (35)
1. the isolated nucleic acid molecules or its complementary series of the nucleotide sequence comprising SEQ ID NO:21.
2. the isolated nucleic acid molecules or its complementary series of the polypeptide of amino acid sequence of the coding comprising SEQ ID NO:22.
3. the isolated nucleic acid molecules or its complementary series of the naturally occurring allelic variant of the polypeptide of amino acid sequence of the coding comprising SEQ ID NO:22.
4. isolated nucleic acid molecules, comprising having at least nucleotide sequence of 50% identity or its complementary series with the whole nucleotide sequence of SEQ ID NO:21.
5. isolated nucleic acid molecules, it includes the segments or its complementary series of at least 15 continuous nucleotides of the nucleotide sequence of SEQ ID NO:21.
6. isolated nucleic acid molecules, coding has at least polypeptide of the amino acid sequence of 50% identity or its complementary series comprising the complete amino acid sequence with SEQ ID NO:22.
7. isolated nucleic acid molecules, the nucleotide sequence of the nucleic acid molecules comprising any one of claim 1-6 and encoding heterologous polypeptide.
8. the carrier of the nucleic acid molecules comprising any one of claim 1-7.
9. the carrier of claim 8, which is expression vector.
10. the host cell that the expression vector of claim 9 transfects.
11. the host cell of claim 10, wherein the cell is microorganism.
12. the host cell of claim 11, wherein the cell belongs to Corynebacterium or brevibacterium.
13. the host cell of claim 10, wherein the expression of described nucleic acid molecules, the adjusting for causing the cell fine chemical to produce.
14. the host cell of claim 14, wherein described fine chemical is selected from following substance: organic acid, proteinogenic amino acids, nonprotein source amino acid, purine bases and pyrimidine bases, nucleosides, nucleotide, lipid, saturation and unsaturated fatty acid, glycol, carbohydrate, aromatic compound, vitamin, co-factor, polyketide and enzyme.
15. the method for producing polypeptide, including cultivating the host cell of claim 10 in suitable culture medium, to produce polypeptide.
16. isolated polypeptide, the amino acid sequence comprising SEQ ID NO:22.
17. isolated polypeptide, the naturally occurring allelic variant of the polypeptide comprising the amino acid sequence containing SEQ ID NO:22.
18. isolated polypeptide, by a kind of nucleic acid molecule encoding, which includes the nucleotide sequence for having at least 50% identity with the whole nucleotide sequence of SEQ ID NO:21.
19. isolated polypeptide, comprising there is the amino acid sequence of at least 50% identity with the complete amino acid sequence of SEQ ID NO:22.
20. isolated polypeptide, the segment of the polypeptide comprising the amino acid sequence containing SEQ ID NO:22, wherein the polypeptide fragment keeps the biological activity of the polypeptide of the amino acid sequence containing SEQ ID NO:22.
21. isolated polypeptide, the amino acid sequence comprising the nucleic acid molecule encoding by the nucleotide sequence comprising SEQ ID NO:21.
22. the isolated polypeptide of any one of claim 16-21, further includes heterologous amino acid sequence.
23. the method for producing fine chemical, the cell including cultivating claim 10, to generate fine chemical.
24. the method for claim 23, wherein described method also comprises the step of recycling fine chemical from described culture.
25. the method for claim 23, wherein described cell belongs to Corynebacterium or brevibacterium.
26. the method for claim 23, wherein described cell is selected from the group: Corynebacterium glutamicum, Corynebacterium herculis, lily bar bacterium, Corynebacterium acctoacidophlum, vinegar paddy bar bacterium, thermophilic acetyl bar bacterium, corynebacterium ammoniagenes, Corynebacterium fujiokense, Corynebacteriumnitrilophilus, brevibacterium ammoniagene, Brevibacterium butanicum, disagreement brevibacterium, brevibacterium flavum, Xi Shi brevibacterium, ketoglutaric acid brevibacterium, Brevibacteriumketosoreductum, brevibacterium, extension brevibacterium, solve bacterial strain listed by paraffin brevibacterium and table 3.
27. the method for claim 23, wherein the expression of the nucleic acid molecules of described carrier, the adjusting for causing the cell fine chemical to produce.
28. the method for claim 23, wherein described fine chemical is selected from following substance: organic acid, proteinogenic amino acids, nonprotein source amino acid, purine bases and pyrimidine bases, nucleosides, nucleotide, lipid, saturation and unsaturated fatty acid, glycol, carbohydrate, aromatic compound, vitamin, co-factor, polyketide and enzyme.
29. the method for claim 23, wherein described fine chemical is amino acid.
30. the method for claim 29, wherein described amino acid is selected from following amino acid: lysine, glutamic acid, glutamine, alanine, aspartic acid, glycine, serine, threonine, methionine, cysteine, valine, leucine, isoleucine, arginine, proline, histidine, tyrosine, phenylalanine, tryptophan.
31. the method for producing fine chemical, including such cell is cultivated, the genomic DNA of the cell has been inserted into the nucleic acid molecules of any one of claim 1-6 and has changed.
32. diagnosing the presence or active method of corynebacterium diphtheriae in subject, the presence of the peptide molecule of at least one nucleic acid molecules or claim 16-21 including claim 1-6 in detection subject, to diagnose the presence or activity of corynebacterium diphtheriae in subject.
33. the host cell of the nucleic acid molecules containing SEQ ID NO:21, wherein the nucleic acid molecules are destroyed.
34. the host cell of the nucleic acid molecules containing SEQ ID NO:21, nucleic acid molecules therein, which contain one or more, modifies the nucleic acid for listing sequence in SEQ ID NO:21.
35. the host cell of the nucleic acid molecules containing SEQ ID NO:21, wherein the nucleic acid molecules adjustment region is modified relative to the molecule wild type adjustment region.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14269199P | 1999-07-01 | 1999-07-01 | |
US60/142691 | 1999-07-01 | ||
US60/150310 | 1999-08-23 | ||
DE19942095.5 | 1999-09-03 | ||
DE19942097.1 | 1999-09-03 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN00812165A Division CN1371420A (en) | 1999-07-01 | 2000-06-27 | Orynebacterium glutamicum genes encoding phosphoenolpyruvate sugar phosphotransferase system proteins |
Publications (1)
Publication Number | Publication Date |
---|---|
CN101054593A true CN101054593A (en) | 2007-10-17 |
Family
ID=34078497
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNA2007100920738A Pending CN101130778A (en) | 1999-07-01 | 2000-06-27 | Corynebacterium glutamicum gene encoding hpr of phosphoenolpyruvate:sugar phosphotransferase system |
CNA2007100920742A Pending CN101054593A (en) | 1999-07-01 | 2000-06-27 | Corynebacterium glutamicum gene encoding hpr of phosphoenolpyruvate:sugar phosphotransferase system |
CNA2007100920723A Pending CN101054592A (en) | 1999-07-01 | 2000-06-27 | Corynebacterium glutamicum gene encoding hpr of phosphoenolpyruvate:sugar phosphotransferase system |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNA2007100920738A Pending CN101130778A (en) | 1999-07-01 | 2000-06-27 | Corynebacterium glutamicum gene encoding hpr of phosphoenolpyruvate:sugar phosphotransferase system |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNA2007100920723A Pending CN101054592A (en) | 1999-07-01 | 2000-06-27 | Corynebacterium glutamicum gene encoding hpr of phosphoenolpyruvate:sugar phosphotransferase system |
Country Status (2)
Country | Link |
---|---|
CN (3) | CN101130778A (en) |
ZA (1) | ZA200200816B (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113015807A (en) * | 2018-08-31 | 2021-06-22 | 新加坡科技研究局 | Method for producing terpenoid |
CN115746110A (en) * | 2021-09-02 | 2023-03-07 | 中国科学院天津工业生物技术研究所 | Mutant of transcriptional regulatory factor LysG and application thereof |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3456833A1 (en) * | 2017-09-18 | 2019-03-20 | Evonik Degussa GmbH | Method for the fermentative production of l-amino acids |
CN109652490B (en) * | 2019-02-25 | 2019-09-03 | 内蒙古拜克生物有限公司 | A kind of fermentation of L-Leu and isolation and purification method |
CN113249286B (en) * | 2021-05-25 | 2023-12-08 | 洛阳华荣生物技术有限公司 | Method for constructing L-sarcosine producing strain |
-
2000
- 2000-06-27 CN CNA2007100920738A patent/CN101130778A/en active Pending
- 2000-06-27 CN CNA2007100920742A patent/CN101054593A/en active Pending
- 2000-06-27 CN CNA2007100920723A patent/CN101054592A/en active Pending
-
2002
- 2002-01-30 ZA ZA200200816A patent/ZA200200816B/en unknown
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113015807A (en) * | 2018-08-31 | 2021-06-22 | 新加坡科技研究局 | Method for producing terpenoid |
CN115746110A (en) * | 2021-09-02 | 2023-03-07 | 中国科学院天津工业生物技术研究所 | Mutant of transcriptional regulatory factor LysG and application thereof |
Also Published As
Publication number | Publication date |
---|---|
ZA200200816B (en) | 2004-10-27 |
CN101054592A (en) | 2007-10-17 |
CN101130778A (en) | 2008-02-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101078016A (en) | Corynebacterium glutamicum genes encoding stress, resistance and tolerance proteins | |
SK18862001A3 (en) | Corynebacterium glutamicum genes encoding metabolic pathway proteins | |
EP2292763A1 (en) | Corynebacterium glutamicum genes encoding proteins involved in carbon metabolism and energy production | |
US20050153402A1 (en) | Corynebacterium glutamicum genes encoding regulatory proteins | |
US7410766B2 (en) | Corynebacterium glutamicum genes encoding phosphoenolpyruvate: sugar phosphotransferase system proteins | |
AU2001223903B2 (en) | Corynebacterium glutamicum genes encoding metabolic pathway proteins | |
SK18882001A3 (en) | Corynebacterium glutamicum genes encoding stress, resistance and tolerance proteins | |
SK18912001A3 (en) | Corynebacterium glutamicum genes encoding proteins involved in membrane synthesis and membrane transport | |
CN1680559A (en) | Corynebacterium glutamicum genes encoding phosphoenolpyruvate: sugar phosphotransferase system proteins | |
SK18902001A3 (en) | Corynebacterium glutamicum genes encoding proteins involved in homeostasis and adaptation | |
US20060269975A1 (en) | Corynebacterium glutamicum genes encoding proteins involved in DNA replication, protein synthesis, and pathogenesis | |
CN101054593A (en) | Corynebacterium glutamicum gene encoding hpr of phosphoenolpyruvate:sugar phosphotransferase system | |
CN1451047A (en) | Corynebacterium glutamicum genes encoding stress resistance and tolerance proteins | |
AU2007202317A1 (en) | Corynebacterium glutamicum genes encoding phosphoenolpyruvate: sugar phosphotransferase system proteins | |
CA2590625A1 (en) | Corynebacterium glutamicum genes encoding phosphoenolpyruvate: sugar phospho-transferase system proteins | |
EP1702980A1 (en) | Corynebacterium glutamicum gene encoding Hpr of phosphoenolpyruvate:sugar phosphotransferase system | |
AU2006200800A1 (en) | Corynebacterium Glutamicum genes encoding phosphoenolpyruvate: sugar phosphotransferase system proteins | |
AU2007202378A1 (en) | Coryneracterium glutamicum genes encoding metabolic pathway proteins | |
AU2007202397A1 (en) | corynebacterium glutamicum genes encoding stress, resistance and tolerance proteins |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Open date: 20071017 |